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Primary aliphatic amines which are ubiquitous in natural products, traditionally 
considered as inert to substitution reactions. Recent studies clearly demonstrated that the 
aliphatic deaminative coupling chemistry can be used to make valuable scaffolds through 
C–N bond activation on transition metal complexes. The catalytic system generated in 
situ from the tetranuclear Ru–H complex with a catechol ligand (2-9/2-16) and 
independently synthesized ruthenium catecholate complex 2-11 was found to be effective 
for the direct deaminative coupling of primary amines. The catalytic system formed in-
situ from the reaction of cationic Ru–H complex 2-10 with 3,4,5,6-tetrachloro-1,2-
benzoquinone 2-12 was found to mediate a regioselective deaminative coupling reaction 
of ketones with amines to form the -alkylated ketone products. The monitoring of the 
coupling reaction of acetophenone and 4-methoxybenzylamine showed a rapid formation 
of PhC(Me)=NCH2C6H4-4-OMe, which was slowly converted to the alkylation product. 
The Hammett plot obtained from the reaction of para-substituted imines showed a strong 
promotional effect by the amine substrates with electron-releasing group (ρ = -0.96 ± 
0.1), while the analogous plot obtained from the reaction of para-substituted imines with 
benzylamine showed a moderate promotional effect from the ketone substrates with 
electron-withdrawing group (ρ = +0.24 ± 0.1). The most significant carbon isotope effect 
was observed on the -carbon of the alkylation product (C = 1.020). The empirical rate 
law was determined as rate = kobs[imine][Ru] from measuring the kinetics of the 
alkylation reaction of the isolated imine substrate. A catalytically active Ru-catecholate 
complex was synthesized and the DFT study revealed a stepwise mechanism of the [1,3]-
carbon migration step via the formation of a Ru(IV)-alkyl species. A plausible 
mechanism of the catalytic alkylation reaction via an intramolecular [1,3]-alkyl migration 
of Ru-enamine intermediate has been proposed. The in situ formed ruthenium catalytic 
systems (2-10/2-16), (2-10/2-12) and the complex 2-11 was also found to be highly 
selective for the dehydrogenative/deaminative coupling reactions to form number of 
pharmaceutically important nitrogen heterocyclic products with amines. The catalytic 
coupling method provides an operationally simple and chemoselective synthetic protocol 
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Chapter 1 
Recent Advances on the Development and Synthetic Applications of Catalytic 
Coupling Methods via C‒N Bond Activation 
1.1 Introduction 
The C−N bond is one of the most abundant chemical bonds found in many 
organic, and biomacromolecules.1 The activation and transformation of C−N bonds2 by 
using  transition-metal catalysis has been emerged as a powerful tool for a variety of C−C 
bond forming reactions, synthesis of amides and other nitrogen-containing molecules.3 In 
a biochemical example, proteins are translated from α-amino acids via the C−N bond 
formation and the reverse process from proteins to α-amino acids via the amide C−N 
bond cleavage for biological systems.4 Compared to catalytic C−H5 and C−O6 bond 
activation reactions, transition-metal catalyzed C−N bond cleavage methods have been 
considerably underexplored, and has been identified as a new emerging area of organic 
chemical transformations. While primary and branched amines have been found to be the 
most prevalent classes of organic compounds, their utilization in C−N bond cleavage 
reactions has been found to be quite challenging, in part due to relatively high C−N bond 
dissociation energy and remains a great challenge in the development of catalytic 
coupling methods via C–N bond cleavage. 
Transition metal mediated C–N bond cleavage reactions have been found to be a 
key step in a number of catalytic coupling methods.3b, 7 Transition metal catalytic species 
have been shown to mediate inert C–N bond activation, which then generate new C-C 
and C-X bonds in the presence of potential electrophilic or nucleophilic species affording 








Figure 1.1: Representation of Catalytic C–N Bond Activation and Product Formation 
 
The designing and utilization of catalytic C–N bond cleavage strategy and synthetic 
applications present a unique challenge due to their inert nature of the unreactive C–N 
bond and their well-known ability to poison the metal catalysts. In the last decades, many 
clever and convenient Catalytic C−N cleavage methods approaches have been developed 
to obtain reliable nitrogen and/or carbon sources. Two main transition metal catalyzed 
C−N bond activation protocols have been classified, namely: N-containing compounds 
such as amines, amides having unactivated C−N bonds, and N-containing compounds 
having activated C−N bonds, such as ammonium salts, diazonium salts, triazoles, strained 
azaheterocycles. 
Fundamental mechanistic understandings on catalytic C−N bond cleavage 





of the active species, but also in designing the next generation of efficient and greener 
C−N bond cleavage protocols. Six major pathways have been identified for the transition-
metal catalyzed C−N bond cleavage reactions as illustrated in Scheme 1.1.3a, 3b 
a) Oxidative addition 
 
b) C-H bond cleavage triggered C-N activation (via imine species) 
 
c) C-H bond cleavage triggered C-N activation (via iminium species) 
 
d) Via ammonium ion species 
 
e) -N elimination 
 






Scheme 1.1: General Mechanistic Pathways for C-N Bond Activation 
 
Selective C−N bond cleavage reactions of sterically non-demanding N-containing 
compounds, such as amines, amides, and ammonium salts have been commonly 
achieved, in which their reactivity and selectivity patterns are depend on the substrate 
structure and reaction conditions. In this chapter, we will discuss the development and 
synthetic applications of transition-metal catalyzed C−N bond hydrogenolysis, C−C, and  
C−heteroatom bond forming reactions via C−N bond activation for nitrogen containing 
compounds reported in last five years. The content is organized according to the types of 
coupling methods involved in the reactions and mechanistic insights listed in Scheme 
1.1.  
1.2 Catalytic C‒N Bond Hydrogenolysis Methods 
Hydrogenolysis of C–N bond is an efficient transformation for the synthesis of 
complex molecules.8 Since traditional methods mainly employ stoichiometric (and in 
practice, excess) quantities of hydride reagents, i.e. LiAlH4 at room temperature, they 
have a number of drawbacks such as the production of stoichiometric amounts of 
byproducts, loss of important raw materials especially in multi-step synthesis, and lack of 
chemo-selectivity during the reduction process. Transition metals catalyzed C–N bond 





efficient, environmentally friendly and economically acceptable solutions to overcome 
these problems.  
1.2.1 Deaminative Hydrogenolysis of Amides 
 
 Due to their low reactivity, transition metal catalyzed C−N hydrogenolysis of 
amides has been considered challenging and scarcely investigated until recent past.9  
 
 






In 2016, Beller group reported ruthenium pincer complex 1-2 bearing an 
imidazolylaminophosphino ligand 1-1 (Eq. 1.1) is an effective catalytic system for the 
hydrogenolysis of primary and secondary amides to generate corresponding alcohols in 
good to excellent yields (Scheme 1.2).10  The ruthenium-PNN pincer complex 1-2 alone 
failed to catalyze the hydrogenolysis reaction for simple amides, but the addition of 10 
mol % KOtBu at 150 °C under 50 bar of H2 gave satisfactory yields of desired products. 
The detailed mechanistic and spectroscopic studies suggested the involvement of 
complexes 1-3 and 1-4 as major species in the catalytic cycle, which are generated from 
the Ru species 1-5 (Scheme 1.3).  
 
 






In 2017, they developed a new catalytic system for hydrogenolysis of amides air stable 
cationic manganese pincer (Mn-PNN) complex, which was synthesized from the reaction 
of imidazolylaminophosphino ligand with [MnBr(CO)5] in ethanol at 90 °C.  Unprotected 
amines and alcohols were afforded in 78% – 99% yield with the  4–15 mol% of KOtBu 










A number of iron pincer complexes (1-6 – 1-9) have been found to catalyze 
selective hydrogenolysis of C−N bonds to form alcohols and amine products (Scheme 
1.4). In 2016, Milstein group reported the first example of homogeneous iron-catalyzed 
hydrogenolysis of amides by using an iron pincer complex 1-6. A variety of activated 
secondary and tertiary N-substituted 2,2,2-trifluoroacetamides have been utilized to form 
the corresponding amines and trifluoroethanol with moderate to good yields under harsh 
conditions (60 bar of H2 at 140 °C) with a 6 mol% of KHMDS and the complex 1-6 as 
the catalyst (Scheme 1.4).12 In 2016, Langer and coworkers reported hydrogenolysis of 
nonactivated amides and lactams by using iron pincer catalyst 1-7. The hydrogenolysis of 
N-phenylbenzamide with 50 bar of H2 at 100 °C in dry THF for 24 h cleanly afforded the 
alcohols and amines (Scheme 1.4).13 Sanford group employed an analogous iron catalyst 
1-8 for the hydrogenolysis of both amides and formamides to form the corresponding 
alcohols and amines up to 300 TON in 3 h.14 In 2017, Bernskoetter group utilized an 
analogous iron pincer PNP complexes 1-7 and 1-8 as the catalyst for the hydrogenolysis 
of amides (Scheme 1.4). In this case, a higher activity was observed for secondary 
formamide derivatives under a slightly lower H2 pressure (30 bar) and at a low catalyst 
loading (0.018−0.07 mol%) in THF (4430 TONs). Interestingly, some challenging 
substrates such as formanilide required 20 equivalents of LiOTf to increase the 
productivity at 120 °C for 16 h under 60 bar of H2.
15 Bergens and coworkers achieved a 
highly enantioselective hydrogenation of racemic α-phenoxy-amides via dynamic kinetic 
resolution under mild conditions.16 The catalytic system of trans-RuCl2((S,S)-
skewphos)((R,R)-dpen) 1-10, 2-PrONa, and 2-PrOH afforded the corresponding alcohol 






Catalyst 1-10 is believed to have possible interactions with primary alcohol products to 
generate active catalytic species 1-11. The authors suggested that 2-PrOH is bonded to 
the diastereomeric transition states of the enantioselective step, favoring one pathway 
over the other.  
  
Nova group performed with density functional theory (DFT) calculations and 
microkinetic modeling studies to investigate the mechanism of the iron-catalyzed 
deaminative hydrogenolysis.17 This study revealed the “hemiaminal” (Eq. 1.4) is the key 





C−N bond cleavage of the hemiaminal (Scheme 1.5), where, the hydrogenation of 
electron rich carbonyl substrate was found to be governed by their carbonyl 
hydrogenation step.  
 
Scheme 1.5: Reaction Mechanism Shown with Hemiaminal Transition State 
 
1.2.2 Deaminative Hydrogenolysis of Carbamates and Urea Derivatives 
 Milstein group in 2011 first reported a catalytic hydrogenolysis of C–N bond of 
urea to generate amines and methanol by using bipyridyl-based PNN Ru(II) pincer 
complex.18 Later, in 2019, they reported the hydrogenolysis of carbamates and urea 







The manganese complex 1-12 (0.02 mmol), tBuOK (0.03 mmol), carbamate (1 mmol) 
and H2 gas (20 bar) in toluene were heated up to 130 °C for 48 hours. The reaction 
tolerated a variety of linear carbamates bearing aliphatic or aromatic substituents in 
producing the corresponding amines and alcohols (Eq. 1.5). A variety of hydrogenation 
resistant urea derivatives were hydrogenated to methanol and amines by using  slightly 
modified catalytic conditions: complex 1-12 (3 mol %), KOtBu (4 mol %), H2 (20 bar)) at 
130 °C for 48 h in THF (Eq. 1.6). 
 
The precatalyst 1-12 reacts with the base to generate the dearomatized complex 1-
13, which is then hydrogenated to give the rearomatized hydride complex 1-14. In 
support of hemilabile properties of the bipyridine moiety, the urea or carbamate 





from metal−ligand cooperation of the complex 1-15 and the elimination of R1XH (X = O, 
NH).  Complex 1-16 continues the catalytic cycle by regenerating complex 1-13 with the 
liberation of N-formamide 1-17, which then reacts with complex 1-14 to form complex 1-
18, and the elimination of amine via metal−ligand cooperation would form the 
formaldehyde complex 1-19. Complex 1-19 reacts with hydrogen to form the methoxide 
complex 1-20 via complex 1-14. Finally, methanol is liberated from the complex 1-20 
and the regeneration of manganese hydride complex 1-14 through the hydrogenation of 
complex 1-13 (Scheme 1.6). One of the mechanistic experiments was revealed that the 
introduction of para-formaldehyde corroborates the possibility of generation of complex 
1-20 from complex 1-19. 
 







1.3 Catalytic C‒C Coupling Methods via C(sp3)‒N Bond Activation 
 Catalytic C-C coupling methods via C(sp3)-N bond activation have emerged as 
an effective alkylation protocol, in which amine substrates are activated via deaminative 
hydrogen transfer or hydrogen borrowing processes. Both activated and non-activated 
amines have been successfully utilized as the substrates for the C-C bond forming 
reactions. 
 
1.3.1 C(sp3)‒N Bond Activation by Oxidative Addition 
 






Transition metal catalyzed C-N bond oxidative addition reactions have been successfully 
employed to form new C-C bonds. In 2018, Wu and coworkers reported palladium/DPPB 
(1,4-bis(diphenylphosphino)butane) 1-21 catalyzed direct carbonylative strategy on 
benzyl amines. They were able to synthesize 2-arylacetates by employing benzyl amines, 
methanol and CO and by using dimethyl carbonate (DMC) as a green solvent.20 
Organopalladium complex was formed by direct oxidative addition of benzylamine on 
palladium. Coordination and insertion of CO gave the acylpalladium intermediate, which 
was nucleophilically attacked by MeOH to give the desired ester product (Scheme 1.7). 
 
1.3.1.1 C(sp3)‒N Bond Activation by Oxidative Addition of Ammonium Salt 
In 2017, Huang group developed a novel Ni(0) catalyzed method by introducing 
amine−I2 charge-transfer (C-T) complex 1-23, which facilitates the C−N bond oxidative 
addition via the formation of Ni(I) complex 1-24.  
 





Migratory insertion of CO into the C−N bond gives a Ni(I) complex 1-25 along with the 
release of I2, which could further react with benzyl amines to form C-T complex 1-23. 
Subsequently, the benzylic radical would react with the active Ni(I) complex 1-25 by 
giving Ni(II) -amide complex 1-26 via outer-sphere electron-transfer process, which 
underwent reductive elimination to afford the desired product and Ni(0) species 1-22 
(Scheme 1.8).21 
 
Scheme 1.9: Palladium Catalyzed Triarylmethane Compounds 
 
Shao group in 2018 reported an efficient palladium-catalyzed Suzuki coupling of 
ammonium triflates with arylboronic acids (Scheme 1.9).22 Many triarylmethane 
derivatives were synthesized by employing 1,1-diarylmethyl-trimethylammonium 
triflates with arylboronic acids via C−N bond oxidative addition as the key step. The 
authors claimed with the oxidative addition of ammonium triflate would form the 
formation of Pd(II) complex 1-27, The oxidative addition step was supported by ESI-MS 
analysis, as they were able to detect corresponding mass for palladium complex 1-27. In 





internal alkyne derivatives by adopting the similar strategy. Diarylmethanes were 
synthesized by employing arylsilanes with benzyltrimethylammonium salts under 
Hiyama cross coupling pathway23 and internal alkyne derivatives by employing benzylic 
ammonium salts with terminal alkynes under Sonogashira coupling pathway.24  
 
Scheme 1.10: Asymmetric Allylation of α-Branched β-Ketoesters 
 
In 2019, Tian and coworkers introduced an asymmetric allylation of α-branched β-
ketoesters, by utilizing O-TBDMS-L-threonine, Pd(OAc)2, and P(4-FC6H4)3 catalyzed 
system with allylic amines (Scheme 1.10).25 Tien group extended the reaction to the 
asymmetric allylation of α-branched β-ketoesters via enamine/palladium catalysis with 
C−N bond cleavage. The chiral α-amino acid activates both α-branched β-ketoester and 
allylic amine by formation of enamine via the formation of complex 1-28. The C−N bond 
activation would generate the π-allylpalladium complex 1-29 by releasing secondary 





and the π-allylpalladium moiety to form the corresponding enantioenriched α,α-
disubstituted β- ketoester products. 
 
1.3.1.2 Catalytic C(sp3)‒N Bond Activation by Oxidative Addition of Strained 
Amines 
In 2015, Doyle group reported Ni-catalyzed Negishi cross-coupling reaction to 
achieve quaternary carbon contained β-substituted phenethylamines.26 They used 
different olefinic ligands to achieve Negishi cross-coupling type transformations. The 
cross-coupling reaction is believed to be occur by an intermediate 1-30, which is 
generated from the aziridine and Ni catalyst via either a SET oxidative addition pathway 
or from an intermediate 1-31, or a SN2-type oxidative addition pathway. Subsequent 
cyclization would form nickelocycle 1-32, and the reductive elimination via the 
transmetallated species 1-33 would afford the desired β-substituted phenethylamine 








Scheme 1.11: Proposed Mechanistic Pathway for Ni-Catalyzed Negishi Cross-Coupling 
Reaction of Aziridines with RZnBr 
 
In 2018, Xiao and coworkers reported similar dual visible light photoredox and nickel-
catalyzed cross-coupling strategy to access β-substituted amines from the reaction of 2-
arylaziridines and potassium benzyltrifluoroborates. The catalytic system provided an 
excellent regioselectivity for more hindered C−N bond cleavage of strained arylaziridine 






The authors proposed a mechanism via in situ formed active Ni(0) 1-34, which 
undergoes an oxidative addition into the more hindered C−N bond of aziridine to give the 
azanickelacyclobutane species 1-36. Here, the electron deficient olefin ligand plays an 
important role in regioselectivity during oxidative addition step. Meanwhile, single 
electron transfer (SET) from potassium benzyltrifluoroborates on photoexcited state 
Ir(III)* would generate benzylic radical, which would be quickly captured by complex 1-
36 by forming alkylnickel(III) intermediate species 1-37. Reductive elimination of 
alkylnickel(III)cyclobutene species 1-37 furnishes the formation of Ni(I) amino complex 
1-38, which then undergoes another SET reduction mediated by the reduced 
photocatalyst Ir(II) to regenerate the active Ir(III) catalyst 1-35 and potassium salt of the 






Scheme 1.12: Proposed Dual Nickel/Photoredox Catalyzed Pathway 
 
 
1.3.2 Catalytic C(sp3)‒N Bond Activation via Imine Species 
Lin and coworkers in 2017 achieved ring opening of N-acylaziridine via 
homolytic cleavage of a more substituted C−N bond. Zn dust (10-20 mol%) as the 
reductant was used generate the active TiIII catalytic species.28 The proposed mechanism 
involves the coordination to N-acylaziridine derivative 1-40 to the redox-active metal 
complex 1-42, which promotes homolytic cleavage of the more substituted C−N bond via 
single-electron transfer from the metal center to the aziridine derivative to form carbon 
radical tethered 1-43. This radical intermediate reacts with an alkene to afford 
intermediate radical species 1-44. Subsequent cyclization yields the [3+2] cycloaddition 






Scheme 1.13: Redox-Relay Catalytic Cycle for [3+2] Cycloaddition of N-Acylaziridine 
Derivative and an Alkene 
 
The proposed redox-relay catalytic cycle, involving reductive aziridine ring opening and 
oxidative ring closure is believed to be turnover limiting step of the radical catalysis. In 
2013, Yi group reported a Ru-catalyzed direct C−N bond activation strategy by 
employing biomass derived - and -amino acid derivatives to construct C−C bond with 
ketones to form 2-alkylketone products. The reaction showed a broad substrate scope and 
excellent diastereoselectivity, and the C−N bond activation step has been proposed to 







1.3.3 Catalytic C(sp3)‒N Bond Activation via Iminium and Ammonium Species 
Sarpong group reported a convenient synthesis of oxazaborinines 1-46 by using 
palladium catalyzed intramolecular coupling of vinylogous N-allylamide 1-45 via an 
iminium intermediate 1-47.30 Vinylogous amide species 1-45 was activated by alkyl 
boron to give the iminium intermediate 1-47. Oxidative addition of  iminium intermediate 
1-47 onto the palladium in the presence of pyridinium p-toluenesulfonate (PPTS; 
Brønsted acid) would afford π-allyl complex 1-48 and enolate equivalent 1-49.  
 
 
Scheme 1.14: Synthesis of Oxazaborinines by Intramolecular Rearrangement via 






Oxazaborinine 1-46 would be liberated by allylic alkylation of an intermediate 1-49 via 
formal [3,3] rearrangement (Scheme 1.14). 
Quaternary ammonium salts are considered very useful substrates as leaving 
group, as illustrated by the pioneering work by Jenny et al. in 1988 on arylammonium 
salts for the cross-coupling reactions.31 In 2015, Li and coworkers demonstrated catalytic 
C−N bond cleavage via elimination of ammonium salts for the C−H insertion reactions of 
arylketones with diazo compounds.32  
 






In this case, the ammonium group was employed as a directing group for the C−H 
activation of phenacylammonium salts 1-50 to synthesize benzocyclopentanones 1-51. It 
is noteworthy that the one-pot reaction of α-bromoacetophenones and trimethylamine led 
to the desired products through the in-situ formed phenacylammonium salt 1-50. On the 
basis of experimental and DFT calculations, the authors proposed a mechanism which 
involves an ortho C−H activation of the phenacylammonium enolate salt 1-50 followed 
by cyclometalation to afford a rhodacyclic intermediate 1-53. Subsequent coordination 
and denitrogenation of a diazo ester would generate the Rh-carbene species 1-54. 
Intramolecular insertion of the Rh−Aryl bond into a carbene species 1-54 generates a 
Rh(III) dialkyl intermediate 1-55, which in the presence of HOAc would facilitate the 
C−N bond activation to result in liberation of HEt3NBr. Finally, the protonolysis of 1-56 
would release the benzocyclopentanone product 1-51 and regenerate the active Rh 
catalyst 1-52 (Scheme 1.15).  
 
In 2016, Martins group reported a nickel-catalyzed reductive carboxylation of benzylic 
C−N bonds with carbon dioxide elimination which is usually associated33 with 





formation of benzyl electrophiles by C−N bond activation of bis(phen)-nickel complexes 
(Eq. 1.9). In 2017, Tortosa and coworkers presented enantioselective catalytic Kumada 
type coupling reaction of secondary propargylic ammonium salts with aryl Grignard 
reagents stereospecific alkynylation transformations. Interestingly, this catalytic system 
gave only the α-regioisomer via SN2 type mechanism by quaternary C−N bond activation 
of the propargylic ammonium salts. (Scheme 1.16).35  
 
 
Scheme 1.16: Stereospecific Substitution Reactions of Propargylic Ammonium salt 
Derivatives 
 
The amino group is amenable to late-stage functionalization and easily purify via 
acid/base extraction, and Watson group developed a new catalytic C−N bond activation 





observed high chemoselectivity for the benzylic C−N bond activation on 
Suzuki−Miyaura type cross coupling reaction on NiI/III catalytic system by employing 
alkylpyridinium salts with aryl boronic acids. The catalytic coupling method provided an 
easy access to alkyl arenes via C−N bond activation, which is amenable for a wide range 
of primary and secondary amines with high degree of functional group tolerance. The 
authors proposed a mechanism which is initiated by SET from a Ni(I) species to the 
pyridinium salt (Katritzky salts) 1-59, triggering fragmentation of 1-60 to give the alkyl 
radical Ni(II) species 1-61. Arylnickel(II) intermediate 1-61 would react with this alkyl 
radical to form arylalkylNi(III) species. Finally, reductive elimination gives desired 
arylated product and active Ni(I) species (Scheme 1.17).37  
 
Scheme 1.17: Use of Alkyl Amines as Electrophiles for Nickel-Catalyzed Cross 





In 2019, they extended same strategy to synthesize various alkyl−alkyl cross-
coupling from alkyl amine derivatives with unactivated alkyl groups.38 Martin group 
independently demonstrated the use of pyridinium salt by using nickel catalyzed C−N 
bond activation for cross-coupling reactions with aryl bromides to forge sp3 C−C 
linkages.39  
 
Scheme 1.18: Representative Examples of the Deaminative Heck Type Reaction 
Including Carbonylative Products. aCO (80 atm) has been used. 
 
  
Xiao group developed visible-light photoredox catalytic strategy to effect the 
deaminative alkyl-Heck-type reaction to promote C−N bond activation via the pyridinium 
salt. A variety of aliphatic primary amines were effectively used as the starting materials 
to access corresponding alkene products in good yields. Moreover, this strategy was 





insertion pathway (Scheme 1.18).40 In 2019, Shu and coworkers developed the C−C 
coupling reaction between C−N electrophiles that demonstrates the C−N bond cleavage. 
By using nickel/Bphen catalytic system, both aryl- and benzyltrimethylammonium 
triflates were employed for the coupling with alkenes to construct substituted alkenes via 
C−N bond cleavage.41 These transformations share a common mechanism involving 
single electron transfer pathways (SET) while tolerating a wide range of functionalities 
with good to excellent yields. 
 





Very recently, Mashima and coworkers reported an asymmetric allylic alkylation of β-
ketoesters 1-62 with allylic amines, where the C–N bond cleavage via ammonium species 
occurred from the protonation of amine moiety (Scheme 1.19).42 A Ni(0) with a chiral 
diphosphine ligand has been found to be effective for the synthesis of alkylated products 
1-63 with a high % e.e. The authors carried out DFT calculations to rationalize the 
mechanism, which is initiated by the coordination of allylic amine onto the Ni(0)-
diphosphine complex in forming complex 1-64. Protonation of the amine moiety by β-
ketoester (endergonically; 22.9 kcal mol−1) generates intermediate 1-65 and enolate 1-62 
which are identified as the key species for the C−N bond cleavage step via formation of a 
nickel-allyl complex 1-66. The complex 1-66 reacts with an outer-sphere enolate anion 1-
62 to form product coordinated complex 1-67. Lastly, an olefin exchange reaction 
between complex 1-67 and an allylamine proceeds to give the corresponding product 1-
63 and the regeneration of active catalytic species 1-64.  
 
1.3.4 Catalytic C(sp3)‒N Bond Activation via -N Elimination 
Gooßen group developed ruthenium catalyzed regiospecific allylation of benzoic 
acids with allyl amines that proceeds via C−N bond activation. This ruthenium catalyzed 
reaction is believed to be proceed via β-amino elimination pathway without formation of 
metal allyl species. This directing group enabled protocol provided the formation of 






Scheme 1.20: Catalytic Cycle Represent C–N Activation via -Amino Elimination 
 
The observed KIEs under parallel experiments (kH/kD = 2.8) and under the competitive 
reaction conditions (kH/kD = 4.5) showed that the C−H activation is the rate-determining 
step. Experimentally determined bond strength of C−H (100 kcal/mol) and C−N (80 
kcal/mol) were further made consistent with the C−H activation as the rate-determining 
step. Reactions were carried out with 1,1-dideuterio-allyl amine under standard 
conditions, which exclusively afforded the γ[D2] allylated product in 61% yield, in 





the benzoic acid would be initiated by an allyl amine most likely acting as an auxiliary 
base by producing intermediate species 1-68. The intermediate complex 1-70 is formed 
by coordination of an allyl amine followed by insertion of the olefinic group via 
intermediate 1-69. The C−N bond cleavage via “β-amine elimination” pathway as a key 
step of the reaction would form the desired product along with ruthenium-amine 
intermediate. Finally, active catalytic species would be regenerated by protonation of the 
ruthenium-amine intermediate (Scheme 1.20).  
 
Scheme 1.21: Iron-mediated Remote C–H Bond Benzylation of 8-Aminoquinoline 
Amide Derivatives 
 
Fu and coworkers in 2017 reported iron catalyzed C5-benzylation of quinoline 
frameworks. The reaction tolerated a wide range of N-benzylic sulfonamide derivatives 
with both aliphatic and aromatic amides (Scheme 1.21).44 Electrophilic substitution 
reaction on electron-rich C5–H position of the chelated iron-aminoquinoline intermediate 
has been proposed for producing the desired benzylated products, in which an in-situ 
generated benzyl cation was generated from N-benzylic sulfonamide in the presence of 







1.4 Catalytic C−C Coupling Methods via Arene C(sp2)−N Bond Activation 
Aryl C–N bonds are particularly inert, and more reactive intermediates such as 
aryldiazonium salts are needed to achieve arene C(sp2)−N bond functionalization. 
Kakiuchi in 2007 first reported catalytic C-C coupling reaction of aryl compounds with 
pivalophenone derivatives and organoboronates via aryl C−N bond cleavage by using 
RuH2(CO)(PPh3)3 catalyst. The reaction was shown proceed via oxidative addition of aryl 
C−N bond to the ruthenium center.45  
 
In 2009, Kakiuchi group clearly demonstrated a direct C−N bond insertion into a 
Ru(0) complex.46 The catalytically active Ru-aryl intermediates were synthesized, and the 
corresponding stoichiometric cross coupling products were obtained under standard 
reaction conditions, which was found to proceed via direct oxidative addition of the 
C(sp2)‒N Bond onto the ruthenium center (Eq. 1.10). 
 
 
1.4.1 Arene C(sp2)‒N Bond Activation by Oxidative Addition 
1.4.1.1 Catalytic Arene C(sp2)‒N Bond Activation via Direct Oxidative Addition 
In 2017, Zeng and coworkers demonstrated an arene C(sp2)‒N bond cleavage 
reaction by adopting both experimental and theoretical study. Chromium(II) chloride 





chemoselective Kumada type C−C coupling reactions.47 Experimental evidences showed 
that the in-situ formed low-valent chromium species with Grignard reagent led to 
activation of the C(sp2)‒N bond. DFT calculations were consistent with the facile 
insertion of the C(sp2)‒N bond mediated by a high-spin chromium(0) complex (S = 2). 
Furthermore, theoretical model indicated that the donation of sole paired d electrons in 
the d6 shell of high-spin chromium(0) complex to the antibonding orbital of the C(sp2)‒N 
bond and the nitrogen ligating interaction plays an important role in promoting the 
oxidative addition step of the reaction (Scheme 1.22). This external ligand-free reactivity 
from the low-spin state-controlled reactivity was found to be unusually sensitive to the 
supporting ligand environment. 
 
Scheme 1.22: Chromium-Catalyzed Cleavage of Aromatic Carbon−Nitrogen Bonds at 
Room Temperature 
 
In 2017, Jiang and coworkers reported a on palladium catalyzed synthesis of aryl ketones 
via C−N bond cleavage by employing arylhydrazines and nitriles using molecular oxygen 





ketone molecule was derived from H2O. The authors proposed a possible catalytic 
pathway by combining with the previous observations and mechanistic insights.  
 
Scheme 1.23: Proposed Reaction Mechanism for Synthesis of Aryl Ketones 
 
Initially, palladiaziridine intermediate 1-71 would form via the metathesis of phenyl 
hydrazide with a palladium catalyst (X=OAc). Subsequent nitrile group coordination 1-





1-73 via C−N bond cleavage. Cleavage of the intermediate 1-73 would generate nitrile 
coordinated arylpalladium species 1-74 and palladiaziridine complex, which would be 
decomposed into active catalytic species via denitrogenative pathway. Palladium 
ketimine intermediate 1-75 would be formed via 1,2-addition of the aryl group to the 
coordinated nitrile moiety. The hydrolysis of the ketimine would release the desired aryl 
ketone products with the regeneration of active catalytic species (Scheme 1.23). Zhao 
and coworkers independently reported palladium catalyzed aerobic oxidative 
carbonylation reaction with aryl hydrazines. The oxidative carbonylation proceeded 
employing molecular oxygen as the terminal oxidant by releasing nitrogen gas and 
water.49  
 
Scheme 1.24: Magnesium-Facilitated Ni(I)/Ni(III) Catalytic Cycle for Suzuki−Miyaura 






Later in 2018, Shi and coworkers reported the Ni-catalyzed Suzuki−Miyaura type cross-
coupling of dimethyl aryl amines with arylboronic esters via C−N bond activation under 
reductive conditions.50 The Ni(I)/Ni(III) catalytic system forged the desired biaryl 
products in the absence of directing groups and preactivation. Based on the EPR and DFT 
studies, the authors proposed a catalytic cycle, in which Ni(I) species 1-76, initially 
generated from the ligand exchange of active catalyst with dimethyl aryl amine, led to 
oxidative addition of sp2 C−N by producing Ni(III) species 1-77. Transmetallation 
followed by reductive elimination on Ni(III) species 1-78 steps forged the desired biaryl 
products with the regeneration of active Ni(I) species (Scheme 1.24). Xia and coworkers 
reported a similar mechanistic insights for the nickel catalyzed Kumada coupling of 
aniline derivatives via selective cleavage of sp2 C−N bond. DFT calculations revealed the 
insertion of nickel complex into sp2 C−N bond as the rate-limiting step, and the Boc 
activation was found to be useful in C−N bond cleavage by weakening of the intrinsic 
bond strength.51  
 






In 2019, Cao group reported Sonogashira cross-coupling reaction where 
aryltrimethylammonium salts were oxidatively added to the palladium-NHC catalytic 
system for releasing trimethylamine (Scheme 1.25).52 DFT calculations showed that the 
oxidative addition step on releasing trimethylamine for the transition state 1-80 is 9.1 
kcal/mol higher than that of the transition state 1-79. Recently, You and coworkers 
reported a similar palladium catalyzed reaction with nitroarenes and terminal alkynes 
which was found to occur via direct oxidative addition of sp2 C−NO2 bond at elevated 
temperatures.53 Very recently, Chelate assisted, Ru3(CO)12 catalyzed Suzuki-type 
carbonylative reaction with anilines and organoboranes via sp2 C−N bond cleavage was 
reported by Wu and coworkers.54 Later, they were able to further extend the scope of this 
reaction following the same strategy by employing alkenyl borates to generate 2-
phenylolefin products.55 
 
1.4.1.2 Arene C(sp2)‒N Bond Activation by Oxidative Addition of Ammonium Salt 
In 2015, Wang group employed both activated and unactivated 
aryltrimethylammonium triflates to synthesize 2-aryl(benzo)oxazoles or 2-
aryl(benzo)thiazoles with oxazoles with the demonstration of good compatibility of 
functional groups.56 The authors proposed a mechanism based on the experimental data 
and prior reports on palladium chemistry. The Pd(0) species reacts with 
aryltrimethylammonium triflates to form an oxidative addition species 1-81 by releasing 
trimethylamine as a byproduct. Next, aryl(heteroaryl) palladium intermediate 1-82 would 





elimination affords the cross-coupling product along with regeneration of the active Pd(0) 
species (Scheme 1.26). 
 
 
Scheme 1.26: Proposed Catalytic Cycle for Palladium Catalyzed Direct C−H Arylation 






1.4.2 Arene C(sp2) ‒N Bond Activation via Ammonium Salt 
 
Scheme 1.27: Mechanistic Route Located by Means of DFT Calculations for the Stille 
Cross-Coupling Reactions of Aryltrimethylammonium Salts via C–N Bond Activation 
 
In 2016, Uchiyama and coworkers reported Stille type cross-coupling with C–N 
electrophiles via cleavage of C(sp2)–N bond, by employing a combination of 





complex 1-84 is formed with -3.0 kcal/mol exothermicity from Ni(ICy)2 and 
aryltrimethylammonium fluoride, which was generated via anion metathesis of 
aryltrimethylammonium triflate and CsF. Migration on the phenyl ring to the proximal 
position of the C–N bond only cost 10.2 kcal/mol to form the more stable complex 1-85. 
The C–N bond cleavage takes place smoothly in a SNAr process to afford intermediate 1-
86 with release of trimethyl amine, in a highly exothermic fashion of -45.5 kcal/mol. The 
dissociation of ICy ligand and the coordination of aryltrimethylstannane to the Ni(II) 
complex 1-86 afford the complex 1-87 with an overall energy loss of 18.4 kcal/mol. The 
reductive elimination of FSnMe3 affords the precursor complex 1-88. Finally, the 
formation of desired biaryl compound takes place with the loss of only 2.3 kcal/mol 
along with regeneration of active catalytic species (Scheme 1.27). 
 
1.4.3 Arene C(sp2)‒N Bond Activation by Free Radical Intermediate  
 






Song and coworkers presented an Cu-catalyzed aromatic metamorphosis via 
oxidative cleavage of two C−N bonds including arene C(sp2)‒N bond of 3-
aminoindazoles.58 DFT calculations and experimental observations indicated that this 
catalytic transformation involves oxidation, selective C−N bond activation, 
denitrogenation and radical cyclization steps. This unprecedented aromatic C–C bond 
formation would be useful for the construction of unsymmetrical nitrile containing 
triphenylenes (Scheme 1.28). 
 
1.5 Catalytic C–C Coupling Methods via Olefinic C(sp2)-N Bond Activation 
 
Scheme 1.29: Pd-Catalyzed Intramolecular C−N Bond Cleavage via Heck type coupling 





In 2015, Loh and coworkers developed a palladium-catalyzed intramolecular 
Heck coupling reaction by employing N-vinylacetamide derivatives via olefinic C(sp2)–N 
bond cleavage (Scheme 1.29).59 The reaction was shown to be compatible with both 
electron-rich and electron -poor substituted phenyl group, where the cleavage of C(sp2)–
N bond is believed to be occur via -N elimination pathway. The oxidative addition of 
the C–Br bond to Pd(0) would form the palladium complex 1-89, which is followed by 
intramolecular 5-exo-cyclization to produce a new five membered palladium complex 1-
90. The C–N bond activation through –N elimination pathway would occur via the 
intermediate palladium species 1-91. Finally, protonation and sequential reductive 
elimination would yield the desired product with regeneration of the active catalytic 
species (Scheme 1.30). 
 





1.6 Catalytic C–C Coupling Methods via C(sp)–N Bond Activation 
Catalytic cyanation methods are a highly desired and user-friendly transformation 
compared to traditional cyanation methods using toxic reagents such as KCN, Zn(CN)2, 
and CuCN. In 2013, Fu and coworkers reported a rhodium catalyzed C−H cyanation 
reaction via C(sp)–N bond activation by using N-cyano-N-phenyl- p-toluenesulfonamide 
(NCTS) as the cyanation agent.60 Later, Glorius group reported a cobalt catalyzed 
protocol for the similar transformation.61 In 2015, Li and Ackermann further developed 
the direct cyanation of arenes and heteroarenes by using cobalt chemistry where -N 
elimination has been proposed for the C(sp)–N bond activation step (Scheme 1.31).62 
Reversible ortho-arene C–H metalation, followed by coordination and insertion of NCTS 
would generate the key intermediate species 1-93 and 1-94. Finally, -N elimination 
furnishes the corresponding cyanated product 1-92. 
 





1.7 Catalytic C–C Coupling Methods via Amide C(sp2)–N Bond Activation 
Suzuki–Miyaura cross coupling reaction has been found to be one of the most versatile 
C–C coupling reactions in both industrial and academic settings.63 In this context, much 
attention has been devoted to transition metal catalyzed amide C(sp2)–N bond activation 
reactions.64 Recent studies revealed that the oxidative addition is an effective strategy for 
transition-metal-catalyzed activation of inert amide C(sp2)–N bond due to 𝑛𝑁 → 𝜋𝐶=𝑂
∗  
conjugation and partial double bond nature.65 Due to partial double bond character, 
carbonyl amides have relatively short N−C(O) bonds with high rotational barrier for 
cis−trans isomerization (typically 15−20 kcal/mol), which have led to lower activity of 
the carbonyl group toward hydrolysis and nucleophilic addition. One approach is to look 
at the amide C(sp2)–N bond activation is the making distorted amides, have been 
attracted the widespread attention, which include steric repulsion; conformational effects; 
anomeric amides; steric restriction (Scheme 1.32).  
 
Scheme 1.32: Amide Bond Destabilization for Transition Metal Catalysis; A. Steric 
Repulsion B. Conformational Effects (ring or allylic strain) C. Anomeric or Electronic 
Delocalization (as manifested in amides of XXN−C(O) type, where X is an 






1.7.1 Amide C(sp2)‒N Bond Activation by Direct Oxidative Addition 
Garg and coworkers reported an uncommon cleavage of the amide C–N bond 
from nickel-catalyzed Suzuki–Miyaura C–C coupling of amides (Scheme 1.33).66 The 
methodology was well tolerated for a variety of carbonyl functional groups that bear 
acidic protons. Potential synthetic utility was also demonstrated by synthesizing 
pharmaceutically important glucagon receptor modulator. 
 
 
Scheme 1.33: Nickel-Catalyzed Suzuki–Miyaura Coupling of Amides 
 
They further showed that the Ni/SIPr system is an effective catalyst for the 
formation of alkyl aryl ketones via Negishi type coupling of amides by utilizing both 





nickel mediated C−C bond formation has been demonstrated by using aliphatic amide 
derivatives.68 Zou69 and Szostak70 groups independently reported analogous palladium 
catalyzed acylative Suzuki coupling of arylboronic acids with carboxylic amides via 
amide C(sp2)‒N bond activation. In 2017, Szostak group reported a more generalized 
version of cross-coupling reaction which is promoted by a commercially available, air- 
and moisture-stable (NHC)Pd(R-allyl)Cl catalyst with several amide derivatives. This Pd-
NHC system provided a significant improvement over other catalytic for amide C−N 
bond activation methods. Both Szostak and Gandhi group employed N-acylsaccharins 1-
96 as a electrophilic acyl transfer reagent via acylmetal intermediates to synthesize a 
variety of functionalized ketones (Scheme 1.34).71  
 
Scheme 1.34: Pd-Catalyzed Suzuki−Miyaura Cross-Coupling of N-Acylsaccharins by 





N-acylsaccharins served as amide-based electrophilic acyl transfer reagents via acylmetal 
intermediates. Mechanistic studies strongly support the amide C−N bond twist as the 
enabling feature for the C−N activation. The Szostak group has demonstrated a palladium 
catalyzed Suzuki−Miyaura cross-coupling with arylboronic acids by using N-acyl-5,5-
dimethylhydantoins 1-97 as a mild acyl-transfer reagent via selective amides C−N bond 
cleavage (Eq. 1.11).72 
 
In 2019, Stanley group used N-benzoyl-N-phenylbenzamides as acyl-transfer 
reagent triggered by nickel-catalyzed amide C−N bond activation, which is a 
intermolecular, three-component carboacylation reaction with norbornene derivatives.73 
Nickel-catalyzed alkylation of amides was reported by Rueping group by employing 
alkylboranes as nucleophilic partners under relatively mild reaction conditions.74 Yu and 
Matsuo presented electrophile cross coupling reaction between alkylpyridinium salts 
(Katritzky salts) and amides via nickel catalyzed amide C−N bond activation. This 
reaction believed to be proceeded through SET mechanism.75 Szostak group further 
looked in to more chemoselective amide C‒N cleavage protocol to develop Heck type 
transformation and they were able to successfully obtain useful olefin derivatives by 







Mechanistic investigations revealed that the reaction involves a cationic palladium 
complex with decarbonylation as the rate limiting step. Relative reactivities further 
suggested that oxidative addition is not the rate limiting step. Also, competitive 
experiments were indicated that the sterically demanding ortho aryl substrates play an 
important role in accelerating the reaction due to steric effects. In 2016, they carried out 
extensive study on nickel, palladium and rhodium to develop C‒C cross coupling 
methods via amide C(sp2)‒N bond activation.  
 
Scheme 1.35: Nickel-Catalyzed Suzuki Biaryl Synthesis Through Cross-Coupling of 





Suzuki–Miyaura biaryl coupling of amides with commercially available boronic acids 
were found to be effective with air-stable Ni(PCy3)2Cl2 complex, without additional 
ligands or hygroscopic additives. Generation of aryl electrophiles on nickel at elevated 
temperatures from bench-stable amides were reported as first nickel catalyzed example 
on biaryl synthesis (Scheme 1.35).77 Formation of an Ar-Ni-CONR2 intermediate 1-98 by 
direct oxidative addition to the aryl–acyl bond might be operative for C‒N bond 
activation. Transmetallation would form the intermediate complex 1-99, which then 
decarbonylation occurred to form complex 1-100. Finally, desired biaryl products will be 
afforded by reductive elimination step (Scheme 1.36).  
 







They successfully developed a rhodium catalytic system via amide C‒N bond activation 
protocol to generate biaryl products, along with arene C‒H activation for the substrates 
with a directing group.78 Rueping group reported a nickel catalyzed Sonogashira type 




This methodology enables a facile route for C(sp2)−C(sp) bond formation via direct 
C(sp2)−N activation followed by decarbonylation of amides (Eq. 1.13).79 Very recently, 
Lee and coworkers reported nickel catalyzed Claisen condensation of two different 




DFT calculations and the experimental data uncovered the formation of the manganese 
enolate during the reaction and the reductive elimination of nickelacylalkyl species has 





mechanistic features for transition metal catalyzed amide bond activation for the 
synthesis of pharmaceutically important products.  
In 2015, Murakami’s group reported palladium catalyzed intramolecular insertion 
of alkenes into the C−N bond of β‑lactams to form the tricyclic nitrogen heterocycles.81 
The proposed mechanism involves via initial oxidative addition of C−N bond to form a 
five-membered palladacycle intermediate. Subsequent alkene insertion by forming seven 
membered palladacycle followed by reductive elimination furnishes the desired products 
(Equation 1.15).  
 
In 2017, Garg group reported an intramolecular non-decarbonylative Mizoroki–
Heck reaction of amide derivatives via amide C‒N bond activation.82 Diastereoselective 
polycyclic or spirocyclic products containing quaternary centers were obtained by using 
sterically hindered tri- and tetrasubstituted olefin derivatives. Moreover, an adduct 
bearing vicinal, highly substituted sp3 carbon stereocenters was also obtained by using 
amide derivatives as building blocks for the assembly of complex scaffolds (Scheme 
1.37). Catalytic conversion would proceed through a sequence akin to classical 
Mizoroki–Heck chemistry, via oxidative addition, subsequent olefin coordination, 
insertion and -hydride elimination steps. Liu and coworkers presented theoretical 
insights for the mechanisms of intramolecular insertion of alkenes into the carbon-





addition, alkene insertion, and reductive elimination are the key steps governing the 
alkene insertion as the rate-determining step for the reaction.83  
 
 
Scheme 1.37: Mizoroki–Heck Cyclization of a Variety of tri- and Tetrasubstituted Olefin 
Substrates 
 
Very recently Dang group carried out DFT calculations which provided detailed 
mechanistic insights for Pd-catalyzed non-decarbonylative and Ni-catalyzed 
decarbonylative Suzuki−Miyaura cross coupling reactions of N-acetylamides.84 Nickel 
catalyst is conducive to the d → 𝜋∗ back donation from nickel to CO 1-102, which 





hand, palladium has a higher electronegativity which possesses weaker d → 𝜋∗ back 
donation from palladium to CO 1-103. Therefore, Pd-catalyzed reaction gives the ketones 
as the product via nondecarbonylative pathway.  This origin of the chemoselectivity has 
been explained by back donation characteristics of the central metal atom. (Scheme 
1.38). 
 
Scheme 1.38: Decarbonylation vs Reductive Elimination of Ni and Pd Catalyzed 
Suzuki−Miyaura Coupling Reactions 
 
In 2017, Pan and coworkers reported a first example using amide as an 
electrophile to couple with another electrophile, via reductive cross-coupling of amides 
and aryl iodides, under nickel chemistry without using highly basic and pyrophoric 
nucleophiles (Scheme 1.39).85 Initially, the active Ni(0) catalyst generates from reduction 
of Ni(II), which activates the C−N bond of glutarimide resulting in the Ni(II) 





results in the phenyl radical, and which undergoes radical oxidative addition to Ni(II) 
species 1-105 to give the nickel(III) intermediate 1-106.  
 
1.7.2 Amide C(sp2) ‒N Bond Activation by Single-electron Reduction 
 






Desired cross-coupling ketone product would be afforded by reductive elimination of 
nickel(III) intermediate 1-106 along with reactive nickel(I) complex 1-107. Reaction of 
nickel(I) complex 1-107 with iodobenzene followed by reduction will be regenerated the 
active Ni(0) catalytic species. According to the general mechanism found in atom-
transfer radical addition reactions86, aryl radicals would also be generated by the reaction 
between Ni(II) intermediate 1-105 and iodobenzene.  
In 2020, Li and coworkers reported an acylation of aryl and alkyl bromides by 
employing acylimidazoles via C−N bond cleavage (Scheme 1.40).87  
 
Scheme 1.40: Ni-Catalyzed Reductive Cross-Coupling of Alkyl/Aryl Imidazolides with 
Alkyl/Aryl Bromides; a10 mol % NiI2, 20 mol % Terpyridine, ZnCl2 (2.0 eq.), Zn (3.0 
eq.), and 110 °C were Used; b10 mol % NiI2, 15 mol % 4-4´-Dimethoxy-2-2´-bipyridine, 






Notably, the homocoupling of aryl and alkyl bromides led to form symmetric ketones as 
the common byproduct. Radical clock experiments revealed that cross-coupling reactions 
of acylimidazoles are derived from primary and secondary acids, and a highly unusual 
carbon monoxide (CO)-extrusion-recombination pathway proceeds via radical 
intermediates. Interestingly, when (bromomethyl)cyclopropane was examined under 
standard conditions, a cyclopropane ring opened product obtained as the exclusive 
product, which indicated that the alkyl bromide had indeed proceeded via a radical 
pathway.  
 
Scheme 1.41: Proposed Mechanistic Pathways; A) Single Electron Transfer for Spatially 
Accessible Acylimidazoles; B) Concerted Oxidative Addition for Sterically hindered 
Acylimidazoles 
 
As indicated in pathway A, Ni(I) complex 1-108, acts as a reducing reagent that 
gives an electron to the less sterically hindered imidazolide via a single-electron transfer 





anion 1-110 gives rise to an acyl radical 1-111 that undergoes CO extrusion to form CO 
and an alkyl radical 1-112. Further reduced imidazolide Ni(II) complex 1-113 by zinc, 
then traps a CO to form Ni(0) carbonyl complex 1-114, which then subjected to oxidative 
addition of alkyl bromide via a radical process affording Ni(II) carbonyl complex 1-115. 
CO insertion followed by combination of the alkyl radical species 1-116 results in 
formation of Ni(III) intermediate 1-117 via Ni(II)complex 1-116. Desired ketone product 
and Ni(I) complex 1-108 will be regenerated after reductive elimination step (Scheme 
1.41). Sterically hindered imidazolides such as the acylimidazoles believed to be 
occurred via two electron process via pathway B. 
 
1.7.3 Lewis Base Promoted Amide C(sp2)‒N Bond Activation 
In 2016, Szostak group reported the synergistic combination of Lewis base and 
palladium catalysis to activate C−N bond of N,N-di-Boc-activated amides. A number of 
structurally diverse biaryl ketone products were synthesized on palladium-catalyzed 
Suzuki−Miyaura cross-coupling by employing di-Boc-activated amides.88  
 






 Synthetic utility was demonstrated by direct functionalization of pharmaceutically useful 
amide scaffolds in a gram scale synthesis. Synergistic mechanism was explained by 
invoking selective oxidative addition into the weak acylammonium bond to generate a 
highly reactive acyl-Pd(II) intermediate (Scheme 1.42). 
 
1.8 Catalytic C-C Coupling Methods via C=N Bond Activation 
2H-Azirines are highly reactive three-membered heterocyclic unsaturated 
compounds analogues to the saturated analogue aziridine which are highly important 
class of compounds found in natural products and biologically active compounds. Also, 
this class of compounds are used as valuable building blocks in organic synthesis due to 
their high ring strain. Number transition metal catalyzed C=N bond activation reactions 
has been developed by employing azirines. In 2018, Ding and coworkers used Zinc 
catalyzed [3 + 2] cycloaddition reaction by employing benzimidates and 2H-azirines to 
synthesize substituted imidazoles (Scheme 1.43). This protocol provided good functional 
group tolerance by having moderate to good yields.89 
 





First, cationic azirine complex 1-118 would be formed in the presence of ZnCl2. Which 
would undergo nucleophilic attack by benzimidate to generate intermediate complex 1-
119. Subsequent ring opening and intramolecular nucleophilic attack of the N to the 
carbocation and OEt as a leaving group form the five membered ring intermediate lead 
the formation of imidazole product. Very recently Song and coworkers reported a Cu-
catalyzed C–H arylation of enamines via C–N bond activation of 3-aminoindazoles. This 
expedient approach yielded 3-aminoindazoles with good to excellent yields by 









Catalytic cycle initiated by oxidation of 3-aminoindazole 1-120 by formation of 
compound 1-122. Simultaneously, tert-butoxyl radical would be generated via single 
electron transferred from the Cu(II) species to TBHP to deliver the Cu(III) species. 
Subsequent abstraction of a proton from the compound 1-122 leads the formation of 
benzonitrile radical intermediate 1-123 with extruding molecular nitrogen. Radical 
addition of intermediate 1-123 with the enamine gives rise to the production of radical 
intermediate 1-124, which is oxidized by the Cu(III) species to afford the carbocation 
intermediate 1-125 and Cu(II) species. Deprotonation of intermediate 1-125 furnishes the 






1.9 Catalytic C–Heteroatom Coupling Methods via C–N Bond Activation 
1.9.1 Catalytic C-N Coupling Methods via C(sp3)-N Bond Activation 
Chemical synthesis of carbon–heteroatom bond is very important transformation 
in the number of industrial and pharmaceutical processes. While various types of carbon–
heteroatom bond formation reactions have been reported, herein we will discuss catalytic 
C-N coupling methods via C–N activation with special reference to the reports came out 
during last five years. Apart from other carbon–heteroatom bonds, C–N coupling 
methods is a ubiquitous motif in most of the natural and synthetic compounds. 
Transition-metal catalyzed C–N coupling methods via C−N bond cleavage by oxidative 
addition, iminium and ammonium species, formation of imine and radical pathways will 
be discussed in this section. 
 
1.9.1.1 C(sp3)-N Bond Activation by Oxidative Addition 
Selective cleavage of the C−N bond of a primary amine is a challenging process 
because amine group is a poor leaving group and the N−H bonds have a relatively low 
tolerance for functional groups. However, protonation of the NH2 group makes it a better 
leaving group by decreasing the C−N bond strength. Therefore, acid-catalyzed C−N bond 
activation through the ammonium ion provides one way of C−N bond cleavage of the 
primary amines. On the other hand, formation of “C−[M]−N” by an oxidative addition to 
the transition metals with or without the aid of the acid should be an effective and direct 
strategy to realize the cleavage of C−N bonds. In 2015, Huang group reported a method 





C(sp3)−N bond activation.91 The reaction proceeded through the efficient insertion of 
carbenoids into the C−N bond of aminals (Scheme 1.45).  
 
 
Scheme 1.45: Substrate Scope of -Diazoesters and Aminals 
 
The mechanistic studies revealed that the formation of three-membered palladocycle 1-
126 was involved in the catalytic cycle. The cationic cyclopalladated species 1-126 reacts 
with a diazoester by giving palladium–carbenoid intermediate 1-127. Subsequent 
migratory insertion of the aminomethyl moiety would generate the species 1-128 
followed by nucleophilic attack release nucleophilic R2N
- to form species 1-129. Finally, 
reductive elimination released the desired α,β-diamino acid ester by regeneration of the  






Scheme 1.46: Proposed Mechanism for the Synthesis of α,β-Diamino Acid Ester 
Derivatives 
 
Alternatively, the intermediate species 1-130 would release nucleophilic R2N
- 
from the intermediate 1-127, which undergoes reductive elimination to give desired 
product under path b (Scheme 1.46). They were able to generate a number of 
pharmaceutically important tetracyclic N-[2-(methoxycarbonyl)-
ethyl]indoloisoquinolinones 1-131 by using a Pd(II)-catalyzed double intramolecular 
cyclization of 1,2-diarylethynes 1-132 bearing an N- methyl-N-[2-







Scheme 1.47: Synthesis of Tetracycles by Oxidative Diamination of Alkynes 
 
Synthetically useful ring expanded products were formed from transition metal catalyzed 
ring expansion of aziridines via oxidative addition of the C−N bond. In 2015, Zhang 
group reported a rhodium-catalyzed intramolecular formal hetero-[5 + 2] cycloaddition of 
vinyl alkyne aziridines 1-133 for the synthesis of fused azepine derivatives 1-134 (Eq. 
1.16).92 This novel catalytic method afforded the number of synthetically useful 
compounds with excellent functional-group compatibility up to >99% enantioselective 







1.9.1.2 C(sp3)-N Bond Activation via Iminium Ion Species  
 






A number of transition metal catalyzed C−N bond cleavage via the formation of 
iminium ion species, have been demonstrated recently. In 2016, Wang and coworkers 
reported the oxidative coupling reaction of tertiary aniline N-oxides 1-135 with internal 
alkynes, to afford N-alkylindole derivatives 1-136. More significantly, dealkylative 
cyclization reaction occurred via C−N bond cleavage through the iminium ion species 
(Scheme 1.48).93 Iminium ion 1-137 was generated from single electron oxidation 
deprotonation, and another single electron oxidation by the use of silver as an oxidant, as 
indicated in the major pathway. Simple hydrolysis of 1-137 would generate an 
intermediate 1-138, which then undergoes an intramolecular nucleophilic cyclization to 
afford indole derivatives 1-139. This strategy has been successfully applied by Huang 
group in 2017 to synthesize α,β-unsaturated amides from alkynes with carbon monoxide 
and tertiary amines as amine source, catalyzed by palladium complex. They were able to 
develop the C−N bond cleavage of tertiary amines by using DTBP (di-tert-butyl 
peroxide) as an oxidant via formation of iminium ion intermediate, and the amine moiety 
was successfully incorporated to the enone products (Scheme 1.49).94 
 






Similarly, catalytic C−N bond cleavage strategy was demonstrated by Song and 
coworkers by using tertiary amines to synthesize imidazo[1,2‑a]pyrimidines 1-140. 
Copper mediated oxidation of tertiary amines afforded the iminium species, which 
undergoes via two different pathways to render acetaldehyde as well as formaldehyde. In 
the presence of water iminium ion was hydrolyzed to yield a secondary amine and 
acetaldehyde products. On the other hand, deprotonation of tertiary amine would yield an 
enamine species, which would react with oxygen to render a dioxygencontaining four-
membered heterocycle, to form corresponding formamide and formaldehyde. Acrolein 1-
141 would be generated from the formaldehyde and acetaldehyde in-situ formed from the 
amine, which finally reacts with 2-aminobenzo[d]imidazoles to produce imidazo[1,2-
a]pyrimidine derivatives 1-140 (Scheme 1.50).95 
 
Scheme 1.50: Synthesis of Imidazo[1,2-A]Pyrimidines by In Situ Generated Acrolein via 






In 2018, Chai group developed a method to form synthetically useful 2‑(furan-3-
yl)acetamides 1-143 following C−N bond cleavage on palladium via formation of 
iminium species by using cascade reactions of allenols 1-142 in the presence of tertiary 
amine.96 Tertiary amine coordinates to the palladium alkyl species 1-144 by giving 
intermediate complex 1-145. Subsequently, iminium ion coordinated intermediate species 
1-146 is given through the elimination of HI from the C−H cleavage of 1-145. The 
intermediate species 1-146 will be further transformed into a palladium amine species 
facilitated by the in situ formed water via C−N bond cleavage, with an elimination of 
acetaldehyde and hydrogen as byproducts (Scheme 1.51).  
 
Scheme 1.51: Synthesis of 2‑(Furan-3-yl)acetamides from Allenols 
 
1.9.1.3 C(sp3)-N Bond Activation via Ammonium Ion Species  
An ammonium species considered as a good leaving group. Hence, converting the 





a Lewis acid-assistance. Common strategy to activation of the Csp3−N bond via 
ammonium ion species is the use of N-sulfonyl compounds, which are easily undergo 
C−N bond cleavage by yielding corresponding carbocations and primary sulfonamides as 
neutral byproducts with the aid of either a Lewis acid or a Brønsted acid conditions.97 In 
2019, Zeng and coworkers reported the substrate scope relevant to Buchwald−Hartwig 
amination reaction, utilizing quaternary ammonium salts via C−N bond cleavage pathway 
with a palladium t-BuXPhos catalytic system. Both N-aryl or N-arylmethyl heteroarenes 
were  afforded in moderate to excellent yields via C−N bond cleavage (Scheme 1.52).98  
 
Scheme 1.52: Palladium-Catalyzed C−N Coupling of Quaternary Ammonium Salts with 
NH-Heteroarenes 
 
Lu and coworkers in 2019 reported the use of 3-methyleneazetidines and diazo 





cycloaddition strategy with the ring expansion.99 Mechanistic studies revealed the C−H 
insertion, O−H insertion100, and olefin cyclopropanation, which are common 
transformations in Rh carbene chemistry, were diminished by predomination of [4+1] 
cycloaddition by indicating robustness of this method to generate 4-methyleneproline 
derivatives. Subsequently, number of tricyclic fused small to moderate N-heterocycles 
were synthesized by intramolecular reaction. Formation of rhodium carbene complexes 
are well established with the reaction of diazo compounds101 1-148, which is being 
nucleophilic attack by the azetidine nitrogen 1-147 to form a ylide 1-150. Subsequently, 
ylide 1-150 is transformed into desired product 1-149 via direct 1,2-migration or ring 
opening with zwitterionic species 1-151 followed by ring closure (Scheme 1.53). 
 
 
Scheme 1.53: Rhodium-Catalyzed Ring Expansion via C−N Activation and Coupling of 







1.9.2 Catalytic C-N Coupling Methods via Amide C(sp2)-N Bond Activation 
Amides are one of the most valuable functional groups as their presence in 
numerous molecules such as pharmaceutical agents, natural products, peptides etc. C–N 
coupling methods via amide C(sp2)–N bond activation examples were reported in related 
with transamidation reactions; those involved the conversion of one amide to another. 
Development of the transamidation reaction, where cleavage of C(sp2)–N bond of an 
amide is a long-standing challenge in synthetic chemistry, due to unfavorable kinetic and 
thermodynamic factors. Reported literature confirmed that the most effective way to 
activate amide C(sp2)–N bond through oxidative addition to the transition metal ion.  
 






In 2016, Garg and coworkers reported a two-step approach to effect the transamidation of 
secondary amides. Simple Boc-activation of the secondary amide followed by nickel-
catalyzed oxidative addition of an acyl C–N bond afforded corresponding amides with 
excellent yields for number of amines including amino-acid derivatives (Scheme 1.54).102 
In 2017, Szostak group reported palladium NHC (NHC = N-heterocyclic carbene) 
catalyzed protocol for transamidation of secondary carboxamides. Wide range of N-Boc 
and N-Ts protected amides were effectively employed for the transamidation with 
commercially available, air- and moisture-stable (NHC)Pd(R-allyl)Cl complexes.103 In 
2018, Lee and coworkers reported nickel briphos ligand system catalyzed direct 
transamidation of secondary amides with amines. In this protocol secondary amides were 
directly used without preactivation by Boc protection, as TMSCl activates the amine 
derivatives by forming corresponding bis(trimethylsilyl)anilines.104     
 
1.10 Summary and Conclusions 
Recent studies on transition-metal-catalyzed C−N activation methods have been 
emerged as effective protocols for using readily available nitrogen containing compounds 
to construct synthetically important molecules. In this chapter we have reviewed new 
C−C and C−N bond formation reactions with special reference to mechanistic insights. 
Mechanistically interesting pathways have been discussed in detail which were supported 
by theoretical calculations. Some of the reactions discussed were achieved via atom-
economical fashion which are expected to broad development by wide investigation in 
near future. We have reviewed number of recent amide C−N bond activation reactions 





reactions, esterification, and transamidation reactions. We have a great expectation that 
the area of C−N bond activation using nonprecious metals will continue to flourish and, 
in turn, will promote the growing use of simple primary amines and un-activated nitrogen 








Efficient Synthesis of Secondary Amines from the Ruthenium-Catalyzed 
Deaminative Coupling Reaction of Amines 
2.1 Introduction 
 
Figure 2.1: Selected Examples of Important Drug Molecules with Alkylated Amine 
Functionalities105 
 
Selective carbon–nitrogen bond formation reactions represent a key step for the 
synthesis of a plethora of pharmaceutically active compounds, with the growing 
repertoire of biologically relevant nitrogen containing molecules.106 Since amines are one 
of the prominent compounds present in pharmaceutical compounds, many synthetic 
methods have been developed over the years. Transition metal catalyzed C-N formation 









Scheme 2.1: Pd(0)-mediated Stochiometric Intramolecular Amination 
 
In 1983, Migita and coworkers reported a palladium catalyzed C–N cross-
coupling reaction of aryl bromides and N,N-diethylamino-tributyltin. They were able to 
demonstrate the limited reaction scope to only for few sterically unencumbered 
substrates.110 Later in 1984, Boger and Panek employed Pd(0)-catalyzed C–N bond 
formation method for the synthesis of lavendamycin (Scheme 2.1)111. In 1994, Hartwig 
group reported a systematic study on Migita’s work by using well-defined palladium 
compounds (Scheme 2.2).112 In the same year, Buchwald group reported an extension of 
the Migita’s work to obtain a variety of secondary amines by introducing transamination 
of Bu3SnNEt2. They were able to improve in both the product yields





substrate scope by using the Pd catalysts with bidentate phosphine ligands, 
diphenylphosphinobinapthyl (BINAP) and diphenylphosphinoferrocene (DPPF).114 Due 
to chelation of diphosphine ligands, the Pd-catalyzed Buchwald–Hartwig amination has 
been shown to be highly effective for forming aryl C-N bond forming reactions. 
 
Scheme 2.2: Palladium Catalyzed Amination (Left: X-Ray Structures of Catalytically 
Relevant Palladium Intermediates; Right: Proposed Catalytic Cycle) 
 
Ullmann and Goldberg initially discovered aromatic nucleophilic substitution 
reactions which required stoichiometric amounts of copper and high reaction 
temperatures. Subsequent improvements have led to the development into catalytic 





intramolecular Ullmann coupling strategy to prepare 4H-benzo[f]imidazo[1,4]diazepin-6-
ones (Eq. 2.1).115  
 
 
Scheme 2.3: Copper Catalyzed Enantioselective Hydroamination 
 
Hydroamination reaction, an addition of N-H bond of amine or ammonia across a 





nucleophilicity would be markedly reduced in the presence of electron-withdrawing 
substituents.116 In 2015, Miura and co-workers reported a Cu-catalyzed asymmetric 
hydroamination of alkenyl boronates with hydrosilanes and hydroxylamines to synthesize 
optically active α-aminoboronic esters. The umpolung electrophilic amination strategy 
enables the construction of chiral centers with  -unactivated alkyl side chains (Scheme 
2.4).117 These procedures require specific metal complexes and often suffer from the co-
production of considerable amounts of wasteful byproducts.  
Borrowing hydrogen and hydrogen auto-transfer methodologies have been 
developed to overcome the drawbacks associated with these C-N bond formation 
methods. Borrowing hydrogen technique is well suited for catalytic reactions involving 
temporary transfer of protons and hydrides from the substrates. The strategy has been 
used for a variety of catalytic process, in which hydrogen-rich substrates are transformed 
into C−C bond forming reactions and products (Scheme 2.5).  
 
Scheme 2.4: Schematic Representation of the Borrowing Hydrogen Technique for the 
Alkylation of Amines by Primary Alcohols 
 
Transition-metal-catalyzed dehydrogenative coupling methods have been shown to be 





alcohols.118 In particular, several late-transition-metal catalysts have been successfully 
employed to promote amine-alcohol coupling reactions via a borrowing hydrogen 
technique to synthesize secondary amines.106, 119 The reaction sequence starts with the 
dehydrogenation of alcohol to the corresponding aldehyde via an iron complex 2-1. One 
‘hydrogen equivalent’ is temporarily stored at the bifunctional catalyst 2-2, converted to 
the intermediate complex 2-3, and the carbonyl intermediate reacts with amine to form an 
imine intermediate and water. The ‘borrowed’ hydrogen equivalent from alcohol is used 
for the reduction of the imine intermediate to afford the desired products (Scheme 2.5).  
 









Traditionally, the synthesis of secondary amines were commonly achieved by 
using the reductive amination methods.120 Most of these traditional methods suffer from 
the formation of copious amounts of salt byproducts and require stoichiometric reducing 
agents and/or additives. Catalytic deaminative coupling methods have been emerged as 
an alternative protocol for the synthesis of secondary amines. In 2007, Beller group121 
used Shvo catalyst121a 2-4 for selective dealkylation reaction of amines. A variety of 
aliphatic amines with anilines react smoothly to give the corresponding aryl amines in 
excellent yields. The authors proposed that the reaction proceeds under transfer 
hydrogenation conditions via the formation of the active catalytic species 2-5 and 2-6.121a 
(Eq. 2.2). The coupling reaction of aniline with primary amines by using soluble Co 
catalysts have been achieved for the synthesis of unsymmetric secondary amines.122 More 
recently, a palladium-absorbed titanium dioxide (Pd/TiO2) photocatalytic system has 
been used for the synthesis of symmetric secondary amines from the coupling of primary 








Very recently, Peng and co-workers reported a CdSe/CdS core/shell quantum dots (QDs) 
system for visible light induced transfer hydrogenation reactions of imines to amines.124 
From both economic and environmental perspectives, the development of chemo-
selective catalytic coupling methods via C−N bond cleavage of amines and related 
nitrogen compounds remains an important goal in the fields of homogeneous catalysis 






2.2 Results and Discussion 
2.2.1 Synthesis of Cationic Ruthenium Hydride Complex 2-10 
 
Scheme 2.6: Synthesis of Cationic Ruthenium Hydride Complex 2-10 
 
Recently, our research group developed a convenient method for the synthesis for 
a well-defined cationic ruthenium-hydride complex [(ɳ6-C6H6)(PCy3)(CO)RuH]
+BF4
- (2-
10) from the protonation reaction of tetranuclear ruthenium complex 
{[(PCy3)(CO)RuH]4(μ-O)(μ-OH)2} 2-9 with HBF4.OEt2. The cationic ruthenium hydride 
complex 2-10 was obtained by two step synthetic procedures from the dimeric ruthenium 
hydride complex (PCy3)2(CO)RuHCl 2-7.
125 Base hydrolysis reaction of 2-7 with 
potassium hydroxide in isopropyl alcohol produced the bimetallic ruthenium complex 2-8 
in >90% yield. The complex 2-8 was purified by either recrystallization techniques (85%) 






Figure 2.2: X-ray Crystal Structure Of 2-9 Drawn With 50% Thermal Ellipsoids. 
Cyclohexyl Groups Are Omitted For Clarity. 
 
 
Figure 2.3: X-Ray Crystal Structure of Cationic Ruthenium Hydride Complex 2-10 
 
with wet acetone at 95 ⁰C yielded the tetranuclear Ru complex 2-9 in 84 % yield as 
brown-red powder. Thus, the treatment of 2-9 (200 mg, 0.12 mmol) with HBF4.OEt2 (64 





complex 2-10, which was isolated in 90% yield as ivory-colored solid (Scheme 2.9). The 
characterization of the ruthenium-hydride complex was performed by NMR 
spectroscopic and X-ray crystallographic techniques. The ruthenium hydride signal of 2-
10 was observed at δ -10.39 (d, JPH = 25.9 Hz) in CD2Cl2, and phosphine signal was 
observed at δ 72.9 ppm by 31P{1H} NMR spectroscopy. The molecular structure of the 
ruthenium hydride 2-10 showed a three-legged piano-stool geometry, which is capped by 
a ɳ6-benzene moiety. 
 
2.2.2 Synthesis of [Ru(3-,5-(tBu)2(1-,2-(O)2)C6H2)(PCy3)2(CO)] 2-11 and 
[Ru(C14H8(1-,2-(O)2))(PCy3)2(CO)] 2-13 Complexes 
The complex 2-10 (117 mg, 0.20 mmol), 3,5-di-tert-butyl-o-benzoquinone 2-12b 
(44 mg, 0.20 mmol), PCy3 (56 mg, 0.20 mmol) were dissolved in CH2Cl2 (3 mL) in a 25 
mL Schlenk tube equipped with a Teflon screw cap stopcock and a magnetic stirring bar 
under N2 stream. After stirring for 24 h in a water bath set at 70 °C, the solvent was 
removed under vacuum, and the residue was washed with 2% hexanes/EtOAc under 
nitrogen atmosphere (Eq. 2.4). The resulting residue was dissolved in acetone (3 mL), 







The resulting solid was filtered through a fritted funnel to yield the complex 2-11 (102 
mg, 56%) as a reddish crystalline solid. Single crystals of 2-11 were obtained by slow 
evaporation in EtOAc/pentanes, and its structure was determined by X-ray 
crystallography (Figure 2.4).  
 




Similar procedure was used to synthesize complex 2-13 from the reaction of 2-10 
with 9,10-phenanthrenequinone 2-12a as the ligand (Eq. 2.5). However, in this case, the 
ruthenium catecholate complex 2-13 was decomposed into the complex [Ru(C14H8(1-,2-
(O)2))(PCy3)2(CO)2] 2-14, which was completely identified by single X-ray 





complex 2-13 was formed in the crude reaction mixture (34% yield) and the procedure 
described in section 6.2.4 afforded the complex 2-13 in 80% yield. High resolution 
ESI/MS data was used to characterize the complex 2-13.  
  
Figure 2.5: Molecular Structure of Side Product [Ru(C14H8(1-,2-(O)2))(PCy3)2(CO)2] 
BF4
- Complex  2-14 
 
2.2.3 Synthesis of [(PCy3)2(CO)RuH(OH2)2]BF4- Complex 2-15 
 
 
Similar procedure as described in section 6.2.5 was used to synthesize the ruthenium 
hydride complex (Eq. 2.6). To our delight, the cationic ruthenium complex 
[(PCy3)2(CO)RuH(OH2)2]BF4
- (2-15) was obtained in 48% yield. However, the water 
coordinated complex 2-15 did not show any activity for the C–N bond cleaved amine 






Figure 2.6: Molecular Structure of [(PCy3)2(CO)RuH(OH2)2]BF4
- Complex 2-15 
 
2.2.4. Synthesis of Symmetric and Unsymmetrical Secondary Amines via C–N Bond 
Activation 
In an effort to develop novel catalytic coupling methods via C–N bond activation 
in which the liberation of ammonia is served as the driving force, we initially explored 
the promotional effect of the bidentate oxygen ligands for the ruthenium complex 2-9 by 
using the coupling reaction of primary amines.126 The coupling reaction of benzylamine 
with cyclohexylamine in the presence of 2-9 and 4-(1,1-dimethylethyl)-1,2-benzenediol 
2-16 afforded the selective formation of symmetric and unsymmetric secondary amines 
(2-17) via C–N bond cleavage (Scheme 2.13). From extensive screening efforts with the 
various oxygen and nitrogen containing ligands, the 1,2-catechol ligands were found to 
promote the one pot selective synthesis of symmetric secondary amines in nearly 
quantitative yields. Both symmetric 2-18 and unsymmetric 2-17 amines were selectively 
afforded from using the isolated ruthenium catecholate complex 2-11 in excellent yields 







Scheme 2.7: Ru-Catechol Homogeneous System for the sp3 C-N Bond Activation 




Scheme 2.8: Synthesis of Symmetric and Unsymmetric Secondary Amines from the 






2.2.5 Ligand Promoted Ruthenium Catalyzed Synthesis of Symmetric and 
Unsymmetrical Secondary Amines via C–N Bond Activation 
2.2.6 Optimization Studies 
 
 
2.2.6.1 Catalyst and Solvent Screening 
We initially screened soluble Ru catalysts with phenol and related oxygen and 
nitrogen ligands to promote the C−N bond activation reactions. We have chosen the 
coupling reaction of benzylamine with cyclohexylamine for screening of both ruthenium 
catalysts and the ligands (Eq. 2.7). Initially, both the tetranuclear Ru−H complex 2-9 and 
the cationic ruthenium complex 2-10 with a catechol ligand were found to exhibit the 
most promising activity for the coupling reaction among the screened Ru catalysts, as 
analyzed by both GC and NMR spectroscopic methods. To improve the yield and the 
selectivity for unsymmetric coupling products (2-17), a variety of parameters such as 
ligands, catalysts, solvents and the temperature were optimized, and the results are 















1 [RuH2(CO)(PPh3)3]  0 
2 RuHCl(p-cymene)2  <1 
3 [RuCl2(PPh3)3]  5/3 
4 [RuCl3
.3H2O)] without 2-16 <1 
5 [RuCl3
.3H2O)]  0/31 
6 [Ru(COD)Cl2]x  14/7 
7 2-7  70/15 
8 2-10 without 2-16 <5 
9 2-10  70/16 
10 2-9  74/22 




aReaction conditions: catalyst (3 mol % Ru), ligand (10 mol %), benzylamine (0.5 
mmol), cyclohexylamine (0.7 mmol), chlorobenzene (2 mL), 130 °C, 16 h. bThe 
product yield was determined by 1H NMR using hexamethylbenzene as an internal 
standard. 
 
We have chosen chlorobenzene as the solvent for the coupling reactions even though 
nonprotic polar solvents such as chlorobenzene and dioxane afforded the highest product 
yields and selectivity. The formation of the byproduct ammonia was detected in the crude 







2.2.6.2  Ligand Screening 
The 4-(1,1-dimethylethyl)-1,2-benzenediol ligand 2-16 was found to give the highest 
activity and selectivity in forming unsymmetric amine product 2-17a over the symmetric 
product 2-18a among the screened oxygen and nitrogen ligands as summarized in Table 
2.2. A 3:1 ratio of catechol ligand to ruthenium catalyst was found to exhibit the optimum 
catalytic activity. Compared to other catechol ligands, 2-16 gave the best product yield 
under the reaction conditions (entry 6). Other catechol ligands such as 2-16a, 2-16b and 
2-16d were found to be less effective (entries 7, 8 and 10). Interestingly, the electron-
deficient catechol ligand 2-16c gave better results (entry 9), and 2-hydroxybenzyl alcohol 
2-21 was quite effective for the transformation (entry 11). Electron rich phenols and 
anilines gave lower reactivity and selectivity in forming the product 2-17a (entry 12-14). 
In general, catechol ligands were found to be as effective as 2-17a for this transformation.  
The coupling reaction did not proceed at below 100 °C, while only a slightly 
improved product yield and the selectivity at an elevated temperature (entry 5, 15 and 
16). To our delight, we recently found that the use of the benzoquinone ligand 2-12, an 
oxidized analogue of catechol, significantly improved the yield of 2-17a to 90% in 1,4-
dioxane (entry 1). A higher coordinating ability of benzoquinone might be beneficial for 
promoting the catalytic activity of ruthenium catalyst. We also found that the isolated 
ruthenium catecholate complex 2-11 at a considerably lower catalyst loading (1 mol%) 






Table 2.2: Ligand Screening for the Reaction of Benzylamine with Cyclohexylamine.a 
 
 
entry ligand deviation from standard condition 
yield (%)d 
2-17a/2-18a 
1b 2-12   88/11 
2b 2-12a   79/16 
3b 2-12b   84/15 
4c - Complex 2-11 (1 mol%) 90/9 
5c - 100 C <1 
6 2-16   74/22 
7 2-16a   67/6 
8 2-16b   68/20 
9 2-16c   80/15 
10 2-16d   63/18 
11 2-21   60/12 
12 2-22   30/15 
13 2-23   15/10 
14 2-24   27/12 
15 2-16 140 C 76/23 
16 2-16 100 C <1 
17 - without Ru-catalyst; NH4PF6  <1 
18 - without Ru-catalyst; BF3  0 
19 - without Ru-catalyst; HBF4
.OEt2  0 
20 - without Ru-catalyst 0 
aReaction conditions: catalyst 2-9 (3 mol % Ru), additive (7 mol %), benzylamine (0.5 
mmol), cyclohexylamine (0.7 mmol), ligand (10 mol %), chlorobenzene (2 mL), 130 °C, 
16 h. bCatalyst 2-10 in 1,4-dioxane (2 mL). cRuthenium complex 2-11 (1 mol %) in 1,4-
dioxane (2 mL). dThe product yield of 2-17a was determined by 1H NMR using 






2.2.7 Reaction Scope  
After further ligand screening and optimization studies, we have established the 
standard reaction conditions at 1.0 mmol scale as: 2-9 (0.75 mol %, 3 Ru mol %)/2-16 
(10 mol %) in chlorobenzene (2 mL) at 130 °C. Although the initial results were obtained 
from the optimized catalyst system 2-9/2-16 under the standard conditions, we further 
tested selected substrates for the coupling reaction with ruthenium catecholate complex 
2-11 in 1,4-dioxane. The optimized standard conditions were used for all these coupling 
reactions, unless otherwise noted as described in Tables 2.3,  2.4 and 2.5 with slight 
modifications on the reaction time and temperature. 
 
2.2.7.1 Synthesis of Unsymmetric Secondary Amines from the Deaminative 
Coupling 
The substrate scope for the synthesis of unsymmetrical secondary amines from 
the deaminative coupling reaction of primary amines is summarized in Table 2.3. The 
coupling of benzylic amines with a variety of aliphatic and benzylic primary amines 
selectively formed the unsymmetric secondary amine products by affording moderate to 
good yields 2-17a−l. An excess amount (1.4 eq.) of the second amine (usually more 
electron rich) was found to improve the product selectivity for the formation of 
unsymmetric amines 2-17, and <20% of the symmetric amine products was formed in the 
crude mixture in most cases. Analytically pure unsymmetric amine products 2-17a−v 
were readily isolated after column chromatographic separation technique by using silica 






Table 2.3: Synthesis of Unsymmetric Secondary Amines from the Deaminative Coupling 
of Primary Amines 
 
Reaction conditions: catalyst 2-9 (3 mol % Ru), amine (1 mmol), amine (1.4 mmol), ligand 
(10 mol %), chlorobenzene (2 mL), 130 °C, 16 h. aRuthenium complex 2-11 (1 mol%) in 
1,4-dioxane (2 mL) were used (1H NMR yield using hexamethylbenzene as an internal 
standard); Ar = C6H4-4-OMe. 
 
The coupling reaction with phenethyl amines was found to be more selective towards 
unsymmetric coupling reaction. The coupling of both electron rich and poor phenethyl 
amines with both benzylic and aliphatic amines also gave the selective formation of 
products 2-17m−p. Piperonylamine and 1,2,3,4-tetrahydro-1-naphthylamine afforded the 
corresponding products in good yields 2-17q−s. Under the standard reaction conditions’ 





cyclohexylamine selectively yielded the unsymmetric secondary amine products in 80%, 
69% and 69% respectively 2-17t−v.126b In sharp contrast, the reaction with 1 mol % of 
isolated ruthenium catecholate complex 2-11 gave enhanced product yields for the same 
set of substrates, 88%, 90% and 81%. For these cases, the coupling of benzylic and other 
aryl-substituted amines with electron-rich amines tends to favor the formation of 
unsymmetrical amines over the symmetrical amines. In contrast, the coupling of two 
different aliphatic amines with a sterically nondemanding group yielded a mixture of 
symmetric and unsymmetric amines. The coupling reaction with secondary and tertiary 
amines was found to be very sluggish and unselective, resulting in a complex mixture of 
products. The catalytic coupling method is operationally simple and exhibits high 
chemoselectivity toward the formation of unsymmetric secondary amines without 
resorting to employing any reactive reagents. 
 
2.2.7.2 Synthesis of Symmetric Secondary Amines from the Deaminative Coupling 
We next explored the substrate scope for the formation of symmetric secondary 
amines by using the catalyst system 2-9/2-16 (Table 2.4). Benzylic primary amines 
reacted smoothly to afford the secondary amine products 2-18a−g without the formation 
of tertiary amines or other side products. The self-coupling reaction of 3-
phenylpropylamine gave a more selective product formation of secondary amine 2-18k, 








Table 2.4: Synthesis of Symmetric Secondary Amines from the Deaminative Coupling of 
Primary Amines 
 
Reaction conditions: catalyst 2-9 (3 mol % Ru), amine (1 mmol), ligand (10 mol %), 
chlorobenzene (2 mL), 130 °C, 16 h. aRuthenium complex 2-11 (1 mol%) in 1,4-dioxane 
(2 mL) were used (1H NMR yield using hexamethylbenzene as an internal standard); Yields 
for isolated products. 
 
The coupling of indanylamines formed the corresponding secondary amine products 2-
18l. Cyclohexyl, thiophene and furan substituted amines predictively yielded the 
corresponding secondary amine products 2-18m−o. Generally, the coupling of chiral 
primary amines led to a 1:1 diastereomeric mixture of products as illustrated by the 
formation of 2-18i and 2-18j, but interestingly, a diastereoselective formation of the 





amine (d.r. = 7:1). A mixture of secondary and tertiary amines (40-50% of tertiary 
amines) was formed for sterically nondemanding aliphatic amines such as n-hexylamine, 
while phenyl ethyl amines selectively formed the predicted products. Delightfully, 
isolated ruthenium catecholate complex 2-11 afforded the almost quantitate product 
formation without having tertiary amine byproduct for both 2-18c and 2-18m−o cases. 
The catalytic method delivers an operationally simple synthesis of symmetric secondary 
amines from readily available primary amines without using any reactive reagents via a 
deaminative coupling strategy.120,122 
 
2.2.7.3 Synthesis of Unsymmetric Secondary Amines from the Deaminative 
Coupling of Anilines with Primary Amines 
To further illustrate the synthetic versatility of the catalytic coupling method, we 
next explored the coupling reaction of aniline derivatives with primary amine substrates 
to synthesize drug candidates such as Piribedil and Alverine, as well as synthetically 
useful tridentate chelating agent Di-(2-picolyl)amine. The coupling of para-substituted 
anilines with benzylic amines led to the selective formation of unsymmetric amine 
products 2-19a−f without any significant amount of the symmetric amine products. 
Similarly, the reaction of para-substituted anilines with 3,4,5-trimethoxybenzylamine 







Table 2.5: Synthesis of Unsymmetric Secondary Amines from the Deaminative Coupling 
of Anilines and Substrates of Biological Relevance with Amines 
 
Reaction conditions: catalyst 2-9 (3 mol % Ru), amine 1 (1 mmol), amine 2 (1.4 mmol), 
ligand (10 mol %), chlorobenzene (2 mL), 140 °C, 20 h. aRuthenium complex 2-11 (1 
mol%) in 1,4-dioxane (2 mL) were used. 1H NMR yield using hexamethylbenzene as an 





The treatment of 3,4,5-trimethoxyaniline with tyramine yielded the product 2-15j 
in 51% yield, and the reaction with ortho-substituted sterically demanding aniline 
compound with phenylpropylamine yielded the selective secondary amine product 2-15k 
in 46% yield. The coupling reaction of 4-methoxyaniline with 2-aminoindane and 3,4-
dihydro-2H-1,5-benzodioxepin-7-amine with 3,4,5-trimethoxybenzylamine yielded the 
corresponding coupling products 2-19l and 2-19m in 74% and 75% yields, respectively. 
The coupling of (R)-(+)-aminoglutathimide with 3,4,5-trimethoxybenzylamine led to the 
optically active coupling product (R)- 2-19n without any detectable racemization.  
Biologically relevant amines were formed in excellent yields when we used the 
isolated ruthenium catecholate complex 2-11 in 1,4-dioxane. The treatment of 3-amino-9-
ethylcarbazole with benzylamine and geranylamine predictively yielded the product 2-
19o−p in 86% and 66% yield respectively. Also, the coupling reaction of 3,5-
dimethoxyaniline with geranylamine afforded the corresponding dehydrogenated 
coupling product 2-19q in 51% yield. The coupling reactions of 4-methoxyaniline with 
(+)-dehydroabietylamine also afforded the corresponding secondary amine product 2-19r 
in 81% yield with >99% single diastereomer. The coupling reaction of L-glutamine with 
3-phenylpropylamine led to the cyclized amine products 2-17w in 75% yield. The 
formation of cyclized product 2-17w can be rationalized by initial dehydrative cyclization 
of glutamine followed by the deaminative coupling with the primary amine substrate. The 
coupling reactions of electron donating aniline derivatives with geranylamine with the 
complex 2-11 gave the cyclized coupling product 2-21a-b in 44% and 38% yields, 
indicating that the novel synthetic route to generate 1,2,3,4-tetrahydro-4,methylquinoline 





important in coordination chemistry were synthesized using 2-11 as the catalyst in 1,4-
dixane by having 51% yield. Finally, the current protocol was extended to a one-pot 
synthesis of pharmaceutically useful drug candidates Piribedil and Alverine. Piribedil 2-
20a is an antiparkinsonian agent and piperazine derivative which acts as a D2 and D3 
receptor agonist and known to have α-adrenergic antagonist properties. 
 
Table 2.6: Synthesis of Drug Candidates and Synthetically useful ligands from the 
Deaminative Coupling of Amines 
 
Reaction conditions: catalyst 2-11 (1 mol%), amine 1 (1 mmol) and/or amine 2 (1.4 mmol) 




The one-pot synthetic reaction of 1-(2-Pyrimidyl)piperazine with piperonylamine 
selectively formed the product Piribedil 2-20a under ruthenium catalyst 2-11 in 1,4-
diaxane as the solvent at 140 C.  Alverine 2-20b is a drug used for irritable bowel 
syndrome, (functional gastrointestinal disorder), which is a known smooth muscle 
relaxant, was synthesized through sequential amine self-condensation of 3-
phenylpropylamine, which yields the product 2-18k followed by N-ethylation with ethyl 





catalytic coupling method provides an environmentally benign, and operationally simple 
protocol to afford the symmetric and unsymmetric secondary amines in moderate to 
excellent yields without formation of wasteful byproducts.  
 
2.2.8 Mechanistic Studies 
2.2.8.1 Reaction Profile Study 
The deaminative coupling reaction of 4-methoxybenzylamine was used to gain 
mechanistic insights. The self condensation of 4-methoxybenzylamine was monitored by 
NMR spectroscopy to probe the overall reaction profile. In a J-Young NMR tube 
equipped with Teflon stopcock, 4-methoxybenzylamine (34 mg, 0.25 mmol) and the 
catalyst system 2-9 (3 mg, 0.75 mol %)/2-16 (4 mg, 10 mol %) were dissolved in toluene-
d8 (0.5 mL). The tube was immersed in an oil bath at 130 °C, and the reaction progress 
was monitored by 1H NMR in 20 min intervals. As shown in Figure 2.7, the secondary 
amine product 2-18c was formed steadily at the expense of the benzylamine substrate. 
Initially, the formation of a minor product was also observed (∼10%), which gradually 
disappeared within 200 min of the reaction time. The structure of minor product was 
subsequently determined to be imine p-OMe-C6H4CH=NCH2C6H4(p-OMe) 2-22 by both 






Figure 2.7: Reaction profile for the coupling of 4-methoxybenzylamine: 4-methoxy-
benzylamine (■), (▲) 2-14c  and p-OMe-C6H4CH=NCH2C6H4(p-OMe) 2-22 (●) 
 
2.2.8.2 Deuterium Labeling Study 
Deuterium-labeling pattern on the product from the reaction of aniline-d7 with 4-
methoxybenzylamine was also investigated. A reaction tube consisting of aniline-d7 (50 
mg, 0.5 mmol) with 4-methoxybenzylamine (69 mg, 0.5 mmol) in the presence of 2-9 (7 
mg, 0.75 mol %)/2-16 (8 mg, 10 mol %) in chlorobenzene (1 mL) was heated in an oil 
bath at 140 °C for 20 h. The product 2-19e-d was isolated by silica gel column 
chromatography, and its deuterium content was analyzed by 1H and 2H NMR (Eq. 2.8). A 
significant amount of deuterium was incorporated into the methylene position of 2-19e-d 






In a control experiment, the treatment of the isolated product 2-19e with aniline-d7 in the 
presence of 2-9 (0.75 mol %)/2-16 (10 mol %) did not lead to any significant deuterium 
exchange into the benzyl position of 2-19e under similar reaction conditions after 20 h. A 
significant amount of the deuterium incorporation suggests that a facile and reversible 
imine-to-amine hydrogenation-dehydrogenation process might have occurred during the 




Figure 2.8: Top: 1H NMR Spetrum for 2-19e; Bottom: 1H and 2H NMR Spetra of H/D 








2.2.8.3 Carbon Isotope Effect Study  
To discern the rate-limiting step of the catalytic reaction, we employed 
Singleton’s high-precision NMR technique to measure the carbon isotope effect for the 
coupling reaction.127 The reaction tube of 4-methoxybenzylamine (2 mmol) and 2-9 (0.75 
mol %)/2-16 (10 mol %) in chlorobenzene (4 mL) was heated at 130 °C for 16 h for high 
conversion product 2-18c and low conversion sample was obtained after 2−3 h of the 
reaction time. The product 2-18c was isolated by column chromatography on silica gel 
and was analyzed by 13C NMR. The most pronounced carbon isotope effect was observed 
on the α-carbon of the product 2-18c when the 13C ratio of the product at three high 
conversions (86−89%) was compared with the sample obtained at low conversions 
(12−15%) [(average of 13C at 87% conversion)/(average of 13C at 13% conversion) at 
benzyl C = 1.015±0.001)] (Eq. 2.9). The significant carbon isotope effect on the α-CH2 
carbon is consistent with the C−N bond cleavage turnover-limiting step. In support of this 
notion, Singleton and co-workers showed that the observation of the most pronounced 
carbon isotope effect has been a definitive tool for establishing the rate-limiting step for 
both C−C and C−O bond-forming reactions.127c  
 
While C−N bond cleavage has been found to be the turnover-limiting step for a 
number of chemical and biochemical coupling reactions,128 very few carbon kinetic 





Fry and co-workers measured pronounced carbon isotope effects in the Hofmann 
elimination reaction of para -substituted (2-phenylethyl)- trimethylammonium bromides, 
which indicated an E2 mechanism involving C−N bond cleavage step.129 In a urease 
catalyzed hydrolysis of hydroxyurea, Cleland and co-workers observed a significant 
carbon isotope effect on the carbonyl carbon but not on the nitrogen atom, which argues 
for the formation of a common intermediate prior to the C−N bond cleavage step.130 
 
2.2.8.4 Hammett Study 
The Hammett plot was constructed from measuring the rate of the coupling 
reaction of a series of para-substituted benzylamines 4-X-C6H4CH2NH2 (X = OMe, Me, 
H, Cl, F, CF3) in the presence of 2-9 (0.75 mol %)/2-16 (10 mol %) in toluene-d8 (Figure 
2.9). The rate of each substrate was obtained by measuring the appearance of the product 
peaks, which were normalized against an internal standard (hexamethyl benzene) as 
analyzed by 1H NMR. The kobs for each catalytic run was determined from a first order 
plot. The Hammett plot of log(kX/kH) vs σp showed a linearly correlated pattern with ρ = 
−0.79 ± 0.1. A relatively high negative slope suggests a significant cationic character 






Figure 2.9: Hammett Plot of the Coupling of 4-Methoxyaniline with p-X-C6H4CH2NH2 
 
 
2.2.9 Detection of an Active Catalytic Species by NMR Method  
Cationic ruthenium hydride complex 2-10 and 4-fluorobenzene1,2-diol 2-16c 
were reacted in a sealed J-Young tube as indicated in the Eq. 2.10, and the products were 
analyzed by 1H and 31P NMR. We tentatively assigned these novel ruthenium hydride 









Figure 2.10: 1H and 31P {1H} NMR of Active Catalytic Species (2-23 and 2-24) Detected 




Figure 2.11: The Plot of Relative Concentration of The Ruthenium Hydride Species 
Generated from the Complex 2-10 (■) vs Time. Complex 2-23 (▲), Complex 2-24 (). 
 
The 1H NMR of active catalytic species 2-23 showed the Ru-H signals (1H-NMR δ -11.76 
(d, JPH = 6.7 Hz), -11.83 (d, JPH = 6.9 Hz); 
31P-NMR {1H} δ 72.5, 72.6) and 2-24 (1H-NMR 





2-23  2-24 






δ -11.30 (d, JPH = 25.5 Hz); 
31P-NMR {1H} δ 71.4)). Free benzene molecule was detected 
from the reaction of 4-fluorobenzene-1,2-diol. The plot of relative concentration of the two 
major catalytic species vs time is shown in Figure 2.11. 
 
2.2.10 Synthesis and X-Ray Crystallographic Determination of Ruthenium 
Catecholate Complexes 
In an effort to develop novel deaminative C–C coupling reaction with the ketone 
substrates and primary amines, we were able to observe a higher activity and selectivity 
when the catechol ligand was replaced with the 1,2-benzoquinone ligand. Delightfully, 
the chelated ruthenium catecholate complexes were isolated and identified (2-11, 2-14 
and 2-15) as described in  the section 2.2.2 and 2.2.3. Synthetic protocol was established 
for the synthesis of complex 2-11 which exhibited a remarkable activity for the C–N 
bond activation coupling reactions including secondary amine synthesis. 
2.3 Proposed Mechanism 
We present a plausible mechanistic hypothesis for the deaminative coupling 
reaction based on these kinetic and spectroscopic results (Scheme 2.9). Considering the 
observation of imine product, we propose the formation of a Ru-imine species 2-24 as a 
catalytically active species, which would be initially generated from the dehydrogenation 
of amine substrate. From the observation of imine product 2-22, we propose the 
formation of a Ru−imine species 2-25 as a catalytically active species, which would be 






Scheme 2.9: Proposed Mechanism for the Deaminative Coupling of Primary Amines 
 
To demonstrate the reversibility of the imine formation, we performed the reaction of 
PhN=CHPh (1.0 mmol) with cyclohexylamine (1.4 mmol) in the presence of 2-9/2-16 at 
130 °C. The reaction produced a complex mixture of aniline and the crossover products. 
In support of this notion, some oxidative C−N bond cleavage reactions are known to 
proceed via the formation of an imine intermediate.131 The coordination of imine 
substrate to the Ru center would increase the electrophilic nature of the imine carbon, and 
the nucleophilic addition of the second amine substrate would proceed to form the Ru 





complexes have been synthesized, and their reactivity patterns have been well 
established.132 The observation of carbon isotope effect provides an experimental support 
for the rate-limiting C−N cleavage step in forming the Ru-aminoalkyl species 2-27. In 
support of this, we have observed the prominent 13C isotope effect on the benzylic carbon 
of the symmetric coupling product 2-18 (C = 1.015±0.001). The dehydrogenation of 
second amine substrate in conjunction with the hydrogen transfer would form the 
coupling products 2-17/2-18 and 2-19 with the regeneration of imine species 2-28. Both 
the detection of imine product and the selective deuterium incorporation on the α-CH2 of 
2-18e-d suggest that the dehydrogenation and hydrogen transfer steps are likely facile and 
reversible under the reaction conditions. 
 
2.4 Summary and Conclusion 
In conclusion, we successfully devised a highly chemoselective synthesis of 
secondary amines from the deaminative coupling of primary amines. The catechol ligand 
promoted ruthenium catalytic system was found to exhibit a uniquely high activity and 
selectivity in forming both symmetric and unsymmetric secondary amines. The activity 
and selectivity were further enhanced by using the ruthenium catalyst 2-10 with 
benzoquinone ligands. The catalytic method is operationally simple, exhibits a broad 
substrate scope, tolerates common organic functional groups, and forms ammonia as the 
sole byproduct without employing any reactive reagents. The kinetic and spectroscopic 
studies indicate that the coupling reaction proceeds via the formation of imine species 





The isolated ruthenium catecholate complex 2-11 has been found to exhibit a 
higher activity for the deaminative coupling reaction illustrating the role of catechol 
additive as a chemo-selective ligand. We have successfully demonstrated synthetic utility 
of the coupling method via C–N activation for the synthesis of both symmetric and 
unsymmetric synthesis of amines, as well as the synthesis of drug candidates biologically 
active compounds. We used the catalytic deaminative method as a key step in the 
synthesis of the drug candidate Piribedil which is a dopamine antagonist for the treatment 
of Parkinson’s disease.133 The isolated ruthenium-catecholate catalyst was used for the 
synthesis of pharmaceutically active molecule Alverine by self-condensation and tertiary 
amine formation. We published an article in J. Org. Chem. 2018, 83, 4932–4947 (DOI: 
doi.org/10.1021/acs.joc.8b00649) on the basis of the part of work described in this 
Chapter. The article has been selected as a Featured Article for the issue and highlighted 








Scope and Mechanistic Study of the Redox-Active 1,2-Benzoquinone Enabled 
Ruthenium-Catalyzed Deaminative -Alkylation of Ketones with Amines 
3.1 Introduction 
The -alkylation of carbonyl compounds via the generation of enolates represents 
one of the most widely used carbon-carbon bond formation methods in organic 
synthesis.134 The -alkylation of carbonyl compounds have been extensively utilized in 
synthesis of natural products and pharmaceutically important drug molecules.135 Since 
traditional alkylation methods using stoichiometric amounts of strong base and organic 
halide coupling partners lead to the formation of copious wasteful byproducts, concerted 
research efforts have been devoted to the development of selective catalytic alkylation 
protocols that would avoid the use of strong base and obviate the formation of wasteful 
byproducts.  
 
Scheme 3.1: Traditional Alpha Alkylation of Ketones by Lithium Enolates  
The industrial processes heavily relies on enolates as pre-activated nucleophiles and alkyl 
halides as activated electrophiles for the formation of C−C bonds of ketones (Scheme 





commonly used to generate metal-enolates, in which the alkylation reaction is performed 
typically under the cryogenic conditions. Moreover, the traditional alkylation methods 
employ alkyl halides, which are expensive and generate halide-containing salts.136 The 
alkylation via Stork enamine provides an alternative strategy to obtain -alkylated 
products from the direct coupling of nucleophilic enamine intermediate upon addition 
with an alkyl halide or Michael acceptor (Scheme 3.2).137 However, the drawbacks of the 
alkylation method are that a stoichiometric amount of salt byproduct is produced and the 
reaction is favored to give a regioselective product at the less hindered side.  
 
Scheme 3.2: General Stork Enamine Reaction 
 
Transition metal-catalyzed “hydrogen borrowing” methodology, which involves 
the dehydrogenation of alcohols followed by aldol-type condensation with the ketone 
substrates, has been shown to be highly effective for promoting the alkylation of ketones 
with alcohols.135a, 138 In a significant advance for sustainable synthesis, earth-abundant 
transition metal catalysts have been successfully employed for the catalytic alkylation 
method via hydrogen borrowing technology.139 Very recently, Donohoe and co-workers 
achieved chemo- and regioselective synthesis of acyl-cyclohexenes by utilizing ketones 
with diols via a tandem acceptorless dehydrogenation-[1,5]-hydride shift cascade reaction 






Scheme 3.3: Chemo- and Regioselective Synthesis of Acyl-Cyclohexenes from Diols; 
AD = Acceptorless Dehydrogenation 
 
Upon oxidation of the diol substrate to the corresponding hydroxyaldehyde, aldol 
condensation with acetophenone would proceed to form an alkoxy enone 3-2. The alkoxy 
enone 3-2 then undergoes a cascade involving an intramolecular [1,5]-hydride shift 3-3 
followed by aldol condensation to form the corresponding cyclohexene 3-4. The 
cyclohexene adduct 3-4 can further be reduced to the corresponding cyclohexane with the 
regeneration of the active iridium catalyst.  
A number of novel catalytic C–H functionalization methods have been devised to 





seminal report, MacMillan and co-workers developed a direct -arylation of cyclic 
ketones with electron-deficient arylnitriles by combining photocatalysis with 
organocatalytic enamine alkylation protocol.142 Fagnoni and co-workers employed 
photoactive tungsten catalysts to achieve the direct coupling of cyclopentanones with 
electron-deficient alkenes to give -alkylated products.143 Widenhoefer and Che groups 
independently reported intramolecular C–H alkylation methods for ,-enone substrates 
to form cyclic ketones by using Pd and Au catalysis.144 Dong and co-workers recently 
reported a direct -alkylation of ketones with simple alkenes by using a bifunctional Rh 
catalytic system, in which an aza-indoline moiety was found to promote the conversion of 
-C–H bond of ketones into an enamine sp2 C–H bond prior to the alkylation reaction.145 
The bifunctional ligand, 7-azaindoline, activates the ketone -C-H bonds via enamine 
formation, 3-7 while the linked pyridyl moiety acted as a directing group, and the 
oxidative addition of a low-valent Rh(I) metal into the resulting enamine C-H bond 
affords the rhodium hydride species 3-8. Olefin insertion followed by reductive 
elimination would generate the intermediate 3-9, which undergoes hydrolysis to 






Scheme 3.4: Proposed Catalytic Cycle for Dong’s Bifunctional Rh Catalytic System 
 
In recent years, transition metal-catalyzed deaminative coupling methods have 
emerged as an effective tool for C–C bond coupling reactions.3a Glorius and co-workers 
devised an efficient deaminative alkylation of amines via the generation of pyridinium 





catalyzed allylic alkylation of carbonyl compounds with allylamines, which has been 
shown to involve a direct allylic C−N bond cleavage via the formation of Pd-allyl 
species.122 Martin and co-workers recently reported a highly regioselective Ni-catalyzed 
deaminative alkylation of unactivated olefins by using pyridinium reagents.147 Fu and co-
workers reported an efficient photocatalytic deaminative and decarboxylative alkylation 
of silyl enol ethers with redox-active esters and N-alkylpyridinium salts.148 From both 
synthetic and environmental points of view, catalytic C−C coupling methods via C−N 
cleavage by employing readily available amines as the substrates have been regarded as a 
highly attractive strategy for the synthesis of complex organic molecules as well as for 
reforming processes of nitrogen-containing biomass feedstocks.3a, 3b, 64b 
 
3.2 Results and Discussion 
We previously discovered that the cationic ruthenium hydride complex [(ɳ6-
C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 is a highly effective catalyst precursor for the 
deaminative and decarboxylative coupling reaction of ketones with amino acids.29 We 
subsequently found that the ruthenium-hydride complex 2-10 with a 1,2-catechol ligand 
exhibits an exceptionally high chemoselectivity for promoting the deaminative coupling 
reactions of amines to form unsymmetric secondary amines and quinazolinone 
derivatives.149 To extend the synthetic utility of ligand controlled catalysis, we have been 
exploring the promotional effects of various oxygen and nitrogen ligands on ruthenium 
catalysts for the deaminative coupling reactions of amines. Herein, we report the 
development and scope of a highly regioselective catalytic deaminative alkylation 





containing a redox-active ortho-benzoquinone ligand. We also delineate comprehensive 
experimental and computational studies for establishing a detailed mechanism of the 
catalytic reaction. The salient features of the catalytic method are that the -alkylation 
ketone products are formed in regio- and stereoselective fashion without employing any 
reactive reagents or forming any wasteful byproducts, while tolerating a number of 
common organic functional groups. 
 
Scheme 3.5: General Scheme for the Alkylation Protocol for Ketones with Amines 
 
3.2.1 Reaction Discovery and Optimization Studies 
We initially discovered that the catalytic system consisted of the Ru–H complex 
2-10 and a redox-active 1,2-benzoquinone ligand exhibited high catalytic activity for the 
deaminative coupling of acetophenone with 4-methoxybenzylamine to form the -
alkylated product 3-10a. The coupling reaction shown in Eq. 3.1 has been used as the 







3.2.2.1 Ligand Screening  
We first evaluated the ligand effect for the reaction of acetophenone with 4-
methoxybenzylamine. Without using any ligand, the 3-10a product was formed in 28% 
yield along with the imine product (Table 3.2; entry 8). While using phenol ligands (3-
11a) or 1-methoxyphenol (3-11b) ligands led to slight improved results compared to the 
ligand-free conditions, catechol ligands (2-16) gave the desired product 3-10a in 
significantly increased yield. In accordance with the previous result in the ruthenium 
catalyzed C(sp3)−N bond cleavage reaction, catechol ligand 2-16 was found to be 
effective and proved to be the optimal ligand for the selective synthesis of secondary 
amines.126b The catechol ligands with both electron donating and withdrawing group 2-
16a-e were shown to be effective for promoting the catalytic reaction by giving modest to 
good yields (65-78%), whereas 2,2´-biphenol ligand 2-12j gave a slight improved yield 
for the coupling reaction. The nitrogen donor ligands 3-32d and 3-33 and aliphatic diols 










aReaction conditions: acetophenone (0.5 mmol), 4-methoxybenzylamine (0.7 mmol), 2-
10 (3 mol %), ligand (10 mol %), 1,4-dioxane (2 mL), 130 °C, 16 h. bThe product yield 
of 3-10a was determined by 1H NMR by using hexamethylbenzene as an internal 
standard. 
 
As shown in Table 3.1, the catalytic activity of 2-10 was found to be substantially 
enhanced by the addition of a 1,2-benzoquinone ligand with the efficient formation of 
product 3-10a. In this case, secondary amine side product was observed as the minor 





complex 2-10 with 3,4,5,6-tetrachloro-1,2-benzoquinone 2-12 was found to exhibit the 
highest activity among screened benzoquinone ligands by affording 92% yield. 
 
3.2.2.2 Catalyst and Solvent Screening   
We found that 1,4-dioxane is the most suitable solvent for the coupling reaction 
(entry 2-7). The complex 2-10 was found to be most effective catalyst among the 
screened ruthenium catalysts (entry 1), where the reaction was tolerated the addition of 2 
equivalents of water (entry 9). Lewis acids and PCy3 did not show any activity for the 
coupling reaction (entry 19-22). A series of ligand screening and optimization efforts 
have led to the standard conditions for the coupling reaction: acetophenone (0.5 mmol), 
benzylamine (0.7 mmol), 2-10 (3 mol %) and 2-12 (10 mol %) in 1,4-dioxane (2 mL) at 
130 °C for 16 h (Table 3.2). The ammonia byproduct, which was detected by GC-MS in 
a crude reaction mixture, was removed under vacuum along with the solvent, and the 
product 3-10a was isolated by a column chromatographic separation on silica gel. 
 




deviation from standard 
conditions 
3-10a (%)b 
1 2-10 none 92 





3 2-10 cyclopentene (1eq.) 79 
4 2-10 chlorobenzene (as a solvent) 46 
5 2-10 1,2-DCE (as a solvent) <10 
6 2-10 xylene (as a solvent) 76 
7 2-10 toluene (as a solvent) 83 
8 2-10 without 2-12 28 





- - 54 
12 (PPh3)3(CO)RuH2 - 22 
13 (p-cymene)2RuHCl - 39 
14 RuCl2(PPh3)3 - 8 
15 RuCl3
.3H2O - trace 
16 [Ru(COD)Cl2]x - trace 
17 (PCy3)2(CO)RuHCl - 22 
18 [(PCy3)(CH3CN)(CO)RuH]
+BF4
- - 56 







aStandard conditions: acetophenone (0.5 mmol), 4-methoxybenzylamine (0.7 mmol), 
[(C6C6)(PCy3)(CO)RuH]
+ BF4
- 2-10 (3 mol %), 2-12 (10 mol %), 1,4-dioxane (2 mL), 130 
°C, 16 h. bThe product yield of 3-10a was determined by 1H NMR using 
hexamethylbenzene as an internal standard. c0.75 mol% of the ruthenium catalyst has been 
used. 
 
3.2.3 Reaction Scope  
3.2.3.1 Deaminative -C–H Alkylation of Ketones with Primary Amines 
The substrate scope of the deaminative alkylation reaction was examined by using 
the in-situ generated catalyst system 2-10/2-12 under standard conditions. We initially 
examined the selective alkylation of methyl ketones with various amine substrates (Table 
3.3). Benzylic amines with para-electron donating group were found to be most effective 





Table 3.3: Deaminative -Alkylation of Methyl Ketones with Aminesa 
 
aReaction conditions: ketone (0.5 mmol), amine (0.7 mmol), 2-10 (3 mol %), 2-12 (10 mol 
%), 1,4-dioxane (2 mL), 130 °C, 16 h. Ar = 4-methoxyphenyl 
 
On the other hand, acetophenones with electron withdrawing group afforded the 
corresponding products in higher yields than the ones with electron donating group 3-10f-
j. Both benzylic and aliphatic primary amines were found to be suitable substrates for aryl-





aliphatic ketones with benzylic and aliphatic amines cleanly formed the -alkylated ketone 
products 3-10p-r. In these cases, methyl carbon was selectively alkylated over methylene 
carbon in good to excellent yields (64-84%). 3′,4′-(Methylenedioxy)acetophenone with 4-
methoxybenzylamine also selectively formed the desired product in 71% yield 3-10s. In 
contrast, analogous 1,3-benzodioxol-5-ylmethylamine afforded the corresponding product 
with an electron rich acetophenone substrate 3-10t in 66% yield. Cyclohexylmethanamine 
was found to be a compatible amine substrate for the coupling reaction to form the products 
3-10u. A variety of heteroatom functional groups 3-10v-x were tolerated in forming the 
desired -alkylated ketone products. Amine substrates containing heterocycles (3-10y) as 
well as both polyaromatic substituted amines 3-10z and ketones 3-10aa were also found to 
be suitable substrates for the coupling reaction. These results demonstrated that the novel 
deaminative coupling method effectively leads to regioselective - alkylation ketone 
substrates. 
 
3.2.3.2 Deaminative -Methylene C–H Alkylation of Ketones with Primary Amines 
We next examined the scope of the coupling reaction of substituted ketone 
substrates (Table 3.4). The electron rich propiophenones with 4-
methoxyphenylethylamine and benzylamine afforded the desired products 3-10ab and 3-
10ac in 84% and 61% yields respectively. In general, the alkylation occurs 
regioselectively at the less substituted -carbon of ketones, but the coupling of 1-phenyl-
2-butanone with a benzylic amine formed the branched alkylated product 3-10ad-ae, 
resulting from the regioselective alkylation on the phenyl-substituted carbon. The 





and benzylic amines smoothly resulted in the alkylation products 3-10af-ak in high 
yields. The coupling reaction of substituted cyclic ketones with benzylic amines resulted 
in a highly diastereoselective alkylation products 3-10al-an. In contrast, the coupling 
with cyclohexanone with a chiral amine (R)-(+)--methylphenethylamine resulted in a 
2.8:1 diastereomeric mixture of 3-10ao. 
 
Table 3.4: Deaminative -Alkylation of Methylene Position of the Ketones with 
Aminesa 
 
aReaction conditions: ketone (0.5 mmol), amine (0.7 mmol), 2-10 (3 mol %), 2-12 (10 mol 






The coupling reaction of propiophenone with a chiral amine (R)-(+)- -
methylphenethylamine resulted in a decreased of both yield and diastereoselectivity. 
Sterically demanding primary or secondary amines with -quaternary carbon did not give 
any alkylation products. 
 
3.2.3.3 Deaminative -Alkylation of Ketones with Biologically Active Primary 
Amines 
We next explored the synthetic utility of the coupling method by employing 
several biologically active ketone and amine substrates (Table 3.5). The coupling of an 
indole-substituted ketone with (-)-cis-myrtanylamine yielded the coupling product 3-10at 
without any detectable racemization on the chiral methyne position, the structure of 
which was determined by X-ray crystallography. The coupling of nabumetone  with (-)-
cis-myrtanylamine also shown the similar reactivity affording corresponding product 3-
10au. The treatment of 4-(1H-indol-3-yl)butan-2-one and nabumetone with geranylamine 
led to the coupling products 3-10av and 3-10aw, with the regioselective hydrogenation 
on the proximal double bond. The treatment of 4-morpholinylacetophenone with 4-
methoxybenzylamine cleanly afforded the -alkylated product 3-10ax in 71% yield, the 
structure of which was also confirmed by X-ray crystallography. 4-Fluoroacetophenone 
and 4-morpholinobenzylamine smoothly formed the coupling product, as illustrated by 
the formation of 3-10ay, and morpholinyl, furan-, and thiophene-substituted amines 





Table 3.5: Deaminative -Alkylation of Ketones with Biologically Active Aminesa 
 
aReaction conditions: ketone (0.5 mmol), amine (0.7 mmol), 2-10 (3 mol %), 2-12 (10 mol 






Unsaturated ketone substrates also well tolerated the reaction by giving good to excellent 
yields as shown in 3-10az-bc. The coupling of acetone with (+)-dehydroabietylamine led 
to an essentially single diastereomer of the alkylation product 3-10bd, while the coupling 
of 5--cholestan-3-one with iso-amylamine resulted in a 6:1 diastereomeric mixture of 
the product 3-10be. These examples amply illustrate the synthetic utility as well as 
heteroatom functional group compatibility of the catalytic method in forming -alkylated 
ketone products. 
 
3.2.4 Mechanistic Studies 
3.2.4.1 Reaction Profile Study 
We have chosen the reaction of acetophenone with benzyl amines for probing the 
mechanism of alkylation reaction. First, we monitored the catalytic coupling reaction of 
acetophenone with 4-methoxybenzylamine by using the NMR method. Thus, the 
treatment of acetophenone (0.10 mmol) with 4-methoxybenzylamine (0.10 mmol) in the 
presence of complex 2-10 (3 mol %)/2-12 (10 mol %) in toluene-d8 (0.5 mL) in a J-
Young NMR tube was immersed an oil bath set at 130 °C. The tube was taken out from 
the oil bath in 20 min intervals and was analyzed by 1H NMR at ambient temperature. As 
shown in Figure 3.1, a rapid formation of the imine product PhMeC=NCH2C6H4-4-OMe 
(3-13a) was initially observed, reaching at its maximum concentration within 40 min. 
After 1 h, the alkylation product 3-10a was gradually appeared at the expense of 3-13a, 
and the complete conversion to 3-10a took about 3 h of the reaction time under these 
conditions. The formation of 3-10a was found to exhibit the first order kinetics, as 






Figure 3.1: Reaction Profile for the Coupling Reaction of Acetophenone with 4-
Methoxybenzylamine. Acetophenone (■), 3-10a (▲), 3-13a (●). 
3.2.4.2 Reaction with Imine Substrate 
In a separate preparatory-scale experiment, we have been able to isolate the imine 
product 3-13a in 99% yield from the dehydrative coupling reaction of acetophenone with 
4-methoxybenzylamine. The subsequent treatment of the isolated imine 3-13a with 2-10 
(3 mol %)/2-12 (10 mol %) and water (2 eq.) under the standard conditions cleanly 









Scheme 3.6: Reaction of Imine Species  3-13a-d Substrates Under Standard Reaction 
Conditions 
 
In this case, the addition of water was found to be essential because a stoichiometric 
amount of water would be required for the hydrolysis of imine in forming the ketone 
product 3-10a. Similar reactivity has been observed when the reaction was performed 
with the aldimine species 3-13b, which was independently generated from the reaction of 
1-(4-methylphenyl)ethylamine with 4-methoxybenzaldehyde. This observation suggested 
that the imine isomerization of 1-(4-methoxyphenyl)-N-(1-(p-tolyl)ethyl) methanimine 3-
13b  to (4-Methoxyphenyl)-N-(1-phenylethylidene) methanamine 3-13a is a possible 
pathway before the alkylation step. Also, independently synthesized aldimines 3-13c and 
3-13d from the reaction of 4-methoxybenzaldehyde with cyclohexylamine and (S)-(+)-1-
cyclohexylethylamine afforded the corresponding alkylated products 3-10bf and 3-10bg 





3.2.4.3 Crossover Experiment 
Both the reaction profile and the imine reaction experiments established that the 
imine 3-13a is the requisite intermediate for the alkylation product 3-10a. To probe 
whether 3-10a is resulted from an intramolecular or an intermolecular disproportionation 
process, we next performed a set of crossover experiments by using the isolated imine 
substrates 3-13a and 3-13c. Thus, a 1:1 mixture of the independently generated 3-13a 
(0.25 mmol) and N-cyclohexylidene-3-phenylpropan-1-amine (3-13c) (0.25 mmol) in 
1,4-dioxane (2 mL) was treated with the catalytic system 2-10/2-12 and water (0.50 
mmol) under otherwise the standard reaction conditions for 16 h (Eq. 3.2).  
 
The isolated product mixture contained a nearly 1:1 mixture of the products 3-10a and 3-
10aj in 94% and 85% respectively, with only a small amount of the crossover products 
(<10%). The absence of crossover coupling products indicates that the conversion of 
initially formed Schiff base 3-13a to the alkylation product 3-10a predominantly 






3.2.4.4 Deuterium Labeling Study 
We next examined the deuterium exchange pattern of the coupling reaction to 
probe the possible imine-to-enamine isomerization process. Thus, the treatment of 
perdeuterated acetophenone C6D5COCD3 (0.50 mmol) with 4-methoxybenzylamine (0.70 
mmol) in the presence of 2-10 (3 mol %)/2-12 (10 mol %) under the standard conditions 
formed the coupling product 3-10a-d, which was isolated by a column chromatography 

















The deuterium content of the isolated product 3-10a-d1 showed 41% on -CH2 
and 21% on -CH2 positions as analyzed by 
1H and 2H NMR (Figure 3.2). The 
analogous coupling reaction of acetophenone with 4-methoxybenzylamine and D2O (2 
eq.) resulted in 26% deuterium incorporation on the -CH2 and 14% on the -CH2 
positions of the product 3-10a-d2 (Eq. 3.4). In a control experiment the treatment of 3-
10a with D2O (2 eq.) under the standard reaction conditions were performed. However, 
significant deuterium exchange only to the -CH2 (30% D) without any measurable 
deuterium on -CH2 position of the product 3-10a and in the 3-10a-d
3 after the reaction 
(Eq. 3.5). A relatively high degree of H/D exchange on the -CH2 group of the isolated 





product during and after the coupling reaction. In contrast, over 20%  of deuterium 
incorporation on the -CH2 position of the product 3-10a-d
1 (21%) and 3-10a-d3 (26%) 
supports the notion that a significant H/D exchange is resulted from the coupling reaction 
with amine substrate, and that the exchange process must have occurred during the 
coupling reaction, as noted by the absence of deuterium exchange under the control 
experiment conditions. 
 
The H/D exchange to -CH2 position can be readily explained by a facile and reversible 
imine-enamine tautomerization process, while the exchange to -CH2 position can be 
explained via an initial amine-imine dehydrogenation reaction (Scheme 3.7).  
 
 
Scheme 3.7: H/D Exchange Mechanism via Imine-Enamine Tautomerization (top); and 





However, an alternate mechanism via the carbonyl-assisted 5-membered metallacyclic 
species cannot be ruled out at this point, in light of the recent development of carbonyl-
directed catalytic sp3 C–H functionalization methods.17 In an unrelated process, an 
extensive H/D exchange on the ortho-arene position (64% of D) of the product 3-10-d1 
can be explained via the chelate-assisted ortho-metalation and the reversible H/D 
exchange. This type of ortho-arene C–H/C–D exchange pattern has been commonly 

















Reversible H/D exchange process during the imine-enamine tautomerization was 
monitored by using the deuterium-labeled imine substrate 3-13b-d1, which was prepared 
from the reaction of 4-methoxybenzaldehyde-d1 with 1-p-tolylethanamine. The treatment 
of 3-13b-d1 (98% D) with H2O under the standard reaction conditions led to the 
formation of 3-10h-d1 with the exclusive deuterium on the -CH2 position (49% D), 
which amounts to >98% retention of the deuterium atom (Eq. 3.6). The absence of 
significant H/D exchange in the formation 3-10h-d1 is consistent with an irreversible 
C=N isomerization of an aldimine 3-13b-d1 to a more stable ketimine prior to the product 
formation. The similar imine-enamine tautomerization process has been observed in a 
number of metal-catalyzed C–C and C–N coupling reactions.19 
 
3.2.4.5 Deuterium Isotope Effect Study 
To probe electronic effects on the -C–H bond activation, we measured the 
deuterium kinetic isotope effect for the -alkylation reaction catalyzed by the complex 2-
10/2-12 ligand with (4-Methoxyphenyl)-N-(1-phenylethylidene)methanamine 3-13a (Eq. 
3.7) and 3-13a-d (Eq. 3.8). Thus, the rate of  3-13a and 3-13a-d in the presence of 2-10 
(3 mol %)/2-12 (10 mol %) was measured by monitoring the appearance of the product 
signals on 1H NMR, which were normalized against the peak of an internal standard 





13a0] vs time (Figure 3.4). Deuterium kinetic isotope effect on the  -hydrogen of the 3-
13a intermediate was found to be kH/kD= 1.00.1, which indicates C–H activation of the 
reaction is not involving in the turnover limiting step. 




Figure 3.4: First Order Plot of the Catalytic -Alkylation of (4-Methoxyphenyl)-N-(1-
phenylethylidene)methanamine (▲) and Deuterated (4-Methoxyphenyl)-N-(1-






3.2.4.6 Hammett Study 
 
Hammett equation describes a linear free-energy relationship of the reaction rates 
and equilibrium constants with respect to electronic nature of the substrates. We 
compared the electronic effects for the alkylation reaction by measuring the rates of the 
alkylation reaction of acetophenone with a series of para-substituted benzylamines p-X-
C6H4CH2NH2 (X = OMe, Me, H, F, Cl, CF3) (Eq. 3.9). The rate of the coupling reaction 
of acetophenone (0.20 mmol) with a para-substituted benzylamine (0.30 mmol) in the 
presence of 2-10 (3 mol %)/2-12 (10 mol %) in toluene-d8 was monitored by NMR.  
  
Figure 3.5: (a) Hammett Plot from the Coupling Reaction of Acetophenone with p-X-







The appearance of the product peak 3-10 was normalized against an internal standard 
(C6Me6) in 30 min intervals, and the kobs of each catalytic reaction was determined from a 
first-order plot of ln[([C6H5COMe]I - [C6H5COMe)]t) /([C6H5COMe)]i)0] vs time. The 
Hammett plot of log(kX/kH) vs σp showed a linear correlation, in which the reaction is 
strongly promoted by an electron-releasing group of the amine substrate (ρ = -0.49 ± 0.1) 
(Figure 3.5a). The analogous Hammett plot was also obtained from the alkylation 
reaction of a series of para-substituted acetophenones p-Y-C6H4COMe (Y = OMe, Me, 
H, F, Cl, CF3) with 4-methoxybenzylamine (Eq. 3.10). 
 
The rate of the coupling reaction of a para-substituted acetophenone (0.20 mmol) with 4-
methoxybenzylamine (0.30 mmol) in the presence of 2-10 (3 mol %)/2-12 (10 mol %) in 
toluene-d8 was measured by NMR, and the kobs of each catalytic reaction was determined 
from a first-order plot of ln[p-OMe-C6H4CH2N=C(Me)-p-Y-C6H4]i-[p-OMe-
C6H4CH2N=C(Me)-p-Y-C6H4]t)/([p-OMe-C6H4CH2N=C(Me)-p-Y-C6H4]i)0] vs time. In 
this case, the coupling reaction was moderately promoted by an electron-withdrawing 
group of the ketone substrate, as indicated by a relatively modest slope (ρ = +0.20 ± 0.1) 
(Figure 3.5b). A strong promotional effect from para-electron-releasing group of the 
benzylamines suggests that the C–N bond cleavage step is strongly influenced by the 
nucleophilicity of the benzylic carbon. On the other hand, a moderate promotional effect 





nature of the -carbon of the ketone substrate is a significant factor for the C–C bond 
formation step. 
With the observations of the Hammett correlation data in hand, we decided to perform a 
set of experiments to avoid the complex reaction kinetics by employing para substituted 
imines as the substrates (p-X-C6H4CH2N=C(Me)C6H5; X = OMe, H, F, CF3) and (p-
OMe-C6H4CH2N=C(Me)-p-Y-C6H4; Y = OMe, H, F, CF3). The kobs was determined from 
a first-order plot of -ln([p-X-C6H4CH2N=C(Me)C6H5]t/[p-X-C6H4CH2N=C(Me)C6H5]0) 
vs time (Figure 3.6). 
   
   
Figure 3.6: First-Order Plots of -ln([p-X-C6H4CH2N=C(Me)C6H5]t/[p-X-






Similarly, the kobs of the analogous reaction was determined from a first-order plot of -
ln([p-OMe-C6H4CH2N=C(Me)-p-Y-C6H4]t/[p-OMe-C6H4CH2N=C(Me)-p-Y-C6H4]0) (Y 
= OMe, H, F, CF3) vs time (Figure 3.7). The Hammett plot of log(kX/kH) vs σp showed a 
linear correlation (Figure 3.8), suggesting that the initial formation and accumulation of 
the imine intermediate is not effectively involve in the overall kinetics for the coupling 
reaction of ketone and amine. This result is consistent with the electrophilic nature of the 




Figure 3.7: First-order Plots of -ln([p-OMe-C6H4CH2N=C(CH3)-p-Y-C6H4]t/[p-OMe-







Figure 3.8: (a) Hammett Plot from the Rearrangement Reaction of p-X-
C6H4CH2N=C(CH3)C6H5 (X = OMe, H, F, CF3); (b) Hammett Plot from the 
Rearrangement Reaction of p-OMe-C6H4CH2N=C(CH3)-p-Y-C6H4 (Y = OMe, H, F, CF3) 
3.2.4.7 Carbon Isotope Effect Study 
 
The Hammett study implicates that either C–N bond cleavage or C–C bond formation is 
the most likely to be rate determining step for the catalytic alkylation reaction. To discern 
between these possible turnover limiting steps, we measured carbon kinetic isotope effect 
for the coupling reaction by employing Singleton’s NMR technique at natural 
abundance.127 Thus, the treatment of acetophenone (2.0 mmol) with 4-
methoxybenzylamine (2.8 mmol) in the presence of 2-10 (3 mol %)/2-12 (10 mol %) in 
1,4-dioxane (8 mL) was heated at 130 °C for 20 h (Eq. 3.11). The product 3-10a was 





three times to obtain a high product conversion sample of 3-10a. The same experimental 
procedure was used for the isolation of a low product conversion sample of 3-10a. The 
high precision 13C NMR analysis showed the significant carbon isotope effect on the -
carbon of the product 3-10a when the 13C ratio of the product from a high conversion was 
compared with the sample obtained from a low conversion (13C (avg 77% 
conversion)/13C (avg 13% conversion) at C = 1.0200.001; average of three runs), 
(Table 3.6). The observed carbon isotope effect on the -carbon of the product 3-10a can 
be rationalized via an asynchronous transition state on the C–C bond formation step. 
Table 3.6: Average 13C Integration of the Product 3-10a Obtained from the Reaction of 
Acetophenone and 4-Methoxybenzylamine at High Conversion (Virgin, R0; 78% 
conversion), at Low Conversion (R; avg 13% conversion) and the Calculated 13C KIE 









1 1.1206 1.1213 0.9994 0.9994 
2  2.1720 2.1728 0.9996 0.9996 
3  2.1094 2.1207 0.9947 0.9947 
4 1.1497 1.1475 1.0019 1.0019 
5 1.1355 1.1351 1.0004 1.0004 
6 1.0694 1.0488 1.0196 1.0196 
7 1.0641 1.0668 0.9975 0.9975 
8 1.1424 1.1481 0.9950 0.9950 
9 2.0528 2.0552 0.9988 0.9988 
10 2.0312 2.0392 0.9961 0.9961 
11 1.1467 1.1504 0.9968 0.9968 
12 (ref) 1.0000 1.0000 1.0000 1.0000 
 
In support of this notion, Singleton and co-workers showed that the observation of most 





limiting step for both C–C and C–O bond forming reactions.151 The C–N bond cleavage 
step has also been commonly considered as the turnover limiting step for catalytic 
reductive coupling reactions of amines and related organonitrogen compounds.3b, 64b 
 
3.2.4.8 Determination of an Empirical Rate Law  
Kinetics for the transformation of the isolated imine 3-13a was measured as a 
function of [2-10], [3-13a] and [H2O] under the standard reaction conditions unless 
otherwise noted (Eq. 3.12). Isolated imine 3-13a has been used as the substrate to avoid 
induction period kinetics during the formation of 3-10a or possible accumulation of 
intermediate species from the initial dehydration reaction. 
 
The initial rate was measured from the appearance of the product of 3-10a at four 
different catalyst concentrations (4-20 M). The plot of 3-10a vs time under four 
different catalyst concentrations clearly shows the concentration dependence with respect 
to 2-10 (Figure 3.9a). The plot of initial rate (ν0) as a function of [2-10] yielded a linear 






Figure 3.9: Plots for the (a) 3-10a vs Time and (b) Initial Rate vs [2-10] 
 
  
Figure 3.10: Plots for the (a) 3-10a vs Time and (b) Initial Rate vs [3-13a] 
 
As expected, the plot of 3-10a vs time under four different imine concentrations of 3-13a 
(0.2-0.8 mM) indicated the first order concentration dependence. The initial rate as a 
function of the substrate concentration [3-13a] (0.2-0.8 mM) also showed the first order 
rate dependence on 3-13a in the range of the catalytically relevant concentrations (0.2-0.8 






Figure 3.11: Plots for the (a) 3-10a vs Time and (b) Initial Rate vs [H2O] 
 
On the other hand, no water concentration dependence was observed for the 
transformation (Figure 3.11a). The plot of initial rate vs [H2O] showed a zero-order 
dependence in the range of 0.4-1.2 mM (Figure 3.11b). On the basis of these kinetic 
data, the empirical rate law for the reaction has been compiled as rate = k[2-10][3-13a]. 
The first order rate dependence on both [3-13a] and the catalyst [2-10] is consistent with 
an intramolecular process on the formation of 3-10a, whereas the rate independence on 
[H2O] indicates a facile imine hydrolysis step during the catalysis. 
 
3.2.5 Detection of Catalytically Relevant Organic Products 
We reasoned that the intramolecular alkyl migration mechanism would be the key 
step for the desired -alkylated product formation, in which an enamine species would be 
a requisite intermediate for the coupling reaction. In an effort to detect the catalytically 
relevant enamine products, we were able to isolate and characterize the (Z)-1,1,1-





14 from the reaction of  4,4,4-trifluoro-1-(2-naphthyl)-1,3-butanedione and 3,4,5-
trimethoxybenzylamine under standard reaction conditions (Eq. 3.13). 
 
The imine product 3-13 was established by both NMR and X-ray crystallographic 
methods, which clearly indicated that the formation of intramolecular hydrogen bonding 
stabilized the enamine intermediate. This observation indirectly supports the formation of 
enamine intermediate as the reaction did not yield the product 3-13 in the absence of the 
ruthenium catalyst 2-10. When the isolated product 3-35 was subjected to the standard 
reaction conditions, it did not form the alkylation product, probably due to the 
stabilization of intramolecular hydrogen bonding and electronic reasons.  
In a separate experiment, we tested the imine isomerization on ruthenium catalytic 
system by employing independently synthesized (E)-N-(4-methoxybenzylidene)-1,1-





product was completely isomerized into a stable ketoimine product N-(4-
Methoxybenzyl)-1,1-diphenylmethanimine 3-13g. 
 
When the catalytic system was tested for the reaction of electron rich ketone with 
4-methoxybenzylamine under the standard reaction conditions, about 20% of unexpected 
byproduct 3-15 was formed along with 56% desired product 3-10g (Eq. 3.15). In this 
case, the formation of trisubstituted pyridine byproduct 3-15 was difficult to rationalize 
due to symmetric nature of the product formation. 
 
In order to understand the reaction mechanism of the trisubstituted pyridine 





of 7-bromo-1-tetralone with 2-thiophenemethylamine. To our delight we were able to 
obtain similar pyridine byproduct 3-16 from the 2:1 coupling of ketone and amine 
substrates (Eq. 3.16).  
 
 
This observation clearly suggested that the formation of the pyridine product 3-16 was 
resulted from the second enolate attack. As the imine intermediate proceeded the 
formation of desired alkylated product, the in-situ generated imine 3-16a, from the initial 
dehydrative coupling of ketone and amine substrates, is the active substrate for the 
catalytic alkylation reaction. Coordination of the imine 3-16a with the active ruthenium 
complex followed by imine-to-enamine isomerization and subsequent C-N bond 
activation would form intermediate ruthenium alkyl complex 3-16b. An intramolecular 
[1,3]-alkyl migration would form the Ru-imine species 3-16c and double bond 
isomerization would form the intermediate species 3-16d and 3-16e. Second enolate 





trisubstituted byproduct 3-16. This observation provides an additional supportive 
evidence for the intra molecular 1,3-alkyl migration from the Ru-imine species. 
 
 
Scheme 3.8: Tentative Reaction Mechanism for the Formation of 2:1 Byproduct 3-16 
from the Reaction of 7-bromo-1-tetralone with 2-thiophenemethylamine 
 
3.2.6 Determination of Catalytic Activity of the Ru-Catecholate Complex 2-11 
In an effort to detect/trap catalytically relevant species, we examined the reaction 
of 2-10 with a number of catechol and benzoquinone ligands. The complex 2-10 (117 mg, 
0.20 mmol), 3,5-di-tert-butyl-o-benzoquinone 2-12b (44 mg, 0.20 mmol), PCy3 (56 mg, 





Teflon screw cap stopcock and a magnetic stirring bar under N2 stream. After stirring for 
24 h in a water bath set at 70 °C, the solvent was removed under vacuum, and the residue 
was washed with 2% hexanes/EtOAc under nitrogen atmosphere. The resulting residue 
was dissolved in acetone (3 mL), layered with n-pentane (4 mL), and stored in a glove 
box for five days for crystallization. The resulting solid was filtered through a fritted 
funnel to yield the complex 2-11 (102 mg, 56%) as a reddish crystalline solid. Single 
crystals of 2-11 were obtained by slow evaporation in EtOAc/pentanes, and its structure 
was determined by X-ray crystallography (Eq. 3.17). 
 
The ruthenium catecholate complex 2-11 was found to exhibit a high catalytic 
activity for the alkylation reaction. For example, the treatment of acetophenone with 4-
methoxybenzylamine in the presence of 2-11 (1 mol %) otherwise under the standard 
conditions efficiently afforded the alkylation product 3-10a in 90% yield within 2 h (Eq. 
3.18). It should be noted that the catalytic activity of 2-11 is substantially higher than the 
in-situ generated one, giving the desired product 3-10a in a shorter reaction time at a 






The rate of the transformation of imine 3-13a to 3-10a was quantitatively measured by 
using the catalyst 2-11 under the similar conditions as described in Eq. 3.12. The initial 
rate of the appearance of the product 3-10a was measured at four different catalyst 
concentrations (4-12 mM), and the plot of initial rate (ν0) as a function of [2-11] yielded 
the observed rate constant k = 7.0  10-3 s-1, which is 2.5 times larger than the rate 
measured from in-situ generated catalyst 2-10/2-12 (k = 2.8  10-3 s-1) (Figure 3-12).  
 
  
Figure 3.12: Plots for the Dependence of the Ruthenium Catecholate Complex 2-11 (a) 
3-10a vs Time and (b) Initial Rate vs [2-11] 
 
Furthermore, to demonstrate its synthetic utility, a gram scale reaction was 





using the catalyst 2-11 (1 mol %), which yielded the product 3-10a in 90% yield under 
the standard reaction conditions (Eq. 3.19). These results clearly demonstrate that the Ru-
catecholate complex 2-11 is a catalytically relevant species for the alkylation reaction. 
 
3.2.7 Computational Studies 
3.2.7.1 Mechanistic Insights on Alkyl Migration Step 
To gain detailed mechanistic insights on the requisite C–N bond cleavage step of 
the reaction, we performed density functional theory (DFT) computational analysis. 
Entire computational work was performed by our collaborator Marat R. Talipov, New 
Mexico State University. Initially, we carried out the calculations on a sigmatropic 
transformation of N,N-ethyl-2-propenylamine 3-18 into pentan-2-imine 3-19 in the 
absence of Ru catalyst by using a closed-shell M06L/def2-TZVPPD//M06L/def2-
SV(P)+PCM(1,4-dioxane) method, which has successfully located the transition state for 
[1,3]-sigmatropic shift of ethyl group (Figure 3.13). However, in this case, the activation 
enthalpy exceeded the total enthalpy of separated ethyl and isopropenyl amino radicals 
(62.5 kcal/mol), which suggests that [1,3]-sigmatropic shift is not an energetically 
feasible pathway for this transformation (DH‡ = 75.7 kcal/mol). Indeed, we found no 





of the same computational method. The DFT analysis of non-catalyzed model system 
clearly suggested the efficacy of Ru-catalyzed enamine-to-imine transformation. We next 
performed the calculations for the same transformation in the presence of the Ru-
catecholate complex 2-11 (without the t-Bu groups). Initial computational efforts to 
locate the transition state via a concerted sigmatropic rearrangement pathway were 
unsuccessful despite numerous attempts using either closed- or open-shell formalism. 
 
Figure 3.13: Schematic Representation of a Sigmatropic Transformation of N,N-Ethyl-2-
Propenylamine to Pentan-2-Imine without Ruthenium Catalyst 
 
The anticipated sigmatropic rearrangement pathway for 3-20a to 3-22a was eventually 
found by using the nudged elastic band (NEB) technique at the CASSCF(2,2)/def2-SV(P) 
level of theory, but the highest point of the pathway has 90 kcal/mol higher energy than 
3-20a, which is prohibitively high for this transformation under normal thermal 
conditions. Instead, our DFT calculations revealed an alternate stepwise mechanistic 






Figure 3.14: Enthalpy Profile for the Ru-mediated Transformation of 3-20a to 3-22a 
(Red Line) and 3-20b to 3-22b (Blue Line), Calculated at the M06L/def2-






Figure 3.15: Computed Structures of the Transition States TS-3-20a and TS-3-21a 
 
The geometrically optimized structure of intermediate 3-21a showed an 
octahedral Ru(IV) atom with a directly bound ethyl moiety. The activation enthalpies for 
both elementary steps were moderately low:  for 3-20a ➝ 3-21a via the transition state 
TS-3-20a has DH‡ = 43.6 kcal/mol, and for 3-21a ➝ 3-22a via the TS-3-21a with DH‡ = 
44.1 kcal/mol. Both activation enthalpy values are reasonable from the standpoint of 
experimental thermal conditions. The optimized structures of TS-3-20a and TS-3-21a 
(Figure 3-15) represent the transition of ethyl group from the nitrogen atom to ruthenium 
atom and from the ruthenium atom to the terminal carbon atom of the double bond, 
respectively. The visual analysis of the transition state structures was further supported 
by the intrinsic reaction coordinate (IRC) analysis. We observed that the reaction 
proceeds on the singlet potential energy surface with a formal Ru(IV) oxidation state, 
although the intermediate 3-21a has a partial open-shell character (<S2> = 0.63/0.05 
before/after the spin annihilation procedure, respectively) with a relatively low singlet-





enamine-to-imine rearrangement 3-20b to 3-22b showed a similar stepwise pathway via 
the Ru-benzyl intermediate 3-21b, whose activation enthalpies were ~10 kcal/mol lower 
than the alkyl-substituted case (∆H‡ = 33.3 kcal/mol for 3-20b ➝ 3-21b, ∆H‡ = 28.5 
kcal/mol for 3-21b ➝ 3-22b) (Figure 3.14). 
 
3.2.7.2 DFT Computational Study on Carbon Kinetic Isotope Effect 
We also computed the carbon KIE by using the standard thermochemical analysis 
for the transformation of 3-20a ➝ 3-22a. Specifically, we recalculated the activation 
enthalpy for the 13C-modified 3-20a and used the Eyring equation to evaluate the isotopic 
effect on the reaction rate. The computed carbon KIE value (C𝛼 = 1.030) was in good 
agreement with the experimental KIE value (C𝛼 = 1.020), which further corroborates a 
stepwise [1,3]-alkyl migration mechanism via the formation of Ru-alkyl intermediate 3-
21. 
 








3.2.7.3 DFT Computational Study on Hammett Study 
Initial DFT calculations on the Hammett correlations by using the standard 
thermochemical analysis for the transformation of 3-20a ➝ 3-21a are consistent with the  
experimental data (Figure 3.17a). Also, the computed carbon enthalpy values for para 
substituted benzyl amine fragment of the enamine X = OMe, CF3 found to be 32.4, 35.3 
kcal/mol respectively and para substituted ketone fragment of the enamine X = CF3, H, 
OMe found to be 32.3, 33.3, 33.6 kcal/mol respectively (Figure 3.17b; 3.18). These data 
shown to be good agreement with the experimental Hammett correlations. These 
observations also further corroborates a stepwise [1,3]-alkyl migration mechanism via the 
formation of Ru-alkyl intermediate 3-41. 
  
Figure 3.17: (a) Hammett Plot from the Reaction of p-X-C6H4CH2N=C(CH3)C6H5 (X = 
OMe, H, F, CF3) (●) and  p-OMe-C6H4CH2N=C(CH3)-p-Y-C6H4 (Y = OMe, H, F, CF3) 
(▲); (b) Computed carbon enthalpy values for para substituted benzyl amine fragment of 







Figure 3.18: Transition States of the Standard Thermochemical Analysis for the 
Transformation of 3-20a ➝ 3-21a    
 
3.3 Proposed Mechanism of the Catalytic Reaction 
We compiled a plausible mechanistic path for the alkylation reaction on the basis 
of these experimental and computational data (Scheme 3.9). The successful synthesis of 
the Ru-catecholate complex 2-11 and the demonstration of its high catalytic activity 
clearly support a coordinatively unsaturated Ru(II)-catecholate complex 3-23 as the 
catalytically active species. The coordinatively unsaturated Ru-catecholate complex 3-23 
would be generated initially from the treatment of 2-10 with the reduced form of 







Scheme 3.9: Proposed Mechanism of the Deaminative -Alkylation of Ketones with 
Amines 
 
The ketimine 3-13, which is formed form the initial dehydrative coupling of ketone and 
amine substrates, is the real substrate for the catalytic alkylation reaction. The 
coordination of imine substrate 3-13 and the subsequent imine-to-enamine isomerization 
should form the Ru-enamine species 3-25 via imine coordinated complex 3-24. The 
deuterium labeling study supports a facile imine-to-enamine tautomerization step. The 
first-order kinetics on [3-13a] as well as the lack of imine crossover results provide 
experimental supports for an intramolecular alkyl migration mechanism in forming the 
Ru-imine species 3-27. The observation of prominent carbon KIE on the -carbon of the 





While the [1,3]-carbon migration step may occur either in stepwise or a concerted 
fashion, we could not find any specific literature examples on [1,3]-carbon shift on either 
enamine or imine compounds. On the other hand, the analogous thermally induced [1,3]-
carbon shift reactions of vinylcycloalkanes have been well-known to occur in a 
concerted, suprafacial fashion, resulting in the inversion of stereochemistry on the 
migrating carbon atom.152 A number of transition metal-catalyzed C–C coupling 
reactions of propargylic esters and related cycloisomerization reactions have been known 
to proceed via a [1,3]-carbon shift process,153 and related Ag-catalyzed [1,3]-halogen 
shift reactions for vinyl and dienyl-containing compounds have also been reported 
recently.154 In these sigmatropic [1,3]-carbon shift reactions, the orbital interactions 
between the -carbon and -orbitals from unsaturated carbon atoms are essential for 
promoting the symmetry-allowed suprafacial carbon migration. 
The DFT study revealed deeper mechanistic insights for the Ru-mediated [1,3]-
alkyl migration step of the reaction. The DFT calculations showed that the direct 
enamine-to-imine rearrangement is a prohibitively high energy process in the absence of 
a Ru catalyst (Figure 3-13). The DFT calculations on  the Ru-mediated enamine-to-imine 
rearrangement showed that the [1,3]-alkyl migration step proceeds in a stepwise fashion 
via the formation of the Ru(IV)-alkyl intermediate species 3-21, apparently to avoid a 
high energy concerted pathway. The geometrical optimization of the Ru-catecholate 
complex 2-11 with the imine substrate led to a locally minimized structure of Ru(IV)-
alkyl intermediate 3-21, with a relatively moderate activation enthalpies (DH‡ = 43-44 
kcal/mol). The DFT computational results as well as experimental Hammett and carbon 





catalytic reaction, in which the alkyl migration (C–N bond cleavage) step is promoted by 
the nucleophilicity of a-imine carbon. The rate independence on [H2O] is consistent with 
a rapid hydrolysis of the resulting imine product to form the alkylation product 3-10 
along with the regeneration of the Ru-catecholate complex 3-23. Both experimental and 
DFT computational results provided new mechanistic insights that the Ru catalytic 
system (2-10/2-12) facilitates a normally energetically demanding and previously 
unexplored deaminative alkylation reaction by promoting a facile imine-to-enamine 
tautomerization and an intramolecular stepwise [1,3]-carbon migration process via the 






3.4 Summary and Conclusion 
In summary, we have successfully developed a highly regioselective catalytic -
alkylation method of simple ketones from the deaminative coupling reaction with amines. 
The in-situ generated catalytic system consisted of the ruthenium-hydride complex and a 
redox-active 1,2-benzoquinone ligand (2-10/2-12) was found to exhibit a uniquely high 
activity and selectivity for promoting the deaminative coupling reaction. Kinetic and 
spectroscopic studies provide a detailed mechanistic picture for the catalytic reaction, 
which involves the initial formation of Schiff base from the dehydrative coupling of 
ketones with amine substrates, Ru-catalyzed imine-to-enamine isomerization and the 
turnover-limiting [1,3]-alkyl migration and hydrolysis steps. The DFT study revealed a 
low energy pathway for the [1,3]-alkyl migration step, which involves a stepwise 
mechanism via the formation of a Ru(IV)-alkyl species. In light of the successful 
synthesis of highly active Ru-catecholate complex 2-11, we are continuing our efforts to 
search for new catalytic coupling methods that are enabled by transition metal catalysts 
with redox-active 1,2-benzoquinone ligands. We submitted a manuscript to Journal of 
American Chemical Society, and it is currently under revision. We are currently 







Synthesis of Quinazoline and Quinazolinone Derivatives via Ligand-Promoted 
Ruthenium-Catalyzed Dehydrogenative and Deaminative Coupling Reaction of 2-
Aminophenyl Ketones and 2-Aminobenzamides with Amines 
4.1 Introduction 
 
Figure 4.1: Selected Examples of Quinazoline and Quinazolinone Based Drugs 
 
Quinazolines and quinazolinones are a privileged class of nitrogen heterocyclic 
scaffolds that have been found to exhibit a broad spectrum of pharmacological activities, 
including anti-inflammatory, antitubercular, and antiviral activities.155 A number of 
quinazoline-based drugs such as prazocin and doxazosine have been approved to treat 
benign prostatic hyperplasia and post-traumatic stress disorder,156 while both erlotinib 





4.1).157 Lapatinib, an inhibitor for epidermal growth factor, has been shown to be 
effective in combination therapy for breast cancer.158 Several quinazolinone-based drugs 
including idelalisib have been shown to exhibit a broad spectrum of antimicrobial, 
antitumor, antifungal, and cytotoxic activities.159 On the other hand, sildenafil is a potent 
and selective inhibitors of the type 5 cGMP phosphodiesterase from both rabbit platelets 
and human corpus cavernosum, which  is currently used for the oral treatment of male 
erectile dysfunction.160  
A number of different synthetic strategies for quinazolines and quinazolinones 
have been developed over the years, in part to meet the growing needs for screening of 
these pharmacologically important derivatives.161 In 2013, Zhou and co-workers reported 
one-pot synthesis of 2-substituted quinazolines by using 2-aminobenzylamines and 
aldehydes via iridium-catalyzed hydrogen transfers with styrene as a hydrogen acceptor 
(Eq. 4.1).162  
 
In 2013, Wu and co-workers reported a palladium catalyzed three component coupling 
protocol for 2-iodoarylcarbodiimide 4-1, phosphite and isocyanide to synthesize 4-imino-
3,4-dihydroquinazolin-2-ylphosphonates 4-2. A one-pot tandem procedure includes the 
nucleophilic isocyanide insertion, and the C-N coupling by reductive elimination through 
seven membered palladacycle (Scheme 4.1).163 In these cases, more reactive reagents 






Scheme 4.1: A Proposed Synthetic Route to Phosphonylated Quinazolines 
 
Several research groups have successfully utilized copper catalyzed Ullmann-type 
coupling methods of aryl bromides and benzamidines for the synthesis of quinazoline 
derivatives.164 Similar Cu-catalyzed oxidative coupling methods of aniline derivatives 
with aldehydes and nitriles have also been developed for the construction of quinoline 
core structures.165 Transition-metal-catalyzed oxidative C−H amination and alkylation 
methods have also been successfully employed to synthesize quinazoline and 





method for the synthesis of quinazolinone derivatives from the coupling reaction of 2-
halobenzoic acid 4-4 derivatives with highly reactive amidines 4-5 (Eq. 4.2).164a  
 
In 2017 Molander and co-workers reported a Csp3-centered alkyl radical cascade reaction 
via C−H alkylation of heterocycles (Eq. 4.3). The key step of this SET reaction involves 
the generation of Csp3-centered radical which engages in the C−H alkylation of 
heterocyclic bases with 1,4-dihydropyridines (DHPs) 4-6.166d  
 
Recently, Shang and co-workers has utilized an imine-protection strategy to synthesize 
quinazolinones via aerobic copper-catalyzed three component annulation reaction.167  
Initially, both aryl and alkyl amines were easily reacted with formaldehyde to form 
imines 4-7 and aliphatic imine. The [4 + 2] cycloaddition168 between 4-7 and aliphatic 
imine followed by isomerization would result an aminal 4-10. Alternatively, the addition 
of alkylamine to imine 4-7 followed by a condensation of aminal 4-8 with formaldehyde 
would generate an iminium ion 4-9. Subsequent intramolecular Friedel–Crafts-type169 of 





dehydrogenation170 of 4-10 under oxidative copper catalysis followed by benzylic 
oxidation171 would afford the desired N-substituted quinazolinone product via 
dihydroquinazoline 4-11 intermediate (Scheme 4.2). 
 
Scheme 4.2: Plausible Reaction Pathways for the Copper-Catalyzed Three Component 
Annulation Reaction 
Cho and co-workers recently devised a practical synthesis of 2-arylquinazoline 
derivatives from the coupling of 2-aminobezylamines with halogenated toluene 
substrates.172 Since the advent of the Niementowski condensation of anthranilic acids 
with amides,173 a variety of sustainable synthetic methods have also been devised for the 
assembly of quinazolinone core structures.174 Much research effort has been devoted to 





constructing quinazolinone core structures. A number of transition-metal catalyzed direct 
coupling methods of aminobenzamides with alcohols and carbonyl compounds have been 
successfully exploited to synthesize quinazolinone derivatives.175 Transition metal-
catalyzed couplings of 2-aminobenzamides with alcohols and ketones176, three-
component couplings of 2-aminobenzamides, aryl halides or equivalents, isocyanides177, 
and copper catalyzed,167, 178 electrochemical,179 are among the notable examples of 
catalytic synthesis of quinazolinones.  
4.2 Results and Discussion  
We previously discovered that the cationic ruthenium hydride complex 2-10 is a 
highly effective catalyst precursor for the deaminative and decarboxylative coupling 
reaction of ketones with amino acids.29 We also reported that a phenol-coordinated 
cationic ruthenium−hydride complex is a highly effective catalyst for mediating the 
hydrogenolysis of aldehydes and ketones.180 We subsequently found that the ruthenium-
hydride complex 2-10 with a 1,2-catechol ligand exhibits an exceptionally high 
chemoselectivity for promoting the deaminative coupling reactions of amines to form 
unsymmetric secondary amines.126b To further extend the synthetic utility of ligand-
promoted catalysis, we have been exploring the promotional effects of various oxygen 
and nitrogen ligands on ruthenium catalysts for the deaminative coupling reactions of 
amines.  
In this Chapter, we disclose an efficient catalytic synthesis of quinazoline and 
quinazolinone derivatives from the dehydrogenative and deaminative coupling reactions 





defined ruthenium catalyst containing a catechol ligand. The salient features of the 
catalytic method are that the regio- and diastereoselective fashion without employing any 
reactive reagents or forming any wasteful byproducts, while tolerating a number of 
common organic functional groups. 
 
Scheme 4.3: Synthesis of Quinazoline and Quinazolinone Derivatives149 
 
4.2.1 Optimization Studies 
We initially explored the coupling reaction of 2-aminoketones with amines by 
employing the ligand promoted catalysis protocol in order to extend the scope and utility 
of deaminative coupling methods. Among the initially screened Ru catalysts and ligands, 
the in-situ generated catalytic system from the cationic ruthenium−hydride complex 2-10 
with 4-(1,1-dimethylethyl)-1,2-benzenediol 2-16 was found to give the highest activity 





in yielding the quinazoline product 4-12a (Table 4.1). The coupling reaction conditions 
as described in Eq. 4.4 have been used as the standard reaction conditions unless 
otherwise noted. 
 
4.2.1.1 Ligand Screening  
We first evaluated the ligand effect for the reaction between 2-
(aminophenyl)ethanone with 4-methoxybenzylamine. In the absence of any ligands, the 
reaction was found to be very sluggish as a trace amount of the product 4-12a was 
obtained with both 2-9 and 2-10 catalysts (Table 4.2; entry 8). The addition of catechol 
ligands (2-16, 2-16a-f) significantly increased desired product 4-12a. Binol 2-12j or 
phenolic ligands (3-11b-d) was not effective for this noble transformation. In accordance 
with the previous results on the ruthenium catalyzed C(sp3)−N bond cleavage reaction, 
the catechol ligand 2-16 was found to be the most effective for the selective synthesis of 
secondary amines.126b The catechol ligands 2-16a-e with both electron donating and 
withdrawing group were shown to be effective for giving the products in giving modest 
to good yields (68-85%), whereas 2,2´-biphenol ligand 2-12j gave only a trace amount of 
the product 4-12a for the coupling reaction. As shown in Table 4.1, the catalytic activity 





the efficient formation of product 4-12a. The nitrogen coordinating ligands 3-11d, 3-12 
and aliphatic diols were found to be completely ineffective for the catalytic reaction.  
 




aReaction conditions: 2-aminophenylethanone (0.5 mmol), 4-methoxybenzylamine (0.7 
mmol), 2-10 (3 mol %), ligand (10 mol %), 1,4-dioxane (2 mL), 140 °C, 20 h. bThe 







4.2.1.2 Catalyst and Solvent Screening   
We screened the activity of commonly available ruthenium catalysts and acid 
catalysts, where 1,4-dioxane was found to be the most suitable solvent for the coupling 
reaction (entry 2-7). Among the screened ruthenium catalysts (entry 9-19), the Ru-H 
complex 2-10 was found to be the most effective catalyst (entry 1). Importantly, Lewis 
acids PCy3 did not exhibit any activity for the coupling reaction (entry 22-24). These 
ligand screening and optimization efforts have led to the standard conditions for the 
coupling reaction: 2-aminophenylethanone (0.5 mmol), benzylamine (0.7 mmol), 2-10 (3 
mol %) and 2-16 (10 mol %) in 1,4-dioxane (2 mL) at 140 °C for 40 h (Table 4.2). The 
water byproduct was detected by NMR in a crude reaction mixture, and hydrogen gas 
was removed under vacuum during the solvent evalopration. The product 4-12a was 
isolated by a column chromatographic separation on silica gel. 
 










- 2-10 none 85 
2 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 t-butylethylenec 8 
3 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 chlorobenzene 52 
4 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 chlorobenzene/cyclopentenec 58 
5 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 1,2-DCE 0 
6 [(C6H6)(PCy3)(CO)RuH]
+BF4







- 2-10 t-amyl alcohol 15 
8 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 No ligand trace 
9 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 2-9 - 45 
10 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 2-9 No ligand 9 
11 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 2-9 chlorobenzene 6 
12 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 2-9 chlorobenzene/cyclopentene
c trace 
13 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 2-9 1,2-DCE 0 
14 (PPh3)3(CO)RuH2 - 25 
15 (p-cymene)2RuHCl - 18 
16 RuCl2(PPh3)3 - 12 
17 RuCl3
.3H2O - 0 
18 [Ru(COD)Cl2]x - 20 
19 (PCy3)2(CO)RuHCl - 18 
20 Ru3(CO)12 - 30 
21 [(PCy3)(CH3CN)(CO)RuH]
+BF4
- - 15 
22 - HBF4
.OEt2 0 
23 BF3OEt2 - 0 
24 PCy3 - 0 
aStandard conditions: 2-aminophenylethanone (0.5 mmol), 4-methoxybenzylamine (0.7 
mmol), catalyst (3 mol %), ligand (10 mol %), 1,4-dioxane (2 mL), 140 °C, 20 h. b The 
product yield of 4-12a was determined by 1H NMR using hexamethylbenzene as an internal 
standard. c0.5 mmol of cyclopentene was added.  
 
4.2.3 Reaction Scope for the Synthesis of Quinazolines and Quinazolinones 
4.2.3.1 Synthesis of Quinazolines from the Coupling of 2-Aminophenyl Ketones with 
Primary Amines 
With the optimized conditions in hand, we explored the substrate scope of the 
coupling reaction by using the in-situ generated catalyst system 2-10/2-16. The coupling 
of 2-aminophenyl ketones with a variety of benzylic amines selectively formed the 






Table 4.3: Synthesis of Quinazolines from the Coupling of 2-Aminophenyl Ketones with 
Aminesa 
 
aReaction conditions: aminoketone (0.5 mmol), amine (0.7 mmol), 2-10 (3 mol %), 2-16 





The coupling of 2-aminophenyl ketones with phenethylamines afforded the desired 
product 4-12q−t (78-67%), 4-12y−ab (48-76%), 4-12ae (64%) and 4-12ag (82%), 
demonstrating the versatility of phenethylamine substrate for the coupling reaction. The 
aliphatic amines also gave the selective formation of 4-12u−ac, in 45-79% yields. While 
the coupling reaction of 2-aminphenyl ketone substrate with a branched amine smoothly 
yielded the coupling products 4-12x and 4-12ad, the coupling with sterically demanding 
secondary amines and branched amines generally yielded only a trace amount of the 
coupling products under the standard reaction conditions (Table 4.3). Interestingly, the 
reaction between 2-aminoacetophenone with allylamine yielded the quinazoline product 
4-12af  with the selectively hydrogenated allylic double bond. Analytically pure 
quinazoline products were readily isolated after silica gel column chromatographic 
separation, and their structures were completely established by spectroscopic methods. 
The structure of 4-12i and 4-12k were also confirmed by X-ray crystallography. We also 
have been able to scale up the coupling reaction to a 2−3 mmol scale reaction to yield 
0.5−0.7 g of 4-12b, 4-12m and 4-12ab. The catalytic coupling method furnishes a direct 
synthesis of quinazoline products without using any reactive reagents and 
environmentally benign water and hydrogen as the byproducts. 
 
4.2.3.2 Synthesis of Quinazolinones from the Coupling of 2-Aminobenzamides with 
Primary Amines 
Adopting the previously developed deaminative coupling protocol,126b we next 
sought the catalytic coupling reaction of the 2-aminoarylamides with amines to form 





Table 4.4: Synthesis of Quinazolinones from the Coupling of 2-Aminobenzamides with 
Amines 
 
Thus, the treatment of 2-aminobenzamide (0.5 mmol) with benzylamine (0.7 mmol) in 
dioxane (2 mL) at 140 °C in the presence of the catalyst system 2-10 (3 mol %)/2-16 (10 
mol %) led to the selective formation of the quinazolinone product 4-13, which was 
analyzed by both GC and NMR spectroscopic methods. The substrate scope of the 





conditions. The coupling of 2-aminobenzamides with both benzyl- and alkyl-substituted 
amines led to the selective formation of the quinazolinone products 4-13a−n (88-51%) 
with no significant amount of the quinazoline or other side products. The analogous 
coupling reaction of N-alkyl-2- benzamides with both benzylamines and alkyl-substituted 
amines afforded the corresponding coupling products 4-13o−t in moderate to high yields. 
Single crystals of 4-13c and 4-13t were obtained by slow evaporation in hexanes/EtOAc 
at room temperature, and its structure was determined by X-ray crystallography. The 
formation of quinazolinone product can be rationalized by initial deaminative coupling of 
amide and amine substrates followed by the cyclization dehydrogenation steps. The 
coupling reaction efficiently assembles synthetically valuable quinazolinone core 
structures by employing readily available amine and benzamide substrates. 
 
4.2.3.3 Coupling Reaction of 2-Aminophenyl Ketones with Biologically Active 
Amines 
To further demonstrate synthetic utility of the catalytic method, we next surveyed 
the substrate scope of the coupling method by employing several biologically active and 
functionalized 2-aminophenylketones and 2-aminobenzamides with a number of 
biologically active amine substrates (Table 4.5). The treatment of 2-
aminophenylethanone with tryptamine led to the indole-substituted product 1-12ah in 
moderate yield under the standard reaction conditions. The analogous coupling with (−)-
cis-myrtanylamine formed the corresponding quinazoline products 4-12ai and 4-12aj in 






Table 4.5: Coupling Reaction of 2-Aminophenyl Ketones and 2-Aminobenzamides 
Biologically Active and Functionalized Aminesa 
 
aReaction conditions: amino ketone or benzamide (0.5 mmol), amine (0.7 mmol), 2-10 (3 
mol %), 2-12 (10 mol %), 1,4-dioxane (2 mL), 140 °C, 20 h. bBenzamide (0.25 mmol), 






The coupling of 2-aminophenylethanone with a 4-morpholinyl-substituted amine 
predictively formed the desired product 4-12ak in 36% yield. The coupling of a 
thiophene substituted amino ketone with electron rich benzyl amines yielded the desired 
products 4-12al and 4-12am  in 46% and 52% yield respectively. The treatment of 2-
aminoacetophenone with geranylamine formed the expected product 4-12an, in 62% 
yield, with the selectively hydrogenated proximal olefinic group. The reaction of  2-
aminoacetophenone with furfuryl amine and 2-thiopheneethanamine afforded the desired 
products 4-12o,p in good yields. This extension clearly demonstrated the general 
applicability of the catalytic coupling method for the synthesis of quinazoline derivatives. 
The analogous treatment of 2-aminobenzamide with geranylamine formed the 
corresponding quinazolinone product 4-13w, in which the neighboring olefinic group is 
selectively hydrogenated, confirming the unique catalytic activity as in the previous 
cases. The treatment of a thiophene-substituted amide with n-hexylamine and 4-
phenylbenzylamine formed the corresponding quinazolinone products 4-13x,y in 
moderate yield. The treatment of the catalytic system with 3-Aminobenzofuran-2-
carboxamide with n-hexylamine afforded the desired product 4-13z in modest yield 
(48%). The coupling of 2-aminobenzamide with (−)-cis-myrtanylamine formed the 
coupling product 4-13aa with a modest diastereoselectivity (d.r. = 1.9:1). In sharp 
contrast, the analogous coupling with (+)-dehydroabietylamine resulted in the formation 
of the coupling product 4-13ab without any detectable racemization. The structure and 
stereochemistry of both 4-13aa (major diastereomer) and 4-13ab quinazolinone products 






4.2.4 Mechanistic Studies 
 
Figure 4.2: 1H and 2H NMR Spectra of 4-12a and 4-12a-d 
 
4.2.4.1 Deuterium Labeling Study 
We have chosen the reaction of 2-aminoacetophenone with 4-
methoxybenzylamine for probing mechanistic insights for the coupling reaction. We 
examined the deuterium-labeling pattern from the reaction of 2-aminophenylethanone-d3 








Thus, the treatment of perdeuterated 2-aminophenylethanone-d3 (0.50 mmol) with 4-
methoxybenzylamine (0.70 mmol) in the presence of 2-10 (3 mol %)/2-16 (10 mol %) 
under the standard reaction conditions formed the coupling product 4-12a-d. The isolated 
product 4-12a-d as analyzed by 1H and 2H NMR contained only 11% of the deuterium on 
the methyl group as most of the deuterium had been washed away (Figure 4.2). A 
relatively small amount of the deuterium on 4-12a-d suggests an extensive keto−enol 
tautomerization under the reaction conditions. 
4.2.4.2 Reaction Profile Study 
To discern the nature of viable intermediate species, we monitored the reaction 
progress for the catalytic coupling reaction of 2-aminoacetophenone with 4-
methoxybenzylamine by using NMR spectroscopic method. In a resealable NMR tube, a 
reaction mixture of 2-aminophenylethanone (0.25 mmol), 4-methoxybenzylamine (0.25 
mmol), and in situ generated catalyst 2-10 (3 mol %)/2-16 (10 mol %) in toluene-d8 (0.5 
mL) was immersed an oil bath set at 140 °C. The tube was taken out from the oil bath at 
20 min intervals, and the reaction progress was recorded by 1H NMR. The appearance of 
new set of peaks due to the imine product 4-14a has been observed initially as both 
starting substrates are consumed. After about 100 min of reaction time, the peaks due to 
the quinazoline product 4-12a began to appear as the imine peaks gradually disappeared. 






Figure 4.3: Reaction Profile for the Coupling Reaction of 2-Aminoacetophenone with 4-
Methoxybenzylamine. 2-Aminophenylethanone (■), 4-Methoxybenzylamine (●) 4-12a 
(), 4-14a (▲). 
4.2.4.3 Reaction with Imine Substrates 
 
To establish the imine as a requisite intermediate for the formation of quinazoline 
product, an independently synthesized 4-14b was treated with in-situ generated catalytic 
system 2-10/2-16 under the standard reaction conditions, which proceeded smoothly to 
afford the quinazoline product 4-12h in 87% yield (Eq. 4.6). In a control experiment, the 
analogous treatment of 4-14b with p-toluenesulfonic acid (5 mol %) did not form the 
product 4-14h under otherwise similar reaction conditions. The results showed that the 
ruthenium catalysis is essential for the cyclization and dehydrogenation steps of the 





was performed under standard reaction conditions (Eq. 4.7). Interestingly, quantitative 
product formation was observed. When the reaction was performed under identical 
conditions without ruthenium catalyst did not give the desired product.  
 
4.2.4.4 Reactivity of Ruthenium Catecholate Complex 2-11 
To gain more insights for the catalytically relevant species, the catalytic activity 
of ruthenium catecholate complex 2-11 (1 mol%) was examined for the coupling reaction 
of 2-aminobenzamide and 4-methoxybenzylamine.  
 
 
Scheme 4.4: Coupling Reaction of 2-Aminobenzamide and 4-Methoxybenzylamine with 





To our delight, the reaction proceeds smoothly to give the product 4-13a in 90% yield 
(Scheme 4.4). This result demonstrates that the ruthenium catecholate is a catalytically 
relevant species. 
4.3 Proposed Mechanism of the Catalytic Synthesis of Quinazoline Derivatives 
 
Scheme 4.5: Possible Mechanistic Sequence for the Formation of Quinazoline Products  
 
We offer a plausible mechanistic sequence for the formation of the quinazoline 
products 4-12 on the basis of these preliminary results (Scheme 4.5). The reaction profile 
study clearly implicates that the imine intermediate 4-14 is generated from initial 
dehydrative coupling of amino ketone and amine substrates. The imine 4-14 would 





Ru catalyst facilitates the imine isomerization to form the imine-coordinated species 4-
17. The subsequent cyclization 4-18 and dehydrogenation steps would yield the 
quinazoline product 4-12. In support of this, we previously found that the 
ruthenium−hydride complexes are efficient catalysts for olefin isomerization reaction125b 
and dehydrogenation of saturated amines and carbonyl compounds.181 While the exact 
role of catechol ligand is yet to be established, we believe that a redox-active catechol 
ligand may be essential for facilitating the dehydrogenation step on the catalysis.182 
 
4.4 Summary and Conclusion 
We have been able to devise a catalytic protocol for the synthesis of quinazoline 
and quinazolinone derivatives from the dehydrogenative and deaminative couplings of 2-
aminophenyl ketones and 2-aminobenzamides with amines. The in-situ formed 
ruthenium−hydride complex with a catechol ligand (2-10/2-16) was found to exhibit 
uniquely high catalytic activity and selectivity in forming these products. The salient 
features of the catalytic method are that it employs readily available amine and 
aminoketone substrates, exhibits a broad substrate scope while tolerating common 
organic functional groups, and does not require any reactive reagents or forms any 
wasteful byproducts. We published an article on the basis of the work described in this 
Chapter: Org. Lett. 2019, 21, 3337-3341 (DOI: 10.1021/acs.orglett.9b01082). Also, the 








Regioselective Synthesis of Quinoline and Dihydroquinazolin-4(1H)-one Derivatives 
via Deaminative and Decarboxylative Coupling Reactions of 2-Aminophenyl 
Ketones and 2-Aminobenzamides with -Amino Acids and Branched Amines 
5.1 Introduction 
Concerted research efforts have been directed to devise transition metal catalyzed 
C−H coupling methods for the synthesis of biologically active nitrogen heterocyclic 
compounds 5-1–5-4 to promote synthetic efficiency and to reduce environmental impacts 
from the generation of harmful byproducts.183 Quinolines are one of the most important 
class of nitrogen heterocyclic scaffolds, which have a wide range of medicinal 
applications in the treatment of various types of diseases as well as natural occurrence in 
plants and animals. Many quinoline derivatives have been shown to exhibit significant 
antimicrobial,184 anticancer185  and antimalarial186 pharmacological activities (Figure 
5.2). As such, the design of new versatile and efficient route for the synthesis of quinoline 
scaffolds remains an active area of research interest in both academia and industry.187 
 






Figure 5.2: Selected Examples of Quinoline, Quinazolinone and Quinoxaline Based 
Drugs 
 
Many transition-metal catalyzed synthetic methods for quinoline scaffolds have 
been reported in the last decades. A number of catalytic C−H coupling methods have 
been achieved by using earth-abundant Co and Ni catalysts.188 Ruthenium complexes 
with trialkylammonium salts were utilized as catalysts to effect intermolecular C−C 
couplings of anilines with diols and glycols to synthesize quinoline derivatives.189 Ir-
BINAP catalytic system has been effectively applied to generate benzoquinoline 
derivatives from the coupling of naphthylamines with 1,3-diols.190 Alami and co-workers 
devised a palladium catalytic system to promote direct decarboxylative coupling reaction 
to generate biheterocyclic quinoline derivatives 5-7 from quinolinone 3-carboxylic Acids 
5-5 with substituted heterocyclic bromides 5-6 (Eq. 5.1). The extrusion of CO2 from 






Amino acids are considered one of the fundamentally important building blocks 
in biochemistry192 and in organic synthesis.193 Amino acids are an attractive class of 
reagents for sustainable synthesis since they are readily available from biomass 
feedstock. While amino acids have been known used as chiral scaffolds and as organo-
catalysts,194 they have scarcely been used as the reagents for organic coupling reactions 
via C–N bond cleavage.29 Natural biosynthetic pathways provide an ample inspiration for 
C–N bond cleavage reactions of amino acids by efficient deaminase, oxidase, and 
dehydrogenase enzymes.195 Recently, Wu and co-workers developed a novel synthetic 
protocol for substituted quinoline syntheses from three component coupling reaction of 
aniline with two distinct -amino acids under decarboxylative and deaminative pathway 
via the formation of imine and enamine intermediates.196 In a seminal report, Wang and 
coworkers devised copper/DIPEA-catalytic system for aldehyde-induced intermolecular 
decarboxylative coupling reaction of natural -amino acids and phosphites/phosphine 
oxides.197 Allylic amination, alkylation, sulfonylation, and phosphinoylation products 
were also synthesized from the copper-catalyzed decarboxylative coupling reactions of 
conjugated β,γ-unsaturated carboxylic acids with corresponding coupling partners.198 
Iridium catalyzed visible-light-induced photoredox catalytic system has been established 





of α-amino acids with nitrone substrates.199 Photoredox decarboxylative coupling of α-
amino acids with carbonyl compounds to access DNA-encoded 1,2-amino alcohols has 
also been reported.200 Recently, Zhou and co-workers demonstrated a nickel catalyzed 
synthesis of 2,3-dihydroquinazolin-4(1H)-ones via decarboxylative pathway.201 In 2017, 
Ogawa and coworkers devised cross-coupling and hydroamination to give 2,2-
disubstituted quinazolinones via copper-catalyzed tandem reaction of vinyl halides 5-8 
and 2-aminobenzamides (Eq. 5.2).202 A number of late transition metal catalysts have 




5.2 Results and Discussion  
We previously discovered that the cationic ruthenium hydride complex 2-10 is a 
highly effective catalyst precursor for the deaminative and decarboxylative coupling 
reaction of ketones with amino acids.29 We also reported that a phenol-coordinated 
cationic ruthenium-hydride complex is a highly effective catalyst for mediating the 
hydrogenolysis of aldehydes and ketones.180 We subsequently found that the ruthenium-
hydride complex 2-10 with a 1,2-catechol ligand exhibits an exceptionally high chemo-
selectivity for promoting the deaminative coupling reactions of amines to form 
unsymmetrical secondary amines126b and quinazolinone149 derivatives. To further extend 





exploring the coupling reactions of 2-aminoketones with amines which led to the 
formation of quinoline byproduct 5-9 along with the expected quinazoline product 4-
12aa (Eq. 5.3).  
 
 
Scheme 5.1: Generation of Quinolines from the Reaction of 2-Aminoacetophenone with 
2-(4-Methoxyphenyl)ethylamine  
 
The regioselective formation of quinoline byproduct 5-9 can be rationalized by 
invoking the initial deaminative coupling126b followed by dehydrative cyclization steps 
via in-situ generated enamine intermediate. To generate quinolines with complete 
regioselectivity, we reasoned that the equilibrium between deaminative coupling vs initial 
imine formation should be the product determining step from the reaction of amine and 
aryl-ketone substrates. We tested the hypothesis by running the reaction with preformed 





85% quinazoline with only a trace quinoline products (Eq. 5.4). While exploring suitable 
substrates in formation of quinoline products, we found that the -amino acids are 
effective partners for the coupling reaction to afford 2-quinoline products (Eq. 5.5). 
 
 
   
In this Chapter, we disclose an efficient catalytic synthesis of quinoline and 
dihydroquinazolin-4(1H)-one derivatives from the dehydrogenative and deaminative 
coupling reactions of amino ketones and aminobenzamides with -amino acids and 
branched amines (Eq. 5.5 and 5.6). The salient features of the catalytic method are that 
the synthetically useful nitrogen heterocyclic core structures are formed in regio- and 
diastereoselective fashion without employing any reactive reagents or forming any 





5.2.1 Optimization Studies 
We initially explored the scope of coupling reaction of 2-aminoketones with -
amino acids by employing the ligand promoted catalysis protocol. Among the initially 
screened Ru catalysts and ligands, the in-situ generated catalytic system from the cationic 
ruthenium−hydride complex 2-10 with 4-(1,1-dimethylethyl)-1,2-benzenediol 2-16 was 
found to give the highest activity and selectivity for the coupling of 2-aminoacetaphenone 
with 3-aminobutanoic acid in yielding the quinoline product 5-9b (Table 5.1). The 
coupling reaction conditions described in Eq. 5.5 have been used as the standard reaction 
conditions unless otherwise noted. 
5.2.1.1 Ligand Screening  
We selected the coupling reaction of 2-aminoacetophenone with 3-aminobutanoic 
acid to evaluate the ligand effects. In the absence of any ligands, the reaction was found 
to be very sluggish as a trace amount of the product 5-9b was obtained with the catalyst 
2-10 (Table 5.3; entry 7). The addition of catechol ligands (2-16, 2-16a-f) significantly 
increased the formation of the desired product 5-9b. In accordance with the previous 
results on the ruthenium catalyzed C(sp3)−N bond cleavage reactions, binol, phenolic 3-
11b,c and amine containing ligands (3-11b, 3-12) were not effective for the 
transformation, and the catechol ligand 2-16 was found to be the most effective for the 
selective synthesis of secondary amines.126b The catechol ligands with both electron 
donating and withdrawing group 2-16a-e were found to be effective for the catalytic 
reaction in giving moderate to good yields (70-88%). As shown in Table 5.1, the 
catalytic activity of 2-10 was found to be substantially enhanced by the addition of a 





Table 5.1: Ligand Screening for the Coupling of 2-Aminophenylethanone with 3-
Aminobutanoic acid a 
 
 
aReaction conditions: 2-aminophenylethanone (0.5 mmol), 3-aminobutanoic acid (0.7 
mmol), 2-10 (3 mol %), ligand (10 mol %), 1,4-dioxane (2 mL), 140 °C, 20 h. bThe 
product yield of 5-9b was determined by 1H NMR using hexamethylbenzene as an 
internal standard. 
 
We initially explored the coupling reaction of 2-aminobenzamide with -amino acids in 
extending the synthetic utility of the coupling reaction. We screened the benzoquinone 
ligands, which gave the best result for branched amine substrates. As shown in the Table 
5.2, the ligand 2-12 has resulted in the formation of desired product in 94% yield. In 











entry ligand 5-10m (%)b 
1 2-12 94 
2 2-12a 86 
3 2-12b 85 
4 2-12f 74 
5 2-12g 81 
6 2-16b 66 
7 2-16c 72 
8 2-16d 68 
9 2-12j 30 
10 3-11b 44 
11 3-11d trace 
12 3-12 0 
aReaction conditions: 2-aminobenzamide (0.5 mmol), cyclohexylamine 
(0.7 mmol), 2-10 (3 mol %), ligand (10 mol %), 1,4-dioxane (2 mL), 
140 °C, 20 h. bThe product yield of 5-10m was determined by 1H NMR 
using hexamethylbenzene as an internal standard. 
 
5.2.2.2 Catalyst and Solvent Screening   
We compared the activity of commonly available ruthenium catalysts, where 1,4-
dioxane was found to be the most suitable solvent for the coupling reaction (entry 2-6). 





most effective catalyst (entry 1). Importantly, Lewis acids and PCy3 did not exhibit any 
activity for the coupling reaction (entry 14-16).  
 
Table 5.3: Catalyst and Additive Screening for the Coupling of 2-Aminophenylethanone 
with Aminobutanoic acida 
 
entry catalyst 






- 2-10 none 88 
2 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 cyclopentenec 82 
3 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 chlorobenzene 54 
4 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 1,2-DCE <10 
5 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 DME <10 
6 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 Toluene 74 
7 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 No ligand 22 
8 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 2-9 - 71 
9 (p-cymene)2RuHCl - 49 
10 RuCl2(PPh3)3 - 44 
11 RuCl3
.3H2O - <10 
12 [Ru(COD)Cl2]x - 32 
13 (PCy3)2(CO)RuHCl - 55 
14 - HBF4
.OEt2 0 
15 BF3 - 0 
16 PCy3 - 0 
aStandard conditions: 2-aminophenylethanone (0.5 mmol), aminobutanoic acid (0.7 
mmol), catalyst (3 mol %), ligand (10 mol %), solvent (2 mL), 140 °C, 20 h. b The 
product yield of 5-9b was determined by 1H NMR using hexamethylbenzene as an 
internal standard. c0.5 mmol of cyclopentene was added.  
 
 
These ligand screening and optimization efforts have led to the standard conditions for 





10 (3 mol %) and 2-16 (10 mol %) in 1,4-dioxane (2 mL) at 140 °C for 20 h (Table 5.3). 
The water byproduct was detected by NMR in a crude reaction mixture, and hydrogen 
gas was removed under vacuum along with the solvent. The product 5-9b was isolated by 
a column chromatographic separation on silica gel.  
 










- 2-10 none 94 
2 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 chlorobenzene 61 
3 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 1,2-DCE <10 
4 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 toluene  79 
5 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 chlorobenzene 74 
6 [(C6H6)(PCy3)(CO)RuH]
+BF4
- 2-10 1,2-DCE <10 
7 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 2-9 - 74 
8 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 2-9 HBF4
.OEt2 86 
9 [RuH2(CO)(PPh3)3] - 41 
10 [(PCy3)(CH3CN)(CO)RuH]
+BF4
- - 45 
11 RuHCl(p-cymene)2 - 50 
12 [Ru(COD)Cl2]x - trace 
13 [RuCl3
.3H2O)] - trace 
14 - HBF4
.OEt2 0 
15 - BF3 0 
16 - PCy3 0 
aStandard conditions: 2-aminophenylethanone (0.5 mmol), cyclohexylamine (0.7 mmol), 
catalyst (3 mol %), ligand (10 mol %), solvent (2 mL), 140 °C, 20 h. b The product yield 
of 5-10m was determined by 1H NMR using hexamethylbenzene as an internal standard. 






Next, we screened the activity of both Ru catalysts and ligands for the coupling 
reaction of 2-aminobenzamide with branched amines. The screening and optimization 
efforts have led to the standard conditions for the coupling reaction: 2-aminoamide (0.5 
mmol), branched amine (0.7 mmol), 2-10 (3 mol %) and 2-12 (10 mol %) in 1,4-dioxane 
(2 mL) at 140 °C for 20 h (Table 5.4). Among the screened ruthenium catalysts, the Ru-
H complex 2-10 was found to be the most effective catalyst (entry 1), and Lewis acid or 
bases did not exhibit any activity, just as in the previous reaction. The product 5-10m was 
isolated by a column chromatographic separation on silica gel. 
 
5.2.2 Synthesis of Quinoline Derivatives from the Coupling of 2-Aminophenyl 
Ketones with -Amino Acids 
With the optimized conditions in hand, we explored the substrate scope of the 
coupling reaction by using the catalyst system 2-10/2-16 under the standard reaction 
conditions as described above. The coupling of 2-aminophenyl ketones with a variety of 
-amino acids formed the quinoline products 5-9a−h in a regioselective fashion in good 
to excellent yields (56-90%). The coupling of 2-aminophenyl ketones with cyclic -
amino acids also gave the selective formation of the desired products 5-9i−p in excellent 
yields. Electron rich 3-amino-3-benzo[1,3]dioxol-5-yl-propionic acid reacted with a 
number of substituted 2-amino ketones to form the products in good to excellent yields 5-
9q−t (50-87%). Linear -amino acids, such as β-homophenylalanine and 3-
aminoheptanoic acid gave a mixture of 2,3-disubstituted quinoline products. This 
observation can be rationalized as a double bond isomerization on ruthenium in forming 





aminobenzaldehyde with β-homophenylalanine afforded the desired 2-substituted 
quinoline product 5-9w-b in only 34% yield along with the non-desired 2,3-disubstituted 
quinoline product 5-9w-a in 65% yield. In contrast, 5-chloro-2-aminobenzophenone with 
β-homophenylalanine afforded the desired 2-substituted quinoline product 5-9y-b in 12% 
yield and undesired 2,3-disubstituted quinoline product 5-9y-a in 87% yield (Scheme 
5.2).  
 
Scheme 5.2: Possible Explanation for the Product Selectivity 
While the coupling reaction of 2-aminphenyl ketone substrate with a (±)-3-amino-
5-methylhexanoic acid smoothly yielded regioselective coupling products 5-9aa-ac, the 
coupling with sterically demanding (±)--leucine gave the desired product 5-9ad in 51% 





Table 5.5: Synthesis of Quinoline Derivatives from the Coupling of 2- Aminophenyl 
Ketones with -Amino Acidsa 
 
aReaction conditions: aminoketone (0.5 mmol), amino acid (0.7 mmol), 2-10 (3 mol %), 






cis-endo-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid was found to be a suitable 
substrate for the coupling reaction without giving any side products 5-9ae,af. When the 
reaction was performed with tryptamine and 2-thiopheneethylamine, a mixture of 
quinazolinone and quinoline products 5-9ag and 5-9ah formed in 40% and 42% 
respectively under the standard reaction conditions. Single crystals of 5-9s were obtained 
by slow evaporation in pentane/acetone at room temperature, and its structure was 
determined by X-ray crystallography. 
5.2.3 Synthesis of Dihydroquinazolin-4(1H)-one from the Coupling of 2-
Aminobenzamides with -Amino Acids and Branched Primary Amines 
Adopting the previously developed conditions, we next sought the catalytic 
coupling reaction of 2-aminobenzamide with -amino acids which formed the desired 
dihydroquinazolin-4(1H)-one product in 80% yield. To further extend the synthetic 
utility, we next explored the coupling reaction of 2-aminobenzamide derivatives with 
branched primary amine substrates. In light of the previously developed deaminative 
coupling reaction of primary amines126b, we sought to achieve a direct C–N bond 
cleavage via imine intermediate. Thus, the treatment of 2-aminobenzamide (0.5 mmol) 
with branched amine (0.70 mmol) in the presence of 2-10 (3 mol %) and 2-12 (10 mol %) 
in 1,4-dioxane (2 mL) at 140 °C smoothly formed the coupling products 5-10a–e in good 
yields, which are analyzed by both GC and NMR spectroscopic methods. Single crystals 
of 5-10a were obtained by slow evaporation in hexanes/EtOAc at room temperature, and 
its structure was determined by X-ray crystallography. The coupling of 2-





selective formation of the dihydroquinazolin-4(1H)-one products 5-10f−k (76-88%) 
without significant amount of the secondary amine or other side products. 
 
Table 5.6: Synthesis of Dihydroquinazolin-4(1H)-one from the Coupling of 2-
Aminobenzamides with Branched Amines 
 
 
aReaction conditions: aminoamide (0.5 mmol), branched amine (0.7 mmol), 2-10 (3 mol 






The analogous coupling reaction of both 2-aminobenzamides and N-alkyl-2- benzamides 
with cyclic amines afforded the corresponding coupling products 5-10l−t in moderate to 
high yields (54-91%). Benzocyclic and bicyclic amines also reacted smoothly to generate 
the desired dihydroquinazolin-4(1H)-one products 5-10u−x. Interestingly, biologically 
relevant oxygen and nitrogen heterocyclic amines gave the desired product in excellent 
yields. The formation of dihydroquinazolin-4(1H)-one product can be rationalized by 
initial deaminative coupling of amide and amine substrates followed by the cyclization 
dehydrogenation steps. The coupling reaction efficiently assembles synthetically valuable 
dihydroquinazolin-4(1H)-one products core structures by employing readily available 
branched amine and benzamide substrates. 
5.2.4 Coupling Reaction of 2-Aminophenylketones with Biologically Active Amines 
To further demonstrate synthetic utility of the catalytic method, we next surveyed 
the substrate scope of the coupling method by employing several functionalized 2-
aminophenyl ketones and 2-aminobenzamides with a number of biologically active amine 
substrates (Table 5.7). Treatment of (3-amino-6-nitrobenzofuran-2-
yl)(phenyl)methanone with (1S,2R)-2-aminocyclohexanecarboxylic acid led to the 
nitro/chloro-substituted products 5-10i−j in excellent yields under the standard reaction 
conditions. The analogous coupling reaction of 5-chloro-2-aminobenzophenone with in-
situ generated 1-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-2-en-2-yl)pyrrolidine and 1-
(3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)buta-1,3-dien-2-yl)pyrrolidine formed 
the corresponding quinoline products 5-9ak and 5-9al in good yields (59, 61% 





Table 5.7: Coupling Reaction of 2-Aminophenyl Ketones and 2-Aminobenzamides 
Biologically Active and Functionalized Aminesa 
 
aReaction conditions: 2-aminoketone or 2-aminobenzamide (0.5 mmol), amine/amino 
acid (0.7 mmol), 2-10 (3 mol %), 2-12 or 2/16 (10 mol %), 1,4-dioxane (2 mL), 140 °C, 





The coupling of 4-amino-1-methyl-3-n-propyl-5-pyrazolecarboxamide with a 4-
morpholinyl-substituted amine predictively formed the desired product 5-10aa in 96% 
yield. The coupling of 2-aminobenzamide with in-situ generated 1-(4-(2,6,6-
trimethylcyclohex-1-en-1-yl)but-2-en-2-yl)pyrrolidine and 1-(4-(6-methoxynaphthalen-2-
yl)but-2-en-2-yl)pyrrolidine yielded the desired dihydroquinazolin-4(1H)-one products 5-
10ab and 5-10ac in 70% and 86% yields, respectively. Delightfully, the reaction of  2-
aminobenzamide with 1-((8S,9R,10R,13S,14R,17S)-10,13-dimethyl-17-((S)-6-
methylheptan-2-yl)-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-
cyclopenta[a]phenanthren-3-yl)pyrrolidine, afforded the desired cholesterol derivative 5-
10ad in an excellent yield (90%). The analogous treatment of 1,2-diamine with 
corresponding enamine also formed the quinoxaline product 5-11a-b. The structures of 
both 5-9ai and 5-11a products have been confirmed by X-ray crystallographic method. 
These examples clearly demonstrated the general applicability of the catalytic coupling 
method in synthesizing biologically active dihydroquinazolin-4(1H)-one derivatives. 
Synthetic utility of the catalytic method has been further tested by running a 
preparatory scale reaction of 2-amino-5-chlorobenzophenone (1.16 g, 5.0 mmol) with 
(1S,2R)-2-aminocyclohexanecarboxylic acid (1.0 g, 7 mmol) under standard reaction 
conditions. Analytically pure product 5-9m was obtained by crystallization in 
dichloromethane and n-hexanes (1.17 g, 80%). Similarly, the reaction of 2-
aminobenzamide (1.04 g, 7.5 mmol) and cyclohexylamine (1.04 g, 10.5 mmol) under 






5.2.5 Mechanistic Studies 
5.2.5.1 Deuterium Labeling Study 
 
We have chosen the coupling reaction of 2-aminoacetophenone with 
cyclohexylamine for probing mechanistic insights. First, we examined the deuterium-
labeling pattern from the reaction of 2-aminophenylethanone-d3 (89% D) with 4-

















Figure 5.3: 1H and 2H NMR Spectra of 5-9k-d Isolated from the Reaction of 2'-





Thus, the treatment of perdeuterated 2-aminophenylethanone-d3 (0.50 mmol) with 2-
aminocyclohexanecarboxylic acid (0.70 mmol) in the presence of 2-10 (3 mol %)/2-16 
(10 mol %) under the standard reaction conditions formed the coupling product 5-9k-d. 
The isolated product 5-9k-d as analyzed by 1H and 2H NMR contained only 11% of the 
deuterium on the methyl group as most of the deuterium had been washed away (Figure 
5.3). A relatively small amount of the deuterium on 5-9k-d suggests an extensive 
keto−enol tautomerization under the reaction conditions. 
 
5.2.5.2 Carbon Isotope Effect Study 
 
To discern between the possible turnover limiting steps, Singleton’s NMR 
technique127 at natural abundance was used to measure the 12C/13C kinetic isotope effect 
(KIE) from the coupling reaction of 5-chloro-2-aminobenzophenone with -leucine in the 
presence of 2-10 (3 mol %)/2-16 (10 mol %) in 1,4-dioxane (8 mL) was heated at 130 °C 
for 20 h (Eq. 5.8). The high precision 13C NMR analysis showed, most pronounced 
carbon KIE was observed on the -carbon atom of the product 5-9ad, when the 12C/13C 
ratio of the product at 92% conversion was compared to the product obtained at a low 





atom of 5-9d suggests that the C-N bond cleavage is intimately involved in the turnover 
limiting step of the coupling reaction. (Table 5.8). 
Table 5.8: Average 13C Integration of the Product 5-9d Obtained from the Reaction of 5-
chloro-2-aminobenzophenone and -Leucine at High Conversion (Virgin, R0; 92% 
conversion), at Low Conversion (R; avg 15% conversion) and the Calculated 13C KIE 









1 (ref) 1 1 1.0000 1.0000 
2  2.1727 2.1722 1.0002 1.0002 
3 1.0749 1.0556 1.0181 1.0181 
4 1.0843 1.0799 1.0041 1.0041 
5  1.4853 1.4899 0.9969 0.9969 
 
 
5.2.5.3 Reaction with Enamine Substrates 
 
To establish the enamine as a requisite intermediate for the formation of quinoline 
product, the reaction of and 1-pyrrolidino-1-cyclohexene was tested under the standard 
reaction conditions, which proceeded smoothly to afford the quinoline product 5-9m in 
85% yield (Eq. 5.9). In a control experiment, analogous treatment of  with p-
toluenesulfonic acid (5 mol %) did not form the product 5-9m under otherwise similar 





afforded the desired product 85% yield indicating ruthenium catecholate is a viable 
catalytic species. The results showed that the ruthenium catalysis is essential for the 
cyclization and dehydrogenation steps of the product formation.  
The reaction with the imine intermediate of the benzamide was performed under 
standard reaction conditions, which led to a quantitative product formation (Eq. 5.10). 
Interestingly, no desired product was formed when the reaction was performed under 
identical conditions without the ruthenium catalyst.  
 
5.2.5.4 Reaction with Dihydrocoumarin Substrates 
To probe the deamination versus decarboxylation sequence, a number of different 
carbonyl substrates were tested with -homoleucine substrate under standard reaction 
condition. The trapped amide product 5-12 was successfully obtained from the treatment 
of dihydrocoumarin with l-leucine (Eq. 5.10), and its structure was established by NMR 
and x-ray crystallography. The selective formation of the amide product 5-12 supports a 
preferential decarboxylation over the deamination step for the amino acid substrate. 
Transition metal catalyzed decarboxylative coupling methods have been successfully 







5.3 Proposed Mechanism of the Catalytic Synthesis of Quinoline Derivatives 
We offer a plausible mechanistic sequence for the formation of the quinoline 
products 5-9 on the basis of these preliminary results (Scheme 5.3). The reaction with 
enamine provides an additional experimental support for the formation of enamine by 
initial decarboxylation of -amino acid. In support of this hypothesis, we previously 
found that the ruthenium−hydride complexes are efficient catalysts for olefin 
isomerization reaction125b and dehydrogenation of saturated amines and carbonyl 
compounds.181 We believe that a redox-active catechol ligand may be essential for 
facilitating the dehydrogenation step on the catalysis.182 The coordination of 2-
aminoacetophenone to the ruthenium intermediate species 5-13 would give an 
intermediate ruthenium complex 5-14. Nucleophilic enolate attack followed by 
dehydrative coupling would afford the ruthenium coordinated imine species 5-8. Final 
deaminative126b annulation steps would afford the corresponding regioselective quinoline 






Scheme 5.3: Proposed Mechanistic Hypothesis for the Regio-selective synthesis of 
Quinolines from 2-Aminophenyl Ketones with -Amino Acids 
 
5.4 Conclusion 
In summary, we have successfully developed a novel catalytic coupling method 
by using readily available -amino acids and amines as substrates for the synthesis of 
nitrogen heterocycles. The salient features of the catalytic method are that it achieves 
direct C–N bond cleavage of biomass-derived -amino acids, exhibits a broad range of 
substrate scope with high regioselectivity, and it does not require any reactive reagents or 
pre-functionalization of the substrates in forming the quinoline products. Synthetic utility 
of the catalytic system has been demonstrated by running a gram scale reaction and the 







6.1 General Information 
All operations were carried out in a nitrogen-filled glove box or by using standard 
high vacuum and Schlenk techniques unless otherwise noted. All the solvents used were 
freshly distilled over appropriate drying reagents. Chlorobenzene was distilled from 
purple solutions of sodium and benzophenone, and hexanes was dried over calcium 
hydride prior to use. All organic substrates were received from commercial sources and 
were used without further purification. The 1H, 2H, 13C, and 31P NMR spectra were 
recorded on a Varian 400 MHz FT-NMR spectrometer, and the data are reported as: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent; 
coupling constant(s) in Hz; integration. In 1H NMR, the chemical shifts were referenced 
to the residual hydrogen signal of the deuterated solvents. In 13C{1H} NMR 
measurements, the signals of deuterated solvents were used as a reference. Reaction 
temperatures were reported as the temperatures of the oil bath. Mass spectra were 
recorded from Agilent 6850 GC-MS spectrometer by using a HP-5 (5% 
phenylmethylpolysiloxane) column (30 m, 0.32 mm, 0.25 μm) or from SHIMADZU GC-
2010 Plus gas chromatography spectrometer coupled with GCMS-QP2010 SE mass 
spectrometer by using a SHIMADZU SH-Rxi-5SilMS (similar to 5% 
diphenyl/95%dimethyl polysiloxane) column (30 m, 0.25 mm, 0.25 μm). High resolution 
mass spectra were obtained at the Mass Spectrometry/ICP Lab, Department of Chemistry 





Instrumentation Center, School of Pharmacy, University of Wisconsin-Madison, 
Madison, WI. Optical rotation was measured by using a 1 mL cell with 1 dm path length 
on a Perkin-Elmer 341 polarimeter with a sodium lamp, and are reported as [𝐶
𝑇] (c = 
g/100 mL, solvent). Elemental analyses were performed at the Midwest Microlab, 
Indianapolis, IN.  
6.2 Experimental Procedures and Data for the Chapter 02 
6.2.1 Synthesis of [(PCy3)(CO)RuH]4(µ4-O)(µ3-OH)(µ2-OH) Complex (2-9) 
The tetranuclear Ruthenium complex 2-9 was synthesized in two steps from the 
5- coordinated Ru-hydride complex (PCy3)2(CO)RuHCl 2-7 (Scheme 2.9). In a 
glovebox, a 500 mL Schlenk reactor equipped with a magnetic stirring bar and Teflon 
stopcock was charged with (PCy3)2(CO)RuHCl (726 mg, 1.0 mmol), KOH (6.5 mmol), 
and 2- propanol (5 mL). The reaction tube was brought out of the box and was stirred in 
an oil bath at 90 °C for 8 h. The solvent was removed under high vacuum, and the 
residue was washed with 2-propanol and benzene to obtain the binuclear Ru complex 2-
8. The binuclear Ru complex 2-8 can be purified by short column by benzene as the 
eluent. In the glove box, the obtained Ru binuclear complex 2-8 (500 mg, 0.46 mmol) 
and acetone (5 mL) were added to a 25 mL Schlenk tube equipped with a magnetic 
stirring bar and Teflon stopcock. The reaction tube was brought out of the glovebox and 
stirred in an oil bath at 100 °C for 4 h. After the tube was cooled to room temperature, the 
resulting red solid was filtered, washed with cold acetone (5 mL, 3 times), and 
recrystallized in dichloromethane to obtain product 2-9 in 90 % yield. Spectroscopic data 





14.56 (d, JPH = 19.2 Hz, Ru-H), -15.02 (d, JPH = 18.0 Hz, Ru-H), -15.28 (d, JPH = 34.8 
Hz, Ru-H), -18.64 (dt, JPH = 13.2, 4.8 Hz, Ru-H-Ru); 
31P{1H} NMR (CDCl3, 121.6 
MHz) δ 82.13 (s, PCy3), 79.01 (d, JPP = 14.0 Hz (PCy3)), 71.96 (s, (PCy3)), 68.89 (d, JPP 
= 14.0 Hz, (PCy3)); IR (CH2Cl2) νOH = 2926, 2849 cm
-1, νCO = 1925, 1912, 1894, 1868 
cm-1. Anal. Calcd for 2-9 C76H138O7P4-Ru4: C 53.95; H 8.22. Found: C 55.03; H 8.14.
125a 
6.2.2 Synthesis of [(η6-C6H6)RuH(CO)(PCy3)]+BF4- Complex (2-10) 
In a glove box, complex 2-9 (200 mg, 0.12 mmol) was dissolved in benzene (10 
mL) in a 25 mL Schlenk tube equipped with a Teflon screw-cap stopcock and a magnetic 
stirring bar. The tube was brought out of the box, and HBF4·OEt2 (64 μL, 0.48 mmol) 
was added via syringe under N2 stream. The color of the solution was changed from dark 
red to pale yellow immediately. After stirring for 1 h at room temperature, the solvent 
was removed under vacuum, and the residue was crashed by adding hexanes (20 mL). 
Filtering the resulting solid through a fritted funnel and recrystallization from 
CH2Cl2/hexanes yielded the product as a pale-yellow powder (262 mg, 95% yield). 
Single crystals of 2-10 suitable for X-ray crystallography were obtained from a slow 
evaporation of benzene and hexanes solution. 
Data for 2-10: 1H NMR (CD2Cl2, 400 MHz) δ 6.53 (s, C6H6), 2.0-1.2 (m, PCy3), -10.39 
(d, JPH = 25.9 Hz, Ru-H); 
13C{1H} NMR (CD2Cl2, 100 MHz), δ 196.4 (d, JCP = 19.3 Hz, 
CO), 100.0 (C6H6), 38.4, 38.2, 30.2, 29.9, 27.4, 27.3 and 26.2 (PCy3); 
31P{1H} NMR 
(CD2Cl2, 162 MHz) δ 72.9 (PCy3); IR (KBr) νCO = 1991 cm
-1; Anal. Calcd for 2-10 







6.2.3 Synthesis of [Ru(PCy3)2(3-,5-(tBu)2(1-,2-(O)2)C6H2)CO] Complex 2-11 
The complex 2-10 (117 mg, 0.20 mmol), 3,5-di-tert-butyl-o-benzoquinone 2-12b 
(44 mg, 0.20 mmol), PCy3 (56 mg, 0.20 mmol) were dissolved in CH2Cl2 (3 mL) in a 25 
mL Schlenk tube equipped with a Teflon screw cap stopcock and a magnetic stirring bar 
under N2 stream. After stirring for 24 h in a water bath set at 70 °C, the solvent was 
removed under vacuum, and the residue was washed with 2% hexanes/EtOAc under 
nitrogen atmosphere. The resulting residue was dissolved in acetone (3 mL), layered with 
n-pentane (4 mL), and stored in a glove box for five days for crystallization. The 
resulting solid was filtered through a fritted funnel to yield the complex 2-11 (102 mg, 
56%) as a reddish crystalline solid. Single crystals of 2-11 were obtained by slow 
evaporation in EtOAc/pentanes, and its structure was determined by X-ray 
crystallography. Data for 2-11: 1H NMR (400 MHz, CDCl3) δ 6.91 (s, 1H), 6.91 (s, 1H), 
2.60–0.70 (m, 84H) ppm; 31P{1H} NMR (100 MHz, CDCl3) δ 75.6, 75.4 ppm; HRMS 
(ESI-TOF) m/z: [M + H]+ Calcd for C51H86O3P2RuH 911.5183; Found 911.5146. 
6.2.3.1 X-Ray Crystal Structure of Complex 2-11 
Dark-red prism like single crystals of 2-11 were grown in pentanes/EtOAc at 
room temperature. A suitable crystal with the dimension of 0.748 × 0.105 × 0.04 mm3 
was selected and mounted on an Oxford SuperNova, Dual Cu at home/near, Atlas 
diffractometer, respectively. The crystal was kept at 100 K during data collection. Using 
Olex2,203 the structure was solved with the olex2.solve204 structure solution program 
using Charge Flipping and refined with the ShelXL205 refinement package using Least 






Figure 6.1: The Molecular Structure of Ruthenium Complex 2-11 
 






6.2.3.2  X-ray Crystallographic Data for the Complex 2-11 
Table 6.1: Crystal Data and Structure Refinement for Ruthenium Complex 2-11 
Identification code  yi4z  
Empirical formula  C51H86O3P2Ru  
Formula weight  910.20  
Temperature/K  100.3(9)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  20.07721(19)  
b/Å  13.38539(14)  
c/Å  17.77134(18)  
α/°  90  
β/°  90.3343(9)  
γ/°  90  
Volume/Å3  4775.81(8)  
Z  4  
ρcalcg/cm
3  1.266  
μ/mm-1  3.586  
F(000)  1960.0  
Crystal size/mm3  0.215 × 0.183 × 0.116  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.938 to 141.126  
Index ranges  -24 ≤ h ≤ 22, -16 ≤ k ≤ 16, -20 ≤ l ≤ 21  
Reflections collected  44427  
Independent reflections  9074 [Rint = 0.0418, Rsigma = 0.0273]  
Data/restraints/parameters  9074/0/520  
Goodness-of-fit on F2  1.027  
Final R indexes [I>=2σ (I)]  R1 = 0.0319, wR2 = 0.0821  
Final R indexes [all data]  R1 = 0.0358, wR2 = 0.0856  
Largest diff. peak/hole / e Å-3  0.87/-0.55  
 
6.2.4.1 X-ray Crystal Structure of Complex 2-14 
Orange needles shaped single crystal of 2-14 were grown in pentanes/EtOAc at 
room temperature. A suitable crystal with the dimension of 0.603 × 0.112 × 0.024 mm3 





diffractometer, respectively. The crystal was kept at 100 K during data collection. Using 
Olex2,203 the structure was solved with the olex2.solve204 structure solution program 
using Charge Flipping and refined with the ShelXL205 refinement package using Least 
Squares minimization.  
 
Figure 6.3: The Molecular Structure of Ruthenium Complex 2-14 
Data for 2-14: 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 7.6 Hz, 2H), 7.61 (d, J = 7.6 
Hz, 2H), 7.21–7.10 (m, 4H), 2.71–0.62 (m, 78H) ppm; 31P{1H} NMR (100 MHz, CDCl3) 







Figure 6.4: Crystal Packing of Ruthenium Complex 2-14 
 
6.2.4.2 X-ray Crystallography Data for the Complex 2-14 
Table 6.2: Crystal Data and Structure Refinement for Ruthenium Complex 2-14 
Identification code  yi5b  
Empirical formula  C53H76BCl2F4O4P2Ru  
Formula weight  1097.85  
Temperature/K  100.00(10)  
Crystal system  monoclinic  
Space group  P21/m  
a/Å  9.83560(10)  
b/Å  15.2197(2)  





α/°  90  
β/°  92.2990(10)  
γ/°  90  
Volume/Å3  2587.25(5)  
Z  2  
ρcalcg/cm
3  1.409  
μ/mm-1  4.468  
F(000)  1150.0  
Crystal size/mm3  0.603 × 0.112 × 0.024  
Radiation  Cu Kα (λ = 1.54184)  
2Θ range for data collection/°  7.74 to 141.174  
Index ranges  
-10 ≤ h ≤ 11, -18 ≤ k ≤ 18, -21 
≤ l ≤ 21  
Reflections collected  24817  
Independent reflections  
5091 [Rint = 0.0364, Rsigma = 
0.0251]  
Data/restraints/parameters  5091/0/354  
Goodness-of-fit on F2  1.042  
Final R indexes [I>=2σ (I)]  R1 = 0.0325, wR2 = 0.0840  
Final R indexes [all data]  R1 = 0.0368, wR2 = 0.0868  
Largest diff. peak/hole / e Å-3  0.78/-1.07  
 
6.2.5 Synthesis of [Ru(PCy3)2(CO)H(OH2)2) Complex 2-15 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (117 mg, 0.2 mmol), water (9 
mg, 0.5 mmol), tricyclohexylphosphine (56 mg, 0.2 mmol) were dissolved in CH2Cl2 (3 
mL) in a 25 mL Schlenk tube equipped with a Teflon screw cap stopcock and a magnetic 
stirring bar under N2 stream. After stirring for 24 h in a 50 °C water bath, the solvent was 
removed under vacuum, and the residue was washed with 2% hexanes/EtOAc in a 
nitrogen atmosphere. The resulting residue was dissolved in acetone (3 mL), layered with 
n-pentane (4 mL), and stored in a glove box for five days for crystallization. The 
resulting solid was filtered through a fritted funnel to yield the product as brownish 





complex 2-15 (78 mg, 48%). Single crystals of 2-15 were obtained by slow evaporation 
in CH2Cl2/pentanes, and its structure was determined by X-ray crystallography. Data for 
2-15: Data for 2-14: 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 7.6 Hz, 2H), 7.61 (d, J = 
7.6 Hz, 2H), 7.21–7.10 (m, 4H), 2.71–0.62 (m, 78H) ppm; 31P{1H} NMR (100 MHz, 
CDCl3) δ 75.0, 74.8 ppm; HRMS (ESI-TOF) m/z: [M + H]
+ Calcd for C37H71O3P2RuH 
728.4005; Found 728.4005. 
6.2.5.1 X-Ray Crystal Structure of Complex 2-15 
Brownish needles shaped single crystal of 2-15 were grown in pentanes/EtOAc at 
room temperature. A suitable crystal with the dimension of 0.612 × 0.123 × 0.077 mm3 
was selected and mounted on an Oxford SuperNova, Dual Cu at home/near, Atlas 
diffractometer, respectively. The crystal was kept at 100 K during data collection. Using 
Olex2,203 the structure was solved with the olex2.solve204 structure solution program 
using Charge Flipping and refined with the ShelXL205 refinement package using Least 
Squares minimization. The molecular structure of 2-15 is shown in Figure 6.5. The 
Ru(II) complex has an octahedral coordination. The hydride ligand was localized 
objectively and refined isotopically. The complex has trans-configuration in respect to 
phosphine ligands and cis-configuration in respect to aqua ligands. The tetrafluoroborate 
anion is disordered. The cations form H-bonds with bridging BF4
- anions making 1-






Figure 6.5: The Molecular Structure of Ruthenium Complex 2-15 
 





6.2.5.2 X-ray Crystallographic Data for the Complex 2-15 
Table 6.3: Crystal Data and Structure Refinement for Ruthenium Complex 2-15 
Identification code  yi4v  
Empirical formula  C37H71BF4O3P2Ru  
Formula weight  813.75  
Temperature/K  101(2)  
Crystal system  triclinic  
Space group  P-1  
a/Å  9.84636(17)  
b/Å  13.5122(3)  
c/Å  17.1420(3)  
α/°  71.3133(18)  
β/°  86.8988(14)  
γ/°  71.7993(17)  
Volume/Å3  2049.67(7)  
Z  2  
ρcalcg/cm
3  1.319  
μ/mm-1  0.511  
F(000)  864.0  
Crystal size/mm3  0.612 × 0.123 × 0.077  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.7 to 59.326  
Index ranges  
-13 ≤ h ≤ 13, -17 ≤ k ≤ 17, -23 
≤ l ≤ 23  
Reflections collected  46281  
Independent reflections  
10496 [Rint = 0.0244, Rsigma = 
0.0237]  
Data/restraints/parameters  10496/20/490  
Goodness-of-fit on F2  1.060  
Final R indexes [I>=2σ (I)]  R1 = 0.0258, wR2 = 0.0575  
Final R indexes [all data]  R1 = 0.0307, wR2 = 0.0604  







6.2.6 General Procedures for the Catalytic Synthesis of Secondary Amines 
In a glove box, complex 2-9 (13 mg, 0.75 mol %) and 4-(1,1-dimethylethyl)-1,2-
benzenediol 2-16, (16 mg, 10 mol %) were dissolved in chlorobenzene (1 mL) in a 25 mL 
Schlenk tube equipped with a Teflon screw cap stopcock and a magnetic stirring bar. The 
resulting mixture was stirred for 5 to 10 minutes until the solution turned to a reddish 
green color. One (procedure for symmetric coupling reactions, 1.0 mmol of primary 
amine substrate) or two amines substrates (1.0 mmol and 1.4 mmol) in chlorobenzene (1 
mL) were added to the reaction tube. After the tube was sealed, it was brought out of the 
glove box, and was stirred in an oil bath maintained at 130-140 °C for 16-20 h. The 
reaction tube was taken out of the oil bath and was cooled to room temperature. After the 
tube was open to air, the solution was filtered through a short silica gel column by eluting 
with CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS. Analytically pure product 
was isolated by a simple column chromatography on silica gel (280-400 mesh, 
hexanes/EtOAc). 
In an alternative procedure, the complex 1-45 (17 mg, 3 mol %) and 1-46 (24 mg, 
10 mol %) or complex 2-9 were dissolved in anhydrous 1,4-dioxane (1 mL) in a 25 mL 
Schlenk tube equipped with a Teflon screw cap stopcock and a magnetic stirring bar. 
After stirring for 5-10 min until the solution was turned light green color, both amine 1 
(0.5 mmol) and an amine 2 (0.7 mmol) substrates, and dioxane (1 mL) was added to the 
tube. The tube was sealed, it was brought out of the glove box, and was stirred in an oil 
bath set at 130-140 °C for 16-20 h. Analytically pure product was isolated by flash 
chromatographic machine, Biotage Isolara™ One. Dry loading of a sample in to a 10g of 





6.2.7.1 Reaction Profile Study 
In a glove box, complex 2-9 (2 mg, 3 mol %) and 2-16 (2 mg, 10 mol %) were 
dissolved in toluene-d8 (0.5 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 10 
minutes until the solution turned to a brownish green color. 4-methoxybenzylamine (14 
mg, 0.10 mmol) were added to the reaction tube, and the solution was transferred into a 
J-Young NMR tube equipped with a Teflon screw cap stopcock. The tube was brought 
out of the glove box, and was immersed an oil bath set at 130 °C. The tube was taken out 
from the oil bath at 20 min intervals, was immediately cooled in ice-water bath, and was 
analyzed by 1H NMR. The appearance of the product signal was normalized against an 
external standard peak (C6Me6). 
 
6.2.7.2 Deuterium Labeling Study 
In a glove box, complex 2-9 (7 mg, 0.75 mol %) and  2-16 (8 mg, 10 mol %) 
were dissolved in chlorobenzene (1 mL) in a 25 mL Schlenk tube equipped with a Teflon 
screw cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5 to 
10 minutes until the solution turned to a reddish green color. Aniline-d7 (50 mg, 0.5 
mmol) and 4-methoxybenzylamine (78 mg) in chlorobenzene (1 mL) were added to the 
reaction tube. After the tube was sealed, it was brought out of the glove box, and was 
stirred in an oil bath maintained at 140 °C for 20 h. Analytically pure product was 
isolated by a simple column chromatography on silica gel (280-400 mesh, n-
hexanes/EtOAc). The 1H and 2H NMR spectra of the product 2-15e-d are recorded 





mg, 0.5 mmol) with Aniline-d7 (50 mg, 0.5 mmol) with the catalyst 2-9 (7 mg, 0.75 mol 
%) and 2-16 (8 mg, 10 mol %) which were dissolved in chlorobenzene (1 mL).  
 
6.2.7.3 Carbon Isotope Effect Study 
In a glove box, complex 2-9 (28 mg, 0.75 mol %) and 2-16 (32 mg, 10 mol %) 
were dissolved in chlorobenzene (2 mL) in a 25 mL Schlenk tube equipped with a Teflon 
screw cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5 to 
10 minutes until the solution turned to a reddish green color. 4-Methoxybenzylamine 
(274 mg, 2.0 mmol) and chlorobenzene (2 mL) were added to the reaction tube. After the 
tube was sealed, those were brought out of the box, and was stirred in an oil bath at 130 
°C for 16 h. The tube was cooled to room temperature and filtered through a small silica 
column (CH2Cl2), and the product conversion was determined by GC (86%, 88% and 
89% conversions). The product 2-14c was isolated by a column chromatography on silica 
gel (hexanes/EtOAc). The procedure was repeated two more times. In a similar 
procedure, complex 2-9 (52 mg, 0.75 mol %) and 2-16 (80 mg, 10 mol %) were 
dissolved in chlorobenzene (5 mL) in a 100 mL Schlenk tube equipped with a Teflon 
screw cap stopcock and a magnetic stirring bar. 4-Methoxybenzylamine (685 mg, 5.0 
mmol) and chlorobenzene (5 mL) were added to the reaction tube. After the tube was 
sealed, it was brought out of the box, and was stirred in an oil bath at 130 °C for 2 h. The 
tube was cooled to room temperature and filtered through a small silica column 
(CH2Cl2), and the product conversion was determined by GC (15%, 13% and 12% 
conversions). The product 2-14c was isolated by a column chromatography on silica gel 





mg) in CDCl3 (0.5 mL) in a 5 mm high precision NMR tube. The 
13C{1H} NMR spectra 
were recorded with H-decoupling and 45-degree pulses. A 60 s delay between pulses was 
imposed to minimize T1 variations (d1 = 120 s, at = 5.0 s, np = 245098, nt = 512, dm = 
‘nny’).  
6.2.7.4 Hammett Study 
In a glove box, complex 2-9 (20 mg, 0.75 mol %) and 2-16 (24 mg, 10 mol %) 
were dissolved in toluene-d8 (1.5 mL) in a 25 mL Schlenk tube equipped with a Teflon 
screw cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5 to 
10 minutes until the solution turned to a reddish green color. 4-Methoxyaniline (185 mg, 
1.5 mmol) was added to the reaction tube, and the solution was stirred for 5 min. The 
solution was divided into 6 equal portions, and p-X-C6H4CH2NH2 (0.3 mmol) (X = OMe, 
Me, H, F, Cl, CF3) was added to each solution. The resulting mixture was transferred into 
six different J-Young NMR tubes each equipped with a Teflon screw cap stopcock. The 
tubes were brought out of the glove box, and were immersed an oil bath set at 140 °C. 
Each tube was taken out from the oil bath at 30 min time intervals, cooled in ice-water 
bath, and was analyzed by 1H NMR. The reaction rate was measured by monitoring the 
appearance of the product signals on 1H NMR, which was normalized against the internal 
standard peak (C6Me6). The kobs was determined from a first-order plot of -ln[(4-






6.2.8.1 Characterization Data of the Novel Unsymmetric Secondary Amines Listed 
in Table 2.3 
N-(4-Chlorobenzyl)-2-(4-
methoxyphenyl)ethanamine (2-17e). A 
chlorobenzene (2.0 mL) solution of complex 2-9 
(13 mg, 0.75 mol %), 2-16 (16 mg, 10 mol %), 4-
chlorobenzylamine (141 mg, 1.0 mmol) and 4-methoxybenzeneethanamine (211 mg, 1.4 
mmol) was stirred at 130 °C for 16 h. The product 2-17e was isolated by a column 
chromatography on silica gel (n-hexane/EtOAc = 100:1 to 10:1; 158 mg, 57%). TLC; Rf 
= 0.4 (20% EtOAc in hexanes). Data for 2-17e: 1HNMR (400 MHz, CDCl3) δ 7.30–7.25 
(m, 2H), 7.24–7.19 (m, 2H), 7.15–7.09 (m, 2H), 6.87–6.82 (m, 2H), 3.79 (s, 3H), 3.76 (s, 
2H), 2.87–2.82 (m, 2H), 2.80–2.74 (m, 2H), 1.73 (br s, 1H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 157.9, 138.6, 132.5, 131.7, 129.5, 129.3, 128.4, 113.8, 55.1, 53.0, 50.5, 
35.2 ppm; GC-MS for C16H18ClNO, m/z = 275 (M
+). HRMS (ESI-TOF) m/z: [M+H]+ 
Calcd for C16H18ClNOH 276.1150; Found 276.1122. 
N-(Biphenyl-4-ylmethyl)hexan-1-amine (2-17f). 
A chlorobenzene (2.0 mL) solution of complex 2-9 
(13 mg, 0.75 mol %), 2-16 (16 mg, 10 mol %), 4-
pheylbenzylamine (183 mg, 1.0 mmol) and 1-hexamine (141 mg, 1.4 mmol) was stirred 
at 130 °C for 16 h. The product 2-17f was isolated by a column chromatography on silica 
gel (n-hexane/EtOAc = 100:1 to 10:1; 176 mg, 66%). TLC; Rf = 0.3 (20% EtOAc in 
hexanes). Data for 2-17f: 1HNMR (400 MHz, CDCl3) δ 7.61–7.54 (m, 4H), 7.46–7.37 





1.36–1.26 (m, 6H), 0.89 (t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
141.0, 139.8, 139.6, 128.7, 128.5, 128.4, 127.1, 127.0, 53.7, 49.6, 31.8, 30.1, 27.0, 22.6, 
14.1 ppm; GC-MS for C19H25N, m/z = 267 (M
+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd 
for C19H25NH 268.2060; Found 268.2061. 
N-(4-(Trifluoromethyl)benzyl)hexan-1-amine (2-
17g). A chlorobenzene (2.0 mL) solution of complex 
2-9 (13 mg, 0.75 mol %), 2-16 (16 mg, 10 mol %), 4-
trifluromethylbenzylamine (175 mg, 1.0 mmol) and 1-hexamine (141 mg, 1.4 mmol) was 
stirred at 130 °C for 16 h. The product 2-17g was isolated by a column chromatography 
on silica gel (n-hexanes/EtOAc = 100:1 to 10:1; 142 mg, 55%). TLC; Rf = 0.4 (20% 
EtOAc in hexanes). Data for 2-17g: 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.2 Hz, 
2H), 7.44 (d, J = 8.2 Hz, 2H), 3.84 (s, 2H), 2.61 (t, J = 7.2 Hz, 2H), 1.58 (br s, 1H), 1.55–
1.46 (m, 2H), 1.37–1.22 (m, 6H), 0.91–0.84 (m, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 144.6, 129.1 (q, JCF = 32.3 Hz), 128.3, 125.3 (q, JCF = 3.8 Hz), 124.2 (q, JCF = 
272.0 Hz), 53.5, 49.5, 31.7, 30.0, 27.0, 22.6, 14.0; GC-MS for C14H20F3N, m/z = 259 
(M+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C14H20F3NH 260.1621; Found 
260.1627. 
4-Fluoro-N-hexylbenzenemethanamine (2-17i). A 
chlorobenzene (2.0 mL) solution of complex 2-9 (13 
mg, 0.75 mol %), 2-16 (16 mg, 10 mol %), 4-
flurobenzylamine (125 mg, 1.0 mmol) and 1-hexamine (141 mg, 1.4 mmol) was stirred at 
130 °C for 16 h. The product 2-17i was isolated by a column chromatography on silica 





hexanes). Data for 2-17i: 1HNMR (400 MHz, CDCl3) δ 7.30–7.24 (m, 2H), 7.02–6.95 (m, 
2H), 3.74 (s, 2H), 2.59 (t, J = 7.3, 2H), 1.53–1.44 (m, 2H), 1.35–1.21 (m, 6H), 0.90–0.84 
(m, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.8 (d, JCF = 244.6 Hz), 136.2 (d, 
JCF = 3.1 Hz), 129.6 (d, JCF = 7.9 Hz), 115.0 (d, JCF = 21.2 Hz), 53.3, 49.4, 31.7, 30.0, 
27.0, 22.6, 14.0 ppm; GC-MS for C13H20FN, m/z = 209 (M
+); HRMS (ESI-TOF) m/z: 
[M+H]+ Calcd for C13H20FNH 210.1653; Found 260.1654. 
N-[(4-fluorophenyl)methyl]-4-methoxy-
benzeneethanamine (2-17k). A chlorobenzene (2.0 
mL) solution of complex 2-9 (13 mg, 0.75 mol %), 2-
16 (16 mg, 10 mol %), 4-flurobenzylamine (125 mg, 
1.0 mmol) and 4-methoxybenzeneethanamine (211 mg, 1.4 mmol) was stirred at 130 °C 
for 16 h. The product 2-17k was isolated by a column chromatography on silica gel (n-
hexane/EtOAc = 100:1 to 10:1; 142 mg, 55%). TLC; Rf = 0.3 (20% EtOAc in hexanes). 
Data for 2-17k: 1H NMR (400 MHz, CDCl3) δ 7.27–7.21 (m, 2H), 7.15–7.10 (m, 2H), 
7.03–6.96 (m, 2H), 6.87–6.82 (m, 2H), 3.79 (s, 3H), 3.76 (s, 2H), 2.88–2.83 (m, 2H), 
2.80–2.74 (m, 2H), 1.69 (br s, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.8 (d, 
JCF = 244.6 Hz), 157.9, 135.8 (d, JCF = 3.1 Hz), 131.8, 129.5, 129.5 (d, JCF = 7.9 Hz), 
115.0 (d, JCF = 21.2 Hz), 113.8, 55.1, 53.0, 50.6, 35.2 ppm; GC-MS for C16H18FNO, m/z 







methylbenzeneethanamine (2-17l). A chlorobenzene 
(2.0 mL) solution of complex 2-9 (13 mg, 0.75 mol %), 2-
16 (16 mg, 10 mol %), 4-flurobenzylamine (125 mg, 1.0 mmol) and β-
methylphenethylamine (189 mg, 1.4 mmol) was stirred at 130 °C for 16 h. The product 2-
17l was isolated by a column chromatography on silica gel (n-hexane/EtOAc = 100:1 to 
10:1; 141 mg, 58%). TLC; Rf = 0.4 (20% EtOAc in hexanes). Data for 2-17l: 
1H NMR 
(400 MHz, CDCl3) δ 7.37–7.30 (m, 2H), 7.26–7.19 (m, 5H), 7.03–6.96 (m, 2H), 3.74 
(ABq, J = 13.5 Hz, 2H), 2.99 (qt, J = 7.1, 7.0 Hz, 1H), 2.84–2.77 (m, 2H), 1.55 (br s, 
1H), 1.28 (d, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.7 (d, JCF = 
244.2 Hz), 145.1, 135.8 (d, JCF = 3.1 Hz), 129.4 (d, JCF = 7.9 Hz), 128.5, 127.1, 126.3, 
115.0 (d, JCF = 21.2 Hz), 56.1, 52.9, 39.9, 20.0 ppm; GC-MS for C16H18FN, m/z = 243 
(M+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H18FNH 244.1496; Found 244.1500. 
N-Cyclohexyl-4-methoxybenzeneethanamine (2-17m). A 
chlorobenzene (2.0 mL) solution of complex 2-9 (13 mg, 
0.75 mol %), 2-16 (16 mg, 10 mol %), 4-
methoxybenzeneethanamine (151 mg, 1.0 mmol) and 
cyclohexylamine (139 mg, 1.4 mmol) was stirred at 130 °C for 16 h. The product 2-17m 
was isolated by a column chromatography on silica gel (n-hexanes/EtOAc = 100:1 to 
10:1; 187 mg, 80%). TLC; Rf = 0.3 (20% EtOAc in hexanes). Data for 2-17m: 
1H NMR 
(400 MHz, CDCl3) δ 7.10 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 8.7 Hz, 2H), 3.75 (s, 3H), 
2.86–2.81 (m, 2H),  2.74–2.68 (m, 2H), 2.39 (tt, J = 10.6, 3.8 Hz, 1H), 1.88–1.78 (m, 





13C{1H} NMR (100 MHz, CDCl3) δ 157.8, 132.0, 129.4, 113.7, 56.6, 55.0, 48.3, 35.5, 
33.4, 26.0, 24.9 ppm; GC-MS for C15H23NO, m/z = 233 (M
+); HRMS (ESI-TOF) m/z: 
[M+H]+ Calcd for C15H23NOH 234.1852; Found 234.1854. 
N-(4-Methoxyphenethyl)-4-phenylbutan-2-amine (2-
17n). A chlorobenzene (2.0 mL) solution of complex 2-
9 (13 mg, 0.75 mol %), 2-16 (16 mg, 10 mol %), 4-
methoxybenzeneethanamine (151 mg, 1.0 mmol) and 
(±)1-methyl-3-phenyl-1-propanamine (209 mg, 1.4 mmol) was stirred at 130 °C for 16 h. 
The product 2-17n was isolated by a column chromatography on silica gel (n-
hexanes/EtOAc = 100:1 to 10:1; 208 mg, 73%. TLC; Rf = 0.3 (20% EtOAc in hexanes). 
Data for 2-17n: 1H NMR (400 MHz, CDCl3)  δ 7.30–7.25 (m, 2H), 7.21–7.11 (m, 5H), 
6.88–6.83 (m, 2H), 3.79 (s, 3H), 2.94–2.84 (m, 1H), 2.82–2.70 (m, 3H), 2.70–2.52 (m, 
3H), 1.82–1.72 (m, 1H), 1.66–1.56 (m, 1H), 1.54 (br s, 1H), 1.10 (d, J = 6.3 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 157.9, 142.2, 132.0, 129.6, 128.3, 128.2, 
125.6, 113.8, 55.2, 52.4, 48.5, 38.5, 35.5, 32.2, 20.2 ppm; GC-MS for C19H25NO, m/z = 
283 (M+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C19H25NOH  284.2009; Found 
284.2010. 
N-(3-Fluorophenethyl)-2,3-dihydro-1H-inden-2-amine (2-
17o). A chlorobenzene (2.0 mL) solution of complex 2-9 (13 
mg, 0.75 mol %), 2-16 (16 mg, 10 mol %), 2-(3-
fluorophenyl)ethylamine (139 mg, 1.0 mmol) and 2-
aminoindane (186 mg, 1.4 mmol) was stirred at 130 °C for 16 h. The product 2-17o was 





mg, 76%). TLC; Rf = 0.4 (10% EtOAc in hexanes). Data for 2-17o:
 1H NMR (400 MHz, 
CDCl3) δ 7.3–7.24 (m, 1H), 7.24–7.12 (m, 4H), 7.06–7.00 (m, 1H), 6.99–6.89 (m, 2H), 
3.67 (quintet, J = 6.9 Hz, 1H), 3.18 (dd, J = 15.5, 7.2 Hz, 2H), 3.01–2.92 (m, 2H), 2.89–
2.81 (m, 2H), 2.75 (dd, J = 15.5, 6.6 Hz, 2H), 1.63 (br s, 1H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 162.8 (d, JCF = 245.5 Hz), 142.5 (d, JCF = 7.2 Hz), 141.5, 129.8 (d, JCF = 
8.3 Hz), 126.4, 124.6, 124.3 (d, JCF = 2.7 Hz), 115.4 (d, JCF = 20.8 Hz), 113.0 (d, JCF = 
21.0 Hz), 59.4, 49.2, 39.9, 36.2 (d, JCF = 1.6 Hz)  ppm; GC-MS for C17H18FN, m/z = 255 
(M+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H18FNH 256.1496; Found 256.1501. 
N-(3-Fluorophenethyl)-1-(4-methoxyphenyl)ethanamine (2-
17p). A chlorobenzene (2.0 mL) solution of complex 2-9 (13 mg, 
0.75 mol %), 2-16 (16 mg, 10 mol %), 2-(3-
fluorophenyl)ethylamine (139 mg, 1.0 mmol) and (R)-(+)-1-(4-
methoxyphenyl)ethylamine (211 mg, 1.4 mmol) was stirred at 
130 °C for 16 h. The product 2-17p was isolated by a column chromatography on silica 
gel (n-hexanes/EtOAc = 100:1 to 10:1; 157 mg, 58%). TLC; Rf = 0.3 (20% EtOAc in 
hexanes). Data for 2-17p: 1H NMR (400 MHz, CDCl3) δ 7.27–7.16 (m, 3H), 6.98–6.80 
(m, 5H), 3.80 (s, 3H), 3.73 (q, J = 6.6 Hz, 1H), 2.83–2.63 (m, 4H), 1.60 (br s, 1H), 1.32 
(d, J = 6.6 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 162.8 (d, JCF = 245.4 Hz), 
158.5, 142.6 (d, JCF = 7.2 Hz), 137.3, 129.7 (d, JCF = 8.3 Hz), 127.5, 124.3 (d, JCF = 2.7 
Hz), 115.4 (d, JCF = 20.9 Hz), 113.7, 112.9 (d, JCF = 21.0 Hz), 57.5, 55.2, 48.5, 36.1 (d, 
JCF = 1.7 Hz), 24.2 ppm; GC-MS for C17H20FNO, m/z = 273 (M
+); HRMS (ESI-TOF) 






methoxyphenyl)ethanamine (2-17q). A 
chlorobenzene (2.0 mL) solution of complex 2-9 (13 
mg, 0.75 mol %), 2-16 (16 mg, 10 mol %), 1-(1,3-benzodioxol-5-yl)methanamine (151 
mg, 1.0 mmol) and (R)-(+)-1-(4-methoxyphenyl)ethylamine (211 mg, 1.4 mmol) was 
stirred at 130 °C for 16 h. The product 2-17q was isolated by a column chromatography 
on silica gel (n-hexane/EtOAc = 100:1 to 10:1; 171 mg, 60%). TLC; Rf = 0.3 (20% 
EtOAc in hexanes). Data for 2-17q: 1H NMR (400 MHz, CDCl3) δ 7.30–7.24 (m, 2H), 
6.93–6.86 (m, 2H), 6.82–6.78 (m, 1H), 6.77–6.67 (m, 2H), 5.93 (s, 2H), 3.82 (s, 3H), 
3.76 (q, J = 6.6 Hz, 1H), 3.52 (ABq, J = 13.2 Hz, 2H), 1.70 (br s, 1H), 1.34 (d, J = 6.6 
Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.5, 147.6, 146.3, 137.4, 134.5, 
127.7, 121.1, 113.8, 108.7, 108.0, 100.8, 56.5, 55.2, 51.3, 24.4 ppm; GC-MS for 
C17H19NO3, m/z = 285 (M
+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H19NO3H 
286.1438; Found 286.1427. 
N-(Benzo[d][1,3]dioxol-5-ylmethyl)-β-
methylbenzeneethanamine (2-17r). A chlorobenzene 
(2.0 mL) solution of complex 2-9 (13 mg, 0.75 mol %), 2-
16 (16 mg, 10 mol %), 1-(1,3-benzodioxol-5-
yl)methanamine (151 mg, 1.0 mmol) and (±)-1-(4-methoxyphenyl)ethylamine (211 mg, 
1.4 mmol) was stirred at 130 °C for 16 h. The product 2-17r was isolated by a column 
chromatography on silica gel (n-hexanes/EtOAc = 100:1 to 10:1; 152 mg, 56%). TLC; Rf 
= 0.3 (20% EtOAc in hexanes). Data for 2-17r: 1H NMR (400 MHz, CDCl3) δ 7.35–7.28 





= 7.9, 1.6 Hz, 1H),  5.93 (s, 2H), 3.66 (ABq, J = 13.2 Hz, 2H), 2.96 (sextet, J = 7.1 Hz, 
1H), 2.77 (d, J = 7.2 Hz, 2H), 1.66 (br s, 1H), 1.26 (d, J = 7.1 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 147.6, 146.4, 145.2, 134.1, 128.5, 127.2, 126.4, 121.1, 108.6, 
108.0, 100.8, 56.0, 53.5, 39.9, 20.1 ppm; GC-MS for C17H19NO2, m/z = 269 (M+); 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H19NO2H 270.1489; Found  270.1463. 
N-[2-(4-Methoxyphenyl)ethyl]-1,2,3,4-tetrahydro-1-
naphthalenamine (2-17s). A chlorobenzene (2.0 mL) 
solution of complex 2-9 (13 mg, 0.75 mol %), 2-16 (16 
mg, 10 mol %), 1,2,3,4-tetrahydro-1-naphthalenamine 
(147 mg, 1.0 mmol) and 4-methoxybenzeneethanamine (211 mg, 1.4 mmol) was stirred 
at 130 °C for 16 h. The product 2-17s was isolated by a column chromatography on silica 
gel (n-hexanes/EtOAc = 100:1 to 10:1; 177 mg, 63%). TLC; Rf = 0.3 (10% EtOAc in 
hexanes). Data for 2-17s: 1H NMR (400 MHz, CDCl3) δ 7.28–7.23 (m, 1H), 7.21–7.13 
(m, 4H), 7.12–7.07 (m, 1H), 6.90–6.85 (m, 2H), 3.82 (s, 3H), 3.81 (t, J = 4.7 Hz, 1H), 
3.05–2.89 (m, 2H), 2.87–2.69 (m, 4H), 2.01–1.86 (m, 3H), 1.80–1.70 (m, 1H), 1.63 (br s, 
1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 157.9, 139.0, 137.3, 132.1, 129.6, 129.0, 
128.5, 126.5, 125.6, 113.7, 55.3, 55.2, 48.6, 35.7, 29.3, 28.2, 19.0 ppm; GC-MS for 
C19H23NO, m/z = 281 (M
+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C19H23NOH 





N-Cyclohexyl-5-methoxytryptamine (2-17t). A 1,4-dioxane 
(2.0 mL) solution of complex 2-11 (10 mg, 1 mol %), 5-
methoxytryptamine (190 mg, 1.0 mmol) and cyclohexylamine 
(139 mg, 1.4 mmol) was stirred at 130 °C for 16 h. The 
product 2-17t was isolated by a column chromatography on 
silica gel (n-hexane/EtOAc = 100:1 to 10:1; 88%). TLC; Rf = 0.2 (30% EtOAc in 
hexanes). Data for 2-17t: 1H NMR (400 MHz, CDCl3) δ 8.21 (br s, 1H), 7.26–7.20 (m, 
1H), 7.08–7.05 (m, 1H), 7.02–6.99 (m, 1H), 6.85 (dd, J = 8.8, 2.5 Hz, 1H), 3.86 (s, 3H), 
3.07–2.90 (m, 4H), 2.45 (tt, J = 10.5, 3.7 Hz, 1H), 1.91–1.78 (m, 3H), 1.75–1.65 (m, 2H), 
1.64–1.55 (m, 1H), 1.29–0.99 (m, 5H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 153.8, 
131.5, 127.8, 122.8, 113.6, 112.1, 111.8, 100.6, 56.8, 55.9, 46.8, 33.5, 26.1, 25.9, 25.0 
ppm; GC-MS for C17H24N2O, m/z = 272 (M
+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C17H24FN2OH 273.1961; Found 273.1960. 
4-[2-Cyclohexylaminoethyl]phenol (2-17v). A 1,4-dioxane (2.0 
mL) solution of complex 2-11 (10 mg, 1 mol %), tyramine (136 
mg, 1.0 mmol) and cyclohexylamine (139 mg, 1.4 mmol) was 
stirred at 130 °C for 16 h. The product 2-17v was isolated by a 
column chromatography on silica gel (n-hexane/EtOAc = 100:1 to 
10:1; 81%). TLC; Rf = 0.3 (20% EtOAc in hexanes). Data for 2-17v: 
1H NMR (400 
MHz, CDCl3) δ 7.02 (d, J = 8.3 Hz, 2H), 6.72 (d, J = 8.3 Hz, 2H), 4.71 (br s, 1H), 2.93 (t, 
J = 6.9 Hz, 2H), 2.75 (t, J = 6.9 Hz, 2H), 2.47 (tt, J = 10.6, 3.6 Hz, 1H), 1.92–1.85 (m, 
2H), 1.75–1.66 (m, 2H), 1.64–1.55 (m, 1H), 1.28–1.08 (m, 5H) ppm; 13C{1H} NMR (100 





MS for C14H21NO, m/z = 219 (M
+); Anal. Calcd for C14H21NO: C, 76.67; H, 9.65. Found: 
C, 76.78; H, 9.35; HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C14H21NOH 220.1696; 
Found 220.1698. 
6.2.8.2 Characterization Data of the Novel Symmetric Secondary Amines Listed in 
Table 2.4 
Bis(3,4-methylenedioxybenzyl)amine (2-18g). A 
chlorobenzene (2.0 mL) solution of complex 2-9 (13 
mg, 0.75 mol %), 2-16 (16 mg, 10 mol %) and 1-(1,3-
benzodioxol-5-yl)methanamine (151 mg, 1.0 mmol) was stirred at 130 °C for 16 h. The 
product 2-18g was isolated by a column chromatography on silica gel (n-hexanes/EtOAc 
= 100:1 to 10:1; 110 mg, 77%). TLC; Rf = 0.4 (40% EtOAc in hexanes). Data for 2-18g 
1H NMR (400 MHz, CDCl3) δ 6.85 (s, 2H), 6.77–6.75 (m, 4H), 5.94 (s, 4H), 3.69 (s, 4H), 
1.59 (br s, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 147.7, 146.5, 134.3, 121.2, 
108.7, 108.0, 100.9, 52.7 ppm; GC-MS for C16H15NO4, m/z = 285 (M
+); HRMS (ESI-
TOF) m/z: [M+H]+ Calcd for C16H15NO4H 286.1074; Found 286.1070. 
Di-[2-aminoindane] (2-18l). A chlorobenzene (2.0 mL) 
solution of complex 2-9 (13 mg, 0.75 mol %), 2-16 (16 mg, 10 
mol %) and 2-indanamine (133 mg, 1.0 mmol) was stirred at 
130 °C for 16 h. The product 2-18l was isolated by a column 
chromatography on silica gel (n-hexane/EtOAc = 100:1 to 10:1; 91 mg, 73%). TLC; Rf = 
0.5 (20% EtOAc in hexanes). Data for 2-18l 1H NMR (400 MHz, CDCl3) δ 7.30–7.24 (m, 
4H), 7.24–7.18 (m, 4H), 3.83 (quintet, J = 7.2 Hz, 2H), 3.26 (dd, J = 15.4, 7.2 Hz, 4H), 





141.5, 126.3, 124.5, 58.1, 40.2 ppm; GC-MS for C18H19N, m/z = 249 (M
+); HRMS (ESI-
TOF) m/z: [M+H]+ Calcd for C18H19NH 250.1590; Found 250.1598. 
N-(2-Thienylethyl)-2-thiopheneethanamine (2-18n). A 1,4-
dioxane (2.0 mL) solution of complex 2-11 (10 mg, 1 mol) and 2-
thiopheneethanamine (127 mg, 1.0 mmol) was stirred at 130 °C for 
16 h. The product 2-18n was isolated by a column chromatography 
on silica gel (n-hexane/EtOAc = 100:1 to 10:1; 96%). TLC; Rf = 0.4 (30% EtOAc in 
hexanes). Data for 2-18n 1H NMR (400 MHz, CDCl3) δ 7.22–7.04 (m, 2H), 6.96–6.87 
(m, 2H), 6.85–6.75 (m, 2H), 3.06–2.99 (m, 4H), 2.98–2.90 (m, 4H), 2.45 (br s, 1H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 142.2, 126.8, 125.0, 123.5, 50.7, 30.2 ppm; GC-MS 
for C12H15NS2, m/z = 237 (M
+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C12H15NS2H 
238.0719; Found 238.0716. 
6.2.8.3 Characterization Data of the of Novel Unsymmetric Secondary Listed in 
Table 2.5 
3,4,5-Trimethoxy-N-(4-
chlorophenyl)benzenemethanamine (2-19i). A 
chlorobenzene (2.0 mL) solution of complex 2-9 (7 mg, 
0.75 mol %), 2-16 (8 mg, 10 mol %), 4-chloroaniline (64 
mg, 0.5 mmol) and 3,4,5-trimethoxybenzylamine (138 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 2-19i was isolated by a column chromatography on silica 
gel (n-hexane/EtOAc = 150:1 to 40:1; 111 mg, 72%). TLC; Rf = 0.6 (50% EtOAc in 
hexanes). Data for 2-19i: 1H NMR (400 MHz, CDCl3) δ 7.12 (d, J = 9.0 Hz, 2H), 6.58 (s, 





(100 MHz, CDCl3) δ 153.4, 146.4, 137.0, 134.5, 129.0, 122.3, 114.0, 104.1, 60.8, 56.0, 
48.8 ppm; GC-MS for C16H18ClNO3, m/z = 307 (M
+). Anal. Calcd for C16H18ClNO3: C, 
62.44; H, 5.90. Found: C, 62.88; H, 6.05. 
4-(2-(3,4,5-Trimethoxyphenylamino)ethyl)phenol (2-
19j). A chlorobenzene (2.0 mL) solution of complex 2-9 
(7 mg, 0.75 mol %), 2-16 (8 mg, 10 mol %), 3,4,5-
trimethoxyaniline (91 mg, 0.5 mmol) and 2-(4-
hydroxyphenyl)ethanamine (96 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The 
product 2-19j was isolated by a column chromatography on silica gel (n-hexane/EtOAc = 
150:1 to 40:1; 77 mg, 51%). TLC; Rf = 0.4 (50% EtOAc in hexanes). Data for 2-19j: 
1H 
NMR (400 MHz, CDCl3) δ 7.09–7.05 (m, 2H), 6.81–6.77 (m, 2H), 5.90 (s, 2H), 3.81 (s, 
6H), 3.77 (s, 3H), 3.33 (t, J = 7.1 Hz, 2H), 2.86 (t, J = 7.1 Hz, 2H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 154.4, 153.9, 144.1, 130.7, 130.5, 129.8, 115.5, 91.1, 61.1, 55.9, 
46.2, 34.4 ppm; GC-MS for C17H21NO4, m/z = 303 (M
+); HRMS (ESI-TOF) m/z: 
[M+H]+ Calcd for C17H21NO4H 304.1543; Found 304.1516. 
2,4-dimethoxy-N-(3-phenylpropyl)aniline (2-19k). A 
chlorobenzene (2.0 mL) solution of complex 2-9 (7 mg, 
0.75 mol %), 2-16 (8 mg, 10 mol %), 2,4-
dimethoxyaniline (77 mg, 0.5 mmol) and 3-phenyl-1-
propanamine (95 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 2-19k was 
isolated by a column chromatography on silica gel (n-hexane/EtOAc = 150:1 to 40:1; 97 
mg, 46%). TLC; Rf = 0.6 (50% EtOAc in hexanes). Data for 2-19k: 
1H NMR (400 MHz, 





Hz, 1H), 6.43 (dd, J = 8.5, 2.7 Hz, 1H), 4.19 (br s, 1H), 3.84 (s, 3H), 3.78 (s, 3H), 3.15 (t, 
J = 7.1 Hz, 2H), 2.77 (t, J = 7.6 Hz, 2H), 2.06–1.96 (m, 2H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 152.0, 148.0, 141.7, 132.2, 128.4, 128.3, 125.8, 110.5, 103.7, 99.1, 55.7, 
55.4, 44.1, 33.4, 31.0 ppm; GC-MS for C17H21NO2, m/z = 271 (M
+). HRMS (ESI-TOF) 
m/z: [M+H]+ Calcd for C17H21NO2H 272.1645; Found 272.1640. 
N-(4-Methoxyphenyl)-2,3-dihydro-1H-inden-2-amine (2-
19l). A chlorobenzene (2.0 mL) solution of complex 2-9 (7 
mg, 0.75 mol %), 2-16 (8 mg, 10 mol %), 4-methoxyaniline 
(62 mg, 0.5 mmol) and 2-aminoindan (93 mg, 0.7 mmol) 
was stirred at 140 °C for 20 h. The product 2-19l was isolated by a column 
chromatography on silica gel (n-hexane/EtOAc = 150:1 to 40:1; 88 mg, 74%). TLC; Rf = 
0.5 (30% EtOAc in hexanes). Data for 2-19l: 1H NMR (400 MHz, CDCl3) δ 7.29–7.17 
(m, 4H), 6.86–6.80 (m, 2H), 6.67–6.62 (m, 2H), 4.33 (tt, J = 6.8, 4.4 Hz,1H), 3.79 (s, 
3H), 3.37 (dd, J = 16.0, 6.8 Hz, 2H), 2.90 (dd, J = 16.0, 4.4 Hz, 2H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 152.2, 141.4, 141.4, 126.5, 124.9, 114.9, 114.9, 55.7, 54.9, 40.1 
ppm; GC-MS for C16H17NO, m/z = 239 (M
+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C16H17NOH 240.1383; Found 240.1377. 
N-(3,4,5-Trimethoxybenzyl)-3,4-dihydro-2H-
benzo[b][1,4]dioxepin-7-amine (2-19m). A 
chlorobenzene (2.0 mL) solution of complex 2-9 (7 
mg, 0.75 mol %), 2-16 (8 mg, 10 mol %), 3,4-
dihydro-2H-1,5-benzodioxepin-7-amine (83 mg, 0.5 





20 h. The product 2-19m was isolated by a column chromatography on silica gel (n-
hexane/EtOAc = 150:1 to 40:1; 129 mg, 75%). TLC; Rf = 0.4 (50% EtOAc in hexanes). 
Data for 2-19m: 1H NMR (400 MHz, CDCl3) δ 6.84 (d, J = 8.6 Hz, 1H), 6.59 (s, 2H), 
6.38–6.34 (m, 1H), 6.31–6.26 (m, 1H), 4.19 (s, 2H), 4.15 (t, J = 5.4 Hz, 2H), 4.09 (t, J = 
5.5 Hz, 2H), 3.84 (s, 6H), 3.83 (s, 3H), 2.14 (quintet, J = 5.5 Hz, 2H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 153.3, 152.1, 143.9, 143.6, 137.0, 134.4, 122.2, 108.7, 106.5, 
104.5, 70.9, 70.8, 60.8, 56.1, 49.8, 32.4 ppm; GC-MS for C19H23NO5, m/z = 345 (M
+); 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C19H23FNO5H 346.1649; Found 346.1618. 
(R)-3-Ethyl-3-(4-(3,4,5-
trimethoxybenzylamino)phenyl)piperidine-
2,6-dione (2-19n). A chlorobenzene (2.0 mL) 
solution of complex 2-9 (7 mg, 0.75 mol %), 2-
16 (8 mg, 10 mol %), (R)-(+)-aminoglutethimide 
(116 mg, 0.5 mmol) and 3,4,5-trimethoxybenzylamine (138 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 2-19n was isolated by a column chromatography on silica 
gel (n-hexane/ethyl acetate = 100:1 to 1:1; 82 mg, 40%), []D
22 = +148.2 (c = 0.2 in 
CH2Cl2); TLC; Rf = 0.2 (50% EtOAc in hexanes). Data for 2-19n: δ 7.98 (br s, 1H), 7.07 
(d, J = 8.7 Hz, 2H), 6.64 (d, J = 8.7 Hz, 2H), 6.59 (s, 2H), 4.24 (s, 2H), 3.83 (s, 9H), 
2.62–2.52 (m, 1H), 2.44 (dd, J = 13.2, 4.9 Hz, 1H), 2.31 (ddd, J = 14.2, 4.8, 2.7 Hz, 1H), 
2.16 (dd, J = 13.8, 4.8 Hz, 1H), 1.99 (sext, J = 7.4 Hz, 1H), 1.87 (sextet, J = 7.4 Hz, 1H), 
0.85 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 175.5, 172.5, 153.4, 





9.0 ppm; GC-MS for C23H28N2O5, m/z = 412 (M
+); HRMS (IT-TOF/ESI) Calcd for 
C23H28N2O5-H ([M-H]
-): 411.1925, Found: 411.1908. 
N-benzyl-9-ethyl-9H-carbazol-3-amine (2-19o). A 1,4-
dioxane (2.0 mL) solution of complex 2-11 (10 mg, 1 mol %), 
3-amino-9-ethylcarbazole (105 mg, 0.5 mmol) and 
benzylamine (75 mg, 0.7 mmol) was stirred at 140 °C for 20 
h. The product 2-19o was isolated by a column 
chromatography on silica gel (n-hexane/EtOAc = 150:1 to 40:1; 86%). TLC; Rf = 0.4 
(50% EtOAc in hexanes). Data for 2-19o: 1H NMR (400 MHz, CDCl3) δ 8.00 (dd, J = 
7.8, 1.2 Hz, 1H), 7.48–7.39  (m, 4H), 7.39–7.32 (m, 3H), 7.31–7.28 (m, 1H), 7.24 (d, J = 
8.7 Hz, 1H), 7.15 (dd, J = 7.8, 1.1 Hz, 1H), 6.94 (dd, J = 8.7–2.3 Hz, 1H), 4.45 (s, 2H), 
4.29 (q, J = 7.2 Hz, 2H), 1.39 (t, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 140.8, 140.3, 139.3, 134.3, 128.6, 127.9, 127.3, 125.3, 123.5, 122.6, 120.4, 117.9, 
114.7, 109.1, 108.3, 104.1, 50.2, 37.5, 13.8 ppm; GC-MS for C21H20N2, m/z = 300 (M
+); 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C21H20N2H 301.1699; Found 301.1679. 
N-(3,7-dimethyloct-6-en-1-yl)-9-ethyl-9H-
carbazol-3-amine (2-19p). A 1,4-dioxane 
(2.0 mL) solution of complex 2-9 (10 mg, 1 
mol %), 2-16 (8 mg, 10 mol %), 3-amino-9-
ethylcarbazole (105 mg, 0.5 mmol) and geranylamine (107 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 2-19p was isolated by a column chromatography on silica 
gel (n-hexane/EtOAc = 150:1 to 40:1; 66%). TLC; Rf = 0.4 (50% EtOAc in hexanes). 





1.1 Hz, 1H), 7.40–7.33 (m, 2H), 7.26 (d, J = 8.6 Hz, 1H), 7.19 (td, J = 7.5, 0.9 Hz, 1H), 
6.90 (dd, J = 8.6, 2.3 Hz, 1H), 5.17 (tt, J = 7.1, 1.3 Hz, 1H), 4.32 (q, J = 7.2 Hz, 2H), 3.47 
(brs, 1H), 3.34–3.20 (m, 2H), 2.13–2.00 (m, 2H), 1.81–1.62 (m, 2H), 1.74 (s, 3H), 1.66 
(s, 3H), 1.59–1.46 (m, 2H), 1.42 (t, J = 7.2 Hz, 3H), 1.33–1.23 (m, 1H), 1.03 (d, J = 6.5 
Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ  142.1, 140.2, 133.8, 131.3, 125.2, 
124.7, 123.6, 122.6, 120.3, 117.8, 114.5, 109.0, 108.2, 103.2,  43.5, 37.4, 37.1, 36.9, 30.5, 
25.7, 25.5, 19.7, 17.7, 13.8 ppm; GC-MS for C24H32N2, m/z = 348 (M
+).  
N-(3,7-dimethyloct-6-en-1-yl)-3,5-
dimethoxyaniline (2-19q). A 1,4-dioxane (2.0 
mL) solution of complex 2-9 (10 mg, 1 mol %), 
2-16 (8 mg, 10 mol %), 3,5-dimethoxyaniline (77 
mg, 0.5 mmol) and geranylamine (107 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The 
product 2-19q was isolated by a column chromatography on silica gel (n-hexane/EtOAc 
= 150:1 to 40:1; 51%). TLC; Rf = 0.4 (50% EtOAc in hexanes). Data for 2-19q: 
1H NMR 
(400 MHz, CDCl3) δ 5.87 (t, J = 2.1 Hz, 1H), 5.79 (d, J = 2.1 Hz, 2H), 5.13–5.07 (m, 
1H), 3.75 (s, 6H), 2.07–1.94 (m, 4H), 1.69 (s, 3H), 1.61 (s, 3H), 1.47–1.33 (m, 3H), 1.26–
1.15 (m, 3H), 0.94 (t, J = 6.5 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.7, 
150.4, 131.3, 124.6, 91.4, 89.4, 55.1, 41.9, 37.0, 36.6, 30.4, 25.7, 25.4, 19.5, 17.6 ppm; 










mL) solution of complex 2-9 (10 mg, 1 mol %), 4-methoxyaniline (62 mg, 0.5 mmol) and 
(+)-dehydroabietylamine (200 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 
2-19r was isolated by a column chromatography on silica gel (n-hexane/EtOAc = 150:1 
to 40:1; 88%). TLC; Rf = 0.7 (30% EtOAc in hexanes). Data for 2-19r: 
1H NMR (400 
MHz, CDCl3) δ 7.54 (s, 1H), 7.22–7.19 (m, 1H), 7.05–7.02 (m, 1H), 7.00 (d, J = 8.8 Hz, 
2H), 6.94–6.91 (m, 1H), 6.89 (d, J = 8.8 Hz, 2H), 3.82 (s, 3H), 2.90–2.85 (m, 2H), 2.39–
2.34 (m, 1H),  2.04–1.93 (m, 2H), 1.86–1.73 (m, 6H), 1.55–1.47 (m, 4H), 1.33 (s, 3H), 
1.29 (s, 3H), 1.24 (d, J = 6.9 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 173.4, 
157.5, 146.8, 134.7, 134.0, 127.0, 124.1, 123.9, 121.6, 114.1,55.4, 46.7, 46.1, 43.4, 42.8, 
38.2, 36.1, 33.4, 30.0, 25.3, 24.0, 20.6, 18.4, 16.5, 14.0 ppm; GC-MS for C27H37NO, m/z 
= 391 (M+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C27H37NOH 392.2869; Found 
392.2857. 
3-(3-Phenylpropylamino)piperidine-2,6-dione (2-
17w). A chlorobenzene (2.0 mL) solution of complex 2-9 
(7 mg, 0.75 mol %), 2-16 (8 mg, 10 mol %), L-glutamine 
(73 mg, 0.5 mmol) and 3-phenyl-1-propanamine (95 mg, 
0.7 mmol) was stirred at 140 °C for 20 h. The product 2-17w was isolated by a column 
chromatography on silica gel (n-hexane/ethyl acetate = 50:1 to 1:1; 92 mg, 75%). TLC; 
Rf = 0.2 (50% EtOAc in hexanes). Data for 2-17w: 
1H NMR (400 MHz, CDCl3) δ 7.30–
7.23 (m, 2H), 7.22–7.12 (m, 3H), 6.73 (br s, 1H), 4.08 (dd, J = 9.0, 4.8 Hz, 1H), 3.28 (dd, 
J = 8.9, 4.8 Hz, 1H), 2.63 (t, J = 7.5 Hz, 2H), 2.50–2.37 (m, 1H), 2.37–2.19 (m, 2H), 
2.16–2.05 (m, 1H), 1.84 (quintet, J = 7.4 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, 





GC-MS for C14H18N2O2, m/z = 246 (M
+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C14H18N2O2H 247.1441; Found 247.1408. 
(S)-6-methoxy-4-methyl-4-(4-methylpent-3-en-1-yl)-
1,2,3,4-tetrahydroquinoline (2-21a). A 1,4-dioxane (2.0 
mL) solution of complex 2-9 (10 mg, 1 mol %), 4-
methoxyaniline (62 mg, 0.5 mmol) and geranylamine (107 
mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 2-21a was isolated by a 
column chromatography on silica gel (n-hexane/EtOAc = 150:1 to 40:1; 95%). TLC; Rf = 
0.6 (30% EtOAc in hexanes). Data for 2-21a: 1H NMR (400 MHz, CDCl3) δ 6.75 (d, J = 
2.9 Hz, 1H), 6.58 (dd, J = 8.6, 2.9 Hz, 1H), 6.39 (d, J = 8.6 Hz, 1H), 5.2–4.98 (m, 1H), 
3.73 (s, 3H), 1.72–1.52 (m, 8H), 1.30 (s, 3H), 1.23 (s, 3H), 0.88 (d, J = 6.5 Hz, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 151.7, 137.2, 132.8, 124.6, 114.9, 114.6, 113.0, 
112.1,  55.9, 50.6, 47.2, 43.3, 35.0, 30.9, 27.0, 24.8, 22.2 ppm; GC-MS for C17H25NO, 
m/z = 259 (M+); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H27NOH 260.2014; Found 
260.2014. 
6.2.8.4 Characterization Data from the Compounds Listed in Table 2.6 
Bis(2-pyridylmethyl)amine (2-18p). A 1,4-dioxane (2.0 mL) 
solution of complex 2-9 (10 mg, 1 mol %), 2-
(aminomethyl)pyridine (108 mg, 1 mmol) was stirred at 
130 °C for 16 h. The product 2-18p was isolated by a column chromatography on silica 
gel (n-hexane/EtOAc = 150:1 to 40:1; 51%). TLC; Rf = 0.6 (30% EtOAc in hexanes). 





7.64–7.57 (m, 2H,), 7.26–7.20 (m, 2H), 3.99 (s, 4H), 3.05 (brs, 1H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 159.7, 148.8, 135.9,  122.4,  122.1, 54.5 ppm; GC-MS for 
C12H13N3, m/z = 199 (M
+). 1H and 13C NMR spectral data were in good agreement with 
the literature values.123 
Piribedil (2-20a). A 1,4-dioxane (2.0 mL) solution of 
complex 2-9 (10 mg, 1 mol %), 1-(2-
Pyrimidyl)piperazine (82 mg, 0.5 mmol) and 1-(1,3-
benzodioxol-5-yl)methanamine (151 mg, 1.0 mmol) was stirred at 140 °C for 20 h. The 
product 2-17a was isolated by a column chromatography on silica gel (n-hexane/EtOAc = 
30:1 to 1:1; 39%). Data for 2-17a: 1H NMR (400 MHz, CDCl3) δ 8.29 (d, J = 4.6 Hz, 
2H), 6.89 (s, 1H), 6.74 (s, 2H), 6.45 (t, J = 4.6 Hz, 1H), 5.95 (s, 2H), 3.82–3.79 (m, 4H), 
3.46 (s, 2H), 2.50–2.47 (m, 4H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.6, 157.8, 
147.5, 146.6, 132.0, 122.3, 109.7, 109.4, 107.8, 101.0, 62.8, 52.7, 43.6 ppm; GC-MS for 
C16H18N4O2, m/z = 298 (M
+). 1H and 13C NMR spectral data were in good agreement 
with the literature values.206 
Alverine (2-20b). A 1,4-dioxane (2.0 mL) solution 
of complex 2-9 (10 mg, 1 mol %), 2-14k (127 mg, 
0.5 mmol) and ethylamine (90 mg, 2.0 mmol) was 
stirred at 140 °C for 20 h. The product 2-17b was isolated by a column chromatography 
on silica gel (n-hexane/EtOAc = 150:1 to 40:1; 58%). TLC; Rf = 0.7 (10% EtOAc in 
hexanes). Data for 2-17b: 1H NMR (400 MHz, CDCl3) δ 7.25 (t, J = 7.8 Hz, 4H), 
7.12−7.20 (m, 6H), 2.62−2.58 (m, 4H), 2.51 (q, J = 7.2 Hz, 2H), 2.45 (t, J = 7.3 Hz, 4H), 





CDCl3) δ 142.2, 128.4, 128.3, 125.8, 52.9, 47.5, 33.7, 28.4, 11.4 ppm; GC-MS for 
C20H27N, m/z = 281 (M
+). 1H and 13C NMR spectral data were in good agreement with 






6.3 Experimental Procedures and Data for the Chapter 3 
6.3.1 General Procedure for the Catalytic Deaminative Coupling of Ketones with 
Amines 
In a glove box, complex 2-10 (9 mg, 3 mol %), 3,4,5,6-tetrachloro-1,2-
benzoquinone 2-12 (12 mg, 10 mol %) were dissolved in anhydrous 1,4-dioxane (1 mL) 
in a 25 mL Schlenk tube equipped with a Teflon screw cap stopcock and a magnetic 
stirring bar. After stirring for 5-10 min until the solution was turned light green color, 
both ketone (0.5 mmol) and an amine (0.7 mmol) substrates, and dioxane (1 mL) was 
added to the tube. The tube was sealed, it was brought out of the glove box, and was 
stirred in an oil bath set at 130 °C for 16-20 h. After the reaction tube was cooled to room 
temperature, the tube was open to air, the solution was filtered through a short silica gel 
column by eluting with CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS 
method. Analytically pure product 3-10 was isolated by a simple column chromatography 
on silica gel (280-400 mesh, hexanes/EtOAc). 
6.3.2 General Procedure for the Catalyst and Ligand Screening Study 
In a glove box, a Ru catalyst (3 mol % Ru atom) and a ligand (10 mol %) were 
dissolved in a solvent (1 mL) in a 25 mL Schlenk tube equipped with a Teflon screw cap 
stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5-10 min. 
Phenylethanone (60 mg, 0.5 mmol), 4-methoxybenzylamine (69 mg, 0.7 mmol) and a 
solvent (1 mL) were added to the reaction tube. The tube was brought out of the glove 
box and was stirred in an oil bath at 130 °C for 16 h. The product yield was determined 
by 1H NMR by using hexamethylbenzene as an internal standard. The results are 





6.3.3.1 Reaction Profile Study 
In a glove box, complex 2-10 (2 mg, 3 mol %) and 2-12 (2 mg, 10 mol %) were 
dissolved in toluene-d8 (0.5 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 10 
minutes until the solution turned to a brownish green color. Acetophenone (12 mg, 0.10 
mmol) and 4-methoxybenzylamine (14 mg, 0.10 mmol) were added to the reaction tube, 
and the solution was transferred into a J-Young NMR tube equipped with a Teflon screw 
cap stopcock. The tube was brought out of the glove box, and was immersed an oil bath 
set at 130 °C. The tube was taken out from the oil bath at 20 min intervals, was 
immediately cooled in ice-water bath, and was analyzed by 1H NMR. The appearance of 
the product signals were normalized against an external standard peak (C6Me6). The plot 
of the relative concentrations of substrates and products vs time is shown in Figure 3.1. 
6.3.3.2 Reaction with Imine 
In a glove box, complex 2-10 (2 mg, 3 mol %) and 2-12 (2 mg, 10 mol %) were 
dissolved in a 1,4-dioxane in a 25 mL Schlenk tube equipped with a Teflon screw cap 
stopcock and a magnetic stirring bar. After stirring for 5-10 min until the solution was 
turned light green color, (4-Methoxyphenyl)-N-(1-phenylethylidene)methanamine 3-13a 
(120mg 0.5 mmol) and dioxane (1 mL) was added to the tube. The tube was sealed, it 
was brought out of the glove box, and was stirred in an oil bath set at 130 °C for 16-20 h. 
After the reaction tube was cooled to room temperature, the tube was open to air, the 
solution was filtered through a short silica gel column by eluting with CH2Cl2 (10 mL), 





isolated by a simple column chromatography on silica gel (280-400 mesh, 
hexanes/EtOAc).  
6.3.3.3 Crossover Experiment 
In a glove box, complex 2-10 (2 mg, 3 mol %) and 2-12 (2 mg, 10 mol %) were 
dissolved in a 1,4-dioxane in a 25 mL Schlenk tube equipped with a Teflon screw cap 
stopcock and a magnetic stirring bar. After stirring for 5-10 min until the solution was 
turned light green color, independently generated 3-13a (60 mg, 0.25 mmol), N-
cyclohexylidene-3-phenylpropan-1-amine (3-13c) (54 mg, 0.25 mmol) in 1,4-dioxane (2 
mL) and dioxane (1 mL) was added to the tube. The tube was sealed, it was brought out 
of the glove box, and was stirred in an oil bath set at 130 °C for 16-20 h. After the 
reaction tube was cooled to room temperature, the tube was open to air, the solution was 
filtered through a short silica gel column by eluting with CH2Cl2 (10 mL), and the filtrate 
was analyzed by GC-MS method. Product yields were determined by NMR methods with 
hexamethylbenzene as the internal standard. 
6.3.3.4 Deuterium Labeling Study 
In a glove box, complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 
acetophenone-d8 (64 mg, 0.5 mmol) and 4-methoxybenzylamine (96 mg, 0.7 mmol) were 
dissolved in 1,4-dioxane (2.0 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a stirring bar. The tube was brought out of the glove box, and stirred in 
an oil bath preset at 130 °C for 16 h. The reaction tube was taken out of the oil bath and 
was cooled to room temperature. After the tube was open to air, the solution was filtered 
through a short silica gel column by eluting with CH2Cl2 (10 mL), and the filtrate was 





on silica gel (230-460 mesh, hexanes/EtOAc = 80:1 to 10:1). The 1H and 2H NMR 
spectra of the product 2a-d are shown in Figure 3.2. 
6.3.3.5 Deuterium Isotope Effect Study 
In a glove box, complex 2-10 (3 mg, 3 mol %), 2-12 (3 mg, 10 mol %), water (4 
mg 2eq.) and (4-Methoxyphenyl)-N-(1-phenylethylidene)methanamine 3-13a (24 mg, 0.2 
mmol) were dissolved in toluene-d8 (1 mL) in a 25 mL Schlenk tube equipped with a 
Teflon screw cap stopcock and a magnetic stirring bar. The resulting mixture was stirred 
for 5-10 min until the solid was completely dissolved and transferred into a J-Young 
NMR tube equipped with a Teflon screw cap stopcock. The tube was brought out of the 
glove box, and were immersed an oil bath set at 130 °C. The tube was taken out from the 
oil bath at 30 min time intervals, cooled in ice-water bath, and was analyzed by 1H NMR. 
The reaction rate was measured by monitoring the appearance of the product signals on 
1H NMR, which was normalized against an internal standard peak (C6Me6). The kobs was 
determined from a first-order plot of -ln[(3-13a0) – (3-13at))/3-13a0] vs time. Similar 
procedure was performed with the deuterated (4-Methoxyphenyl)-N-(1-
phenylethylidene)methanamine-d8. (Figure 3.4). 
6.3.3.6 Hammett Study 
In a glove box, complex 2-10 (21 mg, 3 mol %) and 2-12 (29 mg, 10 mol %) were 
dissolved in toluene-d8 (1.5 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5-10 min 
until the solution was turned to a reddish green color. Acetophenone (144 mg, 1.2 mmol) 
was added to the reaction tube and was stirred for 5 min. The solution was divided into 





was added to each solution. The resulting mixture was transferred into six different J-
Young NMR tubes, each equipped with a Teflon screw cap stopcock. The tubes were 
brought out of the glove box, and were immersed an oil bath set at 130 °C. Each tube was 
taken out from the oil bath at 30 min time intervals, cooled in ice-water bath, and was 
analyzed by 1H NMR. The reaction rate was measured by monitoring the appearance of 
the product signals on 1H NMR, which was normalized against an internal standard peak 
(C6Me6). The kobs was determined from a first-order plot of ln[([3-10a]i-[3-10a]t)/([3-
10a]i)0]  vs time. The Hammett plot of log(kX/kH) vs σp is shown in Figure 3.5(a) ( = -
0.49 ± 0.1). The analogous procedure was used to obtain the Hammett correlation for 
ketones by using complex 2-10 (21 mg, 3 mol %)/2-12 (29 mg, 10 mol %), 4-
methoxybenzylamine (247 mg, 1.8 mmol) and p-Y-C6H4COCH3 (0.2 mmol) (Y = OMe, 
Me, H, F, Cl, CF3) in toluene-d8 (1.5 mL). The Hammett plot of log(kX/kH) vs σp is shown 
in Figure 3.5(b) ( = +0.20 ± 0.1). 
6.3.3.7 Carbon Isotope Effect Study 
In a glove box, 2-10 (34 mg, 3 mol %) and 2-12 (48 mg, 10 mol %) were 
dissolved in 1,4-dioxane (2 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a magnetic stirring bar, and a resulting mixture was stirred for 5 to 10 
min. Acetophenone (240 mg, 2.0 mmol), 4-methoxybenzylamine (384 mg, 2.8 mmol), 
and 1,4-dioxane (4 mL) were added to the reaction tube. After the tube was sealed, the 
tube was brought out of the box and was stirred in an oil bath at 130 °C for 20 h. The 
tube was cooled to room temperature and the solution was filtered through a small silica 
column and was eluted with CH2Cl2 (10 mL). The procedure was repeated for two more 





conversion). For low conversion samples, 2-10 (59 mg, 1 mol%) and 2-12 (96 mg, 4 mol 
%) were dissolved in 1,4-dioxane (8 mL) in a 100 mL Schlenk tube equipped with a 
Teflon screw cap stopcock and a magnetic stirring bar. Acetophenone (1.2 g, 10 mmol), 
4-methoxybenzylamine (1.9 g, 14 mmol) and 1,4-dioxane (8 mL) were added to the 
reaction tube. The tube was brought out of the box and was stirred in an oil bath at 130 
°C for 2 h. The procedure was repeated for two more times, and the product conversion 
was determined by GC (11%, 13% and 15% conversion). The product 3-10a was isolated 
by a column chromatography on silica gel (hexanes/EtOAc) for the 13C{1H} NMR 
analysis.  
The 13C{1H} NMR analysis was performed by following Singleton’s 13C NMR 
method127. The NMR sample was prepared identically by dissolving 3-(4-
methoxyphenyl)-1-phenyl-1-propanone (3-10a) (280 mg) in CDCl3 (0.5 mL) in a 5 mm 
high precision NMR tube. The 13C{1H} NMR spectra were recorded with H-decoupling 
and 45 degree pulses. A 60 s delay between pulses was imposed to minimize T1 
variations (d1 = 120 s, at = 5.0 s, np = 245098, nt = 512, dm = ‘nny’). The data obtained 
were summarized in Table 3.6. 
6.3.3.8 Determination of an Empirical Rate Law 
In a glove box, 2-12 (19 mg, 10 mol %), water (29 mg, 2 eq.) and 3-13a (191 mg, 
0.8 mmol) were dissolved in toluene-d8 (1.0 mL) in a 25 mL Schlenk tube equipped with 
a Teflon screw cap stopcock and a magnetic stirring bar. The resulting mixture was 
stirred for 5-10 min until the solution was turned to a reddish green color. The solution 
was divided into four equal portions, and each portion was transferred into four separate 





toluene-d8), were prepared and (52 L, 4 mM), (78 L, 8 mM),  (105 L, 12 mM), (131 
L, 20 mM) was added to the four different tubes respectively. The total volume of the 
reaction mixture was adjusted up to 500 L by adding pure  toluene-d8 and each equipped 
with a Teflon screw cap stopcock. The tubes were brought out of the glove box, and were 
immersed an oil bath set at 130 °C. Each tube was taken out from the oil bath at 15 min 
time intervals, cooled in ice-water bath, and was analyzed by 1H NMR. The reaction rate 
was measured by monitoring the appearance of the product signals on 1H NMR, which 
was normalized against an internal standard peak (C6Me6). The initial rate of the reaction 
was determined from a first-order plot of 3-13a vs time (Figure 3.9(a), (b)). 
For Imine Dependence Study, complex 2-10 (14 mg, 3 mol %), 2-12 (19 mg, 10 
mol %) and water (29 mg, 2eq.) in toluene-d8 (1.0 mL) with 3-13a (0.2, 0.4, 0.6 and 0.8 
mM) was followed the same procedure. The initial rate of the reaction was determined 
from a first-order plot of 3-13a vs time (Figure 3.10 (a), (b)). 
For Water Dependence Study, complex 2-10 (14 mg, 3 mol %), 2-12 (19 mg, 10 
mol %) and 3-13a (191 mg, 0.8 mmol) in toluene-d8 (1.0 mL) with water (0.4, 0.8, 1.0 
and 1.2 mM) has been used by following above procedure (Figure 3.11(a), (b)). 
6.3.3.9 Detection of Catalytically Relevant Organic Products 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 
10 mol %), 4,4,4-trifluoro-1-(2-naphthyl)-1,3-butanedione (133 mg, 0.5 mmol) and 3,4,5-
trimethoxybenzylamine (99 mg, 0.5 mmol) was stirred at 130 °C for 16 h. The product 3-
14 was isolated by column chromatography on silica gel (hexanes/EtOAc = 80:1–15:1; 





completely characterized by both NMR and X-ray crystallographic techniques (Eq. 3.13).  
3-15 and 3-16 compounds were obtained following standard procedure and completely 
characterized by both NMR and X-ray crystallographic techniques (Eq. 3.14, Eq. 3.15). 
6.3.5 X-ray Crystallography Data for the Organic Products 
6.3.5.1 X-ray Crystallography Data for 3-10at 
Colorless plate like single crystals of 3-10at were grown in pentanes/EtOAc at 
room temperature. A suitable crystal with the dimension of 0.36 × 0.305 × 0.043 mm3 
was selected and analyzed. Both symmetrically independent molecules have a planar 
extended conformation (with exception of bicyclic moiety). The molecules differ by 
orientation of the bicycle relative to the rest of the molecule – the dihedral angle C12-
C13-C14-H is -56º in one of them and 45º and 174º in another one, which is disordered in 
a 2:1 population ratio. The compound seems to be  enantiomerically pure; Flack 
parameter [0.2(2)]. The molecules form quasi-centrosymmetric dimers (which contributes 
into the uncertainty of Flack parameter), which are stacked along x axis. Also, the 
molecules form infinite chains along y axis through N-H…O hydrogen bonds. The 






Figure 6.7: Molecular Structure of 3-10at 
 
Figure 6.8: Crystal Packing of 3-10at 
 
Table 6.4: Crystal Data and Structure Refinement for 3-10at 
Identification code  yi4w  





Formula weight  323.46  
Temperature/K  100.00(14)  
Crystal system  monoclinic  
Space group  P21  
a/Å  7.58070(12)  
b/Å  11.25264(18)  
c/Å  21.8958(5)  
α/°  90  
β/°  97.6552(19)  
γ/°  90  
Volume/Å3  1851.13(6)  
Z  4  
ρcalcg/cm
3  1.161  
μ/mm-1  0.535  
F(000)  704.0  
Crystal size/mm3  0.36 × 0.305 × 0.043  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  8.148 to 141.094  
Index ranges  -9 ≤ h ≤ 7, -13 ≤ k ≤ 13, -26 ≤ l ≤ 25  
Reflections collected  15681  
Independent reflections  6735 [Rint = 0.0327, Rsigma = 0.0337]  
Data/restraints/parameters  6735/87/467  
Goodness-of-fit on F2  1.024  
Final R indexes [I>=2σ (I)]  R1 = 0.0527, wR2 = 0.1420  
Final R indexes [all data]  R1 = 0.0599, wR2 = 0.1509  
Largest diff. peak/hole / e Å-3  0.26/-0.21  
Flack parameter 0.2(2) 
 
6.3.5.2 X-ray Crystallography Data for 3-10ax 
Colorless single crystals of 3-10ax were grown in dichloromethane/n-
pentane/EtOAc at room temperature. A suitable crystal with the dimension of 0.803 × 
0.238 × 0.18 mm3 was selected and analyzed. The molecule has an extended, almost 
planar conformation. Methoxy group and morpholine nitrogen are conjugated with the 
adjacent benzene rings. The morpholine group exhibits a multiple disorder, of which two 







Figure 6.9: Molecular Structure of 3-10ax 
 
Figure 6.10: Crystal Packing of 3-10ax; The Molecules form Translational Stacks along 
X Axis 
 
Table 6.5: Crystal Data and Structure Refinement for 3-10ax 
Identification code   yi4t  





Formula weight   325.39  
Temperature/K   100.00(10)  
Crystal system   monoclinic  
Space group   P21/n  
a/Å   5.16080(10)  
b/Å   12.7726(4)  
c/Å   25.3964(7)  
α/°   90  
β/°   93.866(2)  
γ/°   90  
Volume/Å3   1670.24(8)  
Z   4  
ρcalcg/cm
3   1.294  
μ/mm-1   0.087  
F(000)   696.0  
Crystal size/mm3   0.803 × 0.238 × 0.18  
Radiation   MoKα (λ = 0.71073)  
2Θ range for data collection/°   6.58 to 59.448  
Index ranges  -7 ≤ h ≤ 7, -16 ≤ k ≤ 17, -35 ≤ l ≤ 34  
Reflections collected   19263  
Independent reflections  4342 [Rint = 0.0321, Rsigma = 0.0337]  
Data/restraints/parameters   4342/0/230  
Goodness-of-fit on F2   1.031  
Final R indexes [I>=2σ (I)]   R1 = 0.0513, wR2 = 0.1156  
Final R indexes [all data]   R1 = 0.0746, wR2 = 0.1295  
Largest diff. peak/hole / e Å-3   0.35/-0.33  
 
6.3.5.3 X-ray Crystallography Data for 3-14 
Colorless prisms like single crystals of 3-14 were grown in pentanes/EtOAc at 
room temperature. A suitable crystal with the dimension of 0.36 × 0.213 × 0.065 mm3 
was selected analyzed. The central moiety of the molecule has a π-conjugated planar 
structure enhanced by an intra-molecular H-bond N-H…O. The bond lengths C2-C1 
[1.404(2) Å] and C2-C3 [1.391(2) Å] are practically equilibrated. The naphthyl and 





trimethoxybenzyl group, the central methoxy group is rotated by 73° out of conjugation 
because of this too. 
 
Figure 6.11: Molecular Structure of 3-14 
 
Figure 6.12: Crystal Packing of 3-14 
 
Table 6.6: Crystal Data and Structure Refinement for 3-14 
Identification code  yi4u  
Empirical formula  C24H22NO4F3  
Formula weight  445.42  
Temperature/K  100(1)  
Crystal system  monoclinic  





a/Å  18.7249(3)  
b/Å  20.5703(4)  
c/Å  5.47146(10)  
α/°  90  
β/°  96.3997(18)  
γ/°  90  
Volume/Å3  2094.35(7)  
Z  4  
ρcalcg/cm
3  1.413  
μ/mm-1  0.965  
F(000)  928.0  
Crystal size/mm3  0.36 × 0.213 × 0.065  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  8.598 to 140.992  
Index ranges  -21 ≤ h ≤ 22, -24 ≤ k ≤ 24, -6 ≤ l ≤ 6  
Reflections collected  19580  
Independent reflections  3961 [Rint = 0.0301, Rsigma = 0.0197]  
Data/restraints/parameters  3961/0/296  
Goodness-of-fit on F2  1.037  
Final R indexes [I>=2σ (I)]  R1 = 0.0366, wR2 = 0.0941  
Final R indexes [all data]  R1 = 0.0433, wR2 = 0.0995  
Largest diff. peak/hole / e Å-3  0.30/-0.22  
 
6.3.5.4 X-ray Crystallography Data for 3-15 
Colorless needles like single crystals of 3-15 were grown in pentanes/EtOAc at 
room temperature. A suitable crystal with the dimension of 0.35 × 0.07 × 0.03 mm3 was 
selected and analyzed. The structure contains four symmetrically independent molecules 
having a similar non-propeller conformation – the benzene rings adjacent to pyridine N-
atom are rotated in opposite directions for all 4 molecules. In one of the molecules an 
anisyl group is disordered (180° rotation of OMe group with a corresponding parallel 






Figure 6.13: Molecular Structure of 3-15 
 





Table 6.7: Crystal Data and Structure Refinement for 3-15 
Identification code yi3l 
Empirical formula C26H23NO3 
Formula weight 397.45 
Temperature/K 100.15 
Crystal system triclinic 













Crystal size/mm3 0.35 × 0.07 × 0.03 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 8.9 to 141.88 
Index ranges -9 ≤ h ≤ 8, -24 ≤ k ≤ 24, -36 ≤ l ≤ 36 
Reflections collected 74732 
Independent reflections 15636 [Rint = 0.0498, Rsigma = 0.0326] 
Data/restraints/parameters 15636/17/1161 
Goodness-of-fit on F2 1.026 
Final R indexes [I>=2σ (I)] R1 = 0.0471, wR2 = 0.1191 
Final R indexes [all data] R1 = 0.0589, wR2 = 0.1291 
Largest diff. peak/hole / e Å-3 0.27/-0.29 
 
6.3.5.5 X-ray Crystallography Data for 3-16 
Colorless plates like single crystals of 3-15 were grown in pentanes/EtOAc at 
room temperature. A suitable crystal with the dimension of 0.32 × 0.226 × 0.045 mm3 
was selected and analyzed. The molecule has a twisted shape (pseudo-torsion angle Br-
C…C-Br is 26°). The thiophene moiety is rotationally disordered by 30%. The crystal 







Figure 6.15: Molecular Structure of 3-16 
 
Figure 6.16: Crystal Packing of 3-16 
 
Table 6.8: Crystal Data and Structure Refinement for 3-16 





Empirical formula C25H17Br2NS 
Formula weight 523.28 
Temperature/K 100.00(10) 
Crystal system monoclinic 













Crystal size/mm3 0.32 × 0.226 × 0.045 
Radiation Cu Kα (λ = 1.54184) 
2Θ range for data collection/° 8.676 to 141.036 
Index ranges -17 ≤ h ≤ 17, -17 ≤ k ≤ 17, -11 ≤ l ≤ 11 
Reflections collected 18855 
Independent reflections 3826 [Rint = 0.0377, Rsigma = 0.0235] 
Data/restraints/parameters 3826/2/269 
Goodness-of-fit on F2 1.030 
Final R indexes [I>=2σ (I)] R1 = 0.0255, wR2 = 0.0654 
Final R indexes [all data] R1 = 0.0293, wR2 = 0.0675 
Largest diff. peak/hole / e Å-3 0.41/-0.42 
 
6.3.6.1 Characterization Data of Organic Compounds Listed in Table 3.3 
1-(4-Aminophenyl)-3-(4-methoxyphenyl)propan-
1-one (3-10f): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol 
%), 4-acetylaniline (68 mg, 0.5 mmol) and 4-
methoxybenzylamine (96 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 3-
10f was isolated by column chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; 






(400 MHz, CDCl3) δ 7.68 (d, J = 8.8 Hz, 2H), 7.15 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 8.7 
Hz, 2H), 6.56 (d, J = 8.8 Hz, 2H), 3.69 (s, 3H), 3.11–3.04 (m, 2H), 2.81 (t, J = 7.5 Hz, 
2H) ppm; 13C{1H} NMR (100 MHz, DMSO) δ 196.7, 157.6, 153.5, 133.6, 130.5, 129.5, 
124.8, 113.8, 112.9, 55.1, 29.4, 26.0 ppm; GC-MS for C16H17NO2, m/z = 255 (M
+). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C16H17NO2H 256.1332; Found 256.1302. 
3-Cyclohexyl-1-(4-methoxyphenyl)propan-1-one (3-
10l): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 4′-
methoxyacetophenone (75 mg, 0.5 mmol) and 
cyclohexylmethanamine (79 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 
3-10l was isolated by column chromatography on silica gel (hexanes/EtOAc = 120:1–
20:1; TLC: Rf = 0.6 (10% EtOAc in hexanes)). Yield = 94 mg (76%). Data for 3-10l: 
1H 
NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 3.83 (s, 
3H), 2.97–2.85 (m, 2H), 1.79–1.56 (m, 7H), 1.32–1.09 (m, 4H), 0.99–0.85 (m, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 199.4, 163.2, 130.2, 130.1, 113.6, 55.4, 37.4, 35.8, 
33.1, 32.0, 26.5, 26.2 ppm; GC-MS for C16H22O2, m/z = 246 (M
+). HRMS (ESI-TOF) 
m/z: [M + H]+ Calcd for C16H22O2H 247.1693; Found 247.1663. 
3-Cyclohexyl-1-o-tolylpropan-1-one (3-10n). A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 
mg, 10 mol %), 2′-methylacetophenone (75 mg, 0.5 mmol) and 
cyclohexylmethanamine (79 mg, 0.7 mmol) was stirred at 130 
°C for 16 h. The product 3-10n was isolated by column chromatography on silica gel 





(88%). Data for 3-10n: 1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 7.8 Hz, 1H), 7.38–
7.32 (m, 1H), 7.26–7.22 (m, 2H), 2.89 (t, J = 7.7 Hz, 2H), 2.48 (s, 3H), 1.75–1.67 (m, 
4H), 1.62–1.56 (m, 2H), 1.33–1.09 (m, 5H), 0.97–0.87 (m, 2H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 205.2, 138.3, 137.7, 131.8, 130.9, 128.2, 125.5, 39.2, 37.3, 33.1, 31.7, 
26.5, 26.2, 21.2 ppm; GC-MS for C16H22O, m/z = 230 (M
+). HRMS (ESI-TOF) m/z: [M 
+ H]+ Calcd for C16H22OH 231.1743; Found 231.1736. 
3-Cyclohexyl-1-o-tolylpropan-1-one (3-10o). A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-12 (12 mg, 10 mol %), 2′-methoxyacetophenone (75 
mg, 0.5 mmol) and cyclohexylmethanamine (79 mg, 0.7 
mmol) was stirred at 130 °C for 16 h. The product 3-10o was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.6 (10% EtOAc 
in hexanes)). Yield = 105 mg (90%). Data for 3-10o: 1H NMR (400 MHz, CDCl3) δ 7.98 
(dd, J = 8.6, 5.6 Hz, 2H), 7.14–7.07 (m, 2H), 2.93 (t, J = 7.7 Hz, 2H), 1.78–1.57 (m, 7H), 
1.30–1.08 (m, 4H), 1.01–0.86 (m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 199.2, 
165.6 (d, JCF = 254.2 Hz), 133.4 (d, JCF = 3.0 Hz), 130.6 (d, JCF = 9.3 Hz), 115.5 (d, JCF 
= 21.8 Hz), 37.3, 36.0, 33.1, 31.7, 26.5, 26.2 ppm; GC-MS for C15H19FO, m/z = 234 
(M+). 
1-(4-Methoxyphenyl)-6-methylheptan-4-one (3-10q): 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 4-methyl-2-
pentanone (50 mg, 0.5 mmol) and 4-methoxybenzeneethanamine (106 mg, 0.7 mmol) 





chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.5 (10% EtOAc 
in hexanes). Yield = 93 mg (79%). Data for 3-10q: 1H NMR (400 MHz, CDCl3) δ 7.08 
(d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 3.79 (s, 3H), 2.55 (t, J = 7.5 Hz, 2H), 2.37 
(t, J = 7.4 Hz, 2H), 2.25 (d, J = 6.7 Hz, 2H), 2.16–2.07 (m, 1H), 1.86 (pentet, J = 7.5 Hz, 
2H), 0.89 (d, J = 6.7 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 210.8, 157.8, 
133.7, 129.3, 113.7, 55.2, 51.9, 42.4, 34.2, 25.4, 24.5, 22.6 ppm; GC-MS for C15H22O2, 
m/z = 234 (M+). HRMS (ESI-QTOF) m/z: [M + Na]+ Calcd for C15H22O2H 257.1512; 
Found 257.1512. 
3-(benzo[d][1,3]dioxol-5-yl)-1-(4-
methoxyphenyl)propan-1-one (3-10t): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-12 (12 mg, 10 mol %), 4′-
methoxyacetophenone (75 mg, 0.5 mmol) and 1,3-benzodioxol-5-ylmethylamine (106 
mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 3-10t was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.4 (10% EtOAc 
in hexanes)). Yield = 94 mg (66%). Data for 3-10t: 1H NMR (400 MHz, CDCl3) δ 7.93 
(d, J = 9.0 Hz, 2H), 6.92 (d, J = 9.0 Hz, 2H), 6.75–6.71 (m, 2H), 6.71–6.66 (m, 1H), 5.90 
(s, 2H), 3.85 (s, 3H), 3.22–3.16 (m, 2H), 3.00–2.93 (m, 2H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 197.7, 163.4, 147.5, 145.7, 135.2, 130.2, 129.8, 121.1, 113.6, 108.8, 
108.2, 100.7, 55.4, 40.2, 30.0 ppm; GC-MS for C17H16O4, m/z = 284 (M
+). HRMS (ESI-





5-Cyclohexyl-1,1-diphenylpentan-3-one (3-10u). A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-12 (12 mg, 10 mol %), 4,4-diphenyl-2-
butanone (112 mg, 0.5 mmol) and 
cyclohexylmethanamine (79 mg, 0.7 mmol) was stirred 
at 130 °C for 16 h. The product 3-10u was isolated by column chromatography on silica 
gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.8 (10% EtOAc in hexanes)). Yield = 150 
mg (94%). Data for 3-10u: 1H NMR (400 MHz, CDCl3) δ 7.48–7.01 (m, 10H), 4.64 (t, J 
= 7.6 Hz, 1H), 3.18 (d, J = 7.6 Hz, 2H), 2.39–2.31 (m, 2H), 1.71–1.57 (m, 5H), 1.42–1.35 
(m, 2H), 1.22–1.03 (m, 4H), 0.88–0.76 (m, 2H)  ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 209.2, 143.8, 128.4, 127.6, 126.2, 48.5, 45.9, 40.9, 36.8, 32.9, 30.6, 26.4, 26.1 ppm; 
GC-MS for C23H28O, m/z = 320 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C23H28OH 321.2213; Found 321.2207. 
3-Cyclohexyl-1-(1-methyl-1H-pyrrol-3-yl)propan-1-one 
(3-10v): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 3-Acetyl-1-
methylpyrrole (62 mg, 0.5 mmol) and 
cyclohexylmethanamine (79 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 
3-10v was isolated by column chromatography on silica gel (hexanes/EtOAc = 120:1–
20:1; TLC: Rf = 0.3 (10% EtOAc in hexanes)). Yield = 98 mg (89%). Data for 3-10v: 
1H 
NMR (400 MHz, CDCl3) δ 7.21 (t, J = 1.9 Hz, 1H), 6.55 (d, J = 1.9 Hz, 2H), 3.67 (s, 
3H), 2.72–2.66 (m, 2H), 1.77–1.63 (m, 5H), 1.59–1.54 (m, 2H), 1.27–1.10 (m, 4H), 0.95–





37.5, 37.1, 36.5, 33.1, 32.5, 30.9, 26.5, 26.2 ppm; GC-MS for C14H21NO, m/z = 219 
(M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C14H21NOH 220.1696; Found 
220.1698. 
1-(1H-Indol-3-yl)-5-(4-methoxyphenyl)pentan-
3-one (3-10w): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 
mol %), 4-(1H-indol-3-yl)butan-2-one (94 mg, 0.5 
mmol) and 4-methoxybenzylamine (96 mg, 0.7 mmol)was stirred at 130 °C for 16 h. The 
product 3-10w was isolated by column chromatography on silica gel (hexanes/EtOAc = 
120:1–20:1; TLC: Rf = 0.2 (10% EtOAc in hexanes)). Yield = 108 mg (70%). Data for 3-
10w: 1H NMR (400 MHz, CDCl3) δ 8.06 (brs, 1H), 7.59 (dd, J = 7.9, 0.6 Hz, 1H), 7.38–
7.32 (m, 1H), 7.24–7.19 (m, 1H), 7.17–7.12 (m, 1H), 7.08 (d, J = 8.7 Hz, 2H), 6.93 (d, J 
= 2.2 Hz, 1H), 6.83 (d, J = 8.7 Hz, 2H), 3.80 (s, 3H), 3.10–3.02 (m, 2H), 2.90–2.76 (m, 
4H), 2.70 (t, J = 7.6 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 210.2, 157.8, 
136.2, 133.0, 129.2, 127.0, 121.9, 121.5, 119.2, 118.6, 115.0, 113.8, 111.1, 55.2, 44.6, 
43.4, 28.8, 19.2 ppm; GC-MS for C20H21NO2, m/z = 307 (M
+). HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C20H21NO2H 308.1645; Found 308.1639. 
1-(5-Bromobenzofuran-2-yl)-5-methylhexan-1-one 
(3-10x): A 1,4-dioxane (2.0 mL) solution of complex 2-
10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 1-(5-
bromo-1-benzofuran-2-yl)ethan-1-one (119 mg, 0.5 
mmol) and isoamylamine (61 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 





20:1; TLC: Rf = 0.8 (10% EtOAc in hexanes)). Yield = 103 mg (67%). Data for 3-10x: 
1H NMR (400 MHz, CDCl3) 7.83 (d, J = 1.9 Hz, 1H), 7.55 (dd, J = 8.9, 1.9 Hz, 1H), 7.45 
(d, J = 8.9 Hz, 1H), 7.41 (s, 1H), 2.92 (t, J = 7.5 Hz, 2H), 1.80–1.72 (m, 2H), 1.59 
(septet, J = 6.6 Hz, 1H), 1.30–1.24 (m, 2H), 0.90 (d, J = 6.6 Hz, 6H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 191.4, 154.1, 153.6, 131.0, 128.9, 125.7, 116.9, 113.9, 111.3, 39.2, 
38.4, 30.9, 27.8, 22.5 ppm; GC-MS for C15H17BrO2, m/z = 309 (M
+); HRMS (ESI-
QTOF) m/z: [M + H]+ Calcd for C15H17BrO2H 309.0485; Found 309.0476. 
1-(4-Chlorophenyl)-3-(thiophen-2-yl)propan-1-one (3-
10y): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 4′-
chloroacetophenone (77 mg, 0.5 mmol) and 2-
thiophenemethylamine (79 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 3-
10y was isolated by column chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; 
TLC: Rf = 0.8 (10% EtOAc in hexanes)). Yield = 101 mg (81%). Data for 3-10y: 
1H 
NMR (400 MHz, CDCl3) δ  7.94–7.87 (m, 2H), 7.46–7.40 (m, 2H), 7.16–7.10 (m, 1H), 
6.95–6.90 (m, 1H), 6.88–6.83 (m, 1H), 3.35–3.26 (m, 4H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 197.3, 143.5, 139.6, 134.9, 129.4, 128.9, 126.8, 124.7, 123.4, 40.5, 24.1 
ppm; GC-MS for C13H11ClOS, m/z = 250 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd 
for C13H11ClOSH 251.0292; Found 251.0262. 
1-(Anthracen-2-yl)-6-methylheptan-1-one (3-
10aa): A 1,4-dioxane (2.0 mL) solution of complex 
2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-





isoamylamine (61 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 3-10aa was 
isolated by column chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf 
= 0.7 (10% EtOAc in hexanes)). Yield = 132 mg (91%). Data for 3-10aa: 1H NMR (400 
MHz, CDCl3) δ 8.57 (s, 1H), 8.48 (s, 1H), 8.34 (s, 1H), 8.11–7.88 (m, 4H), 7.56–7.45 (m, 
2H), 3.06 (t, J = 7.5 Hz, 2H), 1.89–1.77 (m, 2H), 1.66 (septet, J = 6.6 Hz, 1H), 1.40–1.27 
(m, 2H), 0.96 (d, J = 6.6 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 200.2, 133.7, 
133.0, 132.5, 131.8, 130.8, 130.3, 128.8, 128.5, 128.3, 128.1, 126.5, 126.0, 125.8, 122.7, 
38.6, 38.6, 27.9, 22.5, 22.3 ppm; GC-MS for C21H22O, m/z = 290 (M
+). HRMS (ESI-
QTOF) m/z: [M + H]+ Calcd for C21H22OH 291.1743; Found 291.1734. 
 
6.3.6.2 Characterization Data of the Compounds Listed in Table 3.4 
1,4-Bis(4-methoxyphenyl)-2-methylbutan-1-one 
(3-10ab): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 
mol %), 4′-methoxypropiophenone (82 mg, 0.5 
mmol) and 4-methoxybenzeneethanamine (106 mg, 0.7 mmol) was stirred at 130 °C for 
16 h. The product 3-10ab was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.3 (10% EtOAc in hexanes)). Yield = 125 mg 
(84%). Data for 3-10ab: 7.86 (d, J = 9.0 Hz, 2H), 7.06 (d, J = 8.8 Hz, 2H), 6.91 (d, J = 
9.0 Hz, 2H), 6.81 (d, J = 8.8 Hz, 2H), 3.87 (s, 3H), 3.79 (s, 3H), 3.41 (sextet, J = 6.8 Hz, 
1H), 2.63–2.51 (m, 2H), 2.17–2.08 (m, 1H), 1.74–1.65 (m, 1H), 1.21 (d, J = 6.8 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 202.7, 163.3, 157.8, 133.9, 130.5, 129.5, 





298 (M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C19H22O3H 299.1642; Found 
299.1631. 
1-(4-Methoxyphenyl)-2-phenylpentan-3-one (3-10ad): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-12 (12 mg, 10 mol %), 1-phenyl-2-butanone (74 mg, 0.5 
mmol) and 4-methoxybenzylamine (96 mg, 0.7 mmol) was 
stirred at 130 °C for 16 h. The product 3-10ad was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.7 (10% 
EtOAc in hexanes)). Yield = 95 mg (71%). Data for 3-10ad: 1H NMR (400 MHz, 
CDCl3) δ 7.30–7.21 (m, 3H), 7.19–7.14 (m, 2H), 6.94 (d, J = 8.1 Hz, 2H), 6.72 (d, J = 8.1 
Hz, 2H), 3.87 (t, J = 7.4 Hz, 1H), 3.73 (s, 3H), 3.34 (dd, J = 13.9, 7.9 Hz, 1H), 2.83 (dd, J 
= 13.9, 6.9 Hz, 1H), 2.42–2.32 (m, 1H), 2.25–2.15 (m, 1H), 0.88 (t, J = 7.3 Hz, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ  210.6, 157.8, 138.8, 131.8, 129.9, 128.8, 128.3, 
127.2, 113.6, 60.8, 55.2, 37.9, 35.7, 7.7 ppm; GC-MS for C18H20O2, m/z = 268 (M
+). 
HRMS (ESI-QTOF) m/z: [M + Na]+ Calcd for C18H20O2H 291.1356; Found 291.1346. 
2-(4-Methoxyphenethyl)cyclopentanone (3-10af): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-12 (12 mg, 10 mol %), cyclopentanone (42 mg, 0.5 
mmol) and 4-methoxybenzeneethanamine (106 mg, 0.7 
mmol) was stirred at 130 °C for 16 h. The product 3-10af was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.5 (10% EtOAc 
in hexanes)). Yield = 93 mg (85%). Data for 3-10af: 1H NMR (400 MHz, CDCl3) δ 7.11 





(m, 2H), 2.16–1.97 (m, 4H), 1.81–1.71 (m, 1H), 1.59–1.47 (m, 2H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 221.4, 157.8, 133.6, 129.3, 113.7, 55.2, 48.3, 38.2, 32.6, 31.6, 29.7, 
20.7 ppm; GC-MS for C14H18O2, m/z = 218 (M
+); HRMS (ESI-QTOF) m/z: [M + H]+ 
Calcd for C14H18O2H 219.1380; Found 219.1370. 
2-(4-Methoxyphenethyl)cycloheptanone (3-10ag): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
12 (12 mg, 10 mol %), cycloheptanone (56 mg, 0.5 mmol) and 
2-phenylethylamine (85 mg, 0.7 mmol) was stirred at 130 °C 
for 16 h. The product 3-10ag was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.7 (10% EtOAc in hexanes)). Yield = 85 mg 
(79%). Data for 3-10ag: 1H NMR (400 MHz, CDCl3) δ 7.31–7.25 (m, 2H), 7.23–7.10 (m, 
3H), 2.65–2.39 (m, 5H), 2.07–1.98 (m, 1H), 1.92–1.80 (m, 4H), 1.66–1.54 (m, 2H), 1.42–
1.27 (m, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 216.0, 142.0, 128.4, 128.3, 125.8, 
51.4, 42.9, 33.9, 33.4, 31.4, 29.4, 28.5, 24.4 ppm; GC-MS for C15H20O, m/z = 216 (M
+); 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H20OH 217.1587; Found 217.1557. 
2-(4-Methoxybenzyl)cycloheptan-1-one (3-10ah): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
12 (12 mg, 10 mol %), cycloheptanone (56 mg, 0.5 mmol) and 
4-methoxybenzylamine (96 mg, 0.7 mmol) was stirred at 130 
°C for 16 h. The product 3-10ah was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.6 (10% EtOAc in hexanes)). Yield = 94 mg 
(81%). Data for 3-10ah: 1H NMR (400 MHz, CDCl3) δ 7.06 (d, J = 7.8 Hz, 2H), 6.80 (d, 





(dd, J = 13.4, 8.5 Hz, 2H), 2.46–2.39 (m, 2H), 1.87–1.73 (m, 4H), 1.64–1.53 (m, 1H), 
1.36–1.25 (m, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 215.8, 157.8, 131.8, 130.0, 
113.6, 55.1, 53.8, 43.1, 37.0, 30.2, 29.2, 28.5, 24.2 ppm; GC-MS for C15H20O2, m/z = 232 
(M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H20O2H 233.1536; Found 233.1505. 
2-(4-Methoxybenzyl)cyclooctanone (3-10ai): A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 
mg, 10 mol %), cyclooctanone (63 mg, 0.5 mmol) and 4-
methoxybenzylamine (96 mg, 0.7 mmol) was stirred at 130 °C 
for 16 h. The product 3-10ai was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.7 (10% EtOAc in hexanes)). Yield = 108 mg 
(88%). Data for 3-10ai: 1H NMR (400 MHz, CDCl3) δ 7.03 (d, J = 8.6 Hz, 2H), 6.78 (d, 
J = 8.6 Hz, 2H), 3.75 (s, 3H), 2.95–2.84 (m, 2H), 2.56–2.46 (m, 1H), 2.33–2.25 (m, 1H), 
2.15–2.08 (m, 1H), 2.02–1.92 (m, 1H), 1.84–1.45 (m, 7H), 1.38–1.28 (m, 1H), 1.24–1.15 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 219.5, 157.8, 131.8, 129.8, 113.6, 55.1, 52.1, 
43.0, 37.4, 32.7, 27.6, 25.3, 24.6, 24.5 ppm; GC-MS for C16H22O2, m/z = 246 (M
+); 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C16H22O2H 247.1693; Found 247.1661. 
(2R,5S)-2-(4-Methoxyphenethyl)-5-
methylcyclohexanone (3-10an): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 
mg, 10 mol %), 3-methylcyclohexanone (56 mg, 0.5 
mmol) and 4-methoxybenzeneethanamine (106 mg, 0.7 mmol) was stirred at 130 °C for 
16 h. The product 3-10an was isolated by column chromatography on silica gel 





(84%). Data for 3-10an: 1H NMR (400 MHz, CDCl3) δ 7.09 (d, J = 8.7 Hz, 2H), 6.82 (d, 
J = 8.7 Hz, 2H), 3.78 (s, 3H), 2.62–2.52 (m, 2H), 2.39–2.33 (m, 1H), 2.22–2.06 (m, 3H), 
1.99 (td, J = 12.7, 1.1 Hz, 1H), 1.90–1.80 (m, 2H), 1.47–1.31 (m, 3H), 1.01 (d, J = 6.2 
Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 212.6, 157.6, 134.3, 129.2, 113.7, 
55.2, 50.6, 48.7, 35.7, 34.0, 33.0, 32.2, 30.9, 22.4 ppm; GC-MS for C16H22O2, m/z = 246 
(M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C16H22O2H 247.1693; Found 247.1668. 
2-((S)-2-Phenylpropyl)cyclohexanone (3-10ao): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
12 (12 mg, 10 mol %), cyclohexanone (49 mg, 0.5 mmol) and 
(R)-(+)-β-methylphenethylamine (95 mg, 0.7 mmol) was stirred 
at 130 °C for 16 h. The product 3-10ao was isolated by column chromatography on silica 
gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.8 (10% EtOAc in hexanes)). Yield = 101 
mg (94%). Data for 3-10ao: 1H NMR (400 MHz, CDCl3) δ 7.33–7.26 (m, 2H), 7.24–7.09 
(m, 3H), 2.88–2.72 (m, 1H), 2.41–2.29 (m, 1H), 2.25–2.09 (m, 3H), 2.04–1.89 (m, 2H), 
1.83–1.74 (m, 1H), 1.66–1.52 (m, 2H), 1.42–1.29 (m, 2H), 1.25–1.21 (m, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 213.5, 147.3, 128.4, 127.0, 125.9, 48.7, 42.3, 38.3, 
37.6, 35.1, 28.3, 25.0, 22.9 ppm; GC-MS for C15H20O, m/z = 216 (M
+). HRMS (ESI-





6.3.6.3 Characterization Data of the Compounds Listed in Table 3.5 
1-((1S,2R,5S)-6,6-Dimethylbicyclo[3.1.1]heptan-
2-yl)-5-(1H-indol-3-yl)pentan-3-one (3-10at). A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 4-(1H-
indol-3-yl)butan-2-one (94 mg, 0.5 mmol) and (−)-cis-myrtanylamine (107 mg, 0.7 
mmol) was stirred at 130 °C for 16 h. The product 3-10at was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.4 (10% EtOAc 
in hexanes)). Yield = 126 mg (78%). Data for 3-10at: 1H NMR (400 MHz, CDCl3) δ 8.12 
(brs, 1H), 7.61 (d, J = 7.6 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 7.24–7.18 (m, 1H), 7.16–
7.11 (m, 1H), 6.96 (d, J = 2.3 Hz, 1H), 3.07 (t, J = 7.6 Hz, 2H), 2.83 (t, J = 7.6 Hz, 2H), 
2.38 (t, J = 7.8 Hz, 2H), 2.07–1.99 (m, 1H), 1.91–1.82 (m, 2H), 1.79–1.57 (m, 2H), 1.79–
1.57 (m, 4H), 1.54–1.42 (m, 2H), 1.37–1.24 (m, 2H), 1.20 (s, 3H), 0.81 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 211.6, 136.2, 127.1, 121.9, 121.5, 119.1, 118.6, 
115.1, 111.1, 45.4, 43.1, 40.9, 40.8, 39.2, 34.3, 30.1, 26.7, 24.3, 23.3, 22.2, 20.0, 19.4 
ppm; GC-MS for C22H29NO, m/z = 323 (M
+). HRMS (ESI-QTOF) m/z: [M + Na]+ Calcd 




10au): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), nabumetone (114 mg, 0.5 





The product 3-10au was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.6 (10% EtOAc in hexanes)). Yield = 160 mg 
(88%). Data for 3-10au: 1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 8.4 Hz, 2H), 7.55 (s, 
1H), 7.29 (dd, J = 8.4, 1.8 Hz, 1H), 7.14 (dd, J = 8.8, 2.5 Hz, 1H),  7.11 (d, J = 2.5 Hz, 
1H), 3.90 (s, 3H), 3.03 (t, J = 7.6 Hz, 2H), 2.79 (t, J = 7.6 Hz, 2H), 2.40–2.31 (m, 2H), 
2.05–1.97 (m, 1H), 1.88–1.79 (m, 2H), 1.77–1.56 (m, 4H), 1.51–1.41 (m, 2H), 1.30 (d, J 
= 10.0 Hz, 1H), 1.19 (s, 3H),  0.98–0.85 (m, 1H), 0.79 (s, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 210.6, 157.1, 136.2, 133.0, 128.9, 128.8, 127.5, 126.8, 126.2, 118.7, 
105.5, 55.1, 45.4, 44.2, 40.9, 40.8, 39.2, 34.2, 30.1, 29.7, 26.7, 24.3, 23.3, 22.2, 20.0 
ppm; GC-MS for C25H32O2, m/z = 364 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C25H32O2H 365.2475; Found 305.2457. 
1-(1H-Indol-3-yl)-7,11-dimethyldodec-10-
en-3-one (3-10av). A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 
2-12 (12 mg, 10 mol %), 4-(1H-indol-3-
yl)butan-2-one (94 mg, 0.5 mmol) and geranylamine (107 mg, 0.7 mmol) was stirred at 
130 °C for 16 h. The product 3-10av was isolated by column chromatography on silica 
gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.5 (10% EtOAc in hexanes)). Yield = 117 
mg (72%). Data for 3-10av: 1H NMR (400 MHz, CDCl3) δ 8.14 (brs, 1H), 7.60 (d, J = 
7.8 Hz, 1H), 7.35 (dt, J = 8.0, 1.0 Hz, 1H), 7.24–7.17 (m, 1H), 7.13 (td, J = 7.8, 1.0 Hz, 
1H), 6.97 (s, 1H), 5.10 (tt, J = 7.1, 1.4 Hz, 1H), 3.12–3.01 (m, 2H), 2.89–2.76 (m, 2H), 
2.42–2.32 (m, 2H), 2.02–1.90 (m, 2H), 1.70 (s, 3H), 1.61 (s, 3H), 1.57–1.50 (m, 1H), 





MHz, CDCl3) δ 211.2, 136.2, 131.0, 127.1, 124.8, 121.9, 121.5, 119.1, 118.6, 115.1, 
111.1, 43.3, 43.1, 36.9, 36.4, 32.2, 25.7, 25.4, 21.3, 19.3, 19.3, 17.6 ppm; GC-MS for 
C22H31NO, m/z = 325 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C22H31NOH 
326.2478; Found 326.2474. 
1-(6-Methoxynaphthalen-2-yl)-
7,11-dimethyldodec-10-en-3-one 
(3-10aw). A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 
mol %), 2-12 (12 mg, 10 mol %), nabumetone (114 mg, 0.5 mmol) and geranylamine 
(107 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 3-10aw was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.7 (10% 
EtOAc in hexanes)). Yield = 124 mg (68%). Data for 3-10aw: 1H NMR (400 MHz, 
CDCl3) δ 7.67 (d, J = 8.6 Hz, 2H), 7.55 (s, 1H), 7.29 (dd, J = 8.4, 1.8 Hz, 1H), 7.13 (dd, J 
= 8.8, 2.5 Hz, 1H), 7.10 (d, J = 2.5 Hz, 1H), 5.09 (tt, J = 7.1, 1.4 Hz, 1H), 3.91 (s, 3H), 
3.03 (t, J = 7.6 Hz, 2H), 2.84–2.74 (m, 2H), 2.37 (t, J = 7.4 Hz, 2H), 2.12–1.83 (m, 3H), 
1.69 (s, 3H), 1.61 (s, 3H), 1.56–1.48 (m, 1H), 1.41–1.34 (m, 1H), 1.33–1.19 (m, 2H),  
1.16–1.01 (m, 2H), 0.86 (d, J = 6.5 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
210.4, 157.2, 136.2, 133.0, 131.0, 129.0, 128.8, 127.5, 126.9, 126.2, 124.8, 118.7, 105.5, 
55.2, 44.2, 43.3, 36.9, 36.4, 32.2, 29.7, 25.7, 25.4, 21.2, 19.3, 17.6 ppm; GC-MS for 
C25H34O2, m/z = 366 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C25H34O2H 






morpholinophenyl)propan-1-one (3-10ax). A 
1,4-dioxane (2.0 mL) solution of complex 2-10 
(9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 4′-
morpholinoacetophenone (102 mg, 0.5 mmol) and 4-methoxybenzylamine (96 mg, 0.7 
mmol) was stirred at 130 °C for 16 h. The product 3-10ax was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.1 (10% EtOAc 
in hexanes)). Yield = 116 mg (71%). Data for 3-10ax: 1H NMR (400 MHz, CDCl3) δ 
7.90 (d, J = 9.0 Hz, 2H), 7.17 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 9.0 Hz, 2H), 6.84 (d, J = 
8.6 Hz, 2H), 3.88–3.83 (m, 4H), 3.78 (s, 3H), 3.32–3.27 (m, 4H), 3.21–3.16  (m, 2H), 
3.02–2.96 (m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 197.6, 157.8, 154.0, 133.5, 
130.0, 129.2, 127.7, 113.8, 113.2, 66.4, 55.1, 47.4, 40.1, 29.5 ppm; GC-MS for 
C20H23NO3, m/z = 325 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C20H23NO3H 
326.1751; Found 326.1751. 
1-(4-Fluorophenyl)-3-(4-
morpholinophenyl)propan-1-one (3-10ay): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 4′-
fluoroacetophenone (69 mg, 0.5 mmol) and 4-morpholinobenzylamine (134 mg, 0.7 
mmol) was stirred at 130 °C for 16 h. The product 3-10ay was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.2 (10% EtOAc 
in hexanes)). Yield = 93 mg (59%). Data for 3-10ay: 1H NMR (400 MHz, CDCl3) δ 





3.91–3.84 (m, 4H), 3.27–3.21 (m, 2H), 3.13 (t, J = 4.8 Hz, 4H), 3.04–2.96 (m, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 197.8, 165.6 (d, JCF = 254.5 Hz), 133.2 (d, JCF = 3.1 
Hz), 130.6 (d, JCF = 9.1 Hz), 129.1, 127.8, 117.1, 116.1, 115.6 (d, JCF = 21.8 Hz), 66.8, 
49.7, 40.4, 29.1 ppm; GC-MS for C19H20FNO2, m/z = 313 (M
+). HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C19H20FNO2H 314.1527; Found 314.1517. 
(E)-2-Methyl-5-(4-morpholinophenyl)-1-
(2,6,6-trimethylcyclohex-2-enyl)pent-1-en-3-
one (3-10az). A 1,4-dioxane (2.0 mL) solution 
of complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 
10 mol %), α-cetone (103 mg, 0.5 mmol) and 4-
morpholinobenzylamine (134 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 
3-10az was isolated by column chromatography on silica gel (hexanes/EtOAc = 120:1–
20:1; TLC: Rf = 0.4 (10% EtOAc in hexanes)). Yield = 126 mg (66%). Data for 3-10az: 
1H NMR (400 MHz, CDCl3) δ 7.12 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 6.38 
(dd, J = 11.1, 1.5 Hz, 1H), 5.48–5.39 (m, 1H), 3.87–3.84 (m, 4H), 3.14–3.10 (m, 4H), 
2.98–2.90 (m, 2H), 2.89–2.82 (m, 2H), 2.64 (d, J = 11.1 Hz, 1H), 2.09–2.00 (m, 2H), 
1.86 (d, J = 1.1 Hz, 3H), 1.55–1.48 (m, 3H), 1.47–1.42 (m, 1H), 1.26–1.20 (m, 1H), 0.92 
(s, 3H), 0.78 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ  201.2, 149.6, 144.0, 
139.8, 137.3, 133.2, 129.1, 121.9, 115.9, 66.9, 50.1, 49.6, 39.6, 32.8, 31.7, 30.0, 27.1, 
27.1, 23.0, 22.8, 12.0 ppm; GC-MS for C25H35NO2, m/z = 381 (M
+). HRMS (ESI-QTOF) 






enyl)pentan-3-one (3-10ba): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 
10 mol %), dihydro-β-ionone (97 mg, 0.5 mmol) and 2-
thiophenemethylamine (79 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 3-
10ba was isolated by column chromatography on silica gel (hexanes/EtOAc = 120:1–
20:1; TLC: Rf = 0.8 (10% EtOAc in hexanes)). Yield = 137 mg (94%). Data for 3-10ba: 
1H NMR (400 MHz, CDCl3) δ 7.11 (dd, J = 5.1, 1.1 Hz, 1H), 6.90 (dd, J = 5.1, 3.4 Hz, 
1H), 6.80 (dd, J = 3.4, 1.1 Hz, 1H), 3.13 (t, J = 7.3 Hz, 2H), 2.79 (t, J = 7.4 Hz, 2H), 
2.50–2.45 (m, 2H), 2.31–2.21 (m, 2H), 1.90 (t, J = 6.9 Hz, 2H), 1.58–1.56 (m, 1H), 1.55 
(s, 3H), 1.43–1.39 (m, 2H), 1.09–1.07 (m, 1H), 0.97 (s, 6H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 209.4, 143.6, 135.8, 127.7, 126.7, 124.5, 123.2, 44.2, 43.7, 39.6, 34.9, 
32.6, 28.3, 24.0, 22.1, 19.7, 19.4 ppm; GC-MS for C18H26OS, m/z = 290 (M
+). HRMS 
(ESI-QTOF) m/z: [M + H]+ Calcd for C18H26OSH 291.1777; Found 291.1771. 
1-(Furan-2-yl)-5-(2,6,6-trimethylcyclohex-1-
enyl)pentan-3-one (3-10bb): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 
10 mol %), dihydro-β-ionone (97 mg, 0.5 mmol) and 
furfurylamine (68 mg, 0.7 mmol) was stirred at 130 °C for 16 h. The product 3-10bb was 
isolated by column chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf 
= 0.8 (10% EtOAc in hexanes)). Yield = 118 mg (86%). Data for 3-10bb: 1H NMR (400 
MHz, CDCl3) δ 7.28 (dd, J = 1.9, 0.9 Hz, 1H), 6.26 (dd, J = 3.2, 1.9 Hz, 1H), 5.98 (dd, J 





2.22 (m, 2H), 1.89 (t, J = 7.0 Hz, 2H), 1.57–1.56 (m, 1H), 1.55 (s, 3H), 1.42–1.38 (m, 
2H), 1.07–1.06 (m, 1H), 0.96 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 209.5, 
154.5, 141.0, 135.9, 127.8, 110.1, 105.1, 43.6, 40.6, 39.6, 35.0, 32.7, 28.4, 22.3, 22.2, 
19.7, 19.4 ppm; GC-MS for C18H26O2, m/z = 274 (M
+). HRMS (ESI-QTOF) m/z: [M + 
H]+ Calcd for C18H26O2H 275.2006; Found 275.1994. 
(E)-5-(4-Methoxyphenyl)-2-methyl-1-(2,6,6-
trimethylcyclohex-2-enyl)pent-1-en-3-one (3-
10bc): A 1,4-dioxane (2.0 mL) solution of complex 
2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), α-
cetone (103 mg, 0.5 mmol) and 4-methoxybenzylamine (96 mg, 0.7 mmol) was stirred at 
130 °C for 16 h. The product 3-10bc was isolated by column chromatography on silica 
gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.7 (10% EtOAc in hexanes)). Yield = 155 
mg (95%). Data for 3-10bc: 1H NMR (400 MHz, CDCl3) δ 7.12 (d, J = 8.6 Hz, 2H), 6.83 
(d, J = 8.6 Hz, 2H), 6.38 (dd, J = 11.1, 1.5 Hz, 1H), 5.48–5.39 (m, 1H), 3.78 (s, 3H), 
2.99–2.91 (m, 2H), 2.91–2.83 (m, 2H), 2.65 (d, J = 11.1 Hz, 1H), 2.09–2.00 (m, 2H), 
1.87 (d, J = 1.2 Hz, 3H), 1.52 (dd, J = 3.6, 1.7 Hz, 3H), 1.49–1.42 (m, 1H), 1.27–1.21 (m, 
1H), 0.93 (s, 3H), 0.79 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 201.2, 157.8, 
144.0, 137.3, 133.5, 133.1, 129.2, 121.9, 113.8, 55.1, 50.1, 39.6, 32.7, 31.7, 30.0, 27.1, 
27.0, 22.9, 22.7, 11.9 ppm; GC-MS for C22H30O2, m/z = 326 (M
+). HRMS (ESI-QTOF) 








yl)butan-2-one (3-10bd): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 
mg, 10 mol %), acetone (29 mg, 0.5 mmol) and (+)-dehydroabietylamine (200 mg, 0.7 
mmol) was stirred at 130 °C for 16 h. The product 3-10bd was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 120:1–20:1; TLC: Rf = 0.9 (10% EtOAc 
in hexanes)). Yield = 88 mg (54%). Data for 3-10bd: 1H NMR (400 MHz, CDCl3) δ 7.17 
(d, J = 8.2 Hz, 1H), 6.99 (dd, J = 8.2, 1.9 Hz, 1H), 6.89 (d, J = 1.9 Hz, 1H), 2.95–2.78 
(m, 3H), 2.38–2.29 (m, 2H), 2.14 (s, 3H), 1.88–1.49 (m, 10H), 1.44–1.30 (m, 4H), 1.22 
(d, J = 6.9 Hz, 6H), 0.93 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 209.6, 147.5, 
145.5, 134.7, 126.8, 124.2, 123.8, 47.7, 38.5, 38.2, 37.5, 37.2, 37.0, 35.3, 33.4, 30.2, 30.1, 
29.7, 25.2, 24.0, 20.6, 18.9, 18.6 ppm; GC-MS for C23H34O, m/z = 326 (M
+). HRMS 





one (3-10be): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (5 mg, 3 mol %), 2-12 (6 mg, 10 mol %), 5α-cholestan-3-one 
(97 mg, 0.25 mmol) and isoamylamine (44 mg, 0.5 mmol) was stirred at 130 °C for 16 h. 
The product 3-10be was isolated by column chromatography on silica gel 





(91%). Data for 3-10be: 1H NMR (400 MHz, CDCl3) δ 2.37–2.15 (m, 3H), 2.11–2.02 (m, 
2H), 2.00–1.95 (m, 1H), 1.86–1.76 (m, 2H), 1.75–1.60 (m, 2H), 1.59–1.44 (m, 5H), 1.41–
1.20 (m, 8H), 1.17–0.96 (m, 14H), 0.93–0.81 (m, 15H), 0.73–0.62 (m, 4H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 213.0, 56.2, 56.2, 53.9, 48.1, 46.6, 46.3, 45.1, 42.6, 39.9, 
39.5, 36.5, 36.3, 36.1, 35.7, 35.2, 31.7, 28.7, 28.3, 28.2, 28.0, 26.9, 24.2, 23.8, 22.8, 22.7, 
22.5, 22.5, 21.5, 18.6, 12.5, 12.1 ppm; GC-MS for C32H56O, m/z = 456 (M
+). HRMS 
(ESI-QTOF) m/z: [M + Na]+ Calcd for C32H56OH 479.4223; Found 479.4218. 
(4-Methoxyphenyl)-N-(1-
phenylethylidene)methanamine (3-13a): A mixture of 
acetophenone (240 mg, 2 mmol), 4-methoxybenzylamine 
(274 mg, 2 mmol), p-toluenesulfonic acid (2 mg, 0.4 mol 
%) and 4 Å molecular sieves (15 mg) in toluene (4 mL) was reacted for 5 h under 
refluxing conditions. After filtered through a celite bed, analytically pure product was 
isolated by column chromatography on silica gel (column was flushed with 20 mL of 
pure Et3N before loading the sample; hexanes/Et3N = 100:1–10:1; Yield = 458 mg 
(96%). Data for 3-13a: 1H NMR (400 MHz, CDCl3) δ 7.95–7.87 (m, 2H), 7.45–7.42 (m, 
3H), 7.40 (d, J = 8.7 Hz, 2H), 6.95 (d, J = 8.7 Hz, 2H), 4.72 (s, 2H), 3.83 (s, 3H), 2.35 (s, 
2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 165.5, 158.2, 140.9, 132.6, 129.4, 128.6, 
128.0, 126.6, 113.7, 55.1, 55.0, 15.6 ppm; GC-MS for C16H17NO, m/z = 239 (M
+). 







13b): A mixture of 4-methoxybenzaldehyde (680 mg, 
5 mmol), 1-p-tolylethanamine (676 mg, 5 mmol), p-
toluenesulfonic acid (4 mg, 0.4 mol %) and 4 Å 
molecular sieves (30 mg) in anhydrous toluene (5 mL) was reacted for 2 h under reflux 
conditions. After filtered through a celite, analytically pure product was isolated by 
column chromatography on silica gel (column was flushed with 20 mL of pure Et3N 
before loading the sample; hexanes/Et3N = 100:1–10:1; Yield = 1.21 g (96%). Data for 
3b: 1H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 7.79 (d, J = 8.8 Hz, 2H), 7.39 (d, J = 8.0 
Hz, 2H), 7.21 (d, J = 8.0 Hz, 2H), 6.95 (d, J = 8.8 Hz, 2H), 4.57 (q, J = 6.3 Hz, 1H), 3.74 
(s, 3H), 2.39 (s, 3H), 1.68 (d, J = 6.3 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
161.5, 159.1, 141.7, 136.1, 129.8, 128.9, 128.7, 126.4, 113.7, 66.8, 55.0, 31.3, 20.8 ppm; 
GC-MS for C17H19NO, m/z = 253 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C16H17NOH 254.1539; Found 254.1525. 
N-Cyclohexylidene-3-phenylpropan-1-amine (3-13e): A 
mixture of cyclohexanone (196 mg, 2 mmol), 3-phenyl-1-
propylamine (270 mg, 2 mmol), p-toluenesulfonic acid (2 
mg, 0.2 mol %), and 4 Å molecular sieves (15 mg) in 
anhydrous toluene (4 mL) was reacted for 5 h under reflux conditions. After filtered 
through a celite bed, analytically pure product was isolated by column chromatography 
on silica gel (column was flushed with 20 mL of pure Et3N before loading the sample; 
hexanes/Et3N = 100:1–10:1; Yield = 380 mg (88%). Data for 3-13e: 
1H NMR (400 MHz, 





4H), 2.36–2.11 (m, 3H), 1.96–1.55 (m, 8H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
172.7, 141.9, 128.0, 127.9, 125.4, 49.1, 41.6, 39.6, 33.4, 28.5, 25.7 ppm; GC-MS for 
C15H21N, m/z = 215 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H21NH ; 
216.1747 Found 216.1737. 
(E)-N-(4-methoxybenzylidene)-1,1-
diphenylmethanamine (3-13f): A mixture of α-
aminodiphenylmethane (183 mg, 1 mmol), 4-
methoxybenzaldehyde (136 mg, 1 mmol) and sodium 
sulfate (0.40 g) in CH2Cl2 (2.0 mL) was stirred at room 
temperature for 18 h. After filtered through celite, analytically pure product was isolated 
by recrystallization. Yield = 295 mg (98%). Data for 3-13f: 1H NMR (400 MHz, CDCl3) 
δ 8.40 (s, 1H), 7.84 (d, J = 8.8 Hz, 2H), 7.55–7.49 (m, 1H), 7.47–7.45 (m, 3H), 7.41–7.32 
(m, 4H), 7.31–7.34 (m, 2H), 6.97 (d, J = 8.8 Hz, 2H), 5.62 (s, 1H), 3.86 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 161.6, 160.0, 144.1, 130.0, 129.2, 128.3, 127.6, 
126.8, 113.8, 77.7, 55.3 ppm; GC-MS for C21H19NO, m/z = 301 (M
+). 1H and 13C NMR 
spectral data are in good agreement with the literature values.208 
N-(4-Methoxybenzyl)-1,1-diphenylmethanimine (3g): 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 
3 mol %), 2-12 (12 mg, 10 mol %), (E)-N-(4-
methoxybenzylidene)-1,1-diphenylmethanamine (3-10g) 
(151 mg, 0.5 mmol) was stirred at 130 °C for 2 h. The 
product 3-10e was isolated by column chromatography on silica gel (hexanes/EtOAc = 





10e: 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 8.1 Hz, 2H), 7.52–7.47 (m, 2H), 7.46–
7.30 (m, 4H), 7.30–7.17 (m, 4H), 6.88 (d, J = 8.6 Hz, 2H), 4.58 (s, 2H), 3.80 (s, 3H) 
ppm;  13C{1H} NMR (100 MHz, CDCl3) δ 168.6, 158.3, 139.6, 136.6, 132.6, 130.1, 
128.7, 128.6, 128.5, 128.2, 128.0, 127.8, 113.7, 56.7, 55.2 ppm; GC-MS for C21H19NO, 
m/z = 301 (M+). 1H and 13C NMR spectral data are in good agreement with the literature 
values.209 
6.3.7 DFT Computational Study 
Electronic structure calculations were performed with the Gaussian 16 package, 
revision C01.210 For the density functional theory (DFT) calculations we used M06L 
functional211 in combination with def2-SV(P) basis set.212 After geometry optimization, 
the SCF energies were refined by single-point calculations with triple-zeta def2-TZVPPD 
basis set.212 For Ru, the 28 core electrons were treated using the effective core 
approach213 for both double-zeta and triple-zeta basis sets. Solvent effects were included 
using the implicit integral equation formalism polarizable continuum model (IEF-PCM, 
also referred as PCM)214 with the solvent parameters characteristic for 1,4-dioxane (e = 
2.2099). For all DFT calculations, ultrafine Lebedev’s grid was used with 99 radial shells 
per atom and 590 angular points in each shell. The wave function stability tests were 
performed to ensure that the closed-shell singlet states were the lowest-energy solution 
(for 6’, the SCF solution was found to have a partial open-shell character).215 Tight cutoff 
convergence criteria on atomic forces (2E-6 and 1E-6 au for maximum/RMS forces, 
respectively) and displacements (6E-6 and 4E-6 au for maximum/RMS displacements, 
respectively) were used in geometry optimization procedure. Hessian matrices were 





frequencies for minima and one for transition states). Intrinsic reaction coordinate 
(IRC)216 was followed for the pentan-2-imine to pentan-2-imine (both for the uncatalyzed 
reaction and for the reaction in presence of the Ru-catecholate complex 4 with removed t-
Bu groups) to validate the assignment of transition states to the corresponding elementary 
steps. Thermodynamic functions were calculated using the ideal gas approximation based 
on the particle-in-the-box, rigid rotor, and quantum harmonic oscillator models for the 







6.4 Experimental Procedures and Characterization Data for Chapter 4 
6.4.1.1 General Procedure for the Catalytic Synthesis of Quinazolines  
In a glove box, complex 2-10 (9 mg, 3 mol %), 4-(1,1-dimethylethyl)-1,2-
benzenediol (2-16) (8 mg, 10 mol %) were dissolved in anhydrous 1,4-dioxane (1 mL) in 
a 25 mL Schlenk tube equipped with a Teflon screw cap stopcock and a magnetic stirring 
bar. After stirring for 5-10 min until the solution was turned light green color, both a 2-
aminophenylketone (0.5 mmol) and an amine (0.7 mmol) substrates, and dioxane (1 mL) 
was added to the tube. The tube was sealed, it was brought out of the glove box, and was 
stirred in an oil bath set at 140 °C for 20 h. After the reaction tube was cooled to room 
temperature, the tube was open to air, the solution was filtered through a short silica gel 
column by eluting with CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS 
method. Analytically pure product 4-12 was isolated by a simple column chromatography 
on silica gel (280-400 mesh, hexanes/EtOAc). 
6.4.1.2 General Procedure for the Catalytic Synthesis of Quinazolinones 
In a glove box, complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), were 
dissolved in 1,4-dioxane (1 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5-10 min 
until the solution was turned to light green color. Both 2-aminobenzamide (0.5 mmol) 
and an amine (0.7 mmol) substrates were dissolved in dioxane (1 mL), and the solution 
was added to the reaction tube. The tube was brought out of the glove box and was stirred 
in an oil bath set at 140 °C for 20 h. The reaction tube was taken out of the oil bath, and it 
was cooled to room temperature. The resulting solution was filtered through a short silica 





Analytically pure product 4-13 was isolated by a simple column chromatography on 
silica gel (280-400 mesh, hexanes/EtOAc). 
6.4.2 Catalyst and Ligand Screening Study 
In a glove box, a Ru catalyst (3 mol % Ru atom) and a ligand (10 mol %) were 
dissolved in a solvent (1 mL) in a 25 mL Schlenk tube equipped with a Teflon screw cap 
stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5-10 min. 2-
Aminophenylethanone (68 mg, 0.5 mmol), 4-methoxybenzylamine (69 mg, 0.7 mmol) 
and a solvent (1 mL) were added to the reaction tube. The tube was brought out of the 
glove box and was stirred in an oil bath at 140 °C for 20 h. The product yield was 
determined by 1H NMR by using hexamethylbenzene as an internal standard. The results 
are summarized in Table 4.1 and Table 4.2. 
6.4.3 General Procedures for the Mechanistic Studies 
We have chosen the reaction of 2-aminoacetophenone with 4-
methoxybenzylamine for probing mechanistic insights for the coupling reaction. 
6.4.3.1 Deuterium Labeling Study 
In a glove box, 2-aminophenylethanone-d3 (89 % D, 69 mg, 0.5 mmol), 4-
methoxybenzylamine (96 mg, 0.7 mmol) and complex 2-10 (3 mol %) were dissolved in 
1,4-dioxane (2 mL) in a 25 mL Schlenk tube equipped with a Teflon screw cap stopcock 
and a stirring bar. The tube was brought out of the box, and stirred in an oil bath preset at 
140 °C for 20 h. The reaction tube was taken out of the oil bath, and was cooled to room 





gel column by eluting with CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS. 
Analytically pure product was isolated by column chromatography on silica gel (230-460 
mesh, hexanes/EtOAc = 100:1 to 10:1). The 1H and 2H NMR spectra of the product 4-
12a and 4-12a-d are shown in Figure 4.2. 
6.4.3.2 Reaction Profile Experiment 
In a glove box, complex 2-10 (5 mg, 3 mol %) and 2-16 (4 mg, 10 mol %) were 
dissolved in toluene-d8 (0.5 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5 to 10 
minutes until the solution turned to a blueish green color. 2-aminophenylethanone (34 
mg, 0.25 mmol) and 4-methoxybenzylamine (35 mg, 0.25 mmol) were added to the 
reaction tube, and the solution was transferred into a J-Young NMR tube equipped with a 
Teflon screw cap stopcock. The tube was brought out of the glove box, and was 
immersed an oil bath set at 130 °C. The tube was taken out from the oil bath at 20 min 
intervals, was immediately cooled in ice-water bath, and was analyzed by 1H NMR. The 
appearance of the product signals were normalized against the internal standard peak 
(C6Me6). The plot of relative concentration vs time is shown in Figure 4.3. 
6.4.3.3 Reaction with Imines 
Following the standard procedure, a reaction tube containing 4-chloro-2-(((4-
methoxybenzyl)imino)(phenyl)methyl)aniline 4-14b and complex 2-10 (3 mol %) in 1,4-
dioxane (2 mL) was stirred at 140 °C for 20 h. The column chromatography on silica gel 





Following the standard procedure, a reaction tube containing (E)-2-((4-
methoxybenzylidene)amino)benzamide 4-15 and complex 2-10 (3 mol %) in 1,4-dioxane 
(2 mL) was stirred at 140 °C for 20 h. The column chromatography on silica gel 
(hexanes/EtOAc = 40:1 to 10:1) led to the isolation of the product 4-13c in 87% yield. 
6.4.3.3 Reaction with Ruthenium Catecholate Complex 2-11 
In a glove box, complex 2-11 (9 mg, 1 mol %) was dissolved in 1,4-dioxane (1 
mL) in a 25 mL Schlenk tube equipped with a Teflon screw cap stopcock and a magnetic 
stirring bar. The resulting mixture was stirred for 5-10 min until the solution was turned 
to light green color. Both 2-aminobenzamide (68 mg, 0.5 mmol) and 4-
methoxybenzylamine (96 mg, 0.7 mmol) substrates were dissolved in dioxane (1 mL), 
and the solution was added to the reaction tube. The tube was brought out of the glove 
box and was stirred in an oil bath set at 140 °C for 20 h. The reaction tube was taken out 
of the oil bath, and it was cooled to room temperature. The resulting solution was filtered 
through a short silica gel column by eluting with CH2Cl2 (10 mL), and the filtrate was 
analyzed by GC-MS. Analytically pure product 4-13c was isolated by a simple column 
chromatography on silica gel (280-400 mesh, hexanes/EtOAc). 
6.4.4.1 X-ray Crystallography Data for 4-12i 
Colorless single crystals of 4-12i were grown in dichloromethane/n-
hexane/Ethylacetate at room temperature. A suitable crystal with the dimension of 0.643 
× 0.052 × 0.02 mm3 was selected and analyzed. The 2-phenylquinazoline moiety has a 
planar conjugated structure. The 4-phenyl group is rotated out of its plane and is 





the stacks is apparently caused by two possible equivalent alternated patterns of their 
edge-to-face arrangement both within the stacks and between them. 
 
Figure 6.17: Molecular Structure of 4-12i 
 






Table 6.9: Crystal Data and Structure Refinement for 4-12i 
Identification code yi3p 
Empirical formula C20H13ClN2 
Formula weight 316.77 
Temperature/K 100.15 
Crystal system monoclinic 













Crystal size/mm3 0.643 × 0.052 × 0.02 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 9.428 to 141.218 
Index ranges -19 ≤ h ≤ 19, -6 ≤ k ≤ 5, -23 ≤ l ≤ 23 
Reflections collected 12968 
Independent reflections 2793 [Rint = 0.0568, Rsigma = 0.0355] 
Data/restraints/parameters 2793/0/244 
Goodness-of-fit on F2 1.050 
Final R indexes [I>=2σ (I)] R1 = 0.0619, wR2 = 0.1462 
Final R indexes [all data] R1 = 0.0716, wR2 = 0.1545 
Largest diff. peak/hole / e Å-3 0.43/-0.97 
  
6.4.4.2 X-ray Crystallographic Data for 4-12k 
Colorless single crystals of 4-12k were grown in dichloromethane/n-
hexane/EtOAc at room temperature. A suitable crystal with the dimension of 0.61 × 0.03 
× 0.02 mm3 was selected and analyzed. The 2-phenylquinazoline moiety has a planar 





2 equally populated positions. The molecules form translational stacks along y axis. The 
disorder of the 4-phenyl groups within the stacks is apparently caused by two possible 
equivalent alternated patterns of their edge-to-face arrangement both within the stacks 
and between them. 
 






Figure 6.20: Crystal Packing of 4-12k 
Table 6.10: Crystal Data and Structure Refinement for 4-12k 
Identification code  yi3n  
Empirical formula  C20H12ClFN2  
Formula weight  334.77  
Temperature/K  446.15  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  17.3595(3)  
b/Å  4.85966(9)  
c/Å  19.2750(4)  
α/°  90  
β/°  113.162(2)  
γ/°  90  
Volume/Å3  1494.99(6)  






3  1.487  
μ/mm-1  2.379  
F(000)  688.0  
Crystal size/mm3  0.61 × 0.03 × 0.02  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  9.318 to 141.362  
Index ranges  -20 ≤ h ≤ 21, -5 ≤ k ≤ 5, -23 ≤ l ≤ 23  
Reflections collected  14159  
Independent reflections  2832 [Rint = 0.0454, Rsigma = 0.0320]  
Data/restraints/parameters  2832/24/262  
Goodness-of-fit on F2  1.052  
Final R indexes [I>=2σ (I)]  R1 = 0.0346, wR2 = 0.0895  
Final R indexes [all data]  R1 = 0.0429, wR2 = 0.0957  
Largest diff. peak/hole / e Å-3  0.28/-0.31  
 
6.4.4.3 X-ray Crystallographic Data for 4-13c 
Colorless single crystals of 4-13c were grown in hexanes/EtOAc at room 
temperature. A suitable crystal with the dimension of 0.37 × 0.081 × 0.049 mm3 was 
selected and analyzed. The molecule has an overall planar shape with the OMe group 
conjugated with the adjacent benzene ring. The molecules form centrosymmetric H-
bonded dimers packed into translational stacks along y axis. 
 






Figure 6.22: Crystal Packing of 4-13c 
 
Table 6.11: Crystal Data and Structure Refinement for 4-13c 
Identification code yi3t 
Empirical formula C15H12N2O2 
Formula weight 252.27 
Temperature/K 100.15 
Crystal system monoclinic 













Crystal size/mm3 0.37 × 0.081 × 0.049 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 7.588 to 141.582 





Reflections collected 10343 
Independent reflections 2252 [Rint = 0.0330, Rsigma = 0.0182] 
Data/restraints/parameters 2252/0/174 
Goodness-of-fit on F2 1.074 
Final R indexes [I>=2σ (I)] R1 = 0.0435, wR2 = 0.1259 
Final R indexes [all data] R1 = 0.0458, wR2 = 0.1301 
Largest diff. peak/hole / e Å-3 0.25/-0.23 
 
6.4.4.4 X-ray Crystallography Data for 4-13t 
Colorless single crystals of 4-13t were grown in Ethylacetate/n-hexanes at room 
temperature. A suitable crystal with the dimension of 0.12 × 0.07 × 0.05 mm3 was 
selected and analyzed. The structure has two symmetrically independent molecules. They 
have practically identical dihedral angle between their cyclic moieties – 44.6 and 45.0° 
but the difference in planarity of methoxy group is more perceptible – 5.1 vs. 12.3°. In 
the crystals the molecules form stacks along x axis where both independent molecules 
alternate in a head-to-head fashion. There are no pi-pi interactions in the stacks, rather 
some C-H…pi contacts. 
 






Figure 6.24: Crystal Packing of 4-13t 
Table 6.12: Crystal Data and Structure Refinement for 4-13t 
Identification code yi4h 
Empirical formula C16H14N2O2 
Formula weight 266.29 
Temperature/K 101(1) 
Crystal system triclinic 

















Crystal size/mm3 0.12 × 0.07 × 0.05 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.48 to 59.482 
Index ranges -13 ≤ h ≤ 13, -17 ≤ k ≤ 17, -17 ≤ l ≤ 16 
Reflections collected 28972 
Independent reflections 6544 [Rint = 0.0354, Rsigma = 0.0349] 
Data/restraints/parameters 6544/0/365 
Goodness-of-fit on F2 1.057 
Final R indexes [I>=2σ (I)] R1 = 0.0458, wR2 = 0.1087 
Final R indexes [all data] R1 = 0.0640, wR2 = 0.1213 
Largest diff. peak/hole / e Å-3 0.29/-0.26 
 
 
6.4.4.5 X-ray Crystallography Data for 4-13aa 
Colorless single crystals of 4-13aa were grown in EtOAc/n-hexanes at room 
temperature. A suitable crystal with the dimension of 0.646 × 0.171 × 0.065 mm3 was 
selected and analyzed. The structure contains 2 symmetrically independent molecules 
differing by conformation along C2-C9 bond – the dihedral angle N1-C2-C9-C14 is -
84.4(2)° in one molecule and  -68.1(2)° in another one. Both molecules represent the 
same S,S,S-enantiomer. The absolute configuration was established beyond doubts [Flack 
parameter is 0.01(5)]. The molecules form H-bonded quasi-centrosymmetric dimers 
through N-H…O interactions. The molecules are also stacked along x axis with quasi-






Figure 6.25: Molecular Structure of 4-13aa 
 
Figure 6.26: Crystal Packing of 4-13aa 
 
Table 6.13: Crystal Data and Structure Refinement for 4-13aa 
Identification code yi3z 
Empirical formula C17H20N2O 
Formula weight 268.35 
Temperature/K 101.3(10) 
Crystal system monoclinic 

















Crystal size/mm3 0.646 × 0.171 × 0.065 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 6.98 to 141.282 
Index ranges -8 ≤ h ≤ 8, -18 ≤ k ≤ 18, -15 ≤ l ≤ 16 
Reflections collected 25935 
Independent reflections 5350 [Rint = 0.0201, Rsigma = 0.0127] 
Data/restraints/parameters 5350/1/366 
Goodness-of-fit on F2 1.029 
Final R indexes [I>=2σ (I)] R1 = 0.0303, wR2 = 0.0814 
Final R indexes [all data] R1 = 0.0308, wR2 = 0.0820 
Largest diff. peak/hole / e Å-3 0.20/-0.17 
Flack parameter 0.01(5) 
 
6.4.4.6 X-ray Crystallography Data for 4-13ab 
Colorless single crystals of 4-13ab were grown in EtOAc/Dichloromethane/n-
pentanes at room temperature. A suitable crystal with the dimension of 0.528 × 0.083 × 
0.016 mm3 was selected and analyzed. The molecule represents a C9(R), C13(S)-
enantiomer established objectively with a good probability [Flack parameter 0.18(8)]. 
The saturated 6-membered rings are trans-fused that corresponds to R-configuration of 
chiral center at C22. The Me-groups occupy axial positions and quinazolinone group – an 
equatorial one (the ring C9…C13, C22 has a chair conformation). The ring annealed with 
benzene moiety has C22-sofa conformation. In the crystal, the molecules form H-bonded 
dimers over crystallographic 2-fold axes through N-H…O interactions. The dimers are 






Figure 6.27: Molecular Structure of 4-13ab 
 
Figure 6.28: Crystal Packing of 4-13ab 
 
Table 6.14: Crystal Data and Structure Refinement for 4-13ab 
Identification code  yi4n  
Empirical formula  C27H32N2O  
Formula weight  400.54  
Temperature/K  100.00(10)  
Crystal system  tetragonal  
Space group  P41212  





b/Å  16.41058(8)  
c/Å  16.10936(19)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  4338.37(7)  
Z  8  
ρcalcg/cm
3  1.226  
μ/mm-1  0.571  
F(000)  1728.0  
Crystal size/mm3  0.528 × 0.083 × 0.016  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.618 to 141.342  
Index ranges  -20 ≤ h ≤ 20, -15 ≤ k ≤ 19, -17 ≤ l ≤ 19  
Reflections collected  38387  
Independent reflections  4137 [Rint = 0.0280, Rsigma = 0.0132]  
Data/restraints/parameters  4137/0/280  
Goodness-of-fit on F2  1.056  
Final R indexes [I>=2σ (I)]  R1 = 0.0283, wR2 = 0.0713  
Final R indexes [all data]  R1 = 0.0297, wR2 = 0.0724  
Largest diff. peak/hole / e Å-3  0.16/-0.12  
Flack parameter 0.13(8) 
 
6.4.5.1 Characterization Data of the Quinazolin Compounds Listed in Table 4.3 
2-([1,1'-Biphenyl]-4-yl)-4-methylquinazoline (4-12p): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2-aminophenylethanone 
(68 mg, 0.5 mmol), and 4-phenylbenzylamine (128 mg, 
0.7 mmol) was stirred at 140 °C for 20 h. The product 4-
12p was isolated by column chromatography on silica gel (hexanes/EtOAc = 100:1–10:1; 
TLC: Rf = 0.5 (10% EtOAc in hexanes)). Yield = 101 mg (68%). Data for 4-12p: 
1H 
NMR (400 MHz, CDCl3) δ 8.71 (d, J = 8.4 Hz, 2H), 8.11 (t, J = 8.8 Hz, 2H), 7.93–7.83 





(m, 2H), 7.43–7.35 (m, 1H), 3.04 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
168.4, 159.8, 150.2, 143.1, 140.7, 137.0, 133.6, 129.0, 128.8, 127.6, 127.3, 127.2, 126.9, 
125.0, 123.0, 22.1 ppm; GC-MS for C21H16N2, m/z = 296 (M
+). HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C21H16N2H 297.1386; Found 297.1399.  
2-Phenethyl-4-phenylquinazoline (4-12s): A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 
mg, 10 mol %), 2-aminobenzophenone (99 mg, 0.5 mmol), 
and 3-phenyl-1-propanamine (95 mg, 0.7 mmol) was stirred 
at 140 °C for 20 h. The product 4-12s was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 80:1–10:1; TLC: Rf = 0.3 (10% 
EtOAc in hexanes)). Yield = 104 mg, (67%). Data for 4-12s: 1H NMR (400 MHz, 
CDCl3) δ 8.06 (d, J = 8.9 Hz, 2H), 7.86 (t, J = 7.8 Hz, 1H), 7.78–7.71 (m, 2H), 7.59–7.48 
(m, 4H), 7.35–7.23 (m, 4H), 7.22–7.15 (m, 1H), 3.54–3.46 (m, 2H), 3.35–3.27 (m, 2H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 168.6, 166.0, 151.3, 141.6, 137.3, 133.6, 
129.9, 129.9, 128.6, 128.5, 128.3, 128.3, 127.0, 126.8, 125.9, 121.2, 41.5, 34.8 ppm; GC-
MS for C22H18N2 m/z = 310 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C22H18N2H 311.1543; Found 311.1563. 
 
2-Phenethyl-4-phenylquinazoline (4-12t): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2-aminobenzophenone (99 
mg, 0.5 mmol), and 4-benzenebutanamine (104 mg, 0.7 
mmol) was stirred at 140 °C for 20 h. The product 4-12t 





Rf = 0.3 (10% EtOAc in hexanes)). Yield = 114 mg, (70%). Data for 4-12t: 
1H NMR (400 
MHz, CDCl3) δ 8.04 (d, J = 8.5 Hz, 2H), 7.85 (t, J = 8.6 Hz, 1H), 7.78–7.70 (m, 2H), 
7.60–7.53 (m, 3H), 7.51 (t, J = 8.6 Hz, 1H), 7.29–7.20 (m, 4H), 7.17–7.11 (m, 1H), 3.23 
(t, J = 7.7 Hz, 2H), 2.79 (t, J = 7.8 Hz, 2H), 2.30 (pentet, J = 7.7 Hz, 2H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 168.6, 166.7, 151.3, 142.2, 137.3, 133.5, 129.9, 129.8, 128.6, 
128.5, 128.2, 127.0, 126.7, 125.7, 121.2, 39.6, 35.8, 30.6 ppm; GC-MS for C23H20N2 m/z 
= 324 (M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C22H18N2H 325.1656; Found 
325.1640. 
2-Pentyl-4-phenylquinazoline (4-12v): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 
10 mol %), 2-aminobenzophenone (99 mg, 0.5 mmol), and 
1-hexylamine (71 mg, 0.7 mmol) was stirred at 140 °C for 
20 h. The product 4-12v was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.5 (10% EtOAc in hexanes)). Yield = 62 mg 
(45%). Data for 4-12v: 1H NMR (400 MHz, CDCl3) δ 8.12–8.00 (m, 2H), 7.86 (td, J = 
7.6, 1.2 Hz, 1H), 7.80–7.71 (m, 2H), 7.61–7.54 (m, 3H), 7.52 (t, J = 7.9 Hz, 1H), 3.17 (t, 
J = 7.9 Hz, 2H), 2.0–1.91 (m, 2H), 1.50–1.34 (m, 4H), 0.91 (t, J = 7.1 Hz, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 168.6, 167.2, 151.1, 137.3, 133.6, 129.9, 129.8, 
128.6, 128.1, 127.0, 126.7, 121.2, 40.0, 31.8, 28.8, 22.6, 14.1 ppm; GC-MS for C19H20N2 






4-Methyl-2-(1-phenylethyl)quinazoline (4-12x): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
16 (8 mg, 10 mol %), 2-aminophenylethanone (68 mg, 0.5 
mmol), and (R)-(+)-β-methylphenethylamine (95 mg, 0.7 
mmol) was stirred at 140 °C for 20 h. The product 4-12x was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.5 (20% EtOAc 
in hexanes)). Yield = 98 mg (79%). Data for 4-12x: 1H NMR (400 MHz, CDCl3) δ 8.05–
7.97 (m, 2H), 7.82 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.55 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H), 
7.52–7.47 (m, 2H), 7.31–7.26 (m, 2H), 7.20–7.15 (m, 1H), 4.53 (q,  J = 7.2 Hz, 1H), 2.89 
(s, 3H), 1.82 (d,  J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 171.6, 168.3, 
149.9, 144.5, 133.2, 128.8, 128.2, 127.9, 126.6, 126.3, 124.8, 122.7, 49.1, 21.9, 20.8 
ppm; GC-MS for C17H16N2 m/z = 248 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C17H16N2H 249.1386, Found 249.1353; []D
22 = +5.2 (c = 0.1 g/100 mL in CH2Cl2). 
2-Benzyl-4-methyl-quinazoline (4-12y): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 
mol %), 2-aminophenylethanone (68 mg, 0.5 mmol), and 1-
amino-2-phenylethane (85 mg, 0.7 mmol) was stirred at 140 °C 
for 20 h. The product 4-12y was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 80:1–20:1; TLC: Rf = 0.4 (20% EtOAc in hexanes)). Yield = 62 mg, 
(53%). Data for 4-12y: 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 8.5 Hz, 1H), 7.98 (d, J 
= 8.6 Hz, 1H), 7.86–7.79 (m, 1H), 7.59–7.52 (m, 1H), 7.48–7.42 (m, 2H), 7.32–7.26 (m, 
2H), 7.23–7.17 (m, 1H), 4.41 (s, 2H), 2.90 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 





122.5, 46.3, 21.8 ppm; GC-MS for C16H14N2 m/z = 234 (M
+); HRMS (ESI-TOF) m/z: [M 
+ H]+ Calcd for C16H14N2H 235.1230, Found 235.1203. 
2-Benzyl-4-phenylquinazoline (4-12z): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 
mol %), 2-aminobenzophenone (99 mg, 0.5 mmol), and 1-
amino-2-phenylethane (85 mg, 0.7 mmol) was stirred at 140 °C 
for 20 h. The product 4-12z was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 80:1–10:1; TLC: Rf = 0.6 (20% EtOAc in hexanes). Yield = 99 mg 
(67%). Data for 4-12z: 1H NMR (400 MHz, CDCl3) δ 8.12–7.99 (m, 2H), 7.83 (t, J = 7.7 
Hz, 1H), 7.79–7.69 (m, 2H), 7.56–7.49 (m, 5H), 7.37–7.14 (m, 4H), 4.52 (s, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 168.6, 165.2, 151.5, 138.6, 137.2, 133.4, 130.0, 
129.8, 129.2, 128.7, 128.5, 128.5, 128.3, 126.9, 126.3, 121.2, 46.3 ppm; GC-MS for 
C21H16N2 m/z = 296 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H16N2H 
297.1386, Found 297.1352. 
2-(4-Methoxybenzyl)-4-methylquinazoline (4-12aa): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2-aminophenylethanone 
(68 mg, 0.5 mmol), and 2-(4-methoxyphenyl)ethanamine (106 mg, 0.7 mmol) was stirred 
at 140 °C for 20 h. The product 4-12aa was isolated by column chromatography on silica 
gel (hexanes/EtOAc = 80:1–20:1; TLC: Rf = 0.3 (20% EtOAc in hexanes)). Yield = 63 
mg (48%). Data for 4-12aa: 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 8.3 Hz, 1H), 7.98 
(d, J = 8.5 Hz, 1H), 7.83 (dd,  J = 8.5, 1.6 Hz, 1H), 7.55 (dd, J = 8.3, 1.6 Hz, 1H), 7.37 





13C{1H} NMR (100 MHz, CDCl3) δ 168.6, 165.3, 158.2, 149.9, 133.5, 130.7, 130.1, 
128.6, 126.8, 124.9, 122.5, 113.8, 55.2, 45.3, 21.8 ppm; GC-MS for C17H16N2O m/z = 
264 (M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C17H16N2OH 265.1335, Found 
265.1305. 
2-(4-Methoxybenzyl)-4-phenylquinazoline (4-12ab): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2-aminobenzophenone 
(99 mg, 0.5 mmol), and 2-(4-methoxyphenyl)ethanamine 
(106 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-12ab was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 80:1–20:1; TLC: Rf = 0.3 (20% 
EtOAc in hexanes). Yield = 124 mg, (76%). Data for 4-12ab: 1H NMR (400 MHz, 
CDCl3) δ 8.11 (d, J = 8.5 Hz, 1H), 8.07 (d, J = 8.5 Hz, 1H), 7.87 (td, J = 7.6, 1.1 Hz, 1H), 
7.79–7.71 (m, 2H), 7.59–7.55 (m, 3H), 7.54 (td, J = 7.6, 0.9 Hz, 1H), 7.45 (d, J = 8.6 Hz, 
2H), 6.85 (d, J = 8.6 Hz, 2H), 4.46 (s, 2H), 3.77 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 168.7, 165.5, 158.2, 151.5, 137.3, 133.5, 130.8, 130.2, 130.0, 129.9, 128.5, 
128.4, 126.9, 126.9, 121.2, 113.7, 55.2, 45.4 ppm; GC-MS for C22H18N2O m/z = 326 
(M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C22H18N2OH 327.1492, Found 
327.1467. 
6-Chloro-2-pentyl-4-phenylquinazoline (4-12ac): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2-amino-5-
chlorobenzylphenone (116 mg, 0.5 mmol), and 1-





20 h. The product 4-12ac was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.8 (20% EtOAc in hexanes)). Yield = 78 mg 
(50%). Data for 4-12ac: 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 2.3 Hz, 1H), 8.02 (s, 
1H), 7.80 (dd, J = 9.1, 2.3 Hz, 1H), 7.78–7.68 (m, 2H), 7.64–7.53 (m, 3H), 3.16 (t, J = 
7.9 Hz, 2H), 2.01–1.90 (m, 2H), 1.50–1.33 (m, 4H), 0.91 (t, J = 7.1 Hz, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 167.8, 167.5, 149.7, 136.8, 134.5, 132.3, 130.1, 
129.9, 129.8, 128.8, 125.7, 121.7, 39.9, 31.8, 28.6, 22.5, 14.0 ppm; GC-MS for 
C19H19ClN2 m/z = 310 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C19H19ClN2H 
311.1310, Found 311.1300. 
(R)-6-Chloro-4-phenyl-2-(1-phenylethyl)quinazoline (4-
12ad): A 1,4-dioxane (2.0 mL) solution of complex 2-10 
(9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-amino-5-
chlorobenzylphenone (116 mg, 0.5 mmol), and (R)-(+)-β-
methylphenethylamine (95 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 4-12ad was isolated by column chromatography on silica 
gel (hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.8 (20% EtOAc in hexanes)). Yield = 131 
mg (76%). Data for 4-12ad: 1H NMR (400 MHz, CDCl3) δ 8.14–7.98 (m, 2H), 7.85–7.71 
(m, 3H), 7.66–7.51 (m, 5H), 7.31 (t, J = 7.5 Hz, 2H), 7.21 (t, J = 7.2 Hz, 1H), 4.67 (q, J = 
7.1 Hz, 1H), 1.88 (d, J = 7.1 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 168.7, 
167.7, 149.7, 144.1, 136.9, 134.3, 132.5, 130.3, 130.2, 130.0, 128.7, 128.3, 128.0, 126.5, 
125.6, 121.9, 49.0, 20.7 ppm; GC-MS for C22H17ClN2 m/z = 344 (M
+); HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C22H17ClN2H 345.1153, Found 345.1118; []D
22 = +6.0 (c 





2-(3-fluorobenzyl)-4-methylquinazoline (4-12ae): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2'-aminoacetophenone (68 mg, 0.5 
mmol), and 3-fluorobenzeneethanamine (97 mg, 0.7 mmol) 
was stirred at 140 °C for 20 h. The product 4-12ae was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.5 (10% EtOAc 
in hexanes). Yield = 81 mg, (64%). Data for 4-12ae: 1H NMR (400 MHz, CDCl3) δ 8.06 
(dd,  J = 8.4, 0.7 Hz, 1H), 7.98 (dd, J = 8.4, 0.7 Hz, 1H), 7.85 (dd, J = 8.4, 1.4 Hz, 1H), 
7.58 (dd,  J = 8.3, 1.2 Hz, 1H), 7.26–7.12 (m, 3H), 6.92–6.86 (m, 1H), 4.38 (s, 2H), 2.92 
(s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 168.7, 164.4, 162.8 (d, JCF = 245.1 Hz), 
150.0, 141.0 (d, JCF = 7.6 Hz), 133.6, 129.7 (d, JCF = 8.3 Hz), 128.6, 127.0, 124.9, 124.8 
(d, JCF = 2.8 Hz), 122.5, 116.1 (d, JCF = 21.5 Hz), 113.3 (d, JCF = 21.1 Hz), 45.9 (d, JCF = 
1.7 Hz), 21.8 ppm; GC-MS for C16H13FN2 m/z = 252 (M
+). HRMS (ESI-TOF) m/z: [M + 
H]+ Calcd for C16H13FN2H 253.1136; Found 253.1128. 
2-(Benzo[d][1,3]dioxol-5-ylmethyl)-4-
methylquinazoline (4-12ag): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 
mol %), 2-aminophenylethanone (68 mg, 0.5 mmol), and 2-benzo[1,3]dioxol-5-yl-
ethylamine (116 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-12ag was 
isolated by column chromatography on silica gel (hexanes/EtOAc = 80:1–20:1; TLC: Rf 
= 0.3 (20% EtOAc in hexanes)). Yield = 114 mg (82%). Data for 4-12ag: 1H NMR (400 
MHz, CDCl3) δ 8.02 (d, J = 8.3 Hz, 1H), 7.97 (d, J = 8.5 Hz, 1H), 7.82 (t, J = 7.7 Hz, 





1H), 5.88 (s, 2H), 4.30 (s, 2H), 2.90 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
168.6, 165.0, 149.9, 147.4, 146.0, 133.5, 132.3, 128.6, 126.8, 124.8, 122.4, 122.1, 109.6, 
108.1, 100.7, 45.8, 21.8 ppm; GC-MS for C17H14N2O2 m/z = 278 (M
+). HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C17H14N2O2H 279.1128; Found 279.1099. 
6.4.5.2 Synthesis and Characterization of the Novel Quinazolinone Compounds 
Listed in Table 4.4 
2-(4-Fluorophenyl)quinazolin-4(3H)-one (4-13d): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 
2-16 (8 mg, 10 mol %), anthranilamide (68 mg, 0.5 mmol), 
and 4-fluorobenzylamine (88 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 4-13d was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 20:1–1:1; TLC: Rf = 0.3 (50% EtOAc in 
hexanes)). Yield = 79 mg, (66%). Data for 4-13d: 1H NMR (400 MHz, DMSO-d6) δ 
12.54 (br s, 1H), 8.28–8.19 (m, 2H), 8.15 (d, J = 7.9 Hz, 1H), 7.83 (t, J = 7.7 Hz, 1H), 
7.73 (d, J = 8.1 Hz, 1H), 7.52 (t, J = 7.5 Hz, 1H), 7.44–7.34 (m, 2H) ppm; 13C{1H} NMR 
(100 MHz, DMSO-d6) δ 164.1 (d, JCF = 249.2 Hz), 162.3, 151.5, 148.7, 134.7, 130.4 (d, 
JCF = 8.9 Hz), 129.3 (d, JCF = 1.7 Hz), 127.5, 126.7, 125.9, 120.9, 115.7 (d, JCF = 22.0 
Hz) ppm; GC-MS for C14H9FN2O, m/z = 240 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C14H9FN2OH 241.0772, Found 241.0744. 
2-(3-Phenylpropyl)quinazolin-4(3H)-one (4-13i): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), anthranilamide (68 mg, 





was stirred at 140 °C for 20 h. The product 4-13i was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 20:1–1:1; TLC: Rf = 0.2 (50% EtOAc in 
hexanes)). Yield = 104 mg (79%). Data for 4-13i: 1H NMR (400 MHz, CDCl3) δ 12.32 
(br s, 1H), 8.26 (d, J = 7.9 Hz, 1H), 7.77 (t, J = 7.6 Hz, 1H), 7.70 (d, J = 8.1 Hz, 1H), 
7.47 (t, J = 7.4 Hz, 1H), 7.28–7.13 (m, 5H), 2.96–2.71 (m, 4H), 2.25 (pentet, J = 7.6 Hz, 
2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 164.5, 156.6, 149.4, 141.3, 134.7, 128.4, 
128.3, 127.1, 126.3, 126.1, 125.9, 120.4, 35.3, 35.3, 28.9 ppm; GC-MS for C17H16N2O, 
m/z = 264 (M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C17H16N2OH 265.1335, 
Found 265.1309. 
6-Methoxy-2-pentylquinazolin-4(3H)-one (4-13j): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 
3 mol %), 2-16 (8 mg, 10 mol %), 2-amino-5-
methoxybenzamide (83 mg, 0.5 mmol), and 1-
hexylamine (71 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13j was 
isolated by column chromatography on silica gel (hexanes/EtOAc = 40:1–1:1; TLC: Rf = 
0.6 (50% EtOAc in hexanes)). Yield = 108 mg (88%). Data for 4-13j: 1H NMR (400 
MHz, CDCl3) δ 12.21 (br s, 1H), 7.64 (d, J = 9.0 Hz, 1H), 7.61 (d, J = 2.9 Hz, 1H), 7.35 
(dd, J = 9.0, 2.9 Hz, 1H), 3.92 (s, 3H), 2.79 (t, J = 7.9 Hz, 2H), 1.93–1.84 (m, 2H), 1.46–
1.36 (m, 4H), 0.91 (t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 164.2, 
158.0, 154.9, 143.9, 128.6, 124.9, 121.0, 105.5, 55.7, 35.6, 31.4, 27.3, 22.2, 13.9 ppm; 
GC-MS for C14H18N2O2, m/z = 246 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 





2-Cyclohexyl-6-methoxyquinazolin-4(3H)-one (4-13k): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2-amino-5-
methoxybenzamide (83 mg, 0.5 mmol), and 
cyclohexylmethanamine (79 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 
4-13k was isolated by column chromatography on silica gel (hexanes/EtOAc = 20:1–1:1; 
TLC: Rf = 0.6 (50% EtOAc in hexanes)). Yield = 106 mg (82%). Data for 4-13k: 
1H 
NMR (400 MHz, CDCl3) δ 11.22 (br s, 1H), 7.72–7.59 (m, 2H), 7.36 (dd, J = 9.0, 2.9 Hz, 
1H), 3.92 (s, 3H), 2.67 (tt, J = 12.1, 3.3 Hz, 1H), 2.08–2.01 (m, 2H), 1.95–1.87 (m, 2H), 
1.80–1.64 (m, 3H), 1.50–1.33 (m, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 163.7, 
158.0, 157.7, 144.1, 128.9, 124.8, 121.4, 105.6, 55.7, 44.6, 30.6, 26.0, 25.7 ppm; GC-MS 
for C15H18N2O2, m/z = 258 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C15H18N2O2H 259.1441, Found 259.1413. 
2-Benzyl-6-methoxyquinazolin-4(3H)-one (4-13l): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2-amino-5-
methoxybenzamide (83 mg, 0.5 mmol), and 1-amino-2-
phenylethane (85 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13l was 
isolated by column chromatography on silica gel (hexanes/EtOAc = 20:1–1:1; TLC: Rf = 
0.4 (50% EtOAc in hexanes)). Yield = 101 mg (76%). Data for 4-13l: 1H NMR (400 
MHz, DMSO-d6) δ 12.36 (br s, 1H), 7.56 (d, J = 8.9 Hz, 1H), 7.46 (d, J = 2.3 Hz, 1H), 
7.42–7.34 (m, 3H), 7.34–7.27 (m, 2H), 7.27–7.19 (m, 1H), 3.91 (s, 2H), 3.84 (s, 3H) 





128.6, 128.5, 126.8, 123.9, 121.5, 105.7, 55.6, 40.6 ppm; GC-MS for C16H14N2O2, m/z = 
266 (M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C16H14N2O2H 267.1128, Found 
267.1096. 
7-Chloro-2-pentylquinazolin-4(3H)-one (4-13m): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2-amino-4-
chlorobenzamide (85 mg, 0.5 mmol), and 1-hexylamine 
(71 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13m was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 40:1–1:1; TLC: Rf = 0.8 (50% 
EtOAc in hexanes)). Yield = 107 mg (86%). Data for 4-13m: 1H NMR (400 MHz, 
CDCl3) δ 12.42 (br s, 1H), 8.16 (d, J = 8.6 Hz, 1H), 7.68 (d, J = 1.7 Hz, 1H), 7.38 (dd, J 
= 8.6, 1.7 Hz, 1H), 2.78 (t, J = 7.9 Hz, 2H), 1.93–1.83 (m, 2H), 1.47–1.35 (m, 4H), 0.91 
(t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 164.0, 158.5, 150.4, 141.0, 
127.5, 126.9, 126.8, 118.8, 35.7, 31.3, 27.0, 22.3, 13.9 ppm; GC-MS for C13H15ClN2O, 
m/z = 250 (M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C13H15ClN2OH 251.0946, 
Found 251.0912. 
7-Chloro-2-(4-fluorophenyl)quinazolin-4(3H)-one (4-
13n): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-amino-4-
chlorobenzamide (85 mg, 0.5 mmol), and 4-
fluorobenzylamine (88 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13n 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 40:1–1:1; TLC: 
Rf = 0.8 (50% EtOAc in hexanes)). Yield = 88 mg (64%). Data for 4-13n: 





MHz, DMSO-d6) δ 12.70 (br s, 1H), 8.27–8.21 (m, 2H), 8.14 (d, J = 8.5 Hz, 1H), 7.78 (s, 
1H), 7.55 (d, J = 8.5 Hz, 1H), 7.41 (t, J = 8.6 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, 
DMSO-d6) δ 164.2 (d, JCF = 249.9 Hz), 161.8, 153.0, 149.8, 139.2, 130.6 (d, JCF = 9.1 
Hz), 129.0 (d, JCF = 1.7 Hz), 128.0, 126.8, 126.5, 119.7, 115.7 (d, JCF = 22.0 Hz) ppm; 
GC-MS for C14H8ClFN2O, m/z = 274 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C14H8ClFN2OH 275.0382, Found 275.0351. 
2-(benzo[d][1,3]dioxol-5-yl)-3-ethylquinazolin-4(3H)-one 
(4-13p): A 1,4-dioxane (2.0 mL) solution of complex 2-
10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-amino-N-
ethylbenzamide (82 mg, 0.5 mmol), and 1,3-benzodioxol-5-
ylmethylamine (106 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13p 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 80:1–5:1; 
TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 85 mg, (58%). Data for 4-13p: 
1H 
NMR (400 MHz, CDCl3) δ 8.31 (d, J = 8.0 Hz, 1H), 7.85–7.66 (m, 2H), 7.59–7.43 (m, 
1H), 7.03 (d, J = 8.0 Hz, 1H), 7.00 (s, 1H), 6.93 (d, J = 8.0 Hz, 1H), 6.05 (s, 2H), 4.08 (q, 
J = 7.0 Hz, 2H), 1.23 (t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.9, 
155.7, 148.8, 147.8, 146.8, 134.2, 128.8, 127.1, 126.9, 126.6, 121.9, 120.8, 108.5, 108.3, 
101.6, 41.2, 14.1 ppm; GC-MS for C17H14N2O3, m/z = 294 (M
+). HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C17H14N2O3H 295.1077; Found 295.1050. 
3-Ethyl-2-pentylquinazolin-4(3H)-one (4-13q): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2-amino-N-ethylbenzamide (82 





stirred at 140 °C for 20 h. The product 4-13q was isolated by column chromatography on 
silica gel (hexanes/EtOAc = 80:1–5:1; TLC: Rf = 0.7 (50% EtOAc in hexanes)). Yield = 
79 mg (65%). Data for 4-13q: 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 7.9 Hz, 1H), 
7.69 (t, J = 7.6 Hz, 1H), 7.62 (d, J = 8.1 Hz, 1H), 7.41 (t, J = 7.4 Hz, 1H), 4.17 (q, J = 7.0 
Hz, 2H), 2.81 (t, J = 7.8 Hz, 2H), 1.90–1.80 (m, 2H), 1.50–1.38 (m, 4H), 1.36 (t, J = 7.0 
Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 162.0, 157.0, 134.0, 126.7, 126.6, 
126.2, 120.4, 38.9, 35.0, 31.6, 27.4, 22.4, 14.1, 14.0 ppm; GC-MS for C15H20N2O, m/z = 
244 (M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H20N2OH 245.1648, Found 
245.1622. 
3-Ethyl-2-(p-tolyl)quinazolin-4(3H)-one (4-13r): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 
2-16 (8 mg, 10 mol %), 2-amino-N-ethylbenzamide (82 mg, 
0.5 mmol), and 4-methylbenzylamine (85 mg, 0.7 mmol) was 
stirred at 140 °C for 20 h. The product 4-13r was isolated by column chromatography on 
silica gel (hexanes/EtOAc = 80:1–5:1; TLC: Rf = 0.8 (50% EtOAc in hexanes)). Yield = 
78 mg (59%). Data for 4-13r: 1H NMR (400 MHz, CDCl3) δ 8.31 (d, J = 8.1 Hz, 1H), 
7.76–7.69 (m, 2H), 7.50–7.45 (m, 1H), 7.42 (d, J = 7.6 Hz, 2H), 7.30 (d, J = 7.6 Hz, 2H), 
4.04 (q, J = 7.0 Hz, 2H), 2.42 (s, 3H), 1.20 (t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 161.9, 156.4, 146.8, 139.9, 134.2, 132.3, 129.3, 127.5, 127.1, 126.8, 
126.6, 120.7, 41.1, 21.3, 14.0 ppm; GC-MS for C17H16N2O, m/z = 264 (M
+); HRMS 





3-ethyl-2-(4-fluorophenyl)quinazolin-4(3H)-one (4-13s): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2-amino-N-ethylbenzamide (82 
mg, 0.5 mmol), and 4-fluorobenzylamine (88 mg, 0.7 mmol) 
was stirred at 140 °C for 20 h. The product 4-13s was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 80:1–5:1; TLC: Rf = 0.4 (50% EtOAc in 
hexanes)). Yield = 48 mg, (36%). Data for 4-13s: 1H NMR (400 MHz, CDCl3) δ 8.33 (d, 
J = 8.0 Hz, 1H), 7.91–7.70 (m, 2H), 7.66–7.45 (m, 3H), 7.28–7.19 (m, 2H), 4.05 (q, J = 
7.0 Hz, 2H), 1.22 (t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 163.6 (d, 
JCF = 251.3 Hz), 161.6, 155.6, 146.1, 134.6, 130.7 (d, JCF = 2.6 Hz), 130.0 (d, JCF = 8.8 
Hz), 127.4, 126.8, 123.8, 120.7, 116.1 (d, JCF = 22.0 Hz), 41.3, 14.1 ppm; GC-MS for 
C16H13FN2O, m/z = 268 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C16H13FN2OH 
269.1085; Found 269.1058. 
3-Cyclopropyl-2-(p-tolyl)quinazolin-4(3H)-one (4-13u): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2-amino-N-
cyclopropylbenzamide (88 mg, 0.5 mmol), and 4-
methylbenzylamine (85 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13u 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 80:1–5:1; TLC: 
Rf = 0.8 (50% EtOAc in hexanes)). Yield = 77 mg (56%). Data for 4-13u: 
1H NMR (400 
MHz, CDCl3) δ 8.26 (d, J = 7.8 Hz, 1H), 7.80–7.64 (m, 2H), 7.58 (d, J = 7.6 Hz, 2H), 
7.49–7.39 (m, 1H), 7.27 (d, J = 7.6 Hz, 2H),  3.24–3.00 (m, 1H), 2.41 (s, 3H), 0.98–0.85 





146.9, 140.1, 134.2, 133.1, 129.3, 129.0,128.2, 127.2, 126.7, 126.5, 120.7, 30.3, 21.4, 
11.3 ppm; GC-MS for C18H16N2O, m/z = 276 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C18H16N2OH 277.1335, Found 277.1317. 
3-Isopropyl-2-pentylquinazolin-4(3H)-one (4-13v): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2-amino-N-(propan-2-
yl)benzamide (89 mg, 0.5 mmol), and 1-hexylamine (71 
mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13v was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 80:1–10:1; TLC: Rf = 0.9 (50% EtOAc 
in hexanes)). Yield = 59 mg (46%). Data for 4-13v: 1H NMR (400 MHz, CDCl3) δ 8.21 
(d, J = 8.0 Hz, 1H), 7.69 (t, J = 7.5 Hz, 1H), 7.62 (d, J = 8.0 Hz, 1H), 7.41 (t, J = 7.5 Hz, 
1H), 4.56 (m, 1H), 2.86 (t, J = 7.9 Hz, 2H), 1.85–1.77 (m, 2H), 1.68 (d, J = 6.8 Hz, 6H), 
1.48–1.37 (m, 4H), 0.93 (t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
162.6, 157.3, 146.7, 133.8, 126.3, 126.2, 126.1, 121.7, 36.4, 31.4, 31.2, 27.4, 22.3, 19.6, 
13.8 ppm; GC-MS for C16H22N2O, m/z = 258 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C16H22N2OH 259.1805, Found 259.1774. 
6.4.5.3 Characterization of the Novel Quinazolin and Quinazolinone Compounds 
Listed in Table 4.5 
2-((1H-Indol-3-yl)methyl)-4-methylquinazoline (4-
12ah): A 1,4-dioxane (2.0 mL) solution of complex 2-10 
(9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-
aminophenylethanone (68 mg, 0.5 mmol), and tryptamine 





column chromatography on silica gel (hexanes/EtOAc = 60:1–5:1; TLC: Rf = 0.1 (20% 
EtOAc in hexanes)). Yield = 79 mg (58%). Data for 4-12ah: 1H NMR (400 MHz, 
CDCl3) δ 8.45 (br s, 1H), 8.04–7.97 (m, 2H), 7.84–7.78 (m, 2H), 7.54 (ddd, J = 8.3, 6.9, 
1.2 Hz, 1H), 7.27–7.24 (m, 1H), 7.14–7.09 (m, 2H), 7.06 (ddd, J = 7.8, 7.1, 1.2 Hz, 1H), 
4.56 (s, 2H), 2.90 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 168.6, 165.5, 150.0, 
136.3, 133.5, 128.5, 127.6, 126.7, 124.9, 122.9, 122.5, 121.8, 119.7, 119.2, 112.9, 111.0, 
36.7, 21.8 ppm; GC-MS for C18H15N3 m/z = 273 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C18H15N3H 274.1339, Found 274.1333.  
2-((1S,2S,5S)-6,6-Dimethylbicyclo[3.1.1]heptan-2-yl)-4-
methylquinazoline (4-12ai): A 1,4-dioxane (2.0 mL) solution 
of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-
aminophenylethanone (68 mg, 0.5 mmol), and (−)-cis-
myrtanylamine (107 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-12ai 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 60:1–10:1; TLC: 
Rf = 0.8 (20% EtOAc in hexanes)). Yield = 113 mg (85%), d.r. = 10:1. Data for 4-12ai: 
1H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 8.3 Hz, 1H), 7.95 (d, J = 8.4 Hz, 1H), 7.80 (t, 
J = 7.7 Hz, 1H), 7.52 (t, J = 7.6 Hz, 1H), 3.70–3.59 (m, 1H), 2.90 (s, 3H), 2.62–2.48 (m, 
1H), 2.31–2.23 (m, 1H), 2.16–2.09 (m, 1H), 2.00–1.90 (m, 5H), 1.27 (s, 3H), 1.03 (s, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 170.0, 167.9, 149.9, 133.1, 128.7, 126.3, 
124.7, 122.6, 46.2, 44.8, 40.1, 39.8, 26.6, 24.6, 23.9, 21.8, 20.4, 19.3 ppm; GC-MS for 
C18H22N2, m/z = 266 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C18H22N2H 
267.1856, Found 267.1837; []D







(4-12aj): A 1,4-dioxane (2.0 mL) solution of complex 2-
10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 5-chloro-2-
aminobenzophenone (116 mg, 0.5 mmol), and (−)-cis-
myrtanylamine (107 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-12aj 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 60:1–10:1; TLC: 
Rf = 0.8 (20% EtOAc in hexanes)). Yield = 126 mg (70%), d.r. = 30:1. Data for 4-12aj: 
1H NMR (400 MHz, CDCl3) δ 8.03 (s, 1H), 7.99 (d, J = 9.0 Hz, 1H),  7.79–7.73 (m, 3H), 
7.61–7.56 (m, 3H), 3.82–3.68 (m, 1H), 2.66–2.52 (m, 1H), 2.35–2.29 (m, 1H), 2.17–2.12 
(m, 1H), 2.02–1.94 (m, 5H), 1.28 (s, 3H), 1.04 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 170.6, 167.4, 150.0, 137.1, 134.1, 132.0, 130.4, 130.0, 129.9, 128.7, 125.5, 
121.9, 46.3, 44.9, 40.1, 26.7, 24.5, 23.9, 20.4, 19.4 ppm; GC-MS for C23H23ClN2, m/z = 
362 (M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C23H23ClN2H 363.1623, Found 
363.1599; []D
22 = -34.5 (c = 0.2 g/100 mL in CH2Cl2). 
4-(4-(4-Methylquinazolin-2-yl)phenyl)morpholine (4-
12ak): A 1,4-dioxane (2.0 mL) solution of complex 2-
10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-
aminophenylethanone (68 mg, 0.5 mmol), and 4-
morpholinobenzylamine (135 mg, 0.7 mmol) was 
stirred at 140 °C for 20 h. The product 4-12ak was isolated by column chromatography 
on silica gel (hexanes/EtOAc = 80:1–10:1; TLC: Rf = 0.9 (20% EtOAc in hexanes)). 





Hz, 2H), 8.09–7.94 (m, 2H), 7.82 (t, J = 7.6 Hz, 1H), 7.51 (t, J = 7.6 Hz, 1H), 7.01 (d, J = 
8.4 Hz, 2H), 3.92–3.87 (m, 4H), 3.32–3.27 (m, 4H), 2.98 (s, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 167.9, 160.1, 152.8, 150.5, 133.3, 129.7, 129.4, 128.9, 126.1, 125.0, 
122.6, 114.6, 66.8, 48.4, 22.0 ppm; GC-MS for C19H19N3O, m/z = 305 (M
+); HRMS 
(ESI-TOF) m/z: [M + H]+ Calcd for C19H19N3OH 306.1601, Found 306.1578. 
2-(4-methoxyphenyl)-4-methylthieno[3,2-d]pyrimidine 
(4-12al): A 1,4-dioxane (2.0 mL) solution of complex 2-
10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-acetyl-3-
aminothiophene (71 mg, 0.5 mmol), and 4-
methoylbenzylamine (96 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-
12al was isolated by column chromatography on silica gel (hexanes/EtOAc = 100:1–
10:1; TLC: Rf = 0.4 (10% EtOAc in hexanes)). Yield = 50 mg (39%). Data for 4-12al: 
1H 
NMR (400 MHz, CDCl3) δ 8.49 (d, J = 8.7 Hz, 2H), 7.90 (d, J = 5.4 Hz, 1H), 7.55 (d, J = 
5.4 Hz, 1H), 7.01 (d, J = 8.7 Hz, 2H), 3.88 (s, 3H), 2.83 (s, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 161.4, 161.4, 161.2, 161.2, 134.5, 130.9, 129.8, 127.8, 125.0, 113.8, 
55.3, 23.5 ppm; GC-MS for C14H12N2OS, m/z = 256 (M
+). HRMS (ESI-TOF) m/z: [M + 
H]+ Calcd for C14H12N2OSH 257.0743; Found 257.0710. 
4-Methyl-2-(3,4,5-trimethoxyphenyl)thieno[3,2-
d]pyrimidine (4-12am): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-
acetyl-3-aminothiophene (71 mg, 0.5 mmol), and 3,4,5-
trimethoxybenzylamine (138 mg, 0.7 mmol) was stirred at 





gel (hexanes/EtOAc = 80:1–10:1; TLC: Rf = 0.4 (20% EtOAc in hexanes)). Yield = 82 
mg (52%). Data for 4-12am: 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 5.4 Hz, 1H), 
7.84 (s, 2H), 7.57 (d, J = 5.4 Hz, 1H), 4.02 (s, 6H), 3.92 (s, 3H), 2.85 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 161.4, 161.2, 160.8, 153.3, 140.0, 134.7, 133.6, 
128.3, 125.0, 105.4, 60.9, 56.2, 23.5 ppm; GC-MS for C16H16N2O3S, m/z = 316 (M
+); 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C16H16N2O3SH 317.0954, Found 317.0936. 
2-(2,6-dimethylhept-5-en-1-yl)-4-methylquinazoline 
(4-12an): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 
2'-aminoacetophenone (68 mg, 0.5 mmol), and 
geranylamine (107 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-
12an was isolated by column chromatography on silica gel (hexanes/EtOAc = 80:1–10:1; 
TLC: Rf = 0.4 (10% EtOAc in hexanes)). Yield = 83 mg 62%). Data for 4-12an: 
1H NMR 
(400 MHz, CDCl3) δ 8.06 (d, J = 8.3 Hz, 1H), 7.96 (d, J = 8.4 Hz, 1H), 7.83 (dd, J = 7.6, 
7.6 Hz, 1H), 7.56 (dd, J = 7.6, 7.6 Hz, 1H), 5.09  (t, J = 6.9 Hz, 1H), 3.07 (dd, J = 13.3, 
6.4 Hz, 1H), 2.93 (s, 3H), 2.90–2.82 (m, 1H), 2.34–2.23 (m, 1H), 2.12–1.94 (m, 2H), 1.66 
(s, 3H), 1.58 (s, 3H), 1.51–1.39 (m, 1H), 1.35–1.24 (m, 1H), 0.94 (d, J = 6.7 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 167.9, 166.2, 149.8, 133.4, 131.1, 128.5, 
126.5, 124.9, 124.8, 122.4, 47.3, 37.1, 33.0, 25.7, 25.5, 21.7, 19.3, 17.6 ppm; GC-MS for 
C18H24N2, m/z = 268 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C18H24N2H 





2-(2-Furanyl)-4-methylquinazoline (4-12ao): A 1,4-dioxane 
(2.0 mL) solution of complex 2-16 (9 mg, 3 mol %), 2-16 (8 mg, 
10 mol %), 2'-aminoacetophenone (68 mg, 0.5 mmol), and 
furfurylamine (68 mg, 0.7 mmol) was stirred at 140 °C for 20 h. 
The product 4-12ao was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.6 (10% EtOAc in hexanes)). Yield = 83 mg 
(79%). Data for 4-12ao: 1H NMR (400 MHz, CDCl3) δ 8.09–8.04 (m, 2H), 7.85 (ddd, J = 
8.5, 6.9, 1.2 Hz, 1H), 7.69–7.66 (m, 1H), 7.56 (ddd, J = 8.5, 6.9, 1.2 Hz, 1H), 7.45 (dd, J 
= 3.4, 0.8 Hz, 1H), 6.60 (dd, J = 3.4, 1.8 Hz, 1H), 2.98 (s, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 168.7, 153.3, 150.0, 145.1, 142.0, 133.9, 129.0, 126.9, 125.1, 122.8, 
113.8, 112.2, 21.9 ppm; GC-MS for C13H10N2O m/z = 210 (M
+). 1H and 13C NMR 
spectral data are in good agreement with the literature values.217 
4-Methyl-2-(thiophen-2-ylmethyl)quinazoline (4-12ap): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2-aminophenylethanone (68 mg, 
0.5 mmol), and 2-thiopheneethanamine (89 mg, 0.7 mmol) was 
stirred at 140 °C for 20 h. The product 4-12ap was isolated by column chromatography 
on silica gel (hexanes/EtOAc = 80:1–20:1; TLC: Rf = 0.2 (20% EtOAc in hexanes)). 
Yield = 86 mg (72%). Data for 4-12ap: 1H NMR (400 MHz, CDCl3) δ 8.06 (ddd, J = 8.3, 
1.3, 0.6 Hz, 1H), 7.98 (ddd, J = 8.3, 1.2, 0.6 Hz, 1H), 7.85 (dd, J = 8.3, 1.3 Hz, 1H), 7.58 
(dd, J = 8.3, 0.9 Hz, 1H), 7.18–7.15 (m, 1H), 7.04–7.01 (m, 1H), 6.93 (dd, J = 5.1, 3.4 
Hz, 1H), 4.59 (s, 2H), 2.94 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 168.8, 





ppm; GC-MS for C14H12N2S m/z = 240 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C14H12N2SH 241.0794, Found 241.0765. 
(±)-2-(2,6-Dimethylhept-5-en-1-yl)quinazolin-4(3H)-
one (4-13w): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 
anthranilamide (68 mg, 0.5 mmol), and geranylamine 
(107 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13w was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 40:1–1:1; TLC: Rf = 0.3 (20% 
EtOAc in hexanes)). Yield = 97 mg (72%). Data for 4-13w: 1H NMR (400 MHz, CDCl3) 
δ 12.29 (br s, 1H), 8.28 (d, J = 7.9 Hz, 1H), 7.77 (t,  J = 7.6 Hz, 1H), 7.71 (d, J = 8.0 Hz, 
1H), 7.46 (t, J = 7.6 Hz, 1H), 5.11 (t, J = 6.5 Hz, 1H), 2.85 (dd, J = 13.7, 6.0 Hz, 1H), 
2.59 (dd, J = 13.7, 8.6 Hz, 1H), 2.27–2.19 (m, 1H), 2.17–1.97 (m, 2H), 1.64 (s, 3H), 1.59 
(s, 3H), 1.52–1.42 (m, 1H), 1.41–1.31 (m, 1H), 1.02 (d, J = 6.8 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 164.5, 156.4, 149.5, 134.7, 131.5, 127.2, 126.2, 126.2, 124.3, 
120.4, 43.3, 36.9, 32.3, 25.6, 25.4, 19.2, 17.6 ppm; GC-MS for C17H22N2O, m/z = 270 
(M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C17H22N2OH 271.1805, Found 
271.1770. 
2-Pentylthieno[3,2-d]pyrimidin-4(3H)-one (4-13x): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 3-aminothiophene-2-
carboxamide (71 mg, 0.5 mmol), and 1-hexylamine (71 mg, 
0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13x was isolated by column 





hexanes)). Yield = 50 mg (60%). Data for 4-13x: 1H NMR (400 MHz, CDCl3) δ 12.68 
(brs, 1H), 7.81 (d, J = 5.2 Hz, 1H), 7.33 (d,  J = 5.2 Hz, 1H), 2.82 (t,  J = 7.8 Hz, 2H), 
1.93–1.80 (m, 2H), 1.48–1.32 (m, 4H), 0.91 (t, J = 7.0 Hz, 3H); 13C{1H} NMR (100 
MHz, CDCl3) δ 160.9, 159.2, 159.0, 134.7, 125.1, 120.6, 35.3, 31.3, 27.5, 22.3, 13.9 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C11H14N2OSH 223.0900; Found 223.0899. 
2-([1,1'-Biphenyl]-4-yl)thieno[3,2-d]pyrimidin-4(3H)-
one (4-13y): A 1,4-dioxane (2.0 mL) solution of complex 
2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 3-
aminothiophene-2-carboxamide (71 mg, 0.5 mmol), and 
4-phenylbenzylamine (128 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 4-13y was isolated by crystallization. Yield = 89 mg (59%). 
Data for 4-13y: 1H NMR (400 MHz, DMSO-d6) δ 12.72 (br s, 1H), 8.29–8.19 (m, 3H), 
7.84 (d, J = 8.2 Hz, 2H), 7.76 (d, J = 7.6 Hz, 2H), 7.54–7.46 (m, 3H), 7.44–7.39 (m, 1H) 
ppm; 13C{1H} NMR (100 MHz, DMSO-d6) δ 158.6, 158.6, 154.0, 142.8, 139.0, 135.5, 
131.4, 129.1, 128.5, 128.2, 126.9, 126.8, 125.5, 121.3 ppm; GC-MS for C18H12N2OS, m/z 
= 304 (M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C18H12N2OSH 305.0743, Found 
305.0718. 
2-Pentylbenzofuro[3,2-d]pyrimidin-4(3H)-one (4-13z): 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 
3 mol %), 2-16 (8 mg, 10 mol %), 3-aminobenzofuran-2-
carboxamide (88 mg, 0.5 mmol), and 1-hexylamine (71 
mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 4-13z was isolated by column 





hexanes)). Yield = 61 mg (48%). Data for 4-13z: 1H NMR (400 MHz, DMSO) δ 12.69 
(brs, 1H), 8.00 (d, J = 7.7 Hz, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.69–7.57 (m, 1H), 7.45 (t, J 
= 7.4 Hz, 1H), 2.67 (t, J = 7.6 Hz, 2H), 1.82–1.64 (m, 2H), 1.37–1.24 (m, 4H), 0.95–0.77 
(m, 3H) ppm; 13C{1H} NMR (100 MHz, DMSO) δ 159.8, 156.2, 153.4, 143.8, 137.6, 
129.9, 124.3, 122.4, 121.5, 113.0, 34.3, 30.8, 27.2, 21.9, 13.9 ppm; GC-MS for 
C15H16N2O2, m/z = 256 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H16N2O2H 
257.1285; Found 257.1262. 
2-((1S,2S,5S)-6,6-Dimethylbicyclo[3.1.1]heptan-2-
yl)quinazolin-4(3H)-one (4-13aa): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 
mol %), anthranilamide (68 mg, 0.5 mmol), and (−)-cis-
myrtanylamine (107 mg, 0.7 mmol) was stirred at 140 °C for 
20 h. The product 4-13aa was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 80:1–5:1; TLC: Rf = 0.4 (20% EtOAc in hexanes)). Yield = 91 mg 
(68%), d.r. = 99:1. Data for 4-13aa: 1H NMR (400 MHz, CDCl3) δ 11.69 (br s, 1H), 8.25 
(d, J = 7.9 Hz, 1H),  7.82–7.65 (m, 2H), 7.45 (t, J = 7.1 Hz, 1H), 3.46–3.32 (m, 1H), 
2.63–2.47 (m, 1H), 2.31–2.21 (m, 1H), 2.21–2.12 (m, 1H), 2.02–1.84 (m, 4H), 1.75 (d, J 
= 10.3 Hz, 1H), 1.28 (s, 3H), 1.09 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
164.4, 159.6, 149.5, 134.5, 127.6, 126.1, 126.0, 120.8, 45.4, 41.2, 40.0, 39.8, 26.6, 23.9, 
23.7, 20.3, 17.3 ppm; GC-MS for C17H20N2O, m/z = 268 (M
+); HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C17H20N2OH 269.1648; Found 269.1614)); []D
22 = -28.0 (c = 0.79 







yl)quinazolin-4(3H)-one (4-13ab): A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), anthranilamide (34 
mg, 0.25 mmol), and (+)-((1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-
octahydrophenanthren-1-yl)methanamine (100 mg, 0.35 mmol) was stirred at 140 °C for 
20 h. The product 4-13ab was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.7 (20% EtOAc in hexanes)). Yield = 57 mg 
(57%), d.r. > 99:1. Data for 4-13ab: 1H NMR (400 MHz, CDCl3) δ 11.60 (br s, 1H), 7.80 
(d, J = 7.9 Hz, 1H), 7.75–7.63 (m, 2H), 7.31 (d, J = 7.9 Hz, 2H), 7.09 (d, J = 8.1 Hz, 1H), 
6.82 (s, 1H), 2.91–2.77 (m, 3H), 2.73 (d, J = 12.3 Hz, 1H), 2.46 (d, J = 10.6 Hz, 1H), 
2.08 (t, J = 11.9 Hz, 1H), 1.97 (d, J = 13.6 Hz, 1H), 1.92–1.77 (m, 4H), 1.62 (s, 3H), 
1.47–1.40 (m, 1H), 1.38 (s, 3H), 1.22 (t, J = 7.0 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 163.9, 162.4, 148.8, 147.0, 145.5, 134.7, 134.2, 127.5, 126.8, 126.3, 126.0, 
124.0, 123.8, 120.4, 45.6, 45.1, 38.1, 37.6, 37.4, 33.3, 29.9, 25.4, 24.0, 23.9, 20.8, 19.1, 
17.1 ppm; GC-MS for C27H32N2O, m/z = 400 (M
+); HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C27H32N2OH 401.2587, Found 401.2561; []D






6.5 Experimental Procedures and Characterization Data for Chapter 5 
6.5.1.1 General Procedure for the Catalytic Synthesis of Quinolines 
In a glove box, complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), were 
dissolved in 1,4-dioxane (1 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5-10 min 
until the solution was turned blueish green color. 2'-Aminoacetophenone (68 mg, 0.5 
mmol) and a -amino acid (0.7 mmol) were dissolved in dioxane (1 mL), and the solution 
was added to the reaction tube. The tube was brought out of the glove box, and was 
stirred in an oil bath maintained at 140 °C for 20 h. The reaction tube was taken out of 
the oil bath, and was cooled to room temperature. The resulting solution was filtered 
through a short silica gel column by eluting with CH2Cl2 (10 mL), and the filtrate was 
analyzed by GC-MS. Analytically pure product 5-9 was isolated by a simple column 
chromatography on silica gel (280-400 mesh, hexanes/EtOAc). 
6.5.1.2 General Procedure for the Catalytic Synthesis of 2,3-Dihydroquinazolin-
4(1H)-one Products 
In a glove box, complex 2-10 (9 mg, 3 mol %), 2-16 (12 mg, 10 mol %), were 
dissolved in 1,4-dioxane (1 mL) in a 25 mL Schlenk tube equipped with a Teflon screw 
cap stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5-10 min 
until the solution was turned reddish green color. 2-Aminobenzamide (68 mg, 0.5 mmol) 
and a -amino acid (0.7 mmol) were dissolved in 1,4-dioxane (1 mL), and the solution 
was added to the reaction tube. The tube was brought out of the glove box, and was 
stirred in an oil bath maintained at 140 °C for 20 h. The reaction tube was taken out of 





through a short silica gel column by eluting with CH2Cl2 (10 mL), and the filtrate was 
analyzed by GC-MS. Analytically pure product 5-10 was isolated by a simple column 
chromatography on silica gel (280-400 mesh, hexanes/EtOAc) or crystallization 
technique. 
Alternatively, In a glove box, complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 
mol %), were dissolved in 1,4-dioxane (1 mL) in a 25 mL Schlenk tube equipped with a 
Teflon screw cap stopcock and a magnetic stirring bar. The resulting mixture was stirred 
for 5-10 min until the solution was turned reddish green color. 2-Aminobenzamide (68 
mg, 0.5 mmol) and a branched amine (0.7 mmol) were dissolved in 1,4-dioxane (1 mL), 
and the solution was added to the reaction tube. The tube was brought out of the glove 
box, and was stirred in an oil bath maintained at 140 °C for 20 h. The reaction tube was 
taken out of the oil bath, and was cooled to room temperature. The resulting solution was 
filtered through a short silica gel column by eluting with CH2Cl2 (10 mL), and the filtrate 
was analyzed by GC-MS. Analytically pure product 5-10 was isolated by a simple 
column chromatography on silica gel (280-400 mesh, hexanes/EtOAc) or crystallization 
technique. 
6.5.2 Catalyst and Ligand Screening Study 
In a glove box, a catalyst (3 mol % Ru) and a ligand (10 mol %) were dissolved in 
a solvent (1 mL) in a 25 mL Schlenk tube equipped with a Teflon screw cap stopcock and 
a magnetic stirring bar. The resulting mixture was stirred for 5-10 min until the solution 
was turned reddish green color. 2-Aminobenzamide (68 mg, 0.5 mmol) and 
cyclohexylamine (69 mg, 0.7 mmol) were dissolved in solvent (1 mL), and the solution 





stirred in an oil bath at 140 °C for 20 h. The product yield was determined by 1H NMR 
by using hexamethylbenzene as an internal standard. The results are summarized in 
Tables 5.1 and 5.2. 
6.5.3.1 Deuterium Labeling Study 
In a glove box, 2'-aminoacetophenone Me-D3 (90 % D, 68 mg, 0.5 mmol), 
(1S,2R)-2-aminocyclohexanecarboxylic acid (100 mg, 0.7 mmol), 2-10 (3 mol %), 2-16 
(10 mol %), were dissolved in 1,4-dioxane (2 mL) in a 25 mL Schlenk tube equipped 
with a Teflon screw cap stopcock and a stirring bar. The tube was brought out of the box 
and immersed in an oil bath preset at 140 °C for 20 h. The reaction tube was taken out of 
the oil bath and was cooled to room temperature. After the tube was open to air, the 
solution was filtered through a short silica gel column by eluting with CH2Cl2 (10 mL), 
and the filtrate was analyzed by GC-MS. Analytically pure product was isolated by 
column chromatography on silica gel (230-460 mesh, hexanes/EtOAc = 50:1 to 10:1), 
and it was completely characterized by 1H, 2H NMR and GC-MS spectroscopic methods. 
The 1H and 2H NMR spectra of the product 5-9-d are shown in Figure 5.3.  
In a glove box, 2-aminobenzamide (68 mg, 0.5 mmol), cyclohexylamine (70 mg, 
0.7 mmol), complex 1 (3 mol %) (20mg, 1 mmol) were dissolved in 1,4-dioxane (2 mL) 
in a 25 mL Schlenk tube equipped with a Teflon screw cap stopcock and a stirring bar. 
The tube was brought out of the box and immersed in an oil bath preset at 140 °C for 20 
h. The reaction tube was taken out of the oil bath and was cooled to room temperature. 
After the tube was open to air, the solution was filtered through a short silica gel column 
by eluting with CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS. Analytically 





hexanes/EtOAc = 30:1 to 5:1), and it was completely characterized by 1H, 2H NMR and 
GC-MS spectroscopic methods. The 1H and 2H NMR spectra of the product 5-10-d1 are 
shown in Figure 5.4. 
6.5.3.2 Reaction with Dihydrocoumarin with -Amino Acids 
In a glove box, dihydrocoumarin (74 mg, 0.5 mmol), DL-β-Homoleucine (102 
mg, 0.7 mmol), 2-10 (3 mol %), 2-16 (10 mol %), were dissolved in 1,4-dioxane (2 mL) 
in a 25 mL Schlenk tube equipped with a Teflon screw cap stopcock and a stirring bar. 
The tube was brought out of the box and immersed in an oil bath preset at 140 °C for 20 
h. The reaction tube was taken out of the oil bath and was cooled to room temperature. 
After the tube was open to air, the solution was filtered through a short silica gel column 
by eluting with CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS. Analytically 
pure product 5-12 was isolated by column chromatography on silica gel (230-460 mesh, 
hexanes/EtOAc = 50:1 to 10:1), and it was completely characterized by 1H, 2H NMR and 
GC-MS spectroscopic methods. 5-12 are shown in Figure 5.6. 
6.5.3.3 Reaction with Enamine Substrate 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 
10 mol %), 5-chloro-2-aminobenzophenone (116 mg, 0.5 mmol) and 1-pyrrolidino-1-
cyclohexene (91 mg, 0.6 mmol) was stirred at 140 °C for 20 h. The product 5-9m was 
isolated by column chromatography on silica gel in 90% yield. 
6.5.3.4 Preparatory Scale Reaction for the Synthesis of 5-9n and 5-10m 
Synthesis of 5-9n: In a glove box, complex 1 (85 mg, 3 mol %) and 2-16 (80 mg, 





with a Teflon screw cap stopcock and a magnetic stirring bar. The resulting mixture was 
stirred for 5 to 10 minutes until the solution turned to a blueish green color. 2-Amino-5-
chlorobenzophenone (1.16 g, 5.0 mmol) and (1S,2R)-2-aminocyclohexanecarboxylic acid 
(1.0 g, 7 mmol) 1,4-dioxane (5 mL) were added to the reaction tube. After the tube was 
sealed, those were brought out of the box, and was stirred in an oil bath at 140 °C for 20 
h. The tube was cooled to room temperature and filtered through a small silica column 
(CH2Cl2), and the product conversion was determined by GC (90%). Analytically pure 
product 5-9n was obtained by crystallization in dichloromethane and n-hexanes (1.17 g, 
80%). 
Synthesis of 5-10:  In a glove box, complex 2-10 (128 mg, 3 mol %) and 2-12 (180 mg, 
10 mol %) were dissolved in 1,4-dioxane (5 mL) in a 125 mL Schlenk tube equipped 
with a Teflon screw cap stopcock and a magnetic stirring bar. The resulting mixture was 
stirred for 5 to 10 minutes until the solution turned to a blueish green color. 2-
aminobenzamide (1.04 g, 7.5 mmol) and cyclohexylamine (1.04 g, 10.5 mmol) 1,4-
dioxane (5 mL) were added to the reaction tube. After the tube was sealed, those were 
brought out of the box, and was stirred in an oil bath at 140 °C for 20 h. The tube was 
cooled to room temperature and filtered through a small silica column (CH2Cl2), and the 
product conversion was determined by GC (92%). Analytically pure product 5-10m was 
obtained by crystallization in a mixture of 1:2 dichloromethane and ethyl acetate layered 
with n-hexanes (1.36 g, 84%). 
6.5.4.1 X-ray Crystallography Data for 5-9s 
Colorless needle shape single crystals of 5-10s were grown in dichloromethane/n-





× 0.266 × 0.105 mm3 was selected and analyzed. The Ph substituent is rotated by ~60° 
relative to the quinoline nucleus. The benzodioxolane group is more co-planar with 
quinoline moiety being rotated only by ~10°. The dioxolane ring is slightly non-planar – 
it has an envelope conformation with atom C22 bent out of plane of other atoms of the 
ring by 17.4°. 
 
Figure 6.29: Molecular Structure of 5-9s. 
 





Table 6.15: Crystal Data and Structure Refinement for 5-9s 
Identification code  yi3q  
Empirical formula  C22H15NO2  
Formula weight  325.35  
Temperature/K  100.15  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  6.28303(7)  
b/Å  12.33805(16)  
c/Å  20.3928(2)  
α/°  90  
β/°  91.5260(11)  
γ/°  90  
Volume/Å3  1580.30(3)  
Z  4  
ρcalcg/cm
3  1.367  
μ/mm-1  0.701  
F(000)  680.0  
Crystal size/mm3  0.628 × 0.266 × 0.105  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  8.376 to 141.314  
Index ranges  -5 ≤ h ≤ 7, -15 ≤ k ≤ 15, -24 ≤ l ≤ 24  
Reflections collected  14591  
Independent reflections  3000 [Rint = 0.0236, Rsigma = 0.0171]  
Data/restraints/parameters  3000/0/226  
Goodness-of-fit on F2  1.049  
Final R indexes [I>=2σ (I)]  R1 = 0.0362, wR2 = 0.0902  
Final R indexes [all data]  R1 = 0.0415, wR2 = 0.0946  
Largest diff. peak/hole / e Å-3  0.20/-0.22  
 
 
6.5.4.2 X-ray Crystallography Data for 5-9aj 
Colorless needle like single crystals of 5-9aj were grown in n-hexane/Ethylacetate 
at room temperature. A suitable crystal with the dimension of 0.35 × 0.03 × 0.02 mm3 
was selected and analyzed. The molecule has an overall planar shape with the p-





moiety has C3, C4-half-chair conformation somewhat distorted to C4-sofa. The 
molecules form stacks along screw axes in y direction. 
 
Figure 6.31: Molecular Structure of 5-9aj 
 





Table 6.16: Crystal Data and Structure Refinement for 5-9aj 
Identification code yi3v 
Empirical formula C21H15ClN2O3 
Formula weight 378.80 
Temperature/K 100.15 
Crystal system monoclinic 













Crystal size/mm3 0.35 × 0.03 × 0.02 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 10.514 to 141.458 
Index ranges -18 ≤ h ≤ 17, -8 ≤ k ≤ 8, -19 ≤ l ≤ 20 
Reflections collected 15963 
Independent reflections 3232 [Rint = 0.0442, Rsigma = 0.0290] 
Data/restraints/parameters 3232/0/245 
Goodness-of-fit on F2 1.037 
Final R indexes [I>=2σ (I)] R1 = 0.0338, wR2 = 0.0861 
Final R indexes [all data] R1 = 0.0414, wR2 = 0.0931 
Largest diff. peak/hole / e Å-3 0.28/-0.26 
 
6.5.4.3 X-ray Crystallography Data for 5-10a 
Colorless prism shaped single crystals of 5-10a (regular twins, 57° rotation 
around x axis) were grown in n-hexane/Ethylacetate at room temperature. A suitable 
crystal with the dimension of 0.16 × 0.11 × 0.05 mm3 was selected and analyzed. The 
heterocycle of 2,3-dihydro-2-methyl-2-phenyl-4(1H)-quinazolinone moiety has a C2-sofa 





group has a pyramidal configuration, despite the adjacent pi-conjugated benzene ring (its 
H atom deviates by 16° from NCC plane). The crystal is centrosymmetric, and the 
compound represents a racemic mixture of both enantiomers. The molecules form 
centrosymmetric dimers through H-bonds formed by their amido groups. Imido hydrogen 
does not have an acceptor for H-bond formation but It forms a close N-H…C contact 
with one of C atoms of Ph group of a neighboring molecule.  
 






Figure 6.34: Crystal Packing of 5-10a 
 
Table 6.17: Crystal Data and Structure Refinement for 5-10a 
Identification code  yi4l5  
Empirical formula  C15H14N2O  
Formula weight  238.28  
Temperature/K  100.00(10)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  8.46693(16)  
b/Å  8.7469(2)  
c/Å  16.0808(3)  
α/°  90  
β/°  93.5464(19)  
γ/°  90  





Z  4  
ρcalcg/cm
3  1.332  
μ/mm-1  0.676  
F(000)  504.0  
Crystal size/mm3  0.16 × 0.11 × 0.05  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  11.026 to 141.018  
Index ranges  
-10 ≤ h ≤ 10, -10 ≤ k ≤ 10, -19 ≤ 
l ≤ 19  
Reflections collected  5192  
Independent reflections  5192 [Rint = ?, Rsigma = 0.0110]  
Data/restraints/parameters  5192/0/173  
Goodness-of-fit on F2  1.067  
Final R indexes [I>=2σ (I)]  R1 = 0.0331, wR2 = 0.0888  
Final R indexes [all data]  R1 = 0.0366, wR2 = 0.0913  
Largest diff. peak/hole / e Å-3  0.26/-0.23  
 
6.5.4.4 X-ray Crystallography Data for 5-11n 
Colorless needle like single crystals of 5-11n (Regular twins, rotation 180° over 
reciprocal x*) were grown in n-pentane/Ethylacetate at room temperature. A suitable 
crystal with the dimension of 0.2 × 0.1 × 0.07 mm3 was selected and analyzed. The 
structure contains two symmetrically independent molecules. The planar heterocyclic part 
makes dihedral angles of 20.8 and 15.7° with keto group. The phenyl group is rotated 
relative the keto group by 26.6 and 35.5°. The molecules form infinite stacks along y 
axis. 
 






Figure 6.36: Crystal Packing of 5-11n 
 
Table 6.18: Crystal Data and Structure Refinement for 5-11n 
Identification code yi5p5 
Empirical formula C22H14N2O 
Formula weight 322.35 
Temperature/K 99.90(14) 
Crystal system monoclinic 

















Crystal size/mm3 0.2 × 0.1 × 0.07 
Radiation Cu Kα (λ = 1.54184) 
2Θ range for data collection/° 10.49 to 141.264 
Index ranges -20 ≤ h ≤ 20, -9 ≤ k ≤ 9, -14 ≤ l ≤ 12 
Reflections collected 5515 
Independent reflections 5515 [Rint = ?, Rsigma = 0.0192] 
Data/restraints/parameters 5515/2/452 
Goodness-of-fit on F2 1.053 
Final R indexes [I>=2σ (I)] R1 = 0.0338, wR2 = 0.0882 
Final R indexes [all data] R1 = 0.0366, wR2 = 0.0901 
Largest diff. peak/hole / e Å-3 0.17/-0.19 
Flack parameter 0.39(17) 
 
6.5.4.5 X-ray Crystallography Data for 5-12 
Colorless prism shaped of 5-12 were grown in n-pentane/Acetone at room 
temperature. A suitable single crystal with the dimension of 0.704 × 0.399 × 0.171 mm3 
was selected and analyzed. The molecule has an extended conformation. The trans-amide 
group is planar. The molecule contains a chiral center but the compound represents a 
racemate. In the centrosymmetric crystals, the molecules form layers along bc plane 
being connected through hydrogen bonds N-H…O and O-H…O. 
 






Figure 6.38: Crystal Packing of 5-12 
 
Table 6.19: Crystal Data and Structure Refinement for 5-12 
Identification code yi5o 
Empirical formula C15H23NO2 
Formula weight 249.34 
Temperature/K 100.2(5) 
Crystal system monoclinic 

















Crystal size/mm3 0.704 × 0.399 × 0.171 
Radiation Cu Kα (λ = 1.54184) 
2Θ range for data collection/° 10.482 to 141.238 
Index ranges -18 ≤ h ≤ 18, -12 ≤ k ≤ 12, -11 ≤ l ≤ 11 
Reflections collected 25622 
Independent reflections 2736 [Rint = 0.0355, Rsigma = 0.0148] 
Data/restraints/parameters 2736/0/171 
Goodness-of-fit on F2 1.035 
Final R indexes [I>=2σ (I)] R1 = 0.0337, wR2 = 0.0834 
Final R indexes [all data] R1 = 0.0389, wR2 = 0.0876 
Largest diff. peak/hole / e Å-3 0.20/-0.19 
 
6.5.3 Characterization of the Organic Products 
6.5.5.1 Characterization of the Quinoline Compounds Listed in Table 5.5 
2-Methylquinoline (5-9a): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %) 2-
aminobenzaldehyde (61 mg, 0.5 mmol),  and (±)-3-aminobutyric acid 
(72 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9a was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 110:1–5:1; TLC: Rf = 0.4 (20% 
EtOAc in hexanes)). Yield = 64 mg (90%). Data for 5-9a: 1H NMR (400 MHz, CDCl3) δ 
7.91 (d, J = 8.5 Hz, 1H), 7.76 (d, J = 8.5 Hz, 1H), 7.60–7.41 (m, 2H), 7.27 (t, J = 7.3 Hz, 
1H), 7.00 (d, J = 8.5 Hz, 1H), 2.56 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
158.4, 147.4, 135.6, 128.9, 128.1, 127.1, 126.0, 125.2, 121.5, 24.9 ppm; GC-MS for 
C10H9N, m/z = 143 (M






2,4-Dimethylquinoline (5-9b): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %) 2'-
aminoacetophenone (68 mg, 0.5 mmol),  and (±)-3-aminobutyric acid 
(72 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9b 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 110:1–5:1; TLC: 
Rf = 0.5 (20% EtOAc in hexanes)). Yield = 69 mg (88%). Data for 5-9b: 
1H NMR (400 
MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.92 (d, J = 8.3 Hz, 1H), 7.65 (dd, J = 8.4, 1.4 
Hz, 1H), 7.48 (d, J = 8.3, 1.4 Hz, 1H), 7.10 (s, 1H), 2.68 (s, 3H), 2.63 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 158.5, 147.5, 144.2, 129.0, 129.0, 126.5, 125.3, 
123.5, 122.6, 25.1, 18.5 ppm; GC-MS for C11H11N, m/z = 157 (M
+). 1H and 13C NMR 
spectral data are in good agreement with the literature values.219 
2-Methyl-4-phenylquinoline (5-9c): A 1,4-dioxane (2.0 mL) solution 
of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-
aminobenzophenone (99 mg, 0.5 mmol), and (±)-3-aminobutyric acid 
(72 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9c 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: 
Rf = 0.3 (20% EtOAc in hexanes)). Yield = 71 mg, (65%). Data for 5-9c 
1H NMR (400 
MHz, CDCl3) δ 8.09 (d, J = 8.4 Hz, 1H), 7.86 (d, J = 8.4 Hz, 1H), 7.69 (t, J = 7.6 Hz, 
1H), 7.55–7.45 (m, 5H), 7.43 (t, J = 7.6 Hz, 1H), 7.23 (s, 1H), 2.78 (s, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 158.4, 148.4, 148.3, 138.1, 129.4, 129.2, 129.0, 128.5, 128.3, 
125.7, 125.6, 125.0, 122.2, 25.3 ppm; GC-MS for C16H13N, m/z = 219 (M
+). 1H and 13C 





4-Methyl-2-phenylquinoline (5-9d): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol 
%), 2'-aminoacetophenone (68 mg, 0.5 mmol), and (±)-β-
phenyl-β-alanine (116 mg, 0.7 mmol) was stirred at 140 °C for 
20 h. The product 5-9d was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.4 (20% EtOAc in hexanes)). Yield = 61 mg 
(56%). Data for 5-9d: 1H NMR (400 MHz, CDCl3) δ 8.20 (d, J = 8.4 Hz, 1H), 8.18–8.13 
(m, 2H), 8.00 (d, J = 8.4 Hz, 1H), 7.77–7.69 (m, 2H), 7.59–7.49 (m, 3H), 7.49–7.43 (m, 
1H), 2.77 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 157.1, 148.1, 144.8, 139.8, 
130.2, 129.3, 129.1, 128.7, 127.5, 127.2, 126.0, 123.6, 119.8, 19.0 ppm; GC-MS for 
C16H13N, m/z = 219 (M
+). 1H and 13C NMR spectral data are in good agreement with the 
literature values.221 
2-(3-Methoxyphenyl)-4-methylquinoline (5-9e): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2'-aminoacetophenone (68 mg, 
0.5 mmol), and (±)-β-amino-3-methoxybenzenepropanoic 
acid (137 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9e was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.4 (20% 
EtOAc in hexanes)). Yield = 94 mg (76%). Data for 5-9e: 1H NMR (400 MHz, CDCl3) δ 
8.19 (d, J = 8.5 Hz, 1H), 7.99 (d, J = 8.3 Hz, 1H), 7.77 (s, 1H), 7.75–7.68 (m, 3H), 7.54 
(t, J = 7.6 Hz, 1H), 7.43 (t, J = 7.9 Hz, 1H), 7.02 (dd, J = 8.2, 1.9 Hz, 1H), 3.94 (s, 3H), 
2.75 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.0, 156.8, 148.0, 144.7, 141.2, 





MS for C17H15NO, m/z = 249 (M
+). 1H and 13C NMR spectral data are in good agreement 
with the literature values.222 
2-(3-Methoxyphenyl)-4-phenylquinoline (5-9f): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2-aminobenzophenone (99 mg, 
0.5 mmol), and (±)-β-amino-3-methoxybenzenepropanoic 
acid (137 mg, 0.7 mmol) was stirred at 140 °C for 20 h. 
The product 5-9f was isolated by column chromatography on silica gel (hexanes/EtOAc = 
100:1–10:1; TLC: Rf = 0.6 (20% EtOAc in hexanes)). Yield = 113 mg (73%). Data for 5-
9f: 1H NMR (400 MHz, CDCl3) δ 8.27 (d, J = 8.5 Hz, 1H), 7.93 (d, J = 8.5 Hz, 1H), 7.83 
(s, 1H), 7.82–7.71 (m, 3H), 7.62–7.41 (m, 7H), 7.04 (dd, J = 8.2, 2.2 Hz, 1H), 3.94 (s, 
3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.1, 156.6, 149.1, 148.7, 141.1, 138.3, 
130.1, 129.8, 129.5, 129.5, 128.6, 128.4, 126.3, 125.8, 125.6, 120.0, 119.4, 115.4, 112.6, 
55.4 ppm; GC-MS for C22H17NO, m/z = 311 (M
+). 1H and 13C NMR spectral data are in 
good agreement with the literature values.223 
6-Chloro-2,4-diphenylquinoline (5-9g): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 
10 mol %), 5-chloro-2-aminobenzophenone (116 mg, 0.5 
mmol), and (±)-3-amino-3-phenylpropionic acid (116 mg, 
0.7 mmol) was stirred at 140 °C for 20 h. The product 5-
9g was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.9 (20% EtOAc in hexanes)). Yield = 112 mg 





7.85 (s, 1H), 7.67 (d, J = 9.0 Hz, 1H),7.61–7.46 (m, 8H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 156.9, 148.3, 147.1, 139.0, 137.6, 132.1, 131.6, 130.3, 129.5, 129.3, 128.8, 
128.7, 128.6, 127.4, 126.3, 124.4, 119.9 ppm; GC-MS for C21H14ClN, m/z = 315 (M
+).  
1H and 13C NMR spectral data are in good agreement with the literature values.224 
6-Chloro-2-(3-methoxyphenyl)-4-phenylquinoline 
(5-9h): A 1,4-dioxane (2.0 mL) solution of complex 2-
10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 5-chloro-
2-aminobenzophenone (116 mg, 0.5 mmol), and (±)-β-
amino-3-methoxybenzenepropanoic acid (137 mg, 0.7 
mmol) was stirred at 140 °C for 20 h. The product 5-9h was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.5 (20% EtOAc 
in hexanes)). Yield = 104 mg (60%). Data for 5-9h: 1H NMR (400 MHz, CDCl3) δ 8.18 
(d, J = 9.0 Hz, 1H), 7.87 (d, J = 2.2 Hz, 1H), 7.83 (s, 1H), 7.81–7.77 (m, 1H), 7.73 (d, J = 
7.7 Hz, 1H), 7.67 (dd, J = 9.0, 2.2 Hz, 1H), 7.61–7.51 (m, 5H), 7.43 (t, J = 7.9 Hz, 1H), 
7.03 (dd, J = 8.2, 2.2 Hz, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.1, 156.8, 
148.4, 147.1, 140.6, 137.7, 132.2, 131.7, 130.4, 129.8, 129.4, 128.8, 128.7, 126.5, 124.4, 
120.1, 119.9, 115.6, 112.6, 55.4 ppm; GC-MS for C22H16ClNO, m/z = 345 (M
+). 1H and 
13C NMR spectral data are in good agreement with the literature values.225 
2,3-Dihydro-9-methyl-1H-cyclopenta[b]quinoline (5-9i): A 1,4-
dioxane (1.0 mL) solution of complex 2-10 (5 mg, 3 mol %), 2-16 (4 
mg, 10 mol %), 2'-aminoacetophenone (34 mg, 0.25 mmol), and (±)-
2-amino-cyclopentanecarboxylic acid (45 mg, 0.35 mmol) was stirred at 140 °C for 20 h. 





100:1–5:1; TLC: Rf = 0.2 (20% EtOAc in hexanes)). 88 mg (96%). Data for 5-9i: 
1H 
NMR (400 MHz, CDCl3) δ 7.99 (d, J = 8.4 Hz, 1H), 7.89 (d, J = 8.4 Hz, 1H), 7.59 (dd, J 
= 7.7, 1.4 Hz, 1H), 7.45 (dd, J = 7.7, 1.4 Hz, 1H), 3.14 (t, J = 7.6 Hz, 2H), 3.01 (t, J = 7.4 
Hz, 2H), 2.53 (s, 2H), 2.16 (pentet, J = 7.6 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 166.9, 147.3, 138.0, 133.9, 129.0, 127.9, 126.9, 125.1, 123.2, 35.0, 29.5, 22.9, 
14.8 ppm; GC-MS for C13H13N, m/z = 183 (M
+). 1H and 13C NMR spectral data are in 
good agreement with the literature values.226 
1,2,3,4-Tetrahydroacridine (5-9j): A 1,4-dioxane (2.0 mL) solution 
of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 2-
aminobenzaldehyde (61 mg, 0.5 mmol), and (1S,2R)-2-
aminocyclohexanecarboxylic acid (100 mg, 0.7 mmol) was stirred at 140 °C for 20 h. 
The product 5-9j was isolated by column chromatography on silica gel (hexanes/EtOAc = 
100:1–5:1; TLC: Rf = 0.3 (20% EtOAc in hexanes)). Yield = 82 mg (90%). Data for 5-9j: 
1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 8.5 Hz, 1H), 7.73 (s, 1H), 7.64 (d, J = 8.2 Hz, 
1H), 7.57 (td, J = 7.6, 0.9 Hz, 1H), 7.39 (t, J = 7.5 Hz, 1H), 3.10 (t, J = 6.5 Hz, 2H), 2.92 
(t, J = 6.4 Hz, 2H), 1.99–1.91 (m, 2H), 1.89–1.80 (m, 2H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 159.1, 146.5, 134.8, 130.8, 128.3, 128.1, 127.1, 126.8, 125.4, 33.5, 29.1, 
23.1, 22.8 ppm; GC-MS for C13H13N, m/z = 183. 
1H and 13C NMR spectral data are in 
good agreement with the literature values.227 
9-Methyl-1,2,3,4-tetrahydroacridine (5-9k): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol 
%), 2'-aminoacetophenone (68 mg, 0.5 mmol), and (1S,2R)-2-





The product 5-9k was isolated by column chromatography on silica gel (hexanes/EtOAc 
= 100:1–10:1; TLC: Rf = 0.3 (20% EtOAc in hexanes)). Yield = 88 mg (89%). Data for 5-
9k: 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.4 Hz, 1H), 7.89 (d, J = 8.4 Hz, 1H), 7.56 
(t, J = 7.6 Hz, 1H), 7.40 (t, J = 7.6 Hz, 1H), 3.12–3.03 (m, 2H), 2.83–2.76 (m, 2H) 2.45 
(s, 3H), 1.92–1.82 (m, 4H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.3, 145.7, 141.0, 
128.8, 128.4, 127.9, 126.7, 125.0, 123.1, 34.3, 26.9, 23.0, 22.6, 13.3 ppm; GC-MS for 
C14H15N, m/z = 197 (M
+). 1H and 13C NMR spectral data are in good agreement with the 
literature values.228 
9-Phenyl-1,2,3,4-tetrahydroacridine (5-9l): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol 
%), 2-aminobenzophenone (99 mg, 0.5 mmol), and (1S,2R)-2-
aminocyclohexanecarboxylic acid (100 mg, 0.7 mmol) was stirred 
at 140 °C for 20 h. The product 5-9l was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.3 (20% EtOAc 
in hexanes)). Yield = 124 mg (96%). Data for 5-9l: 1H NMR (400 MHz, CDCl3) δ 8.02 
(d, J = 8.5 Hz, 1H), 7.56 (ddd, J = 7.4, 7.4, 1.2 Hz, 1H), 7.51–7.39 (m, 3H), 7.32–7.24 
(m, 2H), 7.23–7.17 (m, 2H), 3.18 (t, J = 6.6 Hz, 2H), 2.57 (t, J = 6.5 Hz, 2H), 2.02–1.97 
(m, 2H), 1.79–1.70 (m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.9, 146.3, 
146.1, 137.0, 128.9, 128.4, 128.2, 127.6, 126.5, 125.6, 125.2, 34.1, 27.9, 22.9, 22.8 ppm 
(two carbon signals were obscured or overlapping); GC-MS for C19H17N, m/z = 259 





7-Chloro-9-phenyl-1,2,3,4-tetrahydroacridine (5-9m): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
16 (8 mg, 10 mol %), 5-chloro-2-aminobenzophenone (116 mg, 
0.5 mmol), and (1S,2R)-2-aminocyclohexanecarboxylic acid 
(100 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The 
product 5-9m was isolated by column chromatography on silica gel (hexanes/EtOAc = 
100:1–10:1; TLC: Rf = 0.3 (20% EtOAc in hexanes). Yield = 144 mg (98%). Data for 5-
9m: 1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 9.0 Hz, 1H), 7.51–7.38 (m, 4H), 7.25 (d, 
J = 1.9 Hz, 1H), 7.19–7.12 (m, 2H), 3.13 (t, J = 6.6 Hz, 2H), 2.54 (t, J = 6.5 Hz, 2H), 
1.94–1.86 (m, 2H), 1.75–1.68 (m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.3, 
145.5, 144.5, 136.2, 130.9, 129.9, 129.2, 129.0, 128.8, 128.6, 127.9, 127.2, 124.3, 34.0, 
27.9, 22.7, 22.6 ppm; GC-MS for C19H16ClN, m/z = 293 (M
+). 1H and 13C NMR spectral 
data are in good agreement with the literature values.230 
2-Chloro-7,8,9,10-tetrahydro-11-phenyl-6H-
cyclohepta[b]quinoline (5-9n): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol 
%), 5-chloro-2-aminobenzophenone (116 mg, 0.5 mmol), and 
cis-2-aminocycloheptanecarboxylic acid (110 mg, 0.7 mmol) 
was stirred at 140 °C for 20 h. The product 5-9n was isolated by column chromatography 
on silica gel (hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.5 (20% EtOAc in hexanes)). 
Yield = 138 mg (90%). Data for 5-9n: 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.9 Hz, 
1H), 7.58–7.42 (m, 4H), 7.24 (d, J = 1.8 Hz, 1H), 7.22–7.14 (m, 2H), 3.28–3.22 (m, 2H), 





MHz, CDCl3) δ 165.0, 144.6, 144.1, 136.8, 134.8, 131.3, 130.1, 129.2, 128.9, 128.6, 
127.9, 127.6, 125.1, 40.0, 31.8, 30.6, 28.3, 26.9 ppm; GC-MS for C20H18ClN, m/z = 307 
(M+).  1H and 13C NMR spectral data are in good agreement with the literature values.231 
2-Chloro-12-phenyl-6,7,8,9,10,11-
hexahydrocycloocta[b]quinoline (5-9o): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 
10 mol %), 5-chloro-2-aminobenzophenone (116 mg, 0.5 
mmol), and cis-2-amino-cyclooctanecarboxylic acid (120 mg, 
0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9o was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.4 (20% EtOAc 
in hexanes)). Yield = 151 mg (94%). Data for 5-9o: 1HNMR (400 MHz, CDCl3) δ 7.98 
(d, J = 8.9 Hz, 1H), 7.65–7.37 (m, 4H), 7.21 (d, J = 6.5 Hz, 2H), 7.17 (d, J = 1.7 Hz, 1H), 
3.21 (t, J = 6.1 Hz, 2H), 2.74 (t, J = 6.2 Hz, 2H), 2.01–1.86 (m, 2H), 1.56–1.42 (m, 4H), 
1.40–1.27 (m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 163.8, 145.7, 144.7, 136.8, 
132.9, 131.1, 130.1, 129.2, 129.0, 128.5, 127.9, 127.9, 124.8, 36.3, 31.1, 31.1, 28.1, 26.6, 
25.7 ppm; GC-MS for C21H20ClN, m/z = 321 (M
+).  HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C21H20ClNH; 322.1357 Found 322.1327. 
2-Nitro-12-phenyl-6,7,8,9,10,11-
hexahydrocycloocta[b]quinoline (5-9p): A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 
mg, 10 mol %), 5-chloro-2-aminobenzophenone (116 mg, 
0.5 mmol), and cis-2-amino-cyclooctanecarboxylic acid 





column chromatography on silica gel (hexanes/EtOAc = 100:1–10:1; TLC: Rf = 0.4 (20% 
EtOAc in hexanes)). Yield = 142 mg (86%). Data for 5-9p: 1H NMR (400 MHz, CDCl3) 
δ 8.33 (dd, J = 9.2, 1.7 Hz, 1H), 8.15 (d, J = 1.7 Hz, 1H), 8.11 (d, J = 9.2 Hz, 1H), 7.66–
7.45 (m, 3H), 7.27–7.18 (m, 2H), 3.24 (t, J = 6.1 Hz, 2H), 2.78 (t, J = 6.1 Hz, 2H), 1.99–
1.90 (m, 2H), 1.55–1.42 (m, 4H), 1.40–1.29 (m, 2H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 167.8, 148.5, 148.2, 144.8, 135.8, 134.2, 130.2, 129.1, 128.7, 128.5, 126.3, 
123.2, 121.8, 36.6, 31.1, 31.1, 28.2, 26.5, 25.7 ppm; GC-MS for C21H20N2O2, m/z = 332 
(M+); HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C21H20N2O2H, 333.1598 Found 
333.1566. 
2-(1,3-Benzodioxol-5-yl)quinoline (5-9q): A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 
mg, 10 mol %), 2-aminobenzaldehyde (61 mg, 0.5 mmol), 
and (±)-3-amino-3-benzo[1,3]dioxol-5-yl-propionic acid 
(146 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9q was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.5 (20% 
EtOAc in hexanes)). Yield = 108 mg (87%). Data for 5-9q: 1H NMR (400 MHz, CDCl3) 
δ 8.16 (d, J = 8.9 Hz, 1H), 8.13 (d, J = 8.9 Hz, 1H), 7.82–7.76 (m, 2H), 7.75 (d, J = 1.5 
Hz, 1H), 7.71 (td, J = 7.8, 1.0 Hz, 1H), 7.65 (dd, J = 8.1, 1.5 Hz, 1H), 7.50 (t, J = 7.5 Hz, 
1H), 6.95 (d, J = 8.1 Hz, 1H), 6.04 (s, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
156.6, 148.8, 148.3, 148.1, 136.6, 134.0, 129.6, 129.5, 127.4, 126.9, 126.0, 121.7, 118.6, 
108.4, 107.9, 101.3 ppm; GC-MS for C16H11NO2, m/z = 249 (M
+). 1H and 13C NMR 





2-(Benzo[d][1,3]dioxol-5-yl)-4-methylquinoline (5-9r): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2'-aminoacetophenone (68 mg, 
0.5 mmol), and (±)-3-amino-3-benzo[1,3]dioxol-5-yl-
propionic acid (146 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9r was 
isolated by column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; 
TLC: Rf = 0.6 (20% EtOAc in hexanes)). Yield = 73 mg (56%). Data for 5-9r: 
1H NMR 
(400 MHz, CDCl3) δ 8.13 (d, J = 8.4 Hz, 1H), 7.96 (d, J = 8.4 Hz, 1H), 7.74–7.60 (m, 
4H), 7.52 (t, J = 7.5 Hz, 1H), 6.94 (d, J = 8.1 Hz, 1H), 6.03 (s, 2H), 2.73 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 156.3, 148.6, 148.2, 147.9, 144.6, 134.2, 130.0, 
129.3, 127.0, 125.7, 123.5, 121.6, 119.3, 108.4, 107.8, 101.3, 19.0 ppm; GC-MS for 
C17H13NO2, m/z = 263 (M
+).  
2-(Benzo[d][1,3]dioxol-5-yl)-4-phenylquinoline (5-9s): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2-aminobenzophenone (99 mg, 
0.5 mmol), and (±)-3-amino-3-benzo[1,3]dioxol-5-yl-
propionic acid (146 mg, 0.7 mmol) was stirred at 140 °C for 
20 h. The product 5-9s was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.6 (20% EtOAc in hexanes)). Yield = 114 mg 
(70%). Data for 5-9s: 1H NMR (400 MHz, CDCl3) δ 8.20 (d, J = 8.4 Hz, 1H), 7.88 (d, J = 
8.4 Hz, 1H), 7.78 (d, J = 1.1 Hz, 1H), 7.74 (s, 1H), 7.73–7.66 (m, 2H), 7.61–7.49 (m, 
5H), 7.46 (dd, J = 7.6, 7.6 Hz, 1H), 6.95 (dd, J = 8.2 Hz, 1H), 6.04 (s, 2H), ppm; 13C{1H} 





129.5, 128.5, 128.4, 126.1, 125.6, 125.6, 121.7, 118.9, 108.4, 107.9, 101.3 ppm; GC-MS 
for C22H15NO2, m/z = 325 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C22H15NO2H; 326.1176 Found 326.1156.  
2-(Benzo[d][1,3]dioxol-5-yl)-6-chloro-4-
phenylquinoline (5-9t): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 
10 mol %), 5-chloro-2-aminobenzophenone (116 mg, 
0.5 mmol), and (±)-3-amino-3-benzo[1,3]dioxol-5-yl-
propionic acid (146 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9t was 
isolated by column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; 
TLC: Rf = 0.7 (20% EtOAc in hexanes)). Yield = 89 mg (50%). Data for 5-9t: 
1H NMR 
(400 MHz, CDCl3) δ 8.12 (d, J = 9.0 Hz, 1H), 7.84 (s, 1H), 7.75 (d, J = 6.9 Hz, 2H), 7.65 
(t, J = 9.4 Hz, 2H), 7.60–7.49 (m, 5H), 6.93 (d, J = 8.1 Hz, 1H), 6.03 (s, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 156.2, 149.0, 148.4, 148.2, 147.0, 137.7, 133.5, 
131.8, 131.4, 130.3, 129.4, 128.7, 128.6, 126.2, 124.4, 121.7, 119.5, 108.4, 107.7, 101.4 
ppm; GC-MS for C22H14ClNO2, m/z = 359 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd 
for C22H14ClNO2H; 360.0786 Found 360.0773. 
2-Methyl-3-phenylquinoline (5-9u-a): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol 
%), 2-aminobenzaldehyde (61 mg, 0.5 mmol), and (±)-3-amino-
4-phenylbutanoic acid (125 mg, 0.7 mmol) was stirred at 140 °C 
for 20 h. The product 5-9u-a was isolated by column chromatography on silica gel 





(65%). Data for 5-9u-a: 1HNMR (400 MHz, CDCl3) δ 8.07 (d, J = 8.5 Hz, 1H), 7.96 (s, 
1H), 7.79 (d, J = 8.1 Hz, 1H), 7.70 (t, J = 7.7 Hz, 1H),  7.54–7.38 (m, 6H), 2.68 (s, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 157.3, 147.0, 139.9, 136.1, 135.7, 129.3, 
129.2, 128.4, 128.4, 127.6, 127.4, 126.8, 126.0, 24.6 ppm; GC-MS for C16H13N, m/z = 
219 (M+). 1H and 13C NMR spectral data are in good agreement with the literature 
values.233 
 2-(Phenylmethyl)quinoline (5-9u-b): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 
mol %), 2-aminobenzaldehyde (61 mg, 0.5 mmol), and (±)-3-
amino-4-phenylbutanoic acid (125 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The 
product 5-9u-b was isolated by column chromatography on silica gel (hexanes/EtOAc = 
100:1–51; TLC: Rf = 0.3 (20% EtOAc in hexanes)). Yield = 37 mg (34%). Data for 5-9u-
b: 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 8.5 Hz, 1H), 8.01 (d, J = 8.5 Hz, 1H), 7.75 
(d, J = 8.1 Hz, 1H), 7.69 (dd, J = 7.7, 7.7 Hz, 1H), 7.48 (dd, J = 7.5, 7.5 Hz, 1H), 7.33–
7.18 (m, 6H), 4.34 (s, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.2, 147.7, 139.2, 
136.5, 129.5, 129.2, 128.9, 128.6, 127.5, 126.7, 126.5, 126.0, 121.5,  45.5 ppm; GC-MS 
for C16H13N, m/z = 219 (M
+). 1H and 13C NMR spectral data are in good agreement with 
the literature values.234 
2,4-Dimethyl-3-phenylquinoline (5-9v): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 
mol %), 2'-aminoacetophenone (68 mg, 0.5 mmol), and (±)-3-
amino-4-phenylbutanoic acid (125 mg, 0.7 mmol) was stirred at 





(hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.6 (20% EtOAc in hexanes)). Yield = 85 mg 
(73%). Data for 5-9v: 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 8.4 Hz, 1H), 8.00 (d, J 
= 8.4 Hz, 1H), 7.69 (t, J = 7.6 Hz, 1H), 7.58–7.46 (m, 3H), 7.45–7.38 (m, 1H), 7.24–7.17 
(m, 2H), 2.43 (s, 3H), 2.39 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 157.6, 
146.6, 141.2, 139.5, 134.9, 129.3, 129.1, 128.9, 128.7, 127.4, 126.7, 125.7, 124.1, 25.4, 
15.9 ppm; GC-MS for C17H15N, m/z = 233 (M
+). 1H and 13C NMR spectral data are in 
good agreement with the literature values.188 
2-Methyl-3,4-diphenylquinoline (5-9w): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 
mol %), 2-aminobenzophenone (99 mg, 0.5 mmol), and (±)-3-
amino-4-phenylbutanoic acid (125 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 5-9w was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.5 (20% EtOAc 
in hexanes)). Yield = 106 mg (72%). Data for 5-9w: 1H NMR (400 MHz, CDCl3) δ 8.12 
(d, J = 8.4 Hz, 1H), 7.69 (t, J = 7.6 Hz, 1H), 7.50 (d, J = 8.4 Hz, 1H), 7.39 (t, J = 7.6 Hz, 
1H), 7.32–7.15 (m, 6H), 7.14–7.02 (m, 4H), 2.55 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 157.8, 147.0, 146.5, 138.6, 136.7, 134.0, 130.1, 130.0, 129.1, 128.6, 127.9, 
127.6, 127.2, 126.8, 126.6, 126.3, 125.8, 25.4 ppm; GC-MS for C22H17N, m/z = 295 
(M+). 1H and 13C NMR spectral data are in good agreement with the literature values.188 
2,4-Dimethyl-3-propylquinoline (5-9x): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 
mol %), 2'-aminoacetophenone (68 mg, 0.5 mmol), and (±)-3-





for 20 h. The product 5-9x was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.7 (20% EtOAc in hexanes)). Yield = 95 mg 
(95%). Data for 5-9x: 1H NMR (400 MHz, CDCl3) δ 7.97 (t, J = 9.7 Hz, 2H), 7.61 (t, J = 
7.8 Hz, 1H), 7.49 (t, J = 7.8 Hz, 1H), 2.86–2.78 (m, 2H), 2.75 (s, 3H), 2.64 (s, 3H), 1.64–
1.53 (m, 2H), 1.07 (t, J = 7.3 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.2, 
145.6, 140.6, 132.4, 128.9, 128.1, 127.3, 126.6, 125.4, 123.6, 31.8, 24.1, 23.0, 14.5, 14.2 
ppm (two carbon signals obscured or overlapping); GC-MS for C14H17N, m/z = 199 (M
+). 
1H and 13C NMR spectral data are in good agreement with the literature values.235 
6-Chloro-2-methyl-3,4-diphenylquinoline (5-9y-a): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 5-chloro-2-aminobenzophenone 
(116 mg, 0.5 mmol), and (±)-3-amino-4-phenylbutanoic acid 
(125 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The 
product 5-9y-a was isolated by column chromatography on silica gel (hexanes/EtOAc = 
100:1–5:1; TLC: Rf = 0.6 (20% EtOAc in hexanes)). Yield = 143 mg (87%). Data for 5-
9y-a: 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = 9.0 Hz, 1H), 7.60 (dd, J = 9.0, 2.0 Hz, 
1H), 7.45 (d, J = 2.0 Hz, 1H), 7.26–7.14 (m, 6H), 7.10–6.97 (m, 4H), 2.51 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 158.2, 145.8, 145.4, 138.2, 136.0, 134.9, 131.6, 
130.3, 129.9, 129.9, 129.8, 127.9, 127.9, 127.5, 127.1, 127.0, 125.3, 25.4 ppm; GC-MS 
for C22H16ClN, m/z = 329 (M
+). 1H and 13C NMR spectral data are in good agreement 





2-Benzyl-6-chloro-4-phenylquinoline (5-9y-b): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 5-chloro-2-
aminobenzophenone (116 mg, 0.5 mmol), and (±)-3-
amino-4-phenylbutanoic acid (125 mg, 0.7 mmol) was 
stirred at 140 °C for 20 h. The product 5-9y-b was isolated by column chromatography 
on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.4 (20% EtOAc in hexanes)). 
Yield = 19 mg (12%). Data for 5-9y-b: 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 9.0 
Hz, 1H), 7.82 (d, J = 1.7 Hz, 1H), 7.65 (dd, J = 9.0, 1.7 Hz, 1H), 7.57–7.38 (m, 5H), 
7.36–7.18 (m, 6H), 4.36 (s, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.0, 148.1, 
146.7, 138.8, 137.4, 131.9, 131.0, 130.2, 129.4, 129.2, 128.7, 128.6, 126.6, 126.1, 124.5, 
122.4, 45.5 ppm (one carbon signal obscured or overlapping); GC-MS for C22H16ClN, 
m/z = 329 (M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C22H16ClNH; 330.1044 
Found 330.1039.  
6-Chloro-2-methyl-4-phenyl-3-propylquinoline (5-9z): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 5-chloro-2-aminobenzophenone 
(116 mg, 0.5 mmol), and (±)-3-aminoheptanoic acid (102 mg, 
0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9z 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; 
TLC: Rf = 0.6 (20% EtOAc in hexanes)). Yield = 124 mg (84%). Data for 5-9z: 
1H NMR 
(400 MHz, CDCl3) δ 7.94 (d, J = 9.0 Hz, 1H), 7.60–7.44 (m, 4H), 7.22 (d, J = 7.1 Hz, 





(t, J = 7.3 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.0, 145.7, 144.4, 136.7, 
133.2, 131.2, 130.0, 129.2, 129.1, 128.5, 128.0, 127.9, 125.0, 32.5, 23.8, 23.5, 14.5 ppm; 
GC-MS for C19H18ClN, m/z = 295 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C19H18ClNH; 296.1201 Found 296.1177. 
 
2-(2-Methylpropyl)quinoline (5-9aa): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol 
%), 2-aminobenzaldehyde (61 mg, 0.5 mmol), and (±)-3-amino-
5-methylhexanoic acid (102 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-
9aa was isolated by column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; 
TLC: Rf = 0.6 (20% EtOAc in hexanes)). Yield = 79 mg (85%). Data for 5-9aa: 
1H NMR 
(400 MHz, CDCl3) δ 8.03 (d, J = 8.4 Hz, 2H), 7.75 (d, J = 8.2 Hz, 1H), 7.66 (t, J = 7.6 
Hz, 1H), 7.46 (t, J = 7.6 Hz, 1H), 7.25 (d, J = 8.4 Hz, 1H), 2.83 (d, J = 7.6 Hz, 2H), 2.19 
(nonet, J = 6.8 Hz, 1H), 0.96 (d, J = 6.8 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 162.2, 147.9, 135.9, 129.2, 128.8, 127.4, 126.7, 125.6, 122.0, 48.3, 29.4, 22.5 ppm; GC-
MS for C13H15N, m/z = 185 (M
+). 1H and 13C NMR spectral data are in good agreement 
with the literature values.236 
4-Methyl-2-(2-methylpropyl)quinoline (5-9ab): A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 
10 mol %), 2'-aminoacetophenone (68 mg, 0.5 mmol), and (±)-3-
amino-5-methylhexanoic acid (102 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 5-9ab was isolated by column chromatography on silica gel 
(n-hexane/EtOAc = 100:1–5:1; TLC: Rf = 0.6 (20% EtOAc in hexanes)). Yield = 62 mg 





= 8.4 Hz, 1H), 7.66 (t, J = 7.4 Hz, 1H), 7.49 (t, J = 7.6 Hz, 1H), 7.10 (s, 1H), 2.80 (d, J = 
7.4 Hz, 2H) 2.66 (m, 3H), 2.20 (dt, J = 13.6, 6.7 Hz, 1H), 0.97 (d, J = 6.7 Hz, 6H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 161.9, 147.7, 143.8, 129.3, 128.9, 126.7, 125.3, 
123.5, 122.7, 48.2, 29.4, 22.5, 18.7 ppm; GC-MS for C14H17N, m/z = 199 (M
+). 1H and 
13C NMR spectral data are in good agreement with the literature values.237 
6-Chloro-2-isobutyl-4-phenylquinoline (5-9ac): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 5-chloro-2-aminobenzophenone 
(116 mg, 0.5 mmol), and (±)-3-amino-5-methylhexanoic acid 
(102 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9ac was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.7 (20% 
EtOAc in hexanes). Yield = 114 mg (77%). Data for 5-9ac: 1H NMR (400 MHz, CDCl3) 
δ 8.04 (d, J = 9.0 Hz, 1H), 7.84 (s, 1H), 7.60 (dd, J = 9.0, 1.4 Hz, 1H), 7.55–7.37 (m, 
5H), 7.22 (s, 1H), 2.86 (d, J = 7.4 Hz, 2H), 2.24 (nonet, J = 6.8 Hz, 1H), 1.00 (d, J = 6.8 
Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 162.0, 147.4, 146.7, 137.5, 131.5, 
130.8, 129.9, 129.3, 128.6, 128.5, 125.9, 124.3, 122.9, 48.1, 29.3, 22.5 ppm; GC-MS for 
C19H18ClN, m/z = 295 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C19H18ClNH; 
296.1201 Found 296.1167. 
6-Chloro-2-isobutyl-4-phenylquinoline (5-9ad): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 5-chloro-2-aminobenzophenone 
(116 mg, 0.5 mmol), and (±)--leucine (92 mg, 0.7 mmol) 





isolated by column chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; 
TLC: Rf = 0.7 (20% EtOAc in hexanes)). Yield = 71 mg, (51%). Data for 5-9ad: 
1H 
NMR (400 MHz, CDCl3) δ 8.07 (d, J = 9.0 Hz, 1H), 7.85 (s, 1H), 7.60 (dd, J = 9.0, 1.4 
Hz, 1H), 7.55–7.42 (m, 5H), 7.31 (s, 1H), 3.29 (septet, J = 6.9 Hz, 1H), 1.44 (d, J = 6.9 
Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 167.3, 147.8, 146.5, 137.6, 131.4, 
130.9, 129.8, 129.3, 128.6, 128.4, 126.0, 124.2, 120.2, 37.1, 22.4 ppm; GC-MS for 
C18H16ClN, m/z = 281 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C18H16ClNH; 
282.1044 Found 282.1010. 
(1S,4R)-9-Methyl-1,2,3,4-tetrahydro-1,4-methanoacridine (5-
9ae): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 2'-aminoacetophenone (68 mg, 0.5 
mmol), and 3-aminobicyclo[2.2.1]heptane-2-carboxylic acid (109 
mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9ae was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.3 (20% EtOAc 
in hexanes)). Yield = 89 mg, (85%). Data for 5-9ae: 1H NMR (400 MHz, CDCl3) δ 8.00 
(d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.3 Hz, 1H), 7.59 (t, J = 7.6 Hz, 1H), 7.47 (t, J = 7.6 Hz, 
1H), 3.65 (s, 1H), 3.51 (s, 1H), 2.59 (s, 3H), 2.09–1.99 (m, 2H), 1.89 (d, J = 9.3 Hz, 1H), 
1.70 (d, J = 9.3 Hz, 1H), 1.47–1.40 (m, 1H), 1.33–1.23 (m, 1H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 169.6, 146.3, 137.9, 133.2, 129.1, 127.6, 127.6, 125.0, 123.6, 46.2, 45.8, 
40.3, 26.9, 25.8, 14.1 ppm; GC-MS for C15H15N, m/z = 209 (M
+). HRMS (ESI-TOF) 






methanoacridine (5-9af): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 5-
chloro-2-aminobenzophenone (116 mg, 0.5 mmol), and 3-
aminobicyclo[2.2.1]heptane-2-carboxylic acid (109 mg, 0.7 mmol) was stirred at 140 °C 
for 20 h. The product 5-9af was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.4 (20% EtOAc in hexanes)). Yield = 138 mg, 
(90%). Data for 5-9af: 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 8.9 Hz, 1H), 7.62 (s, 
1H), 7.58–7.45 (m, 4H), 7.45–7.27 (m, 2H), 3.57 (s, 1H), 3.38 (s, 1H), 2.13–1.92 (m, 
3H), 1.68 (d, J = 9.3 Hz, 1H), 1.52 (t, J = 10.3 Hz, 1H), 1.40–1.31 (m, 1H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 170.3, 145.2, 138.6, 137.4, 135.3, 131.1, 130.4, 129.7, 129.4, 
128.5, 128.2, 127.3, 124.7,  46.5, 45.8, 40.9, 27.4, 25.7 ppm; GC-MS for C20H16ClN, m/z 
= 305 (M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C20H16ClNH; 306.1044 Found 
306.1013. 
3-(1H-Indol-2-yl)-4-phenylquinoline (5-9ag): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2-aminobenzophenone (99 mg, 
0.5 mmol), and tryptamine (112 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 5-9ag was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.3 (20% EtOAc 
in hexanes)). Yield = 64 mg, (40%). Data for 5-9ag: 1H NMR (400 MHz, CDCl3) δ 9.26 
(s. 1H), 8.42 (brs, 1H), 8.20 (d, J = 8.4 Hz, 1H), 7.72–7.66 (m, 2H), 7.63 (d, J = 8.4 Hz, 





1H), 7.13 (t, J = 7.6 Hz, 1H), 6.64 (d, J = 2.5 Hz, 1H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 152.2, 146.6, 145.7, 137.1, 135.7, 130.1, 129.1, 128.7, 128.2, 127.9, 127.7, 
126.9, 126.8, 126.7, 126.4, 125.1, 122.4, 120.4, 119.3, 113.1, 111.3 ppm; GC-MS for 
C23H16N2, m/z = 320 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C23H16N2H; 
321.1386 Found 321.1382. 
6-Chloro-4-phenyl-3-(thiophen-2-yl)quinoline (5-9ah): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 5-chloro-2-aminobenzophenone 
(116 mg, 0.5 mmol), and 2-thiopheneethylamine (89 mg, 0.7 
mmol) was stirred at 140 °C for 20 h. The product 5-9ah was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.4 (20% EtOAc 
in hexanes)). Yield = 68 mg, (42%). Data for 5-9ah: 1H NMR (400 MHz, CDCl3) δ 9.15 
(s, 1H), 8.12 (d, J = 8.9 Hz, 1H), 7.62 (dd, J = 8.9, 2.3 Hz, 1H), 7.52–7.44 (m, 4H), 7.27–
7.24 (m, 3H), 6.98–6.91 (m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 150.7, 150.7, 
144.9, 139.0, 135.4, 133.3, 130.6, 130.3, 130.0, 128.9, 128.8, 128.5, 128.0, 127.7, 127.1, 
127.1, 125.5 ppm; GC-MS for C19H12ClNS, m/z = 321 (M
+). HRMS (ESI-TOF) m/z: [M 
+ H]+ Calcd for C19H12ClNSH; 322.0452 Found 322.0444. 
3-(4-Methoxyphenyl)-4-methylquinoline (5-9am): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), 2'-aminoacetophenone (68 mg, 
0.5 mmol), and 2-(4-methoxyphenyl)ethanamine (106 mg, 
0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9am was isolated by column 





in hexanes)). Yield = 44 mg, (35%). Data for 5-9am: 1H NMR (400 MHz, CDCl3) δ 8.78 
(s, 1H), 8.16 (dd, J = 8.4, 0.8 Hz, 1H), 8.08 (dd, J = 1.4, 0.6 Hz, 1H), 7.73 (dd,  J = 6.9, 
1.4 Hz, 1H), 7.62 (dd, J = 6.9, 1.4 Hz, 1H), 7.33 (d, J = 8.8 Hz, 2H), 7.04 (d, J = 8.8 Hz, 
2H), 3.89 (s, 3H), 2.66 (s, 3H)  ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.2, 151.4, 
146.4, 141.1, 134.1, 131.1, 130.7, 129.6, 128.9, 128.0,126.8, 124.2, 113.9, 55.4, 15.7 
ppm; GC-MS for C17H15NO, m/z = 249 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd 
for C17H15NOH; 250.1149 Found 250.1144. 
6.5.5.2 Characterization of the Dihydroquinazolin-4(1H)-one Compounds Listed in 
Table 5.6 
2-Methyl-2-phenyl-2,3-dihydroquinazolin-4(1H)-one (5-10a): 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-12 (12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 
mmol) and (±)-α-methylbenzylamine (85 mg, 0.7 mmol) was 
stirred at 140 °C for 20 h. The product 5-10a was isolated by column chromatography on 
silica gel (hexanes/EtOAc = 50:1–5:1; TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 
110 mg (82%). Data for 5-10a: 1H NMR (400 MHz, DMSO-d6) δ 8.80 (brs, 1H), 7.65 
(brs, 1H), 7.53–7.46 (m, 3H), 7.31–7.24 (m, 2H), 7.23–7.14 (m, 2H), 6.77 (d, J = 8.2 Hz, 
1H), 6.57 (t, J = 7.6 Hz, 1H), 1.64 (s, 3H) ppm; 13C{1H} NMR (100 MHz, DMSO-d6) δ 
164.0, 147.7, 147.3, 133.5, 128.1, 127.4, 127.2, 125.3, 117.0, 115.1, 114.4, 70.3, 30.8 
ppm; GC-MS for C15H14N2O, m/z = 238 (M
+). 1H and 13C NMR spectral data are in good 






4(1H)-one (5-10b): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-
aminobenzamide (68 mg, 0.50 mmol) and (S)-(−)-1-(4-
methoxyphenyl)ethylamine (106 mg, 0.70 mmol) was stirred 
at 140 °C for 20 h. The product 5-10b was isolated by column chromatography on silica 
gel (hexanes/EtOAc = 50:1–5:1; TLC: Rf = 0.2 (50% EtOAc in hexanes)). Yield = 124 
mg (93%). Data for 5-10b: 1H NMR (400 MHz, CDCl3) δ 7.88–7.73 (m, 2H), 7.43 (d, J = 
8.7 Hz, 2H), 7.24 (td, J = 7.4, 1.4 Hz, 1H), 6.78–6.66 (m, 4H), 5.24 (brs, 1H), 3.69 (s, 
3H), 1.82 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 165.0, 159.0, 146.0, 137.4, 
133.9, 128.1, 126.5, 118.6, 115.2, 114.8, 113.6, 70.5, 55.1, 29.9 ppm; GC-MS for 
C16H16N2O2, m/z = 268 (M
+). 1H and 13C NMR spectral data are in good agreement with 
the literature values.239 
2-Methyl-2-(p-tolyl)-2,3-dihydroquinazolin-4(1H)-one (5-
10c): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 
3 mol %), 2-12 (12 mg, 10 mol %), 2-aminobenzamide (68 
mg, 0.5 mmol) and 1-(4-methylphenyl)ethylamine (95 mg, 0.7 
mmol) was stirred at 140 °C for 20 h. The product 5-10c was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 50:1–5:1; TLC: Rf = 0.2 (50% EtOAc in 
hexanes)). Yield = 113 mg (92%). Data for 5-10c: 1H NMR (400 MHz, DMSO-d6) δ 8.72 
(br s, 1H), 7.57 (brs, 1H), 7.47 (d, J = 7.8 Hz, 1H), 7.36 (d, J = 7.9 Hz, 2H), 7.19 (t, J = 
7.6 Hz, 1H), 7.07 (d, J = 7.9 Hz, 2H), 6.74 (d, J = 8.1 Hz, 1H), 6.56 (t, J = 7.4 Hz, 1H), 





136.1, 133.2, 128.5, 127.2, 125.1, 116.7, 115.1, 114.3, 70.0, 30.7, 20.5 ppm; GC-MS for 
C16H16N2O, m/z = 252 (M
+). 1H and 13C NMR spectral data are in good agreement with 
the literature values.238-239 
2-(4-Chlorophenyl)-2-methyl-2,3-dihydroquinazolin-
4(1H)-one (5-10d): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-
aminobenzamide (68 mg, 0.5 mmol) and 1-(4-
chlorophenyl)ethylamine (109 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 
5-10d was isolated by recrystallization (50% EtOAc/CH2Cl2 in hexanes). Yield = 108 mg 
(79%). Data for 5-10d: 1H NMR (400 MHz, CDCl3) δ 8.81 (brs, 1H), 7.67 (brs, 1H), 
7.55–7.45 (m, 3H), 7.36 (d, J = 8.6 Hz, 2H), 7.21 (dd, J = 7.6, 1.4 Hz, 1H), 6.77 (d, J = 
8.1 Hz, 1H), 6.59 (td, J = 7.6, 1.0 Hz, 1H), 1.64 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 160.2, 143.4, 143.1, 129.9, 128.3, 124.4, 123.7, 123.6, 113.5, 111.4, 110.8, 
66.4, 26.9 ppm; GC-MS for C15H13ClN2O, m/z = 272 (M
+). 1H and 13C NMR spectral 
data are in good agreement with the literature values.238, 240 
2-(4-Fluorophenyl)-2-methyl-2,3-dihydroquinazolin-
4(1H)-one (5-10e): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-
aminobenzamide (68 mg, 0.5 mmol) and 4-fluoro-α-
methylbenzylamine (97 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-10e 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 50:1–5:1; TLC: 
Rf = 0.2 (50% EtOAc in hexanes)). Yield = 85 mg (66%). Data for 5-10e: 
1H NMR (400 





7.17–7.06 (m, 2H), 6.76 (d, J = 8.0 Hz, 1H), 6.59 (t, J = 7.5 Hz, 1H), 1.63 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, DMSO-d6) δ 163.8, 161.22 (d, JCF = 243.4 Hz), 147.0, 143.86 
(d, JCF = 2.9 Hz), 133.4, 127.3, 127.2, 117.0, 115.0, 114.72 (d, JCF = 21.3 Hz), 114.3, 
69.9, 30.7 ppm; GC-MS for C15H13FN2O, m/z = 256 (M
+). 1H and 13C NMR spectral data 
are in good agreement with the literature values.102 
2-Ethyl-2-phenyl-2,3-dihydroquinazolin-4(1H)-one (5-10f): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 
2-12 (12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 mmol) 
and -ethylbenzylamine (95 mg, 0.7 mmol) was stirred at 140 °C 
for 20 h. The product 5-10f was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 110:1–5:1; TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 106 mg 
(84%). Data for 5-10f: 1H NMR (400 MHz, CDCl3) δ 7.87 (brs, 1H), 7.82 (d, J = 7.9 Hz, 
1H), 7.45 (d, J = 7.5 Hz, 2H), 7.37–7.08 (m, 4H), 6.82–6.64 (m, 2H), 4.97 (brs, 1H), 2.09 
(q, J = 7.4 Hz, 2H), 0.97 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
165.4, 146.1, 144.8, 133.9, 128.4, 128.3, 127.6, 125.4, 118.7, 115.5, 114.8, 73.7, 35.5, 8.1 
ppm; GC-MS for C16H16N2O, m/z = 252 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd 
for C16H16N2OH; 253.1335 Found 253.1326.  
2-Benzyl-2-ethyl-2,3-dihydroquinazolin-4(1H)-one (5-10g): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 
2-12 (12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 mmol) 
and (±)-1-phenylbutan-2-amine (104 mg, 0.7 mmol) was stirred 
at 140 °C for 20 h. The product 5-10g was isolated by recrystallization (50% 
EtOAc/CH2Cl2 in hexanes). Yield = 101 mg (76%). Data for 5-10g: 





CDCl3) δ 7.90 (dd, J = 7.8, 1.3 Hz, 1H), 7.41–7.17 (m, 4H), 7.15–7.07 (m, 2H), 6.81 (t, J 
= 7.4 Hz, 1H), 6.67 (brs, 1H), 6.63 (d, J = 8.1 Hz, 1H), 4.17 (brs, 1H), 3.20 (d, J = 13.3 
Hz, 1H), 2.95 (d, J = 13.3 Hz, 1H), 1.72–1.62 (m, 2H), 1.04 (t, J = 7.4 Hz, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 164.6, 146.1, 135.4, 134.1, 130.4, 128.4, 128.3, 
127.0, 118.4, 114.5, 114.4, 72.3, 46.5, 31.3, 7.8 ppm; GC-MS for C17H18N2O, m/z = 266 
(M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C17H18N2Na; 289.1311 Found 
289.1325. 
2-Methyl-2-phenethyl-2,3-dihydroquinazolin-4(1H)-one 
(5-10h): A 1,4-dioxane (2.0 mL) solution of complex 2-10 
(9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-
aminobenzamide (68 mg, 0.5 mmol) and 3-amino-1-
phenylbutane (104 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-10h was 
isolated by column chromatography on silica gel (hexanes/EtOAc = 50:1–5:1; TLC: Rf = 
0.3 (50% EtOAc in hexanes)). Yield = 112 mg (84%). Data for 5-10h: 1H NMR (400 
MHz, CDCl3) δ 7.87 (d, J = 7.7 Hz, 1H), 7.43 (brs, 1H),  7.28–7.20 (m, 3H), 7.19–7.08 
(m, 3H), 6.78 (d, J = 7.5 Hz, 1H), 6.52 (d, J = 8.0 Hz, 1H) 4.19 (brs, 1H), 2.85–2.68 (m, 
2H), 2.16–1.99 (m, 2H), 1.55 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 164.7, 
146.0, 141.1, 133.9, 128.5, 128.3, 128.2, 126.0, 118.4, 114.5, 114.3, 69.8, 43.6, 30.4, 28.3 
ppm; GC-MS for C17H18N2O, m/z = 266 (M
+). 1H and 13C NMR spectral data are in good 






(5-10i): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-amino-N-
methylbenzamide (75 mg, 0.5 mol %) and 1-(4-
methylphenyl)ethylamine (95 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 
5-10i was isolated by column chromatography on silica gel (hexanes/EtOAc = 50:1–5:1; 
TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 117 mg (88%). Data for 5-10i: 
1H NMR 
(400 MHz, CDCl3) δ 7.56 (d, J = 7.7 Hz, 1H), 7.39 (brs, 1H), 7.26 (d, J = 7.9 Hz, 2H), 
7.20–7.05 (m, 3H), 6.69–6.55 (m, 2H), 2.93 (s, 3H), 2.23 (s, 3H), 1.83 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 176.5, 163.3, 146.0, 141.5, 137.0, 133.1, 128.9, 
127.5, 125.6, 117.0, 114.1, 74.4, 28.9, 26.8, 20.5 ppm; GC-MS for C17H18N2O, m/z = 266 
(M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C17H18N2ONa; 289.1311 Found 
289.1306. 
2-Cyclohexyl-2-methyl-2,3-dihydroquinazolin-4(1H)-one (5-
10j): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-12 (12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 
mmol) and (S)-(+)-α-methylcyclohexanemethylamine (89 mg, 
0.7 mmol) was stirred at 140 °C for 20 h. The product 5-10j was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 50:1–5:1; TLC: Rf = 0.3 (50% EtOAc in 
hexanes)). Yield = 98 mg (80%). Data for 5-10j: 1H NMR (400 MHz, DMSO) δ 7.87 
(brs, 1H), 7.51 (dd, J = 7.7, 1.6 Hz, 1H), 7.17 (td, J = 7.7, 1.6 Hz, 1H), 6.65 (d, J = 8.1 
Hz, 1H), 6.60 (brs, 1H), 6.56–6.52 (m, 1H), 1.80–1.65 (m, 4H), 1.59–1.50 (m, 2H), 1.29 





133.3, 127.1, 115.8, 113.7, 113.5, 71.3, 47.9, 26.7, 26.4, 26.1, 26.0, 26.0, 24.9 ppm; GC-
MS for C15H20N2O, m/z = 244 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C15H20N2OH; 245.1648 Found 245.1622. 
1H and 13C NMR spectral data are in good 
agreement with the literature values.241 
7-Chloro-2-cyclohexyl-2-methyl-2,3-dihydroquinazolin-
4(1H)-one (5-10k): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-
amino-4-chlorobenzamide (85 mg, 0.5 mmol) and (S)-(+)-α-
methylcyclohexanemethylamine (89 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The 
product 5-10k was isolated by column chromatography on silica gel (hexanes/EtOAc = 
50:1–5:1; TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 122 mg (88%). Data for 5-
10k: 1H NMR (400 MHz, DMSO) δ 8.01 (brs, 1H), 7.50 (d, J = 8.3 Hz, 1H), 6.90 (brs, 
1H), 6.69 (d, J = 2.0 Hz, 1H), 6.55 (dd, J = 8.3, 2.0 Hz, 1H), 1.80–1.66 (m, 4H), 1.59–
1.48 (m, 2H), 1.30 (s, 3H), 1.14–0.93 (m, 5H) ppm; 13C{1H} NMR (100 MHz, DMSO) δ 
162.0, 148.0, 137.7, 129.0, 115.7, 112.5, 112.2, 71.6, 48.2, 26.6, 26.3, 25.9, 25.9, 25.0 
ppm; GC-MS for C15H19ClN2O, m/z = 278 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd 
for C15H19ClN2OH; 279.1259 Found 279.1255. 
6'-Methoxy-1'H-spiro[cyclohexane-1,2'-quinazolin]-4'(3'H)-
one (5-10l): A 1,4-dioxane (2.0 mL) solution of complex 2-10 
(9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-amino-5-
methoxybenzamide (83 mg, 0.5 mmol) and cyclohexylamine 
(69 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-10l was isolated by 





1H NMR (400 MHz, DMSO) δ 7.95 (brs, 1H), 7.13 (d, J = 3.0 Hz, 1H), 6.89 (dd, J = 8.7, 
3.0 Hz, 1H), 6.79 (d, J = 8.7 Hz, 1H), 6.25 (brs, 1H),  3.66 (s, 3H),1.80–1.69 (m, 2H), 
1.65–1.34 (m, 7H), 1.27–1.17 (m, 1H) ppm; 13C{1H} NMR (100 MHz, DMSO) δ 163.3, 
151.1, 141.2, 121.3, 116.4, 115.2, 109.9, 68.0, 55.3, 38.9, 36.9, 24.8, 21.0 ppm; GC-MS 
for C14H18N2O2, m/z = 246 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C14H18N2O2H; 247.1441 Found 247.1408. 
1'H-spiro[cyclohexane-1,2'-quinazolin]-4'(3'H)-one (5-10m): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
12 (12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 mmol) and 
cyclohexylamine (69 mg, 0.7 mmol) was stirred at 140 °C for 20 h. 
The product 5-10m was isolated by recrystallization (50% EtOAc/CH2Cl2 in hexanes; 
TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 104 mg (96%). Data for 5-10m: 
1H 
NMR (400 MHz, DMSO) δ 7.93 (brs, H), 7.56 (d, J = 7.4 Hz, 1H), 7.21 (t, J = 7.3 Hz, 
1H), 6.80 (d, J = 8.0 Hz, 1H), 6.70–6.49 (m, 2H), 1.80–1.68 (m, 2H),  1.67–1.48 (m, 6H), 
1.46–1.36 (m, 1H), 1.31–1.16 (m, 1H) ppm; 13C{1H} NMR (100 MHz, DMSO) δ 163.3, 
146.8, 133.2, 127.2, 116.6, 114.6, 114.5, 67.9, 37.2, 24.7, 20.9 ppm; GC-MS for 
C13H16N2O, m/z = 216 (M
+). 1H and 13C NMR spectral data are in good agreement with 
the literature values.242 
6'-Chloro-1'H-spiro[cyclohexane-1,2'-quinazolin]-4'(3'H)-
one (5-10n): A 1,4-dioxane (2.0 mL) solution of complex 2-10 
(9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-amino-5-
chlorobenzamide (85 mg, 0.5 mmol) and cyclohexylamine (69 





recrystallization (50% EtOAc/CH2Cl2 in hexanes; TLC: Rf = 0.3 (50% EtOAc in 
hexanes)). Yield = 104 mg (83%). Data for 5-10n: 1H NMR (400 MHz, DMSO) δ 8.12 
(brs, 1H), 7.50 (d, J = 2.6 Hz, 1H), 7.23 (dd, J = 8.7, 2.6 Hz, 1H), 6.90–6.79 (m, 2H), 
1.79–1.69 (m, 2H), 1.66–1.46 (m, 6H), 1.45–1.37 (m, 1H), 1.28–1.17 (m, 1H) ppm; 
13C{1H} NMR (100 MHz, DMSO) δ 162.1, 145.5, 132.9, 126.3, 120.2, 116.6, 115.6, 
68.1, 37.1, 24.6, 20.9 ppm; GC-MS for C13H15ClN2O, m/z = 250 (M
+). HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C13H15ClN2OH; 251.0946 Found 251.0912. 
6'-Fluoro-1'H-spiro[cyclohexane-1,2'-quinazolin]-4'(3'H)-one 
(5-10o): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-amino-5-
fluorobenzamide (77 mg, 0.5 mmol) and cyclohexylamine (69 
mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-10o was isolated by 
recrystallization (50% EtOAc/CH2Cl2 in hexanes; TLC: Rf = 0.3 (50% EtOAc in 
hexanes)). Yield = 98 mg (84%). Data for 5-10o: 1H NMR (400 MHz, DMSO) δ 8.10 
(brs, 1H), 7.26 (dd, J = 9.1, 3.1 Hz, 1H), 7.11 (td, J = 8.8, 3.1 Hz, 1H), 6.84 (dd, J = 8.8, 
4.5 Hz, 1H), 6.60 (brs, 1H), 1.80–1.69 (m, 2H), 1.65–1.36 (m, 7H), 1.28–1.18 (m, 1H) 
ppm; 13C{1H} NMR (100 MHz, DMSO) δ 162.3, 154.4 (d, JCF = 132.8 Hz), 143.4 (d, JCF 
= 0.8 Hz), 120.5 (d, JCF = 23.0 Hz), 116.2 (d, JCF = 7.0 Hz), 115.1 (d, JCF = 7.0 Hz), 
112.2 (d, JCF = 23.0 Hz), 68.0, 36.9, 24.6, 20.9 ppm; GC-MS for C13H15FN2O, m/z = 234 






1'H-spiro[cyclopentane-1,2'-quinazolin]-4'(3'H)-one (5-10p): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
12 (12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 mmol) and 
cyclopentylamine (60 mg, 0.7 mmol) was stirred at 140 °C for 20 h. 
The product 5-10p was isolated by recrystallization (50% EtOAc/CH2Cl2 in hexanes; 
TLC: Rf = 0.2 (50% EtOAc in hexanes)). Yield = 85 mg (84%). Data for 5-10p: 
1H NMR 
(400 MHz, CDCl3) δ 8.11 (brs, 1H), 7.58 (d, J = 7.7 Hz, 1H), 7.21 (td, J = 7.7, 1.5 Hz, 
1H), 6.74 (brs, 1H), 6.70 (d, J = 8.1 Hz, 1H), 6.62 (t, J = 7.4 Hz, 1H), 1.85–1.74 (m, 4H), 
1.70–1.61 (m, 4H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 163.6, 147.6, 133.1, 127.3, 
116.6, 114.6, 114.4, 77.1, 39.3, 22.0 ppm; GC-MS for C12H14N2O, m/z = 202 (M
+). 1H 
and 13C NMR spectral data are in good agreement with the literature values.242 
1'H-spiro[cycloheptane-1,2'-quinazolin]-4'(3'H)-one (5-10q): 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-12 (12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 
mmol) and cycloheptylamine (79 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 5-10q was isolated by recrystallization (50% 
EtOAc/CH2Cl2 in hexanes; TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 86 mg 
(75%). Data for 5-10q: 1H NMR (400 MHz, DMSO) δ 7.85 (dd, J = 7.8, 1.6 Hz, 1H), 
7.29–7.23 (m, 1H), 6.87 (brs, 1H), 6.81–6.75 (m, 1H), 6.62 (d, J = 8.1 Hz, 1H), 4.43 (brs, 
1H), 2.06–1.95 (m, 4H), 1.64–1.44 (m, 8H) ppm; 13C{1H} NMR (100 MHz, DMSO) δ 
164.1, 145.6, 133.7, 128.2, 118.5, 115.2, 114.8, 72.4, 41.4, 29.0, 21.5 ppm; GC-MS for 
C14H18N2O, m/z = 230 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C14H18N2OH; 





1'H-spiro[cyclooctane-1,2'-quinazolin]-4'(3'H)-one (5-10r): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 
2-12 (12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 mmol) 
and cyclooctylamine (89 mg, 0.7 mmol) was stirred at 140 °C for 
20 h. The product 5-10r was isolated by recrystallization (50% EtOAc/CH2Cl2 in 
hexanes; TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 97 mg (80%). Data for 5-10r: 
1H NMR (400 MHz, DMSO) δ 7.85 (ddd, J = 7.7, 1.6, 0.4 Hz, 1H), 7.27 (dd, J = 7.7, 1.6 
Hz, 1H), 6.79 (dd, J = 7.3, 1.0 Hz, 1H), 6.61 (ddd, J = 8.1, 1.0, 0.4 Hz, 1H), 6.53 (brs, 
1H), 4.31 (brs, 1H), 2.10–1.96 (m, 4H), 1.74–1.42 (m, 10H) ppm; 13C{1H} NMR (100 
MHz, DMSO) δ 164.0, 145.5, 133.8, 128.3, 118.5, 115.2, 114.7, 71.9, 36.0, 27.9, 24.5, 
21.4 ppm; GC-MS for C15H20N2O, m/z = 244 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ 
Calcd for C15H20N2OH; 245.1648 Found 245.1622. 
3'-Methyl-1'H-spiro[cyclohexane-1,2'-quinazolin]-4'(3'H)-one 
(5-10s): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-12 (12 mg, 10 mol %), 2-amino-N-methylbenzamide (75 
mg, 0.5 mmol) and cyclohexylamine (69 mg, 0.7 mmol) was stirred 
at 140 °C for 20 h. The product 5-10s was isolated by recrystallization (50% 
EtOAc/CH2Cl2 in hexanes). Yield = 99 mg (86%). Data for 5-10s: 
1H NMR (400 MHz, 
CDCl3) δ 7.89 (dd, J = 7.7, 1.3 Hz, 1H), 7.26 (td, J = 7.7, 1.3 Hz, 1H), 6.81 (d, J = 7.6 
Hz, 1H), 6.67 (d, J = 8.0 Hz, 1H), 4.61 (brs, 1H), 3.07 (s, 3H), 2.06–1.98 (m, 2H), 1.77–
1.68 (m, 5H), 1.49–1.37 (m, 2H), 1.24–1.12 (m, 1H) ppm; 13C{1H} NMR (100 MHz, 





ppm; GC-MS for C14H18N2O, m/z = 230 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd 
for C14H18N2ONa; 253.1311 Found 253.1302.  
3'-Cyclopropyl-1'H-spiro[cyclohexane-1,2'-quinazolin]-4'(3'H)-
one (5-10t): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-amino-N-
cyclopropylbenzamide (88 mg, 0.5 mmol) and cyclohexylamine 
(69 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-10t was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 40:1–10:1; TLC: Rf = 0.4 (50% 
EtOAc in hexanes)). Yield = 69 mg (54%). Data for 5-10t: 1H NMR (400 MHz, CDCl3) δ 
7.92 (dd, J = 7.8, 1.4 Hz, 1H), 7.27 (td, J = 7.6, 1.4 Hz, 1H), 6.82 (t, J = 7.6 Hz, 1H), 6.66 
(d, J = 8.1 Hz, 1H), 4.63 (brs, 1H), 2.36–2.14 (m, 3H), 2.03–1.92 (m, 2H), 1.80–1.68 (m, 
3H), 1.50–1.33 (m, 2H), 1.28–1.19 (m, 1H), 1.05–0.93 (m, 2H), 0.85–0.78 (m, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 166.5, 144.2, 133.3, 128.6, 118.9, 117.3, 114.7, 74.2, 
42.0, 33.4, 24.6, 22.7, 9.4 ppm; GC-MS for C16H20N2O, m/z = 256 (M
+). HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C16H20N2OH; 257.1648 Found 257.1641. 
3,4-Dihydro-1'H,2H-spiro[naphthalene-1,2'-quinazolin]-
4'(3'H)-one (5-10u): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-
aminobenzamide (68 mg, 0.5 mmol) and (S)-(+)-1,2,3,4-
tetrahydro-1-naphthylamine (103 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The 
product 5-10u was isolated by column chromatography on silica gel (hexanes/EtOAc = 
110:1–5:1; TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield = 92 mg (70%). Data for 5-





7.6 Hz, 1H), 6.60 (d, J = 8.0 Hz, 1H), 5.90 (brs, 1H), 4.71 (brs, 1H), 2.88–2.71 (m, 2H), 
2.34–2.23 (m, 1H), 2.21–2.11 (m, 1H), 1.92–1.76 (m, 2H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 163.5, 145.3, 137.9, 137.7, 134.1, 129.0, 128.9, 128.5, 128.3, 126.7, 
118.5, 114.5, 114.3, 69.9, 37.0, 29.2, 19.0 ppm; GC-MS for C17H16N2O, m/z = 264 (M
+). 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C17H16N2OH; 265.1335 Found 265.1329. 
(1R,4S)-6'-Methoxy-1'H-spiro[bicyclo[2.2.1]heptane-2,2'-
quinazolin]-4'(3'H)-one (5-10v): A 1,4-dioxane (2.0 mL) 
solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 
mol %), 2-amino-5-methoxybenzamide (83 mg, 0.5 mmol) and 
exo-2-aminonorbornane (78 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-
10v was isolated by recrystallization (50% EtOAc/CH2Cl2 in hexanes; TLC: Rf = 0.1 
(50% EtOAc in hexanes)). Yield = 87 mg (76%).  Data for 5-10v: 1H NMR (400 MHz, 
DMSO) δ 8.22 (brs, 1H), 7.13 (t, J = 2.7 Hz, 1H), 6.95–6.83  (m, 1H), 6.79–6.68  (m, 
1H), 6.52 (d, J = 16.5 Hz, 1H), 3.67 (s, 3H), 2.31–2.16 (m, 1H), 2.15–2.05 (m, 1H), 1.89–
1.63 (m, 2H), 1.54–1.06 (m, 6H) ppm; 13C{1H} NMR (100 MHz, DMSO) δ 163.7, 151.1, 
141.9, 121.3, 116.1, 115.8, 110.0, 75.5, 55.4, 45.7, 45.4, 36.7, 35.2, 27.8, 22.2 ppm; GC-
MS for C15H18N2O2, m/z = 258 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C15H18N2O2H; 259.1441 Found 259.1413.  
(1R,4S)-1'H-Spiro[bicyclo[2.2.1]heptane-2,2'-quinazolin]-
4'(3'H)-one (5-10w): A 1,4-dioxane (2.0 mL) solution of complex 
2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-aminobenzamide 
(68 mg, 0.5 mmol) and exo-2-aminonorbornane (78 mg, 0.7 mmol) 





EtOAc/CH2Cl2 in hexanes; TLC: Rf = 0.1 (50% EtOAc in hexanes)). Yield = 97 mg 
(79%). Data for 5-10w: 1H NMR (400 MHz, DMSO) δ 8.22 (brs, 1H), 7.59 (d, J = 7.6 
Hz, 1H), 7.21 (t, J = 7.3 Hz, 1H), 6.85 (d, J = 11.8 Hz, 1H), 6.76 (dd, J = 17.3, 8.0 Hz, 
1H), 6.63 (t, J = 7.3 Hz, 1H), 2.36–2.15 (m, 1H), 2.15–2.06 (m, 1H), 1.91–1.67 (m, 2H), 
1.59–1.51 (m, 1H), 1.51–1.16 (m, 4H), 1.11 (d, J = 9.7 Hz, 1H) ppm; 13C{1H} NMR (100 
MHz, DMSO) δ 163.8, 147.5, 133.1, 127.4, 116.6, 115.4, 114.4, 75.2, 46.1, 45.3, 36.7, 
35.2, 27.7, 22.1 ppm; GC-MS for C14H16N2O, m/z = 228 (M
+). 1H and 13C NMR spectral 
data are in good agreement with the literature values.243 
1,3-Dihydro-1'H-spiro[indene-2,2'-quinazolin]-4'(3'H)-one 
(5-10x): A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 
mg, 3 mol %), 2-12 (12 mg, 10 mol %), 2-aminobenzamide (68 
mg, 0.5 mmol) and 2-aminoindane (67 mg, 0.7 mmol) was 
stirred at 140 °C for 20 h. The product 5-10x was isolated by recrystallization (50% 
EtOAc/CH2Cl2 in hexanes). Yield = 98 mg (78%). Data for 5-10x: 
1H NMR (400 MHz, 
DMSO) δ 8.36 (brs, 1H), 7.63 (d, J = 7.7 Hz, 1H), 7.27–7.15 (m, 5H), 7.09 (brs, 1H), 
6.78–6.64 (m, 2H), 3.22 (ABq, J = 16.2 Hz, 4H) ppm; 13C{1H} NMR (100 MHz, DMSO) 
δ 163.7, 147.2, 139.6, 133.3, 127.4, 126.8, 124.8, 117.1, 114.9, 114.7, 76.9, 46.6 ppm; 
GC-MS for C16H14N2O, m/z = 250 (M
+). 1H and 13C NMR spectral data are in good 






dihydroquinazolin-4(1H)-one (5-10y): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 
mg, 10 mol %), 2-aminobenzamide (34 mg, 0.25 mmol) and 
3-amino-3-benzo[1,3]dioxol-5-yl-propionic acid (73 mg, 0.35 mmol) was stirred at 
140 °C for 20 h. The product 5-10y was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 50:1–5:1; TLC: Rf = 0.1 (50% EtOAc in hexanes)). Yield = 55 mg 
(77%). Data for 5-10y: 1H NMR (400 MHz, DMSO) δ 8.72 (brs, 1H), 7.57 (brs, 1H), 
7.49 (d, J = 7.7 Hz, 1H), 7.21 (td, J = 7.7, 1.3 Hz, 1H), 7.06 (d, J = 1.6 Hz, 1H), 6.92 (dd, 
J = 8.1, 1.6 Hz, 1H), 6.79 (d, J = 8.1 Hz, 1H), 6.76 (d, J = 8.1 Hz, 1H), 6.58 (t, J = 7.7 
Hz, 1H), 5.93 (d, J = 1.8 Hz, 2H), 1.61 (s, 3H) ppm; 13C{1H} NMR (100 MHz, DMSO) δ 
164.0, 147.3, 147.2, 146.3, 141.9, 133.4, 127.3, 118.5, 117.0, 115.1, 114.4, 107.5, 106.0, 
101.1, 70.2, 30.9 ppm; GC-MS for C16H14N2O3, m/z = 282 (M
+). HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C16H14N2O3H; 283.1077 Found 283.1057. 
1'-Methyl-3'-propyl-1',4'-dihydrospiro[cyclohexane-1,5'-
pyrazolo[4,3-d]pyrimidin]-7'(6'H)-one (5-10z): A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 (12 
mg, 10 mol %), 4-amino-1-methyl-3-n-propyl-5-
pyrazolecarboxamide (91 mg, 0.5 mmol) and cyclohexylamine (69 mg, 0.7 mmol) was 
stirred at 140 °C for 20 h. The product 5-10z was isolated by column chromatography on 
silica gel (hexanes/EtOAc = 40:1–10:1; TLC: Rf = 0.3 (50% EtOAc in hexanes)). Yield =  
mg (96%). Data for 5-10z: 1H NMR (400 MHz, CDCl3) δ 6.14 (brs, 1H), 4.03 (s, 3H), 





(t, J = 7.4 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.5, 140.9, 130.1, 123.9, 
71.7, 38.0, 36.7, 27.7, 25.1, 22.1, 21.9, 13.8 ppm; GC-MS for C14H22N4O, m/z = 262 
(M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C14H22N4OH; 263.1866 Found 
263.1862.  
 
6.5.5.3 Characterization of Compounds Listed in Table 5.7 
8-Nitro-11-phenyl-1,2,3,4-tetrahydrobenzofuro[3,2-
b]quinoline (5-9ai): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol %), 
(3-amino-6-nitrobenzofuran-2-yl)(phenyl)methanone 
(141 mg, 0.5 mmol), and (1S,2R)-2-
aminocyclohexanecarboxylic acid (100 mg, 0.7 mmol) was stirred at 140 °C for 20 h. 
The product 5-9ai was isolated by column chromatography on silica gel (hexanes/EtOAc 
= 100:1–5:1; TLC: Rf = 0.6 (50% EtOAc in hexanes)). Yield = 146 mg, (85%). Data for 
5-9ai: 1H NMR (400 MHz, CDCl3) δ (s, 1H), 8.34–8.26 (m, 2H), 7.62–7.49 (m, 3H), 
7.49–7.40 (m, 2H), 3.21 (t, J = 6.6 Hz, 2H), 2.80 (t, J = 6.3 Hz, 2H), 2.03–1.95 (m, 2H), 
1.85–1.78 (m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 155.8, 155.8, 149.2, 147.3, 
138.9, 133.4, 132.2, 131.4, 129.3, 129.3, 128.8, 128.7, 120.9, 118.7, 108.4, 33.3, 28.0, 
22.7, 22.6 ppm; GC-MS for C21H16N2O3, m/z = 344 (M
+). HRMS (ESI-TOF) m/z: [M + 






tetrahydrobenzofuro[3,2-b]quinoline (5-9aj): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol 
%), 2-16 (8 mg, 10 mol %), (3-amino-6-nitrobenzofuran-
2-yl)(4-chlorophenyl)methanone (158 mg, 0.5 mmol), 
and (1S,2R)-2-aminocyclohexanecarboxylic acid (100 
mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-9aj was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.5 (50% EtOAc 
in hexanes)). Yield = 167 mg, (88%). Data for 5-9aj: 1H NMR (400 MHz, CDCl3) δ 8.34 
(s, 1H), 8.30–8.26 (m, 2H), 7.55 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 3.20 (t, J = 
6.6 Hz, 2H), 2.77 (t, J = 6.3 Hz, 2H), 2.02–1.95 (m, 2H), 1.85–1.78 (m, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 155.9, 155.9, 149.0, 147.4, 139.1, 135.0, 132.1, 
131.2, 130.7, 130.6, 129.2, 129.1, 121.0, 118.9, 108.4, 33.3, 28.0, 22.7, 22.6 ppm; GC-
MS for C21H15ClN2O3, m/z = 378 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C21H15ClN2O3H; 379.0844 Found 378.0818. 
6-Chloro-4-phenyl-2-(2-(2,6,6-trimethylcyclohex-1-
en-1-yl)ethyl)quinoline (5-9ak): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
16 (8 mg, 10 mol %), 5-chloro-2-aminobenzophenone 
(116 mg, 0.5 mmol), and in-situ generated 1-(4-(2,6,6-
trimethylcyclohex-1-en-1-yl)but-2-en-2-yl)pyrrolidine (173 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 5-9ak was isolated by column chromatography on silica gel 





(59%). Data for 5-9ak: 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 9.0 Hz, 1H), 7.82 (d, J 
= 2.1 Hz, 1H), 7.62 (dd, J = 9.0, 2.1 Hz, 1H), 7.58–7.47 (m, 5H), 7.26 (s, 1H), 3.09–3.01 
(m, 2H), 2.53–2.47 (m, 2H), 1.96 (t, J = 6.2 Hz, 2H), 1.71 (s, 3H), 1.63–1.58 (m, 2H), 
1.49–1.44 (m, 2H), 1.08 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 162.8, 147.7, 
146.9, 137.7, 136.4, 135.9, 131.5, 131.0, 129.9, 129.4, 128.7, 128.5, 128.0, 127.8, 126.0, 
124.4, 122.1, 44.5, 39.7, 35.1, 32.8, 28.7, 28.4, 22.2, 20.1, 19.5 ppm; GC-MS for 
C26H28ClN, m/z = 389 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C26H28ClNH; 
390.1983 Found 390.1980. 
6-Chloro-4-phenyl-2-(1-(2,6,6-trimethylcyclohex-2-
en-1-yl)prop-1-en-2-yl)quinoline (5-9al): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-16 (8 mg, 10 mol %), 5-chloro-2-
aminobenzophenone (116 mg, 0.5 mmol), and 1-(3-
methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)buta-1,3-dien-2-yl)pyrrolidine (181 mg, 0.7 
mmol) was stirred at 140 °C for 20 h. The product 5-9al was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 100:1–5:1; TLC: Rf = 0.4 (20% EtOAc 
in hexanes)). Yield = 124 mg, (61%). Data for 5-9al: 1H NMR (400 MHz, CDCl3) δ 8.06 
(d, J = 9.0 Hz, 1H), 7.77 (d, J = 2.3 Hz, 1H), 7.61 (dd, J = 9.0, 2.3 Hz, 1H), 7.58–7.45 
(m, 6H), 6.22 (dd, J = 10.9, 0.9 Hz, 1H), 5.44 (s, 1H), 2.80 (dd, J = 10.9 Hz, 1H), 2.37 (d, 
J = 0.9 Hz, 3H), 2.11–2.04 (m, 2H), 1.63 (s, 3H), 1.60–1.54 (m, 1H), 1.30–1.22 (m, 1H), 
0.99 (s, 3H), 0.89 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.9, 147.3, 146.6, 
138.0, 136.3, 135.8, 134.7, 131.5, 131.5, 130.0, 129.4, 128.7, 128.5, 126.2, 124.3, 121.0, 









one (5-10aa): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 
mol %), 4-amino-1-methyl-3-n-propyl-5-
pyrazolecarboxamide (91 mg, 0.5 mmol) and 1-[4-(4-morpholinyl)phenyl]ethanamine 
(144 mg, 0.7 mmol) was stirred at 140 °C for 20 h. The product 5-10aa was isolated by 
column chromatography on silica gel (hexanes/EtOAc = 40:1–10:1; TLC: Rf = 0.2 (50% 
EtOAc in hexanes)). Yield = 143 mg (77%). Data for 5-10aa: 1H NMR (400 MHz, 
CDCl3) δ 7.93 (d, J = 8.9 Hz 2H), 7.01 (brs, 1H), 6.91 (d, J = 8.9 Hz 2H), 6.05 (brs, 1H), 
4.14 (s, 1H), 3.88–3.81 (m, 4H), 3.31–3.22 (m, 4H), 2.31 (t, J = 7.7 Hz 2H), 2.22 (s, 3H), 
1.64–1.54 (m, 2H), 0.86 (t, J = 7.4 Hz 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
168.7, 162.0, 153.1, 140.1, 132.6, 128.7, 124.5, 113.9, 66.5, 47.8, 39.7, 30.8, 28.4, 21.5, 
17.9, 14.0 ppm; GC-MS for C20H27N5O2, m/z = 369 (M
+). HRMS (ESI-TOF) m/z: [M + 
H]+ Calcd for C20H27N5O2H; 370.2238 Found 370.257.2232.  
2-Methyl-2-(2-(2,6,6-trimethylcyclohex-1-en-1-yl)ethyl)-
2,3-dihydroquinazolin-4(1H)-one (5-10ab): A 1,4-dioxane 
(2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 
(12 mg, 10 mol %), 2-aminobenzamide (68 mg, 0.5 mmol) 
and in-situ generated 1-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-2-en-2-yl)pyrrolidine 





column chromatography on silica gel (hexanes/EtOAc = 40:1–10:1; TLC: Rf = 0.2 (50% 
EtOAc in hexanes)). Yield = 109 mg (70%). Data for 5-10ab: 1H NMR (400 MHz, 
CDCl3) δ 7.84 (dd, J = 7.8, 1.2 Hz, 1H), 7.41 (brs, 1H), 7.25 (td, J = 7.8, 1.5 Hz, 1H), 
6.76 (t, J = 7.8 Hz, 1H), 6.62 (d, J = 8.0 Hz, 1H), 4.31 (brs, 1H), 2.21–2.03 (m, 2H), 
1.93–1.72 (m, 4H), 1.68–1.55 (m, 1H), 1.53 (s, 3H), 1.51 (s, 3H), 1.51–1.38 (m, 1H), 
1.37–1.29 (m, 2H), 0.93 (s, 3H), 0.91 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
164.7, 146.1, 135.6, 133.7, 128.2, 127.5, 118.3, 114.6, 114.4, 69.9, 41.8, 39.6, 34.9, 32.7, 
28.5, 28.5, 27.7, 22.6, 19.7, 19.3 ppm; GC-MS for C20H28N2O, m/z = 312 (M
+). HRMS 
(ESI-TOF) m/z: [M + H]+ Calcd for C20H28N2OH; 313.2274 Found 313.2272. 
2-(2-(6-Methoxynaphthalen-2-yl)ethyl)-2-
methyl-2,3-dihydroquinazolin-4(1H)-one (5-
10ac): A 1,4-dioxane (2.0 mL) solution of 
complex 2-10 (9 mg, 3 mol %), 2-12 (12 mg, 10 
mol %), 2-aminobenzamide (68 mg, 0.5 mmol) and in-situ generated 1-(4-(6-
methoxynaphthalen-2-yl)but-2-en-2-yl)pyrrolidine (197 mg, 0.7 mmol) was stirred at 
140 °C for 20 h. The product 5-10ac was isolated by column chromatography on silica 
gel (hexanes/EtOAc = 40:1–10:1; TLC: Rf = 0.2 (50% EtOAc in hexanes)). Yield = 148 
mg (86%). Data for 5-10ac: 1H NMR (400 MHz, CDCl3) δ 8.12 (brs, 1H), 7.72 (d, J = 
9.2 Hz, 2H), 6.32 (d, J = 7.6 Hz, 1H), 7.58 (s, 1H), 7.31 (d, J = 8.4 Hz, 1H), 7.27–7.21 
(m, 2H), 7.11 (dd, J = 9.2, 2.2 Hz, 1H), 6.78 (brs, 1H), 6.72 (d, J = 8.0 Hz, 1H), 6.63 (t, J 
= 7.5 Hz, 1H), 3.84 (s, 3H), 3.43 (s, 3H), 2.91–2.76 (m, 2H), 2.09–1.93 (m, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 163.3, 156.8, 147.3, 137.1, 133.4, 132.7, 128.8, 





29.9, 28.2 ppm; GC-MS for C22H22N2O2, m/z = 346 (M
+). HRMS (ESI-TOF) m/z: [M + 






quinazolin]-4'(3'H)-one (5-10ad): A 1,4-
dioxane (2.0 mL) solution of complex 2-10 (5 mg, 3 mol %), 2-12 (6 mg, 10 mol %), 2-
aminobenzamide (34 mg, 0.25 mmol) and in-situ generated 1-
((8S,9R,10R,13S,14R,17S)-10,13-dimethyl-17-((S)-6-methylheptan-2-yl)-
4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-
yl)pyrrolidine (176 mg, 0.4 mmol) was stirred at 140 °C for 20 h. The product 5-10ad 
was isolated by column chromatography on silica gel (hexanes/EtOAc = 40:1–10:1; TLC: 
Rf = 0.1 (50% EtOAc in hexanes)). Yield = 113 mg (90%). Data for 5-10ad: 
1H NMR 
(400 MHz, DMSO) δ 8.03 (brs, 1H), 7.78 (s, 1H), 7.52 (d, J = 7.6 Hz, 1H), 6.83 (d, J = 
8.1 Hz, 1H), 6.71 (brs, 1H), 6.61–6.58 (m, 1H), 1.95–1.90 (m, 1H), 1.80–1.74 (m, 2H), 
1.64–1.56 (m, 2H), 1.51–1.42 (m, 6H), 1.36–1.25 (m, 6H), 1.20–1.02 (m, 1H), 0.99–0.92 
(m, 3H), 0.88–0.85 (m, 3H), 0.84–0.81 (m, 6H), 0.75 (s, 3H), 0.62–0.56 (m, 3H) ppm; 
13C{1H} NMR (100 MHz, DMSO) δ 163.7, 147.0, 133.5, 127.4, 116.8, 115.1, 114.6, 
68.8, 56.6, 56.2, 55.4, 53.3, 42.6, 36.1, 35.7, 35.5, 35.4, 33.5, 33.4, 32.0, 32.0, 31.9, 28.3, 





= 504 (M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C34H52N2OH; 505.4152 Found 
505.4144. 
(11H-Indeno[1,2-b]quinoxalin-8-
yl)(phenyl)methanone (5-11q): A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 
(8 mg, 10 mol %), (3,4-
diaminophenyl)(phenyl)methanone (106 mg, 0.5 mmol) and in-situ generated 4-(1H-
inden-2-yl)morpholine (121 mg, 0.6 mmol) was stirred at 140 °C for 20 h. The product 5-
11q was isolated by column chromatography on silica gel (hexanes/EtOAc = 40:1–10:1; 
TLC: Rf = 0.5 (20% EtOAc in hexanes)). Yield = 127 mg (79%). Data for 5-11q: 
1H 
NMR (400 MHz, CDCl3) δ 8.48 (s, 1H), 8.29 (d, J = 6.9 Hz, 1H), 8.26–8.20 (m, 2H), 
7.92–7.89 (m, 2H), 7.68 (d, J = 7.1 Hz, 1H), 7.65–7.61 (m, 1H), 7.59–7.52 (m, 4H), 4.17 
(m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 195.7, 160.6, 156.3, 144.2, 143.9, 
140.2, 137.6, 137.3, 137.1, 132.7, 132.2, 131.9, 130.1, 129.6, 129.3, 128.4, 128.3, 125.9, 
123.1, 35.9 ppm; GC-MS for C22H14N2O, m/z = 322 (M
+). HRMS (ESI-TOF) m/z: [M + 
H]+ Calcd for C22H14N2OH; 323.1179 Found 323.1177. 
Phenyl(6,7,8,9-tetrahydrophenazin-2-yl)methanone (5-11r): A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-
16 (8 mg, 10 mol %), (3,4-diaminophenyl)(phenyl)methanone (106 
mg, 0.5 mmol) and  1-pyrrolidino-1-cyclohexene (91 mg, 0.6 mmol) was stirred at 
140 °C for 20 h. The product 5-11r was isolated by column chromatography on silica gel 
(hexanes/EtOAc = 40:1–10:1; TLC: Rf = 0.3 (20% EtOAc in hexanes)). Yield = 62 mg 





(dd, J = 8.3, 1.6 Hz, 1H), 7.57 (dd, J = 8.3, 4.2 Hz, 1H), 3.25–3.11 (m, 4H), 2.06–1.96 
(m, 4H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 157.8, 155.6, 152.8, 150.0, 137.1, 
135.9, 124.2, 33.4, 33.0, 22.5, 22.3 ppm; GC-MS for C11H11N3, m/z = 185 (M
+). 1H and 
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8.1 Future Directions  
We have been able to demonstrate the ligand enabled catalytic protocol for deaminative 
coupling reactions of amines to generate number of synthetically and pharmaceutically useful 
scaffolds. Also, we observed the following set of new coupling reactions which are potentially 
developed in the future. 
8.1.1 Synthesis of Quinolones 
We recently observed a new deaminative and dehydrative cyclization reaction to 
produce Quinolone derivatives of amino ketones with amines. 
 
Characterization of the Quinolone Products 
A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-16 (8 mg, 10 mol 





was stirred at 140 °C for 20 h. The product 4-12p was isolated by column 
chromatography on silica gel (hexanes/EtOAc = 50:1–10:1; Yield = 53 mg (47%).  
NMR data for 1'H-spiro[bicyclo[2.2.1]heptane-2,2'-quinolin]-4'(3'H)-one (A-1a): 1H 
NMR (400 MHz, CDCl3) δ 7.78 (dd, J = 7.9, 1.6 Hz, 1H), 7.27 (dd, J = 7.6, 1.6 Hz, 1H), 
6.68 (td, J = 7.5, 1.0 Hz, 1H), 6.63 (d, J = 8.3 Hz, 1H), 4.39 (brs, 1H), 2.68 (s, 2H), 2.40 
(s, 1H), 2.26 (s, 1H), 1.79–1.72 (m, 1H), 1.68–1.51 (m, 3H), 1.45–1.36 (m, 1H), 1.32–
1.21 (m, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 194.2, 150.8, 135.3, 127.3, 119.0, 
117.5, 115.6, 62.1, 49.8, 45.9, 42.5, 37.0, 36.5, 28.3, 22.8 ppm; GC-MS for C15H17NO, 
m/z = 227 (M+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H17NOH 228.1383, 
Found 228.1358. 
X-ray Crystallographic Data for the Product A-1a: 
 
Molecular Structure of A-1a 
Experimental Features: Pale-yellow needles. The dataset was collected at 100K with an 





Structure Description: The centrosymmetric crystal contains a racemic mixture of RRS 
and SSR diastereomers (RRS is shown on the picture). The dihydropyridine ring has a 
sofa conformation with the spiro-carbon C1 deviating from the rest. However, the sofa is 
distorted toward C1,C2-half-chair (C1 deviates by 0.484 Å and C2 deviates by -0.231 Å 
from the plane of the remaining 4 atoms). The norbornane moiety is disordered. The 









Table A.1 Crystal data and structure refinement for A-1a. 
Identification code yi4a 
Empirical formula C15H17NO 
Formula weight 227.29 
Temperature/K 101(2) 
Crystal system orthorhombic 













Crystal size/mm3 0.441 × 0.057 × 0.042 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 9.736 to 141.376 
Index ranges -13 ≤ h ≤ 12, -20 ≤ k ≤ 20, -11 ≤ l ≤ 15 
Reflections collected 11454 
Independent reflections 2249 [Rint = 0.0178, Rsigma = 0.0114] 
Data/restraints/parameters 2249/0/154 
Goodness-of-fit on F2 1.076 
Final R indexes [I>=2σ (I)] R1 = 0.0830, wR2 = 0.2083 
Final R indexes [all data] R1 = 0.0875, wR2 = 0.2120 
Largest diff. peak/hole / e Å-3 1.00/-0.46 
 
 







X-ray Crystallographic Data for the Product A-1b: 
 
Molecular Structure of A-1b 
Experimental Features: Colorless thin needles. The dataset was collected at 100K with 
an Oxford SuperNova diffractometer using Cu(Kα) radiation. 
Structure Description: The molecule represents a diastereomer with Cl substituent in 
norbornane moiety oriented trans to its methylene bridge. The centrosymmetric crystals 
contain a racemic mixture of it. Interestingly, the imino group has a pyramidal 
configuration – its H atom deviates by 0.38 Å from the CNC plane. 
 
Crystal Packing of A-1b: In the crystal, the molecules form translational H-bonded 





Table A.2 Crystal data and structure refinement for yi4i. 
Identification code yi4i 
Empirical formula C15H16ClNO 
Formula weight 261.74 
Temperature/K 100.00(14) 
Crystal system monoclinic 













Crystal size/mm3 0.465 × 0.042 × 0.018 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 9.628 to 141.19 
Index ranges -8 ≤ h ≤ 8, -22 ≤ k ≤ 22, -12 ≤ l ≤ 12 
Reflections collected 11770 
Independent reflections 2369 [Rint = 0.0280, Rsigma = 0.0190] 
Data/restraints/parameters 2369/0/167 
Goodness-of-fit on F2 1.050 
Final R indexes [I>=2σ (I)] R1 = 0.0370, wR2 = 0.1003 
Final R indexes [all data] R1 = 0.0402, wR2 = 0.1037 








8.1.2 Synthesis of Flavanones 
To further extend the synthetic utility of ligand-promoted C–N bond coupling 
reactions, we have been exploring the coupling reactions of 2-hydroxoketones with 
primary amines which led to the formation of flavanone products A-2. Scope and 
mechanistic investigations are currently underway in our laboratory. A 1,4-dioxane (2.0 
mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 (8 mg, 10 mol %), 2-hydroxyketone 
(0.5 mmol), and primary amine (0.5 mmol) was stirred at 120 °C for 20 h. The products 




NMR Data for the Products  
2-cyclohexyl-6-methoxychroman-4-one (A-2a) 1H NMR (400 MHz, CDCl3) δ 7.28 (d, J 
= 3.2 Hz, 1H), 7.07 (dd, J = 9.0, 3.2 Hz, 1H), 6.90 (d, J = 9.0 Hz, 1H), 4.19–4.10 (m, 
1H), 3.79 (s, 3H), 2.71–2.60 (m, 2H), 2.00–1.94 (m, 1H), 1.82–1.68 (m, 5H), 1.32–1.09 





119.2, 107.1, 82.1, 55.8, 41.7, 40.1, 28.3, 28.2, 26.3, 25.9, 25.9 ppm; GC-MS for 
C16H20O3, m/z = 260 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C16H20O3; 
261.1485 Found 261.1490. 
2-(4-methoxyphenyl)-3-methylchroman-4-one (A-2b) : 1HNMR (400MHz, CDCl3) δ 
7.92 (d, J = 8.1 Hz, 1H), 7.48 (t, J = 8.1 Hz, 1H), 7.39 (d, J = 8.6 Hz, 2H), 7.04 (t, J = 7.5 
Hz, 1H), 7.01–6.93 (m, 3H), 5.01 (d, J = 12.4 Hz, 1H), 3.84 (s, 3H), 3.08–2.97 (m, 1H), 
1.00 (d, J = 6.8 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 207.1, 161.3, 135.8, 
130.1, 128.7, 127.2, 121.4, 120.3, 117.9, 114.1, 85.2, 55.3, 46.3, 30.9, 10.3 ppm; GC-MS 
for C7H16O3, m/z = 268 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 269.1172 
Found 269.1171. 
2-isobutyl-3-methylchroman-4-one (A-2c) 1H NMR (400 MHz, CDCl3) δ 7.87 (dd, J = 
7.8, 1.7 Hz, 1H), 7.48–7.43 (m, 1H), 7.02–6.93 (m, 2H), 4.20 (dt, J = 10.2, 2.9 Hz, 1H), 
2.57 (dq, J = 10.2, 7.0 Hz, 1H), 2.09–1.98 (m, 1H), 1.84–1.76 (m, 1H), 1.51–1.42 (m, 
1H), 1.22 (d, J = 7.0 Hz, 3H), 1.00–0.94 (m, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 195.1, 160.8, 135.7, 127.2, 121.0, 120.2, 117.8, 80.7, 45.7, 42.0, 24.1, 23.7, 21.5, 11.0 
ppm; GC-MS for C14H18O2, m/z = 218 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C14H18O2; 219.1380 Found 1375. 
 
8.1.3 C-C Bond Activation Reaction 
To further extend the synthetic utility of ligand-promoted C–N bond activated C-
C bond formation reactions, we have been exploring the coupling reaction of 1-(1-Ethyl-





homocoupling product A-3. A 1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 
mol %), 2-12 (8 mg, 10 mol %), (0.5 mmol), and tryptamine (0.7 mmol) was stirred at 
130 °C for 20 h. The products were isolated by column chromatography on silica gel 
(hexanes/EtOAc = 40:1–5:1). 
 
NMR Data for 3,3'-(ethane-1,1-diyl)bis(1-ethyl-1H-indole) (A-3) 1H NMR (400 MHz, 
CDCl3) δ 7.58 (d, J = 8.0 Hz, 2H), 7.32 (d, J = 8.3 Hz, 2H), 7.18 (t, J = 7.8 Hz, 2H), 7.02 
(t, J = 7.6 Hz, 2H), 6.85 (s, 2H), 4.67 (d, J = 7.1 Hz, 1H), 4.10 (q, J = 7.4 Hz, 4H), 1.80 
(d, J = 7.1 Hz, 3H),  1.41 (t, J = 7.4 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
136.3, 127.4, 124.3, 121.0, 120.3, 119.9, 118.3, 109.1, 40.7, 28.1, 22.1, 15.5 ppm; GC-
MS for C22H24N2, m/z = 316 (M
+).246 
 
8.1.4 C-C Bond Formation via Alkene Insertion Reaction 
To further extend the ligand-promoted C–C bond formation reactions, we have 
been exploring the coupling reaction of 1,2-dimethylindole with olefin led to the 
formation of olefin inserted product A-4 in 60% yield. This protocol would be promising 
in generating substituted indole derivatives. A 1,4-dioxane (2.0 mL) solution of 





and styrene (0.5 mmol) was stirred at 130 °C for 20 h. The products were isolated by 
column chromatography on silica gel (hexanes/EtOAc = 40:1–5:1). 
 
NMR Data for 1,2-dimethyl-3-(1-phenylethyl)-1H-indole (A-4) 1H NMR (400 MHz, 
CDCl3) δ 7.47 (d, J = 7.9 Hz, 1H), 7.40 (d, J = 7.9 Hz, 1H), 7.33–7.28 (m, 3H), 7.22–
7.16 (m, 2H), 7.03 (td, J = 7.4, 0.9 Hz, 1H), 4.51 (q, J = 7.4 Hz, 1H), 3.69 (s, 3H), 2.39 
(s, 3H), 1.84 (d, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ146.3, 136.7, 
132.4, 128.0, 128.0, 127.3, 125.5, 120.2, 119.3, 118.5, 115.4, 108.6, 35.7, 29.4, 20.7, 10.5 
ppm; GC-MS for C18H19N, m/z = 249 (M
+). 
 
8.1.5 Transamidation Reactions 
The coupling reaction of 2-hydroxybenzamide with primary amines led to the 
formation of N-substituted amide product A-5 in 95% yield via C-N bond activation. A 
1,4-dioxane (2.0 mL) solution of complex 2-10 (9 mg, 3 mol %), 2-12 (8 mg, 10 mol %), 
2-hydroxybenzamide (0.5 mmol), and primary amine (0.6 mmol) was stirred at 130 °C 
for 20 h. The products were isolated by column chromatography on silica gel 






NMR Data for 2-hydroxy-N-isopentylbenzamide (A-5) 1H NMR (400 MHz, CDCl3) δ 
12.44 (brs, 1H), 7.41–7.32 (m, 2H), 6.97 (d, J = 8.3 Hz, 1H), 6.82 (t, J = 6.7 Hz, 1H), 
6.40 (brs, 1H), 3.48–3.42 (m, 2H), 1.67 (septet, J = 6.7 Hz, 1H), 1.55–1.47 (m, 2H),  0.94 
(d, J = 6.7 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 169.9, 161.4, 134.0, 125.2, 
118.6, 118.5, 114.3, 38.2, 38.0, 25.9, 22.4 ppm; GC-MS for C12H17NO2, m/z = 207 (M
+). 
 
8.1.6 Synthesis of Quinoline Derivatives with Primary Amines 
As an extension for the reaction described in chapter 5, 2-aminophenylethanones with 
-amino acids are effective in formation of quinoline products. The reaction was carried 
out with the in-situ generated complex 2-10 (9 mg, 3 mol %), 2-12 (8 mg, 10 mol %) 
with 2-aminophenylethanone and branched amines. This protocol selectively generated 
the substituted quinoline products shown in Table 5.5. This catalytic protocol unveils the 
synthesis of quinoline derivatives via atom economical fashion than the reaction with -







The reaction of aniline derivatives with allyl amine were tested for the potential 
synthesis of quinoline derivatives. The reaction of aniline derivatives (0.5 mmol), allyl 
amine (1.5 mmol) with isolated ruthenium catecholate 2-11 yielded the 1 to 2 coupling 
products in reasonable yields. 
 
However, the reaction of 3,5-dimethoxy aniline (0.5 mmol) with 2-Methyl-2-
propen-1-amine (1 mmol) yielded the 1 to 1 coupling product 5-9aq over 90% yield. 
 
NMR Data for the Quinoline Products.  
2-Ethyl-5,7-dimethoxy-3-methylquinoline (5-9an): 1H NMR (400 MHz, CDCl3) δ  
8.11 (s, 1H), 6.97 (d, J = 2.1 Hz, 1H), 6.43 (d, J = 2.1 Hz, 1H), 3.93 (s, 3H), 3.91 (s, 3H), 
2.94  (q, J = 7.6 Hz, 2H), 2.43 (d, J = 0.8 Hz, 3H), 1.33 (t, J = 7.6 Hz, 3H) ppm; 13C{1H} 





55.6, 55.5, 29.4, 18.9, 13.0 ppm; GC-MS for C14H17NO2, m/z = 231 (M
+). HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C14H17NO2H 232.1332; Found 232.1330.  
2-ethyl-3-methylnaphtho[2,3-g]quinoline (5-9ao): 1H NMR (400 MHz, CDCl3) δ 9.06 
(s, 1H), 8.78 (s, 1H), 8.39 (s, 1H), 8.13–8.10 (m, 1H), 8.08–8.04 (m, 1H), 7.97 (d, J = 9.3 
Hz, 1H), 7.86 (d, J = 9.3 Hz, 1H), 7.59–7.55 (m, 2H), 3.06 (q, J = 7.6 Hz, 2H), 2.62 (s, 
3H), 1.41 (t, J = 7.6 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 132.0, 131.9, 
131.8, 130.3, 129.9, 129.4, 128.2, 127.9, 127.9, 127.1, 127.0, 126.1, 126.0, 125.9, 124.1, 
121.3, 120.6, 29.7, 19.3, 13.1 ppm; GC-MS for C20H17N, m/z = 271 (M
+). HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C20H17NH 272.1434; Found 272.1429. 
2,6-diethyl-3-methyl-6H-pyrido[3,2-b]carbazole (5-9ap): 1H NMR (400 MHz, CDCl3) 
δ 8.20 (s, 1H), 8.10 (d, J = 7.7 Hz, 1H), 7.90 (dd, J = 1.7, 0.7 Hz, 1H), 7.47 (td, J = 7.7, 
1.2 Hz, 1H), 7.37–7.35 (m, 1H), 7.23 (td, J = 7.4, 1.0 Hz, 1H), 6.12 (td, J = 7.4, 0.1 Hz, 
1H), 4.36 (q, J = 7.3 Hz, 2H), 2.37 (pentet, J = 7.5 Hz, 2H), 2.06 (s, 3H), 1.44 (t, J = 7.3 
Hz, 3H), 1.12 (t, J = 7.5 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 163.6, 145.6, 
144.5, 140.4, 138.3, 136.2, 125.7, 123.4, 123.1, 120.5, 119.9, 118.7, 112.2, 108.6, 108.5, 
37.6, 22.1, 13.8, 13.5, 11.4 ppm; GC-MS for C20H20N2, m/z = 288 (M
+). HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C20H20N2H 289.1699; Found 289.1687. 
5,7-Dimethoxy-3-methyl-quinoline (5-9aq): 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J = 
2.2 Hz, 1H), 8.21–8.16 (m, 1H), 6.97 (d, J = 2.2 Hz, 1H), 6.47 (d, J = 2.2 Hz, 1H), 3.93 
(s, 3H), 3.91 (s, 3H), 2.45 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.3, 155.4, 





C12H13NO2, m/z = 203 (M
+). HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C12H13NO2H 
204.1019; Found 204.1014. 
Also, it has been found that the three-component coupling reaction of 3,5-
dimethoxy aniline (0.5 mmol), allyl amine (0.5 mmol) and enamine (0.5 mmol) afforded 
the tri substituted quinoline product 5-9ao. This catalytic protocol enables to synthesize 
complex quinoline products.  
 
 
8.1.7 Detection of Zwitterionic Ruthenium Hydride Complex A-6 
 
In a glove box, complex 2-9 (200 mg, 0.12 mmol) and 5,5-ditertiarybutylcatechol 
(107 mg, 0.48 mmol) was dissolved in dichloromethane (10 mL) in a 25 mL Schlenk tube 
equipped with a Teflon screw-cap stopcock and a magnetic stirring bar. The tube was 
brought out of the box, and HBF4·OEt2 (64 μL, 0.48 mmol) was added via syringe under 





immediately. After stirring for 24 h at 60 ºC, the mixture was filtered through a celite 
bed. Then, the solvent was removed under vacuum, and the residue was dissolved by 
adding acetone (10 mL). The solution was recrystallized from acetone/pentanes yielded 
the product A-6 as a light greenish prism shaped crystals. A suitable colorless prism 
shaped crystal with the dimension of  0.553 × 0.278 × 0.167 mm3 was selected and 
analyzed. The dataset was collected with an Oxford SuperNova diffractometer using 
Mo(Kα) radiation at 100K. 
Structure description: The Ru(I) ion has a tripod coordination with η6-coordinated 
adduct of pyrocatechol with BF2 and carbonyl, phosphine and hydride (not localized) 
“legs”. It exists in an eclipsed conformation. The positions of the carbonyl group and 
presumed hydride ligand are statistically interchanged in the crystal by 20%. This results 
in the respective disorder of adjacent t-butyl and cyclohexyl groups (see below). 
 






Crystal Packing of A-6 
Evaluation of the activity and selectivity of the complex A-6 towards deaminative 
coupling reactions potentially useful in the future research. 
 
Table A-3 Crystal data and structure refinement for yi4p. 
Identification code yi4p 
Empirical formula C33H53BO3F2PRu 
Formula weight 678.60 
Temperature/K 100.00(10) 
Crystal system triclinic 

















Crystal size/mm3 0.553 × 0.278 × 0.167 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 6.724 to 59.408 
Index ranges 
-14 ≤ h ≤ 13, -14 ≤ k ≤ 15, -
22 ≤ l ≤ 21 
Reflections collected 37384 
Independent reflections 
8536 [Rint = 0.0296, Rsigma = 
0.0272] 
Data/restraints/parameters 8536/0/416 
Goodness-of-fit on F2 1.049 
Final R indexes [I>=2σ (I)] R1 = 0.0332, wR2 = 0.0724 
Final R indexes [all data] R1 = 0.0383, wR2 = 0.0755 






8.2 Data for the Computational DFT Study  




M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) nosym int 



















#P M06L/genECP opt(verytight,ts,calcfc,noeigentest) freq scf(fermi,xqc 























M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) nosym int 























20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 








































0\0\\#P M06L/chkbasis opt(verytight,ts,calcfc,noeigentest) freq scf(fe 









































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 









































0\0\\#P M06L/chkbasis opt(verytight,ts,calcfc,noeigentest) freq scf(fe 








































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 









































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 

















































0\0\\#P M06L/chkbasis opt(verytight,ts,calcfc,noeigentest) freq scf(fe 

















































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 


















































0\0\\#P M06L/chkbasis opt(verytight,ts,calcfc,noeigentest) freq scf(fe 





















































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 


















































2020\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) 


















































020\0\\#P M06L/chkbasis opt(verytight,ts,calcfc,noeigentest) freq scf( 



















































2020\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) 



















































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 
























































0\0\\#P M06L/chkbasis opt(verytight,ts,calcfc,noeigentest) freq scf(fe 




















































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 




















































2020\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) 


















































020\0\\#P M06L/chkbasis opt(verytight,ts,calcfc,noeigentest) freq scf( 
























































2020\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) 



















































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 


















































0\0\\#P M06L/chkbasis opt(verytight,ts,calcfc,noeigentest) freq scf(fe 




















































20\0\\#P M06L/chkbasis opt(verytight) freq scf(fermi,xqc,maxcyc=200) n 

























































Aug-2020\0\\#P M06L/genECP opt(verytight) freq scrf(pcm,solvent=1,4-di 






































\#P M06L/genECP opt(verytight) freq scrf(pcm,solvent=1,4-dioxane) scf( 














0\\#P M06L/genECP opt(verytight) freq scrf(pcm,solvent=1,4-dioxane) sc 
f(fermi,xqc,maxcyc=200) nosym int(grid=ultrafine)\\Title\\0,2\H,3.1232 
069079,-0.6309771825,-0.3208757943\N,0.3981145481,-0.799842443,-0.9600 
887402\H,-0.4125927492,1.6038239896,-0.5695186595\C,0.5419854266,1.361 
8663227,-0.0872180185\H,2.2531546759,-1.0993415643,1.1519685083\C,2.38 
9189292,-0.2784727586,0.4253170684\H,2.8370775699,0.5734058517,0.96220 
8767\C,1.0786641522,0.0654047492,-0.2379483923\H,1.0499024723,2.136918 
3586,0.4982917064\H,0.9059277042,-1.6963353233,-0.9827764453\\Version= 
ES64L-G16RevC.01\HF=-172.4482853\S2=0.775006\S2-1=0.\S2A=0.7502\RMSD=3 
.041e-09\RMSF=4.116e-06\Dipole=0.8032785,0.0949672,0.5203757\Quadrupol 
e=1.2380319,1.3481094,-2.5861413,-1.3188939,-0.0712861,0.1592876\PG=C0 
1 [X(C3H6N1)]\\@ 
